{"docstore/data": {"cognitive impairment": {"__data__": {"id_": "cognitive impairment", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "cognitive impairment", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "apolipoprotein e": {"__data__": {"id_": "apolipoprotein e", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "apolipoprotein e", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "dementia": {"__data__": {"id_": "dementia", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "dementia", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "alzheimer's disease": {"__data__": {"id_": "alzheimer's disease", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "alzheimer's disease", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid22815080": {"__data__": {"id_": "pmid22815080", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid22815080: Title: APOE genotype in the diagnosis of Alzheimer's disease in patients with cognitive impairment. Abstract: BACKGROUND: Although an association between the apolipoprotein E (APOE) epsilon4 allele and increased risk of Alzheimer's disease (AD) is established, the utility of APOE genotyping in the clinical diagnosis of AD is still under investigation. METHODS: Medical records of 89 patients with cognitive impairment and APOE genotype data underwent a retrospective review. RESULTS: Comparison of age, age at onset, education, Mini-Mental State Examination, months of follow-up, and family history of dementia did not reveal statistical difference among the patients with different APOE genotypes. The APOE epsilon4 carriers had a higher percentage of AD diagnoses after a median 16 months follow-up than non-APOE epsilon4 carriers. The APOE epsilon4 designation had a high sensitivity and high positive predictive value for the diagnosis of AD but a low negative predictive value and specificity. CONCLUSIONS: The APOE genotyping may be helpful in diagnosing AD especially in patients presenting with atypical features or early age of onset of dementia.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "coma": {"__data__": {"id_": "coma", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "coma", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "infection": {"__data__": {"id_": "infection", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "infection", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid33849471": {"__data__": {"id_": "pmid33849471", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid33849471: Title: Predictive value of geriatric-quickSOFA in hospitalized older people with sepsis.\n Abstract: BACKGROUND: QuickSOFA, a prognostic score proposed for patients with infection, has shown a poor predictive value in the geriatric population, probably because of the inappropriateness of the Glasgow Coma Scale (GCS) in assessing acute alteration of mental status in older patients. Indeed, the GCS might result chronically low in older patient with pre-existing cognitive disorders. The aim of this study was to develop an alternative quickSOFA (geriatric-quickSOFA), using the presence of delirium, assessed according to DSM-5 criteria, instead of GCS assessment, to predict mortality in hospitalized older patients with sepsis. METHODS: Retrospective observational study in Acute Geriatrics Unit of St. Anna Hospital of Ferrara (Italy). The study enrolled 165 patients hospitalized between 2017 and 2018 with diagnosis of sepsis or septic shock. Demographic, clinical data and 30-day survival were collected for each patient. Based on arterial blood pressure, respiratory rate, and the presence of delirium, geriatric-quickSOFA was calculated at admission. Primary outcome was 30-day mortality. RESULTS: One hundred sixty-five patients were enrolled with a median age of 88 years; 60.6% were men. High quickSOFA score was not significantly correlated neither with in-hospital nor 30-day mortality. High geriatric-qSOFA score was significantly related to both in-hospital (13.3%vs 51.5%, p = 0.0003) and 30-day mortality (30.0%vs 84.3%, p < 0.00001). CONCLUSION: Geriatric-quickSOFA is significantly associate with short-term mortality risk in older patients with sepsis. Geriatric quickSOFA seems to represent a more suitable and useful predictive tool than the traditional quickSOFA in the geriatric population.\n.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "sepsis": {"__data__": {"id_": "sepsis", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "sepsis", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "septic shock": {"__data__": {"id_": "septic shock", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "septic shock", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "delirium": {"__data__": {"id_": "delirium", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "delirium", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cognitive disorders": {"__data__": {"id_": "cognitive disorders", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "cognitive disorders", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "gsk 3beta": {"__data__": {"id_": "gsk 3beta", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "gsk 3beta", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "inflammation": {"__data__": {"id_": "inflammation", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "inflammation", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "dopamine": {"__data__": {"id_": "dopamine", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "dopamine", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "parkinson's disease": {"__data__": {"id_": "parkinson's disease", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "parkinson's disease", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "neurodegenerative diseases": {"__data__": {"id_": "neurodegenerative diseases", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "neurodegenerative diseases", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "lithium": {"__data__": {"id_": "lithium", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "lithium", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid33503974": {"__data__": {"id_": "pmid33503974", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid33503974: Title: Parkinson's Disease: Potential Actions of Lithium by Targeting the WNT/beta-Catenin Pathway, Oxidative Stress, Inflammation and Glutamatergic Pathway. Abstract: Parkinson's disease (PD) is one of the major neurodegenerative diseases (ND) which presents a progressive neurodegeneration characterized by loss of dopamine in the substantia nigra pars compacta. It is well known that oxidative stress, inflammation and glutamatergic pathway play key roles in the development of PD. However, therapies remain uncertain and research for new treatment is mandatory. This review focuses on the potential effects of lithium, as a potential therapeutic strategy, on PD and some of the presumed mechanisms by which lithium provides its benefit properties. Lithium medication downregulates GSK-3beta, the main inhibitor of the WNT/beta-catenin pathway. The stimulation of the WNT/beta-catenin could be associated with the control of oxidative stress, inflammation, and glutamatergic pathway. Future prospective clinical trials could focus on lithium and its different and multiple interactions in PD.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "rapamycin": {"__data__": {"id_": "rapamycin", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "rapamycin", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "h2o2": {"__data__": {"id_": "h2o2", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "h2o2", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "3 ma": {"__data__": {"id_": "3 ma", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "3 ma", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "reactive oxygen species": {"__data__": {"id_": "reactive oxygen species", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "reactive oxygen species", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "hypoxic": {"__data__": {"id_": "hypoxic", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "hypoxic", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "neurological diseases": {"__data__": {"id_": "neurological diseases", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "neurological diseases", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "p53": {"__data__": {"id_": "p53", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "p53", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid29871517": {"__data__": {"id_": "pmid29871517", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid29871517: Title: Hypoxic Preconditioning Protects SH-SY5Y Cell against Oxidative Stress through Activation of Autophagy. Abstract: Oxidative stress plays a role in many neurological diseases. Hypoxic preconditioning (HPC) has been proposed as an intervention that protects neurons from damage by altering their response to oxidative stress. The aim of this study was to investigate the mechanisms by which HPC results in neuroprotection in cultured SH-SY5Y cells subjected to oxidative stress to provide a guide for future investigation and targeted interventions. SH-SY5Y cells were subjected to HPC protocols or control conditions. Oxidative stress was induced by H2O2. Cell viability was determined via adenosine triphosphate assay. Rapamycin and 3-methyxanthine (3-MA) were used to induce and inhibit autophagy, respectively. Monodansylcadaverine staining was used to observe the formation of autophagosomes. Levels of Microtubule-associated protein light chain 3 B (LC3B), Beclin 1, and p53 were measured by Western blot. Reactive oxygen species (ROS) were also determined. Cell viability in the HPC group following 24-h exposure to 600 muM H2O2 was 65.04 +- 12.91% versus 33.14 +- 5.55% in the control group. LC3B, Beclin 1, and autophagosomes were increased in the HPC group compared with controls. Rapamycin mimicked the protection and 3-MA decreased the protection. There was a moderate increase in ROS after HPC, but rapamycin can abolish the increase and 3-MA can enhance the increase. p53 accumulated in a manner consistent with cell death, and HPC-treated cells showed reduced accumulation of p53 as compared with controls. Treatment with rapamycin decreased p53 accumulation, and 3-MA inhibited the decrease in p53 induced by HPC. HPC protects against oxidative stress in SH-SY5Y cells. Mechanisms of protection may involve the activation of autophagy induced by ROS generated from HPC and the following decline in p53 level caused by activated autophagy in oxidative stress state. This is in line with recent findings in nonneuronal cell populations and may represent an important advance in understanding how HPC protects neurons from oxidative stress.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "covid 19": {"__data__": {"id_": "covid 19", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "covid 19", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "trd": {"__data__": {"id_": "trd", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "trd", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "depressive symptoms": {"__data__": {"id_": "depressive symptoms", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "depressive symptoms", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid36968708": {"__data__": {"id_": "pmid36968708", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid36968708: Title: Mindfulness skills and experiential avoidance as therapeutic mechanisms for treatment-resistant depression through mindfulness-based cognitive therapy and lifestyle modification.\n Abstract: Background/objective: The COVID-19 pandemic and consequent physical distancing has made it difficult to provide care for those with Treatment-Resistant Depression (TRD). As a secondary analysis of a clinical trial, the aim of this study was to explore potential mechanisms through which three online-delivered approaches, added to treatment as usual, improve depressive symptoms in TRD patients. Methods: The three approaches included (a) Minimal Lifestyle Intervention (MLI), (b) Mindfulness-Based Cognitive Therapy (MBCT), and (c) Lifestyle Modification Program (LMP). Sixty-six participants with TRD completed assessments pre-post intervention (mindfulness skills [FFMQ]; self-compassion [SCS]; and experiential avoidance [AAQ-II]) and pre-intervention to follow-up (depressive symptoms [BDI-II]). Data were analyzed using within-subjects regression models to test mediation. Results: Mindfulness skills mediated the effect of MBCT on depressive symptoms (ab = -4.69, 95% CI = -12.93 to-0.32), whereas the lack of experiential avoidance mediated the effect of LMP on depressive symptoms (ab = -3.22, 95% CI = -7.03 to-0.14). Conclusion: Strengthening mindfulness skills and decreasing experiential avoidance may promote recovery in patients with TRD, MBCT, and LMP have demonstrated that they may help increase mindfulness skills and decrease experiential avoidance, respectively. Future work will need to unpick the components of these interventions to help isolate active ingredients and increase optimization.\n.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "baclofen": {"__data__": {"id_": "baclofen", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "baclofen", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid29198063": {"__data__": {"id_": "pmid29198063", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid29198063: Title: Baclofen in gamma-hydroxybutyrate withdrawal: patterns of use and online availability.\n Abstract: PURPOSE: Gamma-hydroxybutyrate (GHB) withdrawal is a life-threatening condition that does not always respond to standard treatment with benzodiazepines. Baclofen has potential utility as a pharmacological adjunct and anecdotal reports suggest that it is being used by drug users to self-manage GHB withdrawal symptoms. Here, we investigate current patterns of use and the online availably of baclofen. METHODS: Data triangulation techniques were applied to published scientific literature and publicly accessible Internet resources (grey literature) to assess the use of baclofen in GHB withdrawal. An Internet snapshot survey was performed to identify the availability of baclofen for online purchase and the compliance of retailers with the UK regulations. Data were collected according to pre-defined criteria. RESULTS: A total of 37 cases of baclofen use in GHB withdrawal were identified in the scientific literature, as well as 51 relevant discussion threads across eight Internet forums in the grey literature. Baclofen was available to purchase from 38 online pharmacies, of which only one conformed to the UK regulations. CONCLUSIONS: There is limited published evidence on the use of baclofen in GHB withdrawal, but both scientific and grey literature suggests clinical utility. Online pharmacies are readily offering prescription-only-medication without prescription and due to inadequate regulation, pose a danger to the public.\n.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "gamma hydroxybutyrate": {"__data__": {"id_": "gamma hydroxybutyrate", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "gamma hydroxybutyrate", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "withdrawal symptoms": {"__data__": {"id_": "withdrawal symptoms", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "withdrawal symptoms", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "benzodiazepines": {"__data__": {"id_": "benzodiazepines", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "benzodiazepines", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "learning impairment": {"__data__": {"id_": "learning impairment", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "learning impairment", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "entorhinal cortex lesions": {"__data__": {"id_": "entorhinal cortex lesions", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "entorhinal cortex lesions", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "traumatic brain injury": {"__data__": {"id_": "traumatic brain injury", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "traumatic brain injury", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "behavioral deficits": {"__data__": {"id_": "behavioral deficits", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "behavioral deficits", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "damage to the entorhinal cortex": {"__data__": {"id_": "damage to the entorhinal cortex", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "damage to the entorhinal cortex", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "integration deficits": {"__data__": {"id_": "integration deficits", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "integration deficits", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "stroke": {"__data__": {"id_": "stroke", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "stroke", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid11302296": {"__data__": {"id_": "pmid11302296", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid11302296: Title: Effects of entorhinal cortex lesions on sensory integration and spatial learning. Abstract: BACKGROUND: The entorhinal cortex provides sensory information to the hippocampus for memory and learning. Damage to the entorhinal cortex is common in patients who experience traumatic brain injury, stroke, and Alzheimer's disease. Entorhinal damage is assumed to interfere with sensory integration; however, substantive knowledge of behavioral patterns is lacking. OBJECTIVES: To describe specific behavioral deficits associated with entorhinal cortex injury related to special senses identification, sensory integration, and spatial learning. METHOD: Adult male rats received bilateral entorhinal cortex damage (n = 19) or sham surgery (n = 11) with a subset randomized to participate in special senses identification, exploration, and sensory integration testing. Spatial learning was examined using a water maze. RESULTS: Lesion and control animals were similar in special senses identification testing. Sensory integration was markedly impaired in lesion animals over 3 days for all integration tasks; however, travel deficit persisted for 4 days. By day 5 sensory integration ability was equal. Lesion animals were significantly impaired across all days of spatial learning for swim time (p = .0001) and directional heading error (p = .03). Control animals exposed to sensory testing demonstrated significantly more efficient learning (p = .005) on swim days 2 and 3 versus control animals not exposed to sensory testing. CONCLUSIONS: Early and prolonged behavioral changes are evident following entorhinal cortex damage including sensory integration deficits and persistent spatial learning impairment.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "neurofibrillary tangles": {"__data__": {"id_": "neurofibrillary tangles", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "neurofibrillary tangles", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid1407551": {"__data__": {"id_": "pmid1407551", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid1407551: Title: N-methyl-D-aspartate receptor complex in the hippocampus of elderly, normal individuals and those with Alzheimer's disease. Abstract: The various ligand binding sites of the N-methyl-D-aspartate receptor complex in the hippocampal formation and parahippocampal gyrus of Alzheimer's disease patients and age-matched normal individuals were examined using quantitative autoradiography. The hippocampus and parahippocampal gyrus of the normal elderly brain exhibited virtually identical distributions of L-[3H]glutamate, [3H]5-methyl-10,11-dihydro-5H- dibenzo[a,d]cyclohepten-5,10-iminemaleate ([3H]MK-801), [3H][(+/-)2-carboxypiperazine-4-yl]propyl-1-phosphonic acid ([3H]CPP) and strychnine-insensitive [3H]glycine binding sites (r greater than 0.87) suggesting that binding occurred to different domains of the same receptor macromolecule. The binding of [3H]MK-801 to channel-associated phencyclidine sites appeared to be most severely impaired in Alzheimer's disease, especially at the anterior hippocampal level. When the data were averaged and the means for Alzheimer's disease and control group compared, a 34% decrease (P less than 0.01) in [3H]MK-801 binding was identified in the CA1 stratum pyramidale and a smaller decrease was found in the dentate gyrus molecular layer, parahippocampal gyrus and subiculum. The CA1 region exhibited a similar 35% reduction (P less than 0.05) in L-[3H]glutamate binding to N-methyl-D-aspartate-sensitive sites. This decrease most probably reflected a decline in receptor density. Binding of [3H]CPP to antagonist-preferring sites and [3H]glycine to glycine modulatory sites did not change significantly. However, a marked intersubject variability in N-methyl-D-aspartate receptor binding was observed in control and Alzheimer's disease groups. This variability was not related to age, sex or post mortem delay. Some Alzheimer's disease patients showed markedly reduced receptor binding levels, while others showed no changes or even increased binding. The loss of N-methyl-D-aspartate-sensitive sites did not correlate with a loss of neurons in the CA1 region (r = 0.286). Similarly, no correlation between the level of binding to N-methyl-D-aspartate-sensitive sites and the density of neuritic plaques and neurofibrillary tangles was found. Intersubject variability in N-methyl-D-aspartate receptor responses in the Alzheimer's disease group may partially explain conflicting reports in the literature on the N-methyl-D-aspartate receptor changes in Alzheimer's disease, and imply that caution should be exercised before making any generalizations about receptor changes in Alzheimer's disease based on mean values only. The analysis of the individual Alzheimer's disease cases may also be valuable in determining the mechanism(s) underlying the disease.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "multi infarct dementia": {"__data__": {"id_": "multi infarct dementia", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "multi infarct dementia", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid11336076": {"__data__": {"id_": "pmid11336076", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid11336076: Title: Experience of ApoE study in Thai elderly. Abstract: UNLABELLED: The association between ApoE E4 and dementia is reported in Alzheimer's disease and other dementia such as in multi-infarct dementia. OBJECTIVES: To examine the association between apolipoprotein E genotype (ApoE) and dementia in Thai elderly and patients to examine the alleles frequencies of ApoE in a Thai population. MATERIAL AND METHOD: Seventy-eight cases and ninety-four controls from a community based population were recruited. Their ages were all over 50 years. Dementia was diagnosed by DSM IV criteria. Blood was taken and stored for DNA extraction and for restriction enzyme analysis of ApoE genotype. Descriptive analysis and odds ratios from SPSS 9.0 program were used in this study. RESULTS: Alleles frequencies of ApoE E2, E, E4 in normal controls were 0.03, 0.80, 0.17 and alleles frequencies of ApoE E3, E4 in dementia subjects were 0.71 and 0.29, respectively. Odds ratios for dementia risk of apolipoprotein genes were as follows: 0.62 for ApoE E3 and 1.98 for ApoE E4. In this study, forty-two dementia subjects had Alzheimer's disease. Fifty nine point five per cent of Alzheimer's disease subjects carried ApoE E4 (positive predictive value is 0.60). CONCLUSION: Thai elderly carry ApoE genotype distribution similar to that reported in other ethnic groups. Bearing ApoE E4 gene increases the risk of developing dementia. The use of ApoE genotyping can only be a diagnostic adjunct for Alzheimer's disease.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "deaths": {"__data__": {"id_": "deaths", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "deaths", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid30559156": {"__data__": {"id_": "pmid30559156", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid30559156: Title: In-hospital dementia-related deaths following implementation of the national dementia plan: observational study of national death certificates from 1996 to 2016. Abstract: OBJECTIVE: To examine changes in places of dementia-related death following implementation of the national dementia plan and other policy initiatives. DESIGN: Observational study. SETTING: Japan between October 1996 and September 2016. Four major changes in health and social care systems were identified: (1) the public long-term care insurance programme (April 2000); (2) community centres as a first access point for older residents (April 2006); (3) medical care system for older people (April 2008) and (4) the national dementia plan (April 2013). PARTICIPANTS: 9 60 423 decedents aged 65 years or older whose primary cause of death was Alzheimer's disease, vascular or other types of dementia or senility. MAIN OUTCOME MEASURES: Place of death which was classified into 'hospital', 'intermediate geriatric care facility' (rehabilitation facility aimed at home discharge), 'nursing home' or 'own home'. RESULTS: The annual number of deaths at hospital was consistently increased over time from 1996 to 2016 (age-adjusted OR: 6.01; 95% CI 5.81 to 6.21 versus home deaths). Controlling for individual characteristics, regional supply of hospital and nursing home beds and other changes in health and social care systems, death from dementia following the national dementia plan was likely to occur in hospital (adjusted OR: 1.21; 95% CI 1.18 to 1.24), intermediate geriatric care facility (adjusted OR: 1.53; 95% CI 1.48 to 1.58) or nursing home (adjusted OR: 1.64; 95% CI 1.60 to 1.69) rather than at home. CONCLUSIONS: As the number of deaths from dementia increased over the decades, in-hospital deaths increased regardless of the national dementia plan. Further strategies should be explored to improve the availability of palliative and end-of-life care at patients' places of residence.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "terminal cancer": {"__data__": {"id_": "terminal cancer", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "terminal cancer", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid36104140": {"__data__": {"id_": "pmid36104140", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid36104140: Title: Nursing support for symptoms in patients with cancer and caregiver burdens: a scoping review protocol.\n Abstract: INTRODUCTION: Terminally ill patients with cancer experience a variety of symptoms, and their families experience certain caregiver burdens. Most studies on this topic have focused on the symptoms experienced by patients with cancer. There is little established evidence to show how nursing support affects these symptoms and burdens. Nurses provide support by extrapolating their clinical experience, practical knowledge and insights gained from the treatment phase of patients with cancer, regardless of the existence or degree of evidence. This study presents a scoping review protocol with the aim of categorising the feasibility of nursing support from the initial to the terminal phases in the trajectory of cancer care. METHOD AND ANALYSIS: This review will be guided by Arksey and O'Malley's five-stage scoping review framework and Levac's extension. Our research project team will focus on the pain, dyspnoea, nausea and vomiting, constipation, delirium, fatigue and skin disorders experienced by patients with cancer as well as the burdens experienced by caregivers of such patients. All available published articles from database inception to 31 January 2022 will be systematically searched using the following electrical databases: PubMed, CINAHL, CENTRAL in the Cochrane Library and Ichushi-Web of the Japan Medical Abstract Society databases. In addition, we will assess relevant studies from the reference list and manually search each key journal. The formula creation phase of the literature search involves working with a librarian to identify relevant keywords. At least two reviewers will independently screen and review articles and extract data using a data chart form. Results will be mapped according to study design and analysed for adaptation in the field of terminal cancer. ETHICS AND DISSEMINATION: This review does not require ethical approval as it is a secondary analysis of pre-existing, published data. The findings will be disseminated through peer-reviewed publications and conference presentations.\n.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "fatigue": {"__data__": {"id_": "fatigue", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "fatigue", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "constipation": {"__data__": {"id_": "constipation", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "constipation", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pain": {"__data__": {"id_": "pain", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pain", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "nausea and vomiting": {"__data__": {"id_": "nausea and vomiting", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "nausea and vomiting", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "skin disorders": {"__data__": {"id_": "skin disorders", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "skin disorders", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "hypotension": {"__data__": {"id_": "hypotension", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "hypotension", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "blood loss": {"__data__": {"id_": "blood loss", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "blood loss", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "impairment of cognitive functions": {"__data__": {"id_": "impairment of cognitive functions", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "impairment of cognitive functions", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid26991989": {"__data__": {"id_": "pmid26991989", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid26991989: Title: Impact of Controlled Induced Hypotension on Cognitive Functions of Patients Undergoing Functional Endoscopic Sinus Surgery.\n Abstract: BACKGROUND: Controlled induced hypotension guarantees less blood loss and better visibility of the surgical site. The impact of hypotension on post-operative cognitive functions is still being discussed. The objective of this study was to evaluate the effects of controlled induced hypotension on the cognitive functions of patients undergoing functional endoscopic sinus surgery (FESS). MATERIAL/METHODS: We allocated 47 patients with a good grade of preoperative cognitive functions evaluated with the Mini-Mental State Examination to 3 groups (1 - mild hypotension, 2 - intermediate hypotension, 3 - severe hypotension) according to the degree of mean intraoperative arterial pressure compared with preoperative blood pressure. Cognitive functions were evaluated preoperatively, 6 h, and 30 h postoperatively with standardized tests: the Stroop Test, Trail Making Test (TMT), and Verbal Fluency Test (VFT). A decrease in the test results and increase in the number of mistakes made were considered an impairment of cognitive functions. RESULTS: A total of 47 patients (group 1 - mild hypotension - 15, group 2 - intermediate hypotension - 19, group 3 - severe hypotension - 13) were included in the study. A significant decrease was observed in all the 3 groups after Stroop A test 6h postoperatively but it improved 30h postoperatively, without differences between the groups. Neither a significant decrease in the test results nor an increase in the number of mistakes was noted for Stroop B tests, TMT A&B tests and VFT. CONCLUSIONS: The degree of controlled intraoperative hypotension during FESS did not influence the results of psychometric tests.\n.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid34281087": {"__data__": {"id_": "pmid34281087", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid34281087: Title: Exploring Differential Perceptions and Barriers to Advance Care Planning in Dementia among Asian Patient-Caregiver Dyads-A Mixed-Methods Study.\n Abstract: A parallel mixed-methods study on 20 patient-caregiver dyads in an Asian population was conducted to explore the differential perceptions and barriers to ACP in dementia. We recruited English-speaking patients with mild dementia and their caregivers. A trained ACP facilitator conducted ACP counseling. Patient-caregiver dyads completed pre-post surveys and participated in post-counseling qualitative interviews. We used mixed-methods analysis to corroborate the quantitative and qualitative data. Differential perceptions of ACP were reported among dyads, with caregivers less inclined for further ACP discussions. Post-ACP counseling, caregivers were significantly more likely to acknowledge barriers to ACP discussions than patients (57.9% versus 10.5%, p = 0.005). Thematic analysis of the interview transcripts revealed four themes around barriers to ACP: patient-related factors (transference of decision making, poor cognition and lack of understanding, and dis-inclination to plan for the future), caregiver-related factors (perceived negative impact on the patient, caregiver discomfort, and confidence in congruent decision making), socio-cultural factors (taboos, superstitions, and religious beliefs), and the inappropriate timing of discussions. In a collectivist Asian culture, socio-cultural factors pose important barriers, and a family-centric approach to initiation of ACP may be the first step towards engagement in the ACP process. For ACP in dementia to be effective for patients and caregivers, these discussions should be culturally tailored and address patient, caregiver, socio-cultural, and timing barriers.\n.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "kidney disease": {"__data__": {"id_": "kidney disease", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "kidney disease", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "renal failure": {"__data__": {"id_": "renal failure", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "renal failure", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "chronic kidney disease": {"__data__": {"id_": "chronic kidney disease", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "chronic kidney disease", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "vascular disease": {"__data__": {"id_": "vascular disease", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "vascular disease", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cerebral white matter": {"__data__": {"id_": "cerebral white matter", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "cerebral white matter", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid32747970": {"__data__": {"id_": "pmid32747970", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid32747970: Title: Association of Renal Clearance with Cerebral White Matter Vascular Disease in Hospitalized Veterans With and Without Delirium.\n Abstract: OBJECTIVES: To assess the relation between renal function and delirium and to assess and compare the relation between cerebral white matter lesion (WML) and renal function as estimated by three formulas for the estimated glomerular filtration rate (eGFR) in older adult hospitalized veterans with and without delirium. METHODS: Commonly used formulas to assess renal function-the four-variable Modification of Diet in Renal Disease (MDRD), the six-variable MDRD, and the Cockcroft-Gault eGFR equations-were used to assess renal function in 100 older adult hospitalized veterans with delirium (delirium group) and 100 hospitalized veterans without delirium (nondelirium group) that were age, sex, and race matched. WML location and volumes were assessed using brain computed tomography imaging for each of the 200 veterans in the study. One radiologist, blinded to the diagnoses of the veterans, examined head computed tomography scans for WML in the cortex, subcortex (frontal, temporal, parietal, occipital lobes), basal ganglia (globus pallidus, caudate, putamen), and internal capsule. WML were graded as not present, <1 cm, 1 to 2 cm, or >2 cm. Exploratory chi2 analyses were used to determine the association between the stage of chronic kidney disease and WML. Simple logistic regression analyses were then used to estimate the strength of association between the stages of kidney disease and WML for particular regions of the brain. RESULTS: The mean age of delirium group and nondelirium group veterans was 66 years. chi2 tests revealed no reliable relation between stages of renal disease and delirium. chi2 exploratory analyses of WML in brain regions by renal disease stages demonstrated significant differences in associations among the MDRD-4, MDRD-6, and Cockcroft-Gault formulas for measuring eGFR. The MDRD-4 formula was least associated with the presence or absence of WML. The Cockcroft-Gault estimation of eGFR was most associated with the presence or absence of WML. Simple logistic regressions showed notable increases in the association between stages of renal failure and WMLs in specific areas of the brain, with the MDRD-4 being the least associative with the fewest specific areas and the Cockcroft-Gault formula being the most associative with the most specific areas. CONCLUSIONS: The association between stages 2 through 5 of chronic kidney disease and WLM support the role of kidney function as a potential risk factor for WML in older adult military veterans. The Cockcroft-Gault formula is an important renal index of suspected WML and renal stages 2 through 5, superior to the MDRD-6 and MDRD-4, respectively, in association with WML in older adult military veterans.\n.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "alzheimer's amyloidosis": {"__data__": {"id_": "alzheimer's amyloidosis", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "alzheimer's amyloidosis", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "d pinitol": {"__data__": {"id_": "d pinitol", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "d pinitol", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "insulin resistance": {"__data__": {"id_": "insulin resistance", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "insulin resistance", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "leptin": {"__data__": {"id_": "leptin", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "leptin", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "claudin 3": {"__data__": {"id_": "claudin 3", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "claudin 3", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cognitive decline": {"__data__": {"id_": "cognitive decline", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "cognitive decline", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ghrelin": {"__data__": {"id_": "ghrelin", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "ghrelin", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "lipopolysaccharide": {"__data__": {"id_": "lipopolysaccharide", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "lipopolysaccharide", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cyclin dependent kinase 5": {"__data__": {"id_": "cyclin dependent kinase 5", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "cyclin dependent kinase 5", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid39683582": {"__data__": {"id_": "pmid39683582", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid39683582: Title: Therapeutic Efficacy of the Inositol D-Pinitol as a Multi-Faceted Disease Modifier in the 5xFAD Humanized Mouse Model of Alzheimer's Amyloidosis. Abstract: BACKGROUND/OBJECTIVES: Alzheimer's disease (AD), a leading cause of dementia, lacks effective long-term treatments. Current therapies offer temporary relief or fail to halt its progression and are often inaccessible due to cost. AD involves multiple pathological processes, including amyloid beta (Abeta) deposition, insulin resistance, tau protein hyperphosphorylation, and systemic inflammation accelerated by gut microbiota dysbiosis originating from a leaky gut. Given this context, exploring alternative therapeutic interventions capable of addressing the multifaceted components of AD etiology is essential. METHODS: This study suggests D-Pinitol (DPIN) as a potential treatment modifier for AD. DPIN, derived from carob pods, demonstrates insulin-sensitizing, tau hyperphosphorylation inhibition, and antioxidant properties. To test this hypothesis, we studied whether chronic oral administration of DPIN (200 mg/kg/day) could reverse the AD-like disease progression in the 5xFAD mice. RESULTS: Results showed that treatment of 5xFAD mice with DPIN improved cognition, reduced hippocampal Abeta and hyperphosphorylated tau levels, increased insulin-degrading enzyme (IDE) expression, enhanced pro-cognitive hormone circulation (such as ghrelin and leptin), and normalized the PI3K/Akt insulin pathway. This enhancement may be mediated through the modulation of cyclin-dependent kinase 5 (CDK5). DPIN also protected the gut barrier and microbiota, reducing the pro-inflammatory impact of the leaky gut observed in 5xFAD mice. DPIN reduced bacterial lipopolysaccharide (LPS) and LPS-associated inflammation, as well as restored intestinal proteins such as Claudin-3. This effect was associated with a modulation of gut microbiota towards a more balanced bacterial composition. CONCLUSIONS: These findings underscore DPIN's promise in mitigating cognitive decline in the early AD stages, positioning it as a potential disease modifier.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "acute myelogenous leukemia": {"__data__": {"id_": "acute myelogenous leukemia", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "acute myelogenous leukemia", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid35836706": {"__data__": {"id_": "pmid35836706", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid35836706: Title: Budd-Chiari Syndrome as an Initial Presentation of Non-Promyelocytic Acute Myelogenous Leukemia.\n Abstract: Budd-Chiari syndrome (BCS) is a rare disease characterized by hepatic venous outflow tract obstruction, frequently due to an underlying thrombophilic disorder. Acute myeloid leukemia rarely presents as acute BCS due to hyperfibrinolysis, hyperleukocytosis, nonspecific proteolytic activity, and disseminated intravascular coagulation causing acute hepatic vein thrombosis. In patients presenting with acute BCS with acute liver failure (ALF), a high index of suspicion and exclusion of underlying malignancy is a must, as it is a contraindication for liver transplantation. We report a case of a 19-year-old Caucasian male who presented with acute BCS causing ALF as an initial presentation of acute myelogenous leukemia.\n.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "disseminated intravascular coagulation": {"__data__": {"id_": "disseminated intravascular coagulation", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "disseminated intravascular coagulation", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "non promyelocytic acute myelogenous leukemia": {"__data__": {"id_": "non promyelocytic acute myelogenous leukemia", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "non promyelocytic acute myelogenous leukemia", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "acute liver failure": {"__data__": {"id_": "acute liver failure", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "acute liver failure", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "hepatic venous outflow tract obstruction": {"__data__": {"id_": "hepatic venous outflow tract obstruction", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "hepatic venous outflow tract obstruction", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "malignancy": {"__data__": {"id_": "malignancy", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "malignancy", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "thrombophilic disorder": {"__data__": {"id_": "thrombophilic disorder", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "thrombophilic disorder", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cumic alcohol": {"__data__": {"id_": "cumic alcohol", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "cumic alcohol", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "trans,trans 2,4 hexadienol": {"__data__": {"id_": "trans,trans 2,4 hexadienol", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "trans,trans 2,4 hexadienol", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "piperonal": {"__data__": {"id_": "piperonal", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "piperonal", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cuminaldehyde": {"__data__": {"id_": "cuminaldehyde", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "cuminaldehyde", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "carbon": {"__data__": {"id_": "carbon", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "carbon", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "piperonyl alcohol": {"__data__": {"id_": "piperonyl alcohol", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "piperonyl alcohol", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "peaao2": {"__data__": {"id_": "peaao2", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "peaao2", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "p anisyl alcohol": {"__data__": {"id_": "p anisyl alcohol", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "p anisyl alcohol", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "veratryl alcohol": {"__data__": {"id_": "veratryl alcohol", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "veratryl alcohol", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "benzyl alcohol": {"__data__": {"id_": "benzyl alcohol", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "benzyl alcohol", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid32949280": {"__data__": {"id_": "pmid32949280", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid32949280: Title: High-level expression of aryl-alcohol oxidase 2 from Pleurotus eryngii in Pichia pastoris for production of fragrances and bioactive precursors. Abstract: The fungal secretome comprises various oxidative enzymes participating in the degradation of lignocellulosic biomass as a central step in carbon recycling. Among the secreted enzymes, aryl-alcohol oxidases (AAOs) are of interest for biotechnological applications including production of bio-based precursors for plastics, bioactive compounds, and flavors and fragrances. Aryl-alcohol oxidase 2 (PeAAO2) from the fungus Pleurotus eryngii was heterologously expressed and secreted at one of the highest yields reported so far of 315 mg/l using the methylotrophic yeast Pichia pastoris (recently reclassified as Komagataella phaffii). The glycosylated PeAAO2 exhibited a high stability in a broad pH range between pH 3.0 and 9.0 and high thermal stability up to 55  C. Substrate screening with 41 compounds revealed that PeAAO2 oxidized typical AAO substrates like p-anisyl alcohol, veratryl alcohol, and trans,trans-2,4-hexadienol with up to 8-fold higher activity than benzyl alcohol. Several compounds not yet reported as substrates for AAOs were oxidized by PeAAO2 as well. Among them, cumic alcohol and piperonyl alcohol were oxidized to cuminaldehyde and piperonal with high catalytic efficiencies of 84.1 and 600.2 mM-1 s-1, respectively. While the fragrance and flavor compound piperonal also serves as starting material for agrochemical and pharmaceutical building blocks, various positive health effects have been attributed to cuminaldehyde including anticancer, antidiabetic, and neuroprotective effects. PeAAO2 is thus a promising biocatalyst for biotechnological applications. KEY POINTS:   Aryl-alcohol oxidase PeAAO2 from P. eryngii was produced in P. pastoris at 315 mg/l.   Purified enzyme exhibited stability over a broad pH and temperature range.   Oxidation products cuminaldehyde and piperonal are of biotechnological interest. Graphical abstract.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cytotoxicity": {"__data__": {"id_": "cytotoxicity", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "cytotoxicity", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "mtt": {"__data__": {"id_": "mtt", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "mtt", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "hng": {"__data__": {"id_": "hng", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "hng", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid23349038": {"__data__": {"id_": "pmid23349038", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid23349038: Title: S14G-humanin inhibits Abeta1-42 fibril formation, disaggregates preformed fibrils, and protects against Abeta-induced cytotoxicity in vitro. Abstract: The aggregation of soluble amyloid-beta (Abeta) peptide into oligomers/fibrils is one of the key pathological features in Alzheimer's disease (AD). The Abeta aggregates are considered to play a pivotal role in the pathogenesis of AD. Therefore, inhibiting Abeta aggregation and destabilizing preformed Abeta fibrils would be an attractive therapeutic target for prevention and treatment of AD. S14G-humanin (HNG), a synthetic derivative of Humanin (HN), has been shown to be a strong neuroprotective agent against various AD-related insults. Recent studies have shown that HNG can significantly improve cognitive deficits and reduce insoluble Abeta levels as well as amyloid plaque burden without affecting amyloid precursor protein processing and Abeta production in transgenic AD models. However, the potential mechanisms by which HNG reduces Abeta-related pathology in vivo remain obscure. In the present study, we found that HNG could significantly inhibit monomeric Abeta1-42 aggregation into fibrils and destabilize preformed Abeta1-42 fibrils in a concentration-dependent manner by Thioflavin T fluorescence assay. In transmission electron microscope study, we observed that HNG was effective in inhibiting Abeta1-42 fibril formation and disrupting preformed Abeta1-42 fibrils, exhibiting various types of amorphous aggregates without identifiable Abeta fibrils. Furthermore, HNG-treated monomeric or fibrillar Abeta1-42 was found to significantly reduce Abeta1-42-mediated cytotoxic effects on PC12 cells in a dose-dependent manner by MTT assay. Collectively, our results demonstrate for the first time that HNG not only inhibits Abeta1-42 fibril formation but also disaggregates preformed Abeta1-42 fibrils, which provides the novel evidence that HNG may have anti-Abeta aggregation and fibrillogenesis, and fibril-destabilizing properties. Together with previous studies, we concluded that HNG may have promising therapeutic potential as a multitarget agent for the prevention and/or treatment of AD.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "deep vein thrombosis": {"__data__": {"id_": "deep vein thrombosis", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "deep vein thrombosis", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "end stage knee osteoarthritis": {"__data__": {"id_": "end stage knee osteoarthritis", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "end stage knee osteoarthritis", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid34635383": {"__data__": {"id_": "pmid34635383", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid34635383: Title: Simultaneous bilateral total knee arthroplasty is safe and effective for patients in different ages.\n Abstract: BACKGROUND: Simultaneous bilateral total knee arthroplasty is considered beneficial for patients with bilateral end-stage knee osteoarthritis, even though there could be potential postoperative complications. Presently, there is a paucity of evidence of the efficacy and safety of SB-TKA for elderly patients. This study aimed to compare the clinical outcomes of simultaneous bilateral total knee arthroplasty by different age groups. METHODS: A total of 216 knees of 108 patients, who underwent simultaneous bilateral total knee arthroplasty for osteoarthritis at our hospital between April 2015 and September 2018, were divided into three groups based on age: 60s (44 knees), 70s (106 knees), and 80s (66 knees). Perioperative data and postoperative clinical outcomes 1 year after surgery were compared between the age groups. RESULTS: The patients in the Group 60s were characterized by a higher body mass index (BMI) (P < 0.01), a lower pre-operative knee function score (P < 0.01), longer operation time (P < 0.01), greater intra-operative (P < 0.01), and postoperative bleeding (P = 0.026). No significant difference was found in terms of occurrence of various postoperative complications, although deep vein thrombosis and delirium occurred slightly more frequently in the Group 70s and the Group 80s than in the Group 60s group. The Knee Society Knee Score, a function score, and patient satisfaction scores were significantly improved in all groups 1 year after surgery. Moreover, these indexes of clinical outcomes were similar among the three groups. CONCLUSION: Performing simultaneous bilateral total knee arthroplasty in 80s patients was found to be as safe and effective as in the 60s and 70s patients. LEVEL OF EVIDENCE: 3 (A retrospective cohort study).\n.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "bleeding": {"__data__": {"id_": "bleeding", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "bleeding", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ps2": {"__data__": {"id_": "ps2", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "ps2", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "presenilin 1": {"__data__": {"id_": "presenilin 1", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "presenilin 1", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "calcium": {"__data__": {"id_": "calcium", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "calcium", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "presenilin (ps) 1, 2": {"__data__": {"id_": "presenilin (ps) 1, 2", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "presenilin (ps) 1, 2", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "alzheimer disease": {"__data__": {"id_": "alzheimer disease", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "alzheimer disease", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "m calpain": {"__data__": {"id_": "m calpain", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "m calpain", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid10677567": {"__data__": {"id_": "pmid10677567", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid10677567: Title: Molecular interactions between presenilin and calpain: inhibition of m-calpain protease activity by presenilin-1, 2 and cleavage of presenilin-1 by m-, mu-calpain. Abstract: Several mutations of presenilin (PS)-1, 2 result in early onset Alzheimer disease. Using the yeast two-hybrid system, the interaction between PS2 loop domain and the C-terminal region of mu-calpain was previously identified. Calpain is a calcium dependent-protease and there are two isoforms, m-calpain and mu-calpain, which differ in the calcium concentration required for activation. m-Calpain needs about 10(-3) M calcium ions, whereas mu-calpain about 10(-5) M. When PS and calpain were separately expressed in COS cells by cDNA transfection and then combined in vitro, or both were co-transfected to be co-expressed in vivo in COS cells, PS1 and PS2 reduced the casein proteolysis activity of m-calpain but not that of mu-calpain. Some of the PS mutations related to Alzheimer disease decreased this inhibitory activity. On the other hand, PS1 was cleaved by m-calpain and mu-calpain at a different site from those already reported (constitutive cleavage or alternative cleavage). These results suggest a regulatory function of presenilin on the calpain system.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "atherosclerosis": {"__data__": {"id_": "atherosclerosis", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "atherosclerosis", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "monocyte chemoattractant protein 1": {"__data__": {"id_": "monocyte chemoattractant protein 1", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "monocyte chemoattractant protein 1", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "elastin": {"__data__": {"id_": "elastin", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "elastin", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pitava nps": {"__data__": {"id_": "pitava nps", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pitava nps", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "abdominal aorta": {"__data__": {"id_": "abdominal aorta", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "abdominal aorta", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "abdominal aortic aneurysm (aaa)": {"__data__": {"id_": "abdominal aortic aneurysm (aaa)", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "abdominal aortic aneurysm (aaa)", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "abdominal aortic aneurysm": {"__data__": {"id_": "abdominal aortic aneurysm", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "abdominal aortic aneurysm", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "rupture": {"__data__": {"id_": "rupture", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "rupture", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "macrophage accumulation": {"__data__": {"id_": "macrophage accumulation", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "macrophage accumulation", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid33455994": {"__data__": {"id_": "pmid33455994", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid33455994: Title: Nanoparticle-Mediated Delivery of Pitavastatin to Monocytes/Macrophages Inhibits Angiotensin II-Induced Abdominal Aortic Aneurysm Formation in Apoe-/- Mice. Abstract: AIM: Abdominal aortic aneurysm (AAA) is a lethal and multifactorial disease. To prevent a rupture and dissection of enlarged AAA, prophylactic surgery and stenting are currently available. There are, however, no medical therapies preventing these complications of AAA. Statin is one of the candidates, but its efficacy on AAA formation/progression remains controversial. We have previously demonstrated that nanoparticles (NPs) incorporating pitavastatin (Pitava-NPs)-clinical trials using these nanoparticles have been already conducted-suppressed progression of atherosclerosis in apolipoprotein E-deficient ( Apoe-/-) mice. Therefore, we have tested a hypothesis that monocytes/macrophages-targeting delivery of pitavastatin prevents the progression of AAA. METHODS: Angiotensin II was intraperitoneally injected by osmotic mini-pumps to induce AAA formation in Apoe-/- mice. NPs consisting of poly(lactic-co-glycolic acid) were used for in vivo delivery of pitavastatin to monocytes/macrophages. RESULTS: Intravenously administered Pitava-NPs (containing 0.012 mg/kg/week pitavastatin) inhibited AAA formation accompanied with reduction of macrophage accumulation and monocyte chemoattractant protein-1 (MCP-1) expression. Ex vivo molecular imaging revealed that Pitava-NPs not only reduced macrophage accumulation but also attenuated matrix metalloproteinase activity in the abdominal aorta, which was underpinned by attenuated elastin degradation. CONCLUSION: These results suggest that Pitava-NPs inhibit AAA formation associated with reduced macrophage accumulation and MCP-1 expression. This clinically feasible nanomedicine could be an innovative therapeutic strategy that prevents devastating complications of AAA.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "poly(lactic co glycolic acid)": {"__data__": {"id_": "poly(lactic co glycolic acid)", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "poly(lactic co glycolic acid)", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "apoe": {"__data__": {"id_": "apoe", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "apoe", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pitavastatin": {"__data__": {"id_": "pitavastatin", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pitavastatin", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "lipofuscin": {"__data__": {"id_": "lipofuscin", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "lipofuscin", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "amyloid formation": {"__data__": {"id_": "amyloid formation", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "amyloid formation", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "amylin": {"__data__": {"id_": "amylin", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "amylin", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "type 2 diabetes": {"__data__": {"id_": "type 2 diabetes", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "type 2 diabetes", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "age related degenerative diseases": {"__data__": {"id_": "age related degenerative diseases", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "age related degenerative diseases", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid29580826": {"__data__": {"id_": "pmid29580826", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid29580826: Title: Protein aggregates and proteostasis in aging: Amylin and beta-cell function. Abstract: The ubiquitin-proteasomal-system (UPS) and the autophagy-lysosomal-system (ALS) are both highly susceptible for disturbances leading to the accumulation of cellular damage. A decline of protein degradation during aging results in the formation of oxidatively damaged and aggregated proteins finally resulting in failure of cellular functionality. Besides protein aggregation in response to oxidative damage, amyloids are a different type of protein aggregates able to distract proteostasis and interfere with cellular functionality. Amyloids are clearly linked to the pathogenesis of age-related degenerative diseases such as Alzheimer's disease. Human amylin is one of the peptides forming fibrils in beta-sheet conformation finally leading to amyloid formation. In contrast to rodent amylin, human amylin is prone to form amyloidogenic aggregates, proposed to play a role in the pathogenesis of Type 2 Diabetes by impairing beta-cell functionality. Since aggregates such as lipofuscin and beta-amyloid are known to impair proteostasis, it is likely to assume similar effects for human amylin. In this review, we focus on the effects of IAPP on UPS and ALS and their role in amylin degradation, since both systems play a crucial role in maintaining proteome balance thereby influencing, at least in part, cellular fate and aging.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "inflammatory": {"__data__": {"id_": "inflammatory", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "inflammatory", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "central nervous system diseases": {"__data__": {"id_": "central nervous system diseases", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "central nervous system diseases", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ppargamma": {"__data__": {"id_": "ppargamma", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "ppargamma", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pparbeta/delta": {"__data__": {"id_": "pparbeta/delta", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pparbeta/delta", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pparalpha": {"__data__": {"id_": "pparalpha", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pparalpha", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid34833044": {"__data__": {"id_": "pmid34833044", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid34833044: Title: PPARalpha Modulation-Based Therapy in Central Nervous System Diseases. Abstract: The burden of neurodegenerative diseases in the central nervous system (CNS) is increasing globally. There are various risk factors for the development and progression of CNS diseases, such as inflammatory responses and metabolic derangements. Thus, curing CNS diseases requires the modulation of damaging signaling pathways through a multitude of mechanisms. Peroxisome proliferator-activated receptors (PPARs) are a family of nuclear hormone receptors (PPARalpha, PPARbeta/delta, and PPARgamma), and they work as master sensors and modulators of cellular metabolism. In this regard, PPARs have recently been suggested as promising therapeutic targets for suppressing the development of CNS diseases and their progressions. While the therapeutic role of PPARgamma modulation in CNS diseases has been well reviewed, the role of PPARalpha modulation in these diseases has not been comprehensively summarized. The current review focuses on the therapeutic roles of PPARalpha modulation in CNS diseases, including those affecting the brain, spinal cord, and eye, with recent advances. Our review will enable more comprehensive therapeutic approaches to modulate PPARalpha for the prevention of and protection from various CNS diseases.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "guanidine": {"__data__": {"id_": "guanidine", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "guanidine", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "barbital": {"__data__": {"id_": "barbital", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "barbital", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "hydrogen": {"__data__": {"id_": "hydrogen", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "hydrogen", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ureide": {"__data__": {"id_": "ureide", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "ureide", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "metformin": {"__data__": {"id_": "metformin", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "metformin", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid34299653": {"__data__": {"id_": "pmid34299653", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid34299653: Title: Multicomponent Crystal of Metformin and Barbital: Design, Crystal Structure Analysis and Characterization. Abstract: The formation of most multicomponent crystals relies on the interaction of hydrogen bonds between the components, so rational crystal design based on the expected hydrogen-bonded supramolecular synthons was employed to establish supramolecular compounds with desirable properties. This theory was put into practice for metformin to participate in more therapeutic fields to search for a fast and simple approach for the screening of candidate crystal co-formers. The prediction of intermolecular synthons facilitated the successful synthesis of a new multicomponent crystal of metformin (Met) and barbital (Bar) through an anion exchange reaction and cooling crystallization method. The single crystal X-ray diffraction analysis demonstrated the hydrogen bond-based ureide/ureide and guanidine/ureide synthons were responsible for the self-assembly of the primary structural motif and extended into infinite supramolecular heterocatemeric structures.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "neuroinflammation": {"__data__": {"id_": "neuroinflammation", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "neuroinflammation", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "nervous system": {"__data__": {"id_": "nervous system", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "nervous system", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "oral infection": {"__data__": {"id_": "oral infection", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "oral infection", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "periodontitis": {"__data__": {"id_": "periodontitis", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "periodontitis", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid24919005": {"__data__": {"id_": "pmid24919005", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid24919005: Title: Alzheimer's disease and periodontitis--an elusive link. Abstract: Alzheimer's disease is the preeminent cause and commonest form of dementia. It is clinically characterized by a progressive descent in the cognitive function, which commences with deterioration in memory. The exact etiology and pathophysiologic mechanism of Alzheimer's disease is still not fully understood. However it is hypothesized that, neuroinflammation plays a critical role in the pathogenesis of Alzheimer's disease. Alzheimer's disease is marked by salient inflammatory features, characterized by microglial activation and escalation in the levels of pro-inflammatory cytokines in the affected regions. Studies have suggested a probable role of systemic infection conducing to inflammatory status of the central nervous system. Periodontitis is common oral infection affiliated with gram negative, anaerobic bacteria, capable of orchestrating localized and systemic infections in the subject. Periodontitis is known to elicit a \"low grade systemic inflammation\" by release of pro-inflammatory cytokines into systemic circulation. This review elucidates the possible role of periodontitis in exacerbating Alzheimer's disease. Periodontitis may bear the potential to affect the onset and progression of Alzheimer's disease. Periodontitis shares the two important features of Alzheimer's disease namely oxidative damage and inflammation, which are exhibited in the brain pathology of Alzheimer's disease. Periodontitis can be treated and hence it is a modifiable risk factor for Alzheimer's disease.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "1,3 linked pyrimidine quinolone hybrids": {"__data__": {"id_": "1,3 linked pyrimidine quinolone hybrids", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "1,3 linked pyrimidine quinolone hybrids", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "lactate dehydrogenase a": {"__data__": {"id_": "lactate dehydrogenase a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "lactate dehydrogenase a", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "4 aryl 2 chloropyrimidines": {"__data__": {"id_": "4 aryl 2 chloropyrimidines", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "4 aryl 2 chloropyrimidines", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "aminophenylsulfide": {"__data__": {"id_": "aminophenylsulfide", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "aminophenylsulfide", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "3 (((2/4 aminophenyl)thio)methyl)quinolin 2(1h) ones 22/": {"__data__": {"id_": "3 (((2/4 aminophenyl)thio)methyl)quinolin 2(1h) ones 22/", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "3 (((2/4 aminophenyl)thio)methyl)quinolin 2(1h) ones 22/", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "2 aminophenylsulfide": {"__data__": {"id_": "2 aminophenylsulfide", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "2 aminophenylsulfide", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pyrimidine quinolone": {"__data__": {"id_": "pyrimidine quinolone", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pyrimidine quinolone", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "quinolone": {"__data__": {"id_": "quinolone", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "quinolone", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid35890090": {"__data__": {"id_": "pmid35890090", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid35890090: Title: Design and Synthesis of New Pyrimidine-Quinolone Hybrids as Novel hLDHA Inhibitors. Abstract: A battery of novel pyrimidine-quinolone hybrids was designed by docking scaffold replacement as lactate dehydrogenase A (hLDHA) inhibitors. Structures with different linkers between the pyrimidine and quinolone scaffolds (10-21 and 24-31) were studied in silico, and those with the 2-aminophenylsulfide (U-shaped) and 4-aminophenylsulfide linkers (24-31) were finally selected. These new pyrimidine-quinolone hybrids (24-31)(a-c) were easily synthesized in good to excellent yields by a green catalyst-free microwave-assisted aromatic nucleophilic substitution reaction between 3-(((2/4-aminophenyl)thio)methyl)quinolin-2(1H)-ones 22/23(a-c) and 4-aryl-2-chloropyrimidines (1-4). The inhibitory activity against hLDHA of the synthesized hybrids was evaluated, resulting IC50 values of the U-shaped hybrids 24-27(a-c) much better than the ones of the 1,4-linked hybrids 28-31(a-c). From these results, a preliminary structure-activity relationship (SAR) was established, which enabled the design of novel 1,3-linked pyrimidine-quinolone hybrids (33-36)(a-c). Compounds 35(a-c), the most promising ones, were synthesized and evaluated, fitting the experimental results with the predictions from docking analysis. In this way, we obtained novel pyrimidine-quinolone hybrids (25a, 25b, and 35a) with good IC50 values (<20 muM) and developed a preliminary SAR.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "25a, 25b, and 35a": {"__data__": {"id_": "25a, 25b, and 35a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "25a, 25b, and 35a", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pyrimidine": {"__data__": {"id_": "pyrimidine", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pyrimidine", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "calretinin": {"__data__": {"id_": "calretinin", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "calretinin", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "toxicity": {"__data__": {"id_": "toxicity", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "toxicity", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "neurotoxicity": {"__data__": {"id_": "neurotoxicity", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "neurotoxicity", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid7743217": {"__data__": {"id_": "pmid7743217", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid7743217: Title: Calretinin-immunoreactive neurons are resistant to beta-amyloid toxicity in vitro. Abstract: The molecular pathways by which beta-amyloid protein (A beta) induces neurotoxicity in vitro are unknown. We report that cultured hippocampal neurons exhibiting immunoreactivity for the calcium binding protein calretinin are relatively resistant to degeneration resulting from exposure to either beta 25-35 or beta 1-42. These findings suggest that intrinsic characteristics of calretinin cells, possibly including enhanced calcium buffering capacity, underlie the resistance of these cells to A beta toxicity in vitro and perhaps similar insults in Alzheimer's disease.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "amyloid beta": {"__data__": {"id_": "amyloid beta", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "amyloid beta", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "metabolic dysregulation": {"__data__": {"id_": "metabolic dysregulation", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "metabolic dysregulation", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "tau tangle": {"__data__": {"id_": "tau tangle", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "tau tangle", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cholesterol and phospholipid transporter": {"__data__": {"id_": "cholesterol and phospholipid transporter", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "cholesterol and phospholipid transporter", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "mci": {"__data__": {"id_": "mci", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "mci", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "lipid": {"__data__": {"id_": "lipid", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "lipid", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid38938596": {"__data__": {"id_": "pmid38938596", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid38938596: Title: Brain and serum lipidomic profiles implicate Lands cycle acyl chain remodeling association with APOEepsilon4 and mild cognitive impairment. Abstract: Introduction: At least one-third of the identified risk alleles from Genome-Wide Association Studies (GWAS) of Alzheimer's disease (AD) are involved in lipid metabolism, lipid transport, or direct lipid binding. In fact, a common genetic variant (epsilon4) in a cholesterol and phospholipid transporter, Apolipoprotein E (APOEepsilon4), is the primary genetic risk factor for late-onset AD. In addition to genetic variants, lipidomic studies have reported severe metabolic dysregulation in human autopsy brain tissue, cerebrospinal fluid, blood, and multiple mouse models of AD. Methods: We aimed to identify an overarching metabolic pathway in lipid metabolism by integrating analyses of lipidomics and transcriptomics from the Religious Order Study and Rush Memory Aging Project (ROSMAP) using differential analysis and network correlation analysis. Results: Coordinated differences in lipids were found to be dysregulated in association with both mild cognitive impairment (MCI) and APOEepsilon4 carriers. Interestingly, these correlations were weakened when adjusting for education. Indeed, the cognitively non-impaired APOEepsilon4 carriers have higher education levels in the ROSMAP cohort, suggesting that this lipid signature may be associated with a resilience phenotype. Network correlation analysis identified multiple differential lipids within a single module that are substrates and products in the Lands Cycle for acyl chain remodeling. In addition, our analyses identified multiple genes in the Lands Cycle acyl chain remodeling pathway, which were associated with cognitive decline independent of amyloid-beta (Abeta) load and tau tangle pathologies. Discussion: Our studies highlight the critical differences in acyl chain remodeling in brain tissue from APOEepsilon4 carriers and individual non-carriers with MCI. A coordinated lipid profile shift in dorsolateral prefrontal cortex from both APOEepsilon4 carriers and MCI suggests differences in lipid metabolism occur early in disease stage and highlights lipid homeostasis as a tractable target for early disease modifying intervention.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid18599956": {"__data__": {"id_": "pmid18599956", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid18599956: Title: Predictors of placebo group decline in the Alzheimer's disease Assessment Scale-cognitive subscale (ADAS-Cog) in 24 week clinical trials of Alzheimer's disease. Abstract: One limitation of several recent 24 week Alzheimer's disease (AD) clinical trials was the lack of cognitive decline detected by the AD Assessment Scale-cognitive subscale (ADAS-cog) in the placebo groups, possibly obscuring true medication effects. Data from 733 individuals in the placebo arms of six AD clinical trials performed 1996-1997 were pooled to examine the relationship of clinical, demographic, and genetic characteristics with the 24 week change in ADAS-cog. Baseline cognitive and functional status and the screening-to-baseline change in ADAS-cog were the strongest independent predictors of the 24 week change in ADAS-cog. The ADAS-cog did not detect progression in patients with mild dementia (screening Mini-Mental State Exam, MMSE, >or=20). The change in ADAS-cog from screening to baseline was inversely correlated with the 24 week change score; it was more difficult to detect cognitive decline at 24 weeks if individuals markedly worsened from screening to baseline. The effects of baseline MMSE and screening-to-baseline change in ADAS-cog generalized to the placebo group (N=106) of another AD study performed in 2004-2005. Overcoming lack of placebo decline in AD clinical trials will require scales more sensitive to cognitive decline in mild AD and strategies to reduce within-person variability in outcome measures.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "phospholipid": {"__data__": {"id_": "phospholipid", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "phospholipid", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "coenzyme q": {"__data__": {"id_": "coenzyme q", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "coenzyme q", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "age related diseases": {"__data__": {"id_": "age related diseases", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "age related diseases", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid26999099": {"__data__": {"id_": "pmid26999099", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid26999099: Title: Coenzyme Q and Its Role in the Dietary Therapy against Aging. Abstract: Coenzyme Q (CoQ) is a naturally occurring molecule located in the hydrophobic domain of the phospholipid bilayer of all biological membranes. Shortly after being discovered, it was recognized as an essential electron transport chain component in mitochondria where it is particularly abundant. Since then, more additional roles in cell physiology have been reported, including antioxidant, signaling, death prevention, and others. It is known that all cells are able to synthesize functionally sufficient amounts of CoQ under normal physiological conditions. However, CoQ is a molecule found in different dietary sources, which can be taken up and incorporated into biological membranes. It is known that mitochondria have a close relationship with the aging process. Additionally, delaying the aging process through diet has aroused the interest of scientists for many years. These observations have stimulated investigation of the anti-aging potential of CoQ and its possible use in dietary therapies to alleviate the effects of aging. In this context, the present review focus on the current knowledge and evidence the roles of CoQ cells, its relationship with aging, and possible implications of dietary CoQ in relation to aging, lifespan or age-related diseases.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "crenezumab": {"__data__": {"id_": "crenezumab", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "crenezumab", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "psen1": {"__data__": {"id_": "psen1", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "psen1", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid30090848": {"__data__": {"id_": "pmid30090848", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid30090848: Title: Adherence/Retention Alzheimer's Prevention Initiative Colombia Plan. Abstract: INTRODUCTION: The Alzheimer's Prevention Initiative Colombia Trial is a collaborative project involving the Neurosciences Group of Antioquia, Genentech/Roche, and the Banner Alzheimer's Institute, studying whether crenezumab can delay or prevent the clinical onset of Alzheimer's disease in cognitively unimpaired individuals who carry the PSEN1 E280A mutation. In an effort to optimize participant compliance and adherence and maintain interest in the trial for its duration, the Neurosciences Group of Antioquia developed an \"Adherence/Retention Plan.\" This plan identifies potential barriers to trial adherence related to characteristics of the participants and study partners, protocol design, sponsors, investigators, environmental factors, and characteristics of this population in general and identifies potential solutions to these barriers. METHODS: Neurosciences Group of Antioquia designed and implemented a number of strategies including a) a prescreening process that emphasized detailed and staged informed consent involving the participant and family and/or friends, b) a schedule of visits and assessments designed to minimize burden while achieving the trial's aims, c) appointment reminders, d) reimbursement for transportation and missed work, e) meals during study visits, f) birthday cards, g) quarterly newsletters, h) annual in-person feedback meetings, i) a supplemental health plan to participants, and j) a social plan to support family members. All the methods used in this plan were approved by local ethics committees. RESULTS: By the end of the fourth year of the trial, participant retention was 94.0%, with most participants reporting that they felt \"very satisfied\" with their participation in the trial. DISCUSSION: The Adherence/Retention Plan plays a crucial role in maintaining adherence and compliance needed to achieve the ambitious goals of the Alzheimer's Prevention Initiative-Colombia Autosomal Dominant Alzheimer's Disease Trial and may offer guideposts for other prevention trials.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "polyglutamate": {"__data__": {"id_": "polyglutamate", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "polyglutamate", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "mefox": {"__data__": {"id_": "mefox", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "mefox", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "formyl folate": {"__data__": {"id_": "formyl folate", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "formyl folate", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "s pyrazino triazine": {"__data__": {"id_": "s pyrazino triazine", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "s pyrazino triazine", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "folate mono  and polyglutamates": {"__data__": {"id_": "folate mono  and polyglutamates", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "folate mono  and polyglutamates", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b9 vitamins": {"__data__": {"id_": "b9 vitamins", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "b9 vitamins", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid32717862": {"__data__": {"id_": "pmid32717862", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid32717862: Title: Comprehensive Vitamer Profiling of Folate Mono- and Polyglutamates in Baker's Yeast (Saccharomyces cerevisiae) as a Function of Different Sample Preparation Procedures. Abstract: Folates are a group of B9 vitamins playing an important role in many metabolic processes such as methylation reactions, nucleotide synthesis or oxidation and reduction processes. However, humans are not able to synthesize folates de novo and thus rely on external sources thereof. Baker's yeast (Saccharomyces cerevisiae) has been shown to produce high amounts of this vitamin but extensive identification of its folate metabolism is still lacking. Therefore, we optimized and compared different sample preparation and purification procedures applying solid phase extraction (SPE). Strong anion exchange (SAX), C18 and hydrophilic-lipophilic-balanced (HLB) materials were tested for their applicability in future metabolomics studies. SAX turned out to be the preferred material for the quantitative purification of folates. Qualification of several folate vitamers was achieved by ultra-high pressure liquid chromatography quadrupole time of flight mass spectrometry (UHPLC-Q-ToF-MS) measurements and quantification was performed by liquid chromatography tandem mass spectrometry (LC-MS/MS) applying stable isotope dilution assays (SIDAs). The oxidation product s-pyrazino-triazine (MeFox) was included into the SIDA method for total folate determination and validation. Applying the best protocol (SAX) in regard to folate recovery, we analyzed 32 different vitamers in different polyglutamate states up to nonaglutamates, of which we could further identify 26 vitamers based on tandem-MS (MS2) spectra. Total folate quantification revealed differences in formyl folate contents depending on the cartridge chemistry used for purification. These are supposedly a result of interconversion reactions occurring during sample preparation due to variation in pH adjustments for the different purification protocols. The occurrence of interconversion and oxidation reactions should be taken into consideration in sample preparation procedures for metabolomics analyses with a focus on folates.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "renal tubular injury and dysfunction": {"__data__": {"id_": "renal tubular injury and dysfunction", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "renal tubular injury and dysfunction", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "rhabdomyolysis": {"__data__": {"id_": "rhabdomyolysis", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "rhabdomyolysis", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "nlrp3": {"__data__": {"id_": "nlrp3", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "nlrp3", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "glycerol": {"__data__": {"id_": "glycerol", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "glycerol", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "rhabdomyolysis induced aki": {"__data__": {"id_": "rhabdomyolysis induced aki", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "rhabdomyolysis induced aki", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "interleukin (il) 1beta": {"__data__": {"id_": "interleukin (il) 1beta", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "interleukin (il) 1beta", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "asc": {"__data__": {"id_": "asc", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "asc", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "caspase 1": {"__data__": {"id_": "caspase 1", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "caspase 1", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid26045078": {"__data__": {"id_": "pmid26045078", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid26045078: Title: Role of NLRP3 Inflammasomes for Rhabdomyolysis-induced Acute Kidney Injury. Abstract: Rhabdomyolysis is one of the main causes of community-acquired acute kidney injury (AKI). Although inflammation is involved in the pathogenesis of rhabdomyolysis-induced AKI (RIAKI), little is known about the mechanism that triggers inflammation during RIAKI. Recent evidence has indicated that sterile inflammation triggered by tissue injury can be mediated through multiprotein complexes called the inflammasomes. Therefore, we investigated the role of NLRP3 inflammasomes in the pathogenesis of RIAKI using a glycerol-induced murine rhabdomyolysis model. Inflammasome-related molecules were upregulated in the kidney of RIAKI. Renal tubular injury and dysfunction preceded leukocyte infiltration into the kidney during the early phase of RIAKI, and they were markedly attenuated in mice deficient in NLRP3, ASC, caspase-1, and interleukin (IL)-1beta compared with those in wild-type mice. No difference in leukocyte infiltration was observed between wild-type and NLRP3-deficient mice. Furthermore, NLRP3 deficiency strikingly suppressed the expression of renal injury markers and inflammatory cytokines and apoptosis of renal tubular cells. These results demonstrated that NLRP3 inflammasomes contribute to inflammation, apoptosis, and tissue injury during the early phase of RIAKI and provide new insights into the mechanism underlying the pathogenesis of RIAKI.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "estrogen receptor": {"__data__": {"id_": "estrogen receptor", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "estrogen receptor", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "sirtuin 1": {"__data__": {"id_": "sirtuin 1", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "sirtuin 1", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "27 hydroxycholesterol": {"__data__": {"id_": "27 hydroxycholesterol", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "27 hydroxycholesterol", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "locomotor behavior disorder": {"__data__": {"id_": "locomotor behavior disorder", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "locomotor behavior disorder", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "resveratrol": {"__data__": {"id_": "resveratrol", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "resveratrol", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "17beta estradiol": {"__data__": {"id_": "17beta estradiol", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "17beta estradiol", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid34239694": {"__data__": {"id_": "pmid34239694", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid34239694: Title: Resveratrol Alleviates 27-Hydroxycholesterol-Induced Senescence in Nerve Cells and Affects Zebrafish Locomotor Behavior via Activation of SIRT1-Mediated STAT3 Signaling. Abstract: The oxysterol 27-hydroxycholesterol (27HC) is the first identified endogenous selective estrogen receptor modulator (SERM), which like endogenous estrogen 17beta-estradiol (E2) induces the proliferation of estrogen receptor- (ER-) positive breast cancer cells in vitro. However, 27HC differs from E2 in that it shows adverse effects in the nervous system. Our previous study confirmed that 27HC could induce neural senescence by activating phosphorylated signal transducer and activator of transcription, which E2 could not. The purpose of the present study is to investigate whether STAT3 acetylation was involved in 27HC-induced neural senescence. Microglia (BV2 cells) and rat pheochromocytoma cells (PC12 cells) were used in vitro to explore the effect of resveratrol (REV) on 27HC-induced neural senescence. Senescence-associated beta-galactosidase (SA-beta-Gal) staining was performed using an SA-beta-Gal Staining Kit in cells and zebrafish larvae. Zebrafish were used in vivo to assess the effect of 27HC on locomotor behavior and aging. We found that 27HC could induce senescence in neural cells, and REV, which has been employed as a Sirtuin-1 (SIRT1) agonist, could attenuate 27HC-induced senescence by inhibiting STAT3 signaling via SIRT1. Moreover, in the zebrafish model, REV attenuated 27HC-induced locomotor behavior disorder and aging in the spinal cord of zebrafish larvae, which was also associated with the activation of SIRT1-mediated STAT3 signaling. Our findings unveiled a novel mechanism by which REV alleviates 27HC-induced senescence in neural cells and affects zebrafish locomotor behavior by activating SIRT1-mediated STAT3 signaling.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "nuclear factor of activated t cells, cytoplasmic 1": {"__data__": {"id_": "nuclear factor of activated t cells, cytoplasmic 1", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "nuclear factor of activated t cells, cytoplasmic 1", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cilostazol": {"__data__": {"id_": "cilostazol", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "cilostazol", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "receptor activator of nuclear factor kappab ligand": {"__data__": {"id_": "receptor activator of nuclear factor kappab ligand", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "receptor activator of nuclear factor kappab ligand", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "adenosine 3',5' cyclic monophosphate": {"__data__": {"id_": "adenosine 3',5' cyclic monophosphate", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "adenosine 3',5' cyclic monophosphate", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "bone loss": {"__data__": {"id_": "bone loss", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "bone loss", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "metabolic syndrome": {"__data__": {"id_": "metabolic syndrome", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "metabolic syndrome", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "loss of ovarian function": {"__data__": {"id_": "loss of ovarian function", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "loss of ovarian function", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid25992691": {"__data__": {"id_": "pmid25992691", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid25992691: Title: Cilostazol attenuates ovariectomy-induced bone loss by inhibiting osteoclastogenesis. Abstract: BACKGROUND: Cilostazol has been reported to alleviate the metabolic syndrome induced by increased intracellular adenosine 3',5'-cyclic monophosphate (cAMP) levels, which is also associated with osteoclast (OC) differentiation. We hypothesized that bone loss might be attenuated via an action on OC by cilostazol. METHODOLOGY AND PRINCIPAL FINDINGS: To test this idea, we investigated the effect of cilostazol on ovariectomy (OVX)-induced bone loss in mice and on OC differentiation in vitro, using muCT and tartrate-resistant acid phosphatase staining, respectively. Cilostazol prevented from OVX-induced bone loss and decreased oxidative stress in vivo. It also decreased the number and activity of OC in vitro. The effect of cilostazol on reactive oxygen species (ROS) occurred via protein kinase A (PKA) and cAMP-regulated guanine nucleotide exchange factor 1, two major effectors of cAMP. Knockdown of NADPH oxidase using siRNA of p47phox attenuated the inhibitory effect of cilostazol on OC formation, suggesting that decreased OC formation by cilostazol was partly due to impaired ROS generation. Cilostazol enhanced phosphorylation of nuclear factor of activated T cells, cytoplasmic 1 (NFAT2) at PKA phosphorylation sites, preventing its nuclear translocation to result in reduced receptor activator of nuclear factor-kappaB ligand-induced NFAT2 expression and decreased binding of nuclear factor-kappaB-DNA, finally leading to reduced levels of two transcription factors required for OC differentiation. CONCLUSIONS/SIGNIFICANCE: Our data highlight the therapeutic potential of cilostazol for attenuating bone loss and oxidative stress caused by loss of ovarian function.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "abdominal pain": {"__data__": {"id_": "abdominal pain", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "abdominal pain", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "diarrhoea": {"__data__": {"id_": "diarrhoea", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "diarrhoea", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "gastrointestinal dysmotility": {"__data__": {"id_": "gastrointestinal dysmotility", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "gastrointestinal dysmotility", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "vomiting": {"__data__": {"id_": "vomiting", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "vomiting", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "drop of power": {"__data__": {"id_": "drop of power", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "drop of power", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "memantine": {"__data__": {"id_": "memantine", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "memantine", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "magnesium": {"__data__": {"id_": "magnesium", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "magnesium", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "gastric myoelectric": {"__data__": {"id_": "gastric myoelectric", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "gastric myoelectric", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "gastric arrhythmia": {"__data__": {"id_": "gastric arrhythmia", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "gastric arrhythmia", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid31978146": {"__data__": {"id_": "pmid31978146", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid31978146: Title: The pharmacokinetic parameters and the effect of a single and repeated doses of memantine on gastric myoelectric activity in experimental pigs. Abstract: BACKGROUND: Memantine, currently available for the treatment of Alzheimer's disease, is an uncompetitive antagonist of the N-methyl-D-aspartate type of glutamate receptors. Under normal physiologic conditions, these unstimulated receptor ion channels are blocked by magnesium ions, which are displaced after agonist-induced depolarization. In humans, memantine administration is associated with different gastrointestinal dysmotility side effects (vomiting, diarrhoea, constipation, motor-mediated abdominal pain), thus limiting its clinical use. Mechanism of these motility disorders has not been clarified yet. Pigs can be used in various preclinical experiments due to their relatively very similar gastrointestinal functions compared to humans. The aim of this study was to evaluate the impact of a single and repeated doses of memantine on porcine gastric myoelectric activity evaluated by means of electrogastrography (EGG). METHODS: Six adult female experimental pigs (Sus scrofa f. domestica, mean weight 41.7+-5.0 kg) entered the study for two times. The first EGG was recorded after a single intragastric dose of memantine (20 mg). In the second part, EGG was accomplished after 7-day intragastric administration (20 mg per day). All EGG recordings were performed under general anaesthesia. Basal (15 minutes) and study recordings (120 minutes) were accomplished using an EGG stand (MMS, Enschede, the Netherlands). Running spectral analysis based on Fourier transform was used. Results were expressed as dominant frequency of gastric slow waves (DF) and power analysis (areas of amplitudes). RESULTS: Single dose of memantine significantly increased DF, from basic values (1.65+-1.05 cycles per min.) to 2.86 cpm after 30 min. (p = 0.008), lasting till 75 min. (p = 0.014). Basal power (median 452; inter-quartile range 280-1312 muV^2) raised after 15 min. (median 827; IQR 224-2769; p = 0.386; NS), lasting next 30 min. Repetitively administrated memantine caused important gastric arrhythmia. Basal DF after single and repeated administration was not different, however, a DF increase in the second part was more prominent (up to 3.18+-2.16 after 15 and 30 min., p<0.001). In comparison with a single dose, basal power was significantly higher after repetitively administrated memantine (median 3940; IQR 695-15023 muV^2; p<0.001). Next dose of 20 mg memantine in the second part induced a prominent drop of power after 15 min. (median 541; IQR 328-2280 muV^2; p<0.001), lasting till 120 min. (p<0.001). CONCLUSIONS: Both single and repeated doses of memantine increased DF. Severe gastric arrhythmia and long-lasting low power after repeated administration might explain possible gastric dysmotility side effects in the chronic use of memantine.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "motility disorders": {"__data__": {"id_": "motility disorders", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "motility disorders", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "tor pathway": {"__data__": {"id_": "tor pathway", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "tor pathway", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "whi2": {"__data__": {"id_": "whi2", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "whi2", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "msn2": {"__data__": {"id_": "msn2", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "msn2", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cancer": {"__data__": {"id_": "cancer", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "cancer", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid28646136": {"__data__": {"id_": "pmid28646136", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid28646136: Title: Recurrent background mutations in WHI2 impair proteostasis and degradation of misfolded cytosolic proteins in Saccharomyces cerevisiae. Abstract: Proteostasis promotes viability at both the cellular and organism levels by maintaining a functional proteome. This requires an intricate protein quality control (PQC) network that mediates protein folding by molecular chaperones and removes terminally misfolded proteins via the ubiquitin proteasome system and autophagy. How changes within the PQC network can perturb proteostasis and shift the balance between protein folding and proteolysis remain poorly understood. However, given that proteostasis is altered in a number of conditions such as cancer and ageing, it is critical that we identify the factors that mediate PQC and understand the interplay between members of the proteostatic network. In this study, we investigated the degradation of a thermally unstable cytosolic model substrate and identified a surprisingly high number of strains in the yeast knockout collection that displayed impaired turnover of the misfolded substrate. We found that this phenotype was caused by frequent background mutations in the general stress response gene WHI2. We linked this proteostatic defect to the lack of activity of the stress response transcription factor Msn2, potentially under conditions where the TOR pathway is active. Our results underscore how changes to the elaborate PQC network can perturb proteostasis and impair degradation of misfolded cytosolic proteins.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid25875657": {"__data__": {"id_": "pmid25875657", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid25875657: Title: Expression of phosphoinositide-specific phospholipase C isoforms in native endothelial cells. Abstract: Phospholipase C (PLC) comprises a superfamily of enzymes that play a key role in a wide array of intracellular signalling pathways, including protein kinase C and intracellular calcium. Thirteen different mammalian PLC isoforms have been identified and classified into 6 families (PLC-beta, gamma, delta, epsilon, zeta and eta) based on their biochemical properties. Although the expression of PLC isoforms is tissue-specific, concomitant expression of different PLC has been reported, suggesting that PLC family is involved in multiple cellular functions. Despite their critical role, the PLC isoforms expressed in native endothelial cells (ECs) remains undetermined. A conventional PCR approach was initially used to elucidate the mRNA expression pattern of PLC isoforms in 3 distinct murine vascular beds: mesenteric (MA), pulmonary (PA) and middle cerebral arteries (MCA). mRNA encoding for most PLC isoforms was detected in MA, MCA and PA with the exception of eta2 and beta2 (only expressed in PA), delta4 (only expressed in MCA), eta1 (expressed in all but MA) and zeta (not detected in any vascular beds tested). The endothelial-specific PLC expression was then sought in freshly isolated ECs. Interestingly, the PLC expression profile appears to differ across the investigated arterial beds. While mRNA for 8 of the 13 PLC isoforms was detected in ECs from MA, two additional PLC isoforms were detected in ECs from PA and MCA. Co-expression of multiple PLC isoforms in ECs suggests an elaborate network of signalling pathways: PLC isoforms may contribute to the complexity or diversity of signalling by their selective localization in cellular microdomains. However in situ immunofluorescence revealed a homogeneous distribution for all PLC isoforms probed (beta3, gamma2 and delta1) in intact endothelium. Although PLC isoforms play a crucial role in endothelial signal transduction, subcellular localization alone does not appear to be sufficient to determine the role of PLC in the signalling microdomains found in the native endothelium.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "delta4": {"__data__": {"id_": "delta4", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "delta4", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "neurological disorders and stroke": {"__data__": {"id_": "neurological disorders and stroke", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "neurological disorders and stroke", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid16917086": {"__data__": {"id_": "pmid16917086", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid16917086: Title: National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Abstract: BACKGROUND AND PURPOSE: One in 3 individuals will experience a stroke, dementia or both. Moreover, twice as many individuals will have cognitive impairment short of dementia as either stroke or dementia. The commonly used stroke scales do not measure cognition, while dementia criteria focus on the late stages of cognitive impairment, and are heavily biased toward the diagnosis of Alzheimer disease. No commonly agreed standards exist for identifying and describing individuals with cognitive impairment, particularly in the early stages, and especially with cognitive impairment related to vascular factors, or vascular cognitive impairment. METHODS: The National Institute for Neurological Disorders and Stroke (NINDS) and the Canadian Stroke Network (CSN) convened researchers in clinical diagnosis, epidemiology, neuropsychology, brain imaging, neuropathology, experimental models, biomarkers, genetics, and clinical trials to recommend minimum, common, clinical and research standards for the description and study of vascular cognitive impairment. RESULTS: The results of these discussions are reported herein. CONCLUSIONS: The development of common standards represents a first step in a process of use, validation and refinement. Using the same standards will help identify individuals in the early stages of cognitive impairment, will make studies comparable, and by integrating knowledge, will accelerate the pace of progress.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "mesencephalic astrocyte derived neurotrophic factor": {"__data__": {"id_": "mesencephalic astrocyte derived neurotrophic factor", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "mesencephalic astrocyte derived neurotrophic factor", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid34234505": {"__data__": {"id_": "pmid34234505", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid34234505: Title: The Potential Protective Effect of Mesencephalic Astrocyte-Derived Neurotrophic Factor on Post-Operative Delirium via Inhibiting Inflammation and Microglia Activation.\n Abstract: BACKGROUND: The increased inflammation is closely correlated with post-operative delirium (POD). Mesencephalic astrocyte-derived neurotrophic factor (MANF) shows protective effect on inflammatory diseases. However, the relationship between MANF and POD is still undefined. This study aimed to explore the potential effect of MANF on POD. METHODS: Pre- and post-operative levels of MANF and inflammatory cytokines were measured in serum from POD and non-POD patients by ELISA, as well as endogenous MANF in serum from healthy individuals with different ages. Endogenous MANF in mice brain from different ages was also measured. Abdominal surgery was performed for POD mice model. POD-like behavior changes in mice were evaluated using buried food test, open field test and Y maze test. RESULTS: Endogenous MANF was decreased in age-dependent manner in both humans and mice. The pre-operative level of MANF in serum from POD patients was lower compared with that in non-POD patients (p=0.016). MANF increase in serum after surgery was less in POD patients than that in non-POD patients (p<0.001). In mice, recombinant human MANF reversed the surgery-induced elongation of latency to eat food, increase in latency to center and increase in time in center in open field test, and also increase in duration in novel arm in Y maze test. In addition, MANF inhibited surgery-induced inflammation, microglial activation and M1 polarization in mice. CONCLUSION: The relative low MANF level may contribute to POD in the elderly. MANF has a protective role against POD-like behavior changes in mice.\n.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "sensory deprivation": {"__data__": {"id_": "sensory deprivation", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "sensory deprivation", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid2872139": {"__data__": {"id_": "pmid2872139", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid2872139: Title: Delirium: recognition and management in the older patient.\n Abstract: The EEG can be an enormous aid in distinguishing between organic and \"functional\" problems and between acute drug intoxication and other forms of delirium. The characteristic EEG finding in delirium is bilateral diffuse slowing that parallels the severity of the syndrome. The vulnerability of the elderly cannot be overstressed. Their health and nutritional status, borderline cerebral changes, and sensory deprivation due to impaired vision or hearing are all predisposing factors for delirium.\n.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "impaired vision or hearing": {"__data__": {"id_": "impaired vision or hearing", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "impaired vision or hearing", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "glucose": {"__data__": {"id_": "glucose", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "glucose", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid35740018": {"__data__": {"id_": "pmid35740018", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid35740018: Title: Focus on the Contribution of Oxidative Stress in Skin Aging. Abstract: Skin aging is one of the most evident signs of human aging. Modification of the skin during the life span is characterized by fine lines and wrinkling, loss of elasticity and volume, laxity, rough-textured appearance, and pallor. In contrast, photoaged skin is associated with uneven pigmentation (age spot) and is markedly wrinkled. At the cellular and molecular level, it consists of multiple interconnected processes based on biochemical reactions, genetic programs, and occurrence of external stimulation. The principal cellular perturbation in the skin driving senescence is the alteration of oxidative balance. In chronological aging, reactive oxygen species (ROS) are produced mainly through cellular oxidative metabolism during adenosine triphosphate (ATP) generation from glucose and mitochondrial dysfunction, whereas in extrinsic aging, loss of redox equilibrium is caused by environmental factors, such as ultraviolet radiation, pollution, cigarette smoking, and inadequate nutrition. During the aging process, oxidative stress is attributed to both augmented ROS production and reduced levels of enzymatic and non-enzymatic protectors. Apart from the evident appearance of structural change, throughout aging, the skin gradually loses its natural functional characteristics and regenerative potential. With aging, the skin immune system also undergoes functional senescence manifested as a reduced ability to counteract infections and augmented frequency of autoimmune and neoplastic diseases. This review proposes an update on the role of oxidative stress in the appearance of the clinical manifestation of skin aging, as well as of the molecular mechanisms that underline this natural phenomenon sometimes accelerated by external factors.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "adenosine triphosphate": {"__data__": {"id_": "adenosine triphosphate", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "adenosine triphosphate", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "autoimmune and neoplastic diseases": {"__data__": {"id_": "autoimmune and neoplastic diseases", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "autoimmune and neoplastic diseases", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "mitochondrial dysfunction": {"__data__": {"id_": "mitochondrial dysfunction", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "mitochondrial dysfunction", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "copper": {"__data__": {"id_": "copper", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "copper", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "protein misfolding diseases": {"__data__": {"id_": "protein misfolding diseases", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "protein misfolding diseases", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "metal chaperones": {"__data__": {"id_": "metal chaperones", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "metal chaperones", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid20536399": {"__data__": {"id_": "pmid20536399", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid20536399: Title: Plant metal chaperones: a novel perspective in dementia therapy. Abstract: Dys-homeostasis of copper metabolism and oxidative stress are major hallmarks in the brains of Alzheimer patients. Therefore, metal bioavailability and mechanisms of copper ion homeostasis throughout the body are crucial and potential targets for therapeutic agents. Many of the medications used or suggested, respectively, at present time, may either be toxic, reveal a lack of specificity or have unknown mechanisms of action in vivo. Metal chaperones from medicinal plants are proposed as medications that are relatively free from these disadvantages. Furthermore, these agents are a promising class of molecules for studies aimed at developing innovative and etiological treatments for protein-misfolding diseases, especially Alzheimer's disease.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid23662612": {"__data__": {"id_": "pmid23662612", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid23662612: Title: Heat-stable components of wood ear mushroom, Auricularia polytricha (higher Basidiomycetes), inhibit in vitro activity of beta secretase (BACE1). Abstract: The consumption of mushrooms has been linked with protection against dementia, including Alzheimer's disease (AD), by several biological pathways including inhibiting beta-site APP-cleaving enzyme (BACE1), which is responsible for releasing toxic beta-amyloid peptide in the brain. We have investigated the capacity of several medicinal mushroom species-Auricularia polytricha (wood ear mushroom), Agaricus bisporus (button mushroom), Flammulina velutipes (winter or enoki mushroom), and Lentinus edodes (shiitake mushroom)-in the regulation of BACE1. Mushrooms were subjected to a generic food-compatible processing method to detect process-stable or process-modified products; the effects of processing were interpreted to infer the chemical classes associated with bioactivity. We have shown previously that in addition to enzyme inhibition, in the presence of the BACE1 proenzyme, heteropolymeric species such as heparin can activate BACE1 by modulating access to the catalytic site. We observed both inhibitory and activating components of the various mushrooms. Only BACE1 inhibitory species were detected in unprocessed and processed forms of A. polytricha, whereas the dominant extracted species from A. bisporus, F. velutipes, and L. edodese were activators of BACE1. It is not known whether activating species were masking the presence of inhibitory species in A. bisporus, F. velutipes, and L. edodes. Inhibitory species were attributed to hispidin-derived polyphenols, whereas activating species were attributed to soluble polysaccharides and possibly low-mass Maillard products produced during processing. Larger molecular BACE1-activating species are unlikely to be bioavailable to brain in contrast with possible brain bioavailability of smaller, lipophilic hispidins.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "polyphenols": {"__data__": {"id_": "polyphenols", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "polyphenols", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "hispidins": {"__data__": {"id_": "hispidins", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "hispidins", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "polysaccharides": {"__data__": {"id_": "polysaccharides", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "polysaccharides", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "alcohol dependence": {"__data__": {"id_": "alcohol dependence", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "alcohol dependence", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "addiction medicine": {"__data__": {"id_": "addiction medicine", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "addiction medicine", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "calcium acetylhomotaurine": {"__data__": {"id_": "calcium acetylhomotaurine", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "calcium acetylhomotaurine", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid23399877": {"__data__": {"id_": "pmid23399877", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid23399877: Title: Safety and efficacy of acamprosate for the treatment of alcohol dependence.\n Abstract: Acamprosate (calcium acetylhomotaurine) is an amino acid modulator that has displayed efficacy in some clinical trials in reducing craving and promoting abstinence in alcohol dependent patients following detoxification. While acamprosate is safe and generally well-tolerated, not all studies have demonstrated clinical efficacy that is superior to placebo. In addition, the precise neurochemical mechanisms of action of acamprosate have still not yet been identified. In this review, we summarize current clinical data on the safety, efficacy, and pharmacokinetic properties of acamprosate, as well theories on its potential mechanism of action. We also discuss tolerability and patient preference issues and conclude with a discussion of the place of acamprosate in addiction medicine and therapy.\n.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "alcohol": {"__data__": {"id_": "alcohol", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "alcohol", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "wrinkles": {"__data__": {"id_": "wrinkles", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "wrinkles", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "laxity": {"__data__": {"id_": "laxity", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "laxity", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "elastosis": {"__data__": {"id_": "elastosis", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "elastosis", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "osteoporosis": {"__data__": {"id_": "osteoporosis", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "osteoporosis", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "aberrant pigmentation": {"__data__": {"id_": "aberrant pigmentation", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "aberrant pigmentation", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "aged skin": {"__data__": {"id_": "aged skin", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "aged skin", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "telangiectasia": {"__data__": {"id_": "telangiectasia", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "telangiectasia", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "degenerative diseases": {"__data__": {"id_": "degenerative diseases", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "degenerative diseases", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid36698629": {"__data__": {"id_": "pmid36698629", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid36698629: Title: Mechanism of action and therapeutic effects of oxidative stress and stem cell-based materials in skin aging: Current evidence and future perspectives. Abstract: Aging is associated with multiple degenerative diseases, including atherosclerosis, osteoporosis, and Alzheimer's disease. As the most intuitive manifestation of aging, skin aging has received the most significant attention. Skin aging results from various intrinsic and extrinsic factors. Aged skin is characterized by wrinkles, laxity, elastosis, telangiectasia, and aberrant pigmentation. The underlying mechanism is complex and may involve cellular senescence, DNA damage, oxidative stress (OS), inflammation, and genetic mutations, among other factors. Among them, OS plays an important role in skin aging, and multiple antioxidants (e.g., vitamin C, glutathione, and melatonin) are considered to promote skin rejuvenation. In addition, stem cells that exhibit self-replication, multi-directional differentiation, and a strong paracrine function can exert anti-aging effects by inhibiting OS. With the further development of stem cell technology, treatments related to OS mitigation and involving stem cell use may have a promising future in anti-skin aging therapy.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "myocardial infarction": {"__data__": {"id_": "myocardial infarction", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "myocardial infarction", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "antiplatelet": {"__data__": {"id_": "antiplatelet", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "antiplatelet", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "coronary artery disease": {"__data__": {"id_": "coronary artery disease", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "coronary artery disease", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid36130806": {"__data__": {"id_": "pmid36130806", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid36130806: Title: Coronary endarterectomy in patients with diffuse coronary artery disease: assessment of graft patency with computed tomography angiography.\n Abstract: BACKGROUND: With a growing population of patients with advanced coronary artery disease (CAD), many of whom have undergone prior percutaneous coronary interventions, coronary endarterectomy (CE) allows for the extension of revascularization in patients with otherwise limited options. Whether adjunctive CE associated with standard surgery, combined with contemporary antiplatelet therapy, improves outcomes remains largely unknown. METHODS: We studied 147 consecutive patients who underwent 154 adjunctive CE procedures for advanced CAD between January 2015 and January 2018. We used computed tomography angiography (CTA) in a subgroup of 32 consecutive patients who underwent CE during coronary artery bypass grafting after June 2016 to assess graft and coronary patency. RESULTS: Patients (mean age 67 +- SD 10 yr) underwent CE of the right (102 patients), the left anterior descending (LAD, 22 patients) and the circumflex (17 patients) coronary arteries. Seven patients (5%) experienced a procedural myocardial infarction and there were no perioperative deaths. Among the 32 patients who underwent CTA 3 months after surgery, the mean patency of the endarterectomized coronary arteries and bypass grafts was 90% and 88%, respectively. All 6 arterial grafts on the LAD artery were patent. The mean survival rate and the mean rate of freedom from major adverse cardiovascular events was 95% +- 2% and 95% +- 6%, respectively. The patency rate was 100 % for patients evaluated at 3-year follow up. CONCLUSION: Coronary endarterectomy offers a surgical option for patients with diffuse CAD who may be unsuitable for coronary bypass alone. Grafts and endarterectomized coronary artery patency remain adequate and explain the excellent patient survival and the freedom rate from major adverse cardiovascular events.\n.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "decisional impairment": {"__data__": {"id_": "decisional impairment", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "decisional impairment", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid11986134": {"__data__": {"id_": "pmid11986134", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid11986134: Title: Impaired decision-making ability in subjects with Alzheimer's disease and willingness to participate in research. Abstract: OBJECTIVE: Ethical concerns persist over research participation of decisionally impaired persons, such as those suffering from Alzheimer's disease. Such persons may be poor judges of the burdens and risks of specific research protocols. Since even decisionally incapacitated persons cannot be enrolled in studies against their objection, their preferences convey important ethical information. The authors examined the effects of cognitive and decisional impairment on willingness to participate in research among persons with Alzheimer's disease. METHOD: Cognitive status, decision-making ability, and willingness to participate in four hypothetical research protocols of varying risk/benefit profiles were measured in 34 subjects with mild to mild/moderate Alzheimer's disease and 14 healthy elderly comparison subjects. Univariate and multivariate methods were used to analyze the effects of impairment in cognitive and decision-making abilities on willingness to participate in research. RESULTS: There were no differences in willingness to participate found between the Alzheimer's and the healthy comparison subjects for three of the four hypothetical protocols. In both groups, willingness declined as risk increased. Within the Alzheimer's disease group, the presence of greater decisional impairment tended to predict less willingness to participate in research, even after adjusting for cognitive impairment, gender, and education. CONCLUSIONS: Persons with decisional impairment due to Alzheimer's disease are as a group able to distinguish between research protocols of varying risk/benefit profiles. Because declining decision-making abilities may predict declining willingness to participate in research, informed consent procedures for Alzheimer's disease research should be sensitive to this possibility.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "so2/3": {"__data__": {"id_": "so2/3", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "so2/3", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "obstructive sleep apnea": {"__data__": {"id_": "obstructive sleep apnea", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "obstructive sleep apnea", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid36552694": {"__data__": {"id_": "pmid36552694", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid36552694: Title: Hyperoxidized Peroxiredoxin 2 Is a Possible Biomarker for the Diagnosis of Obstructive Sleep Apnea. Abstract: Peroxiredoxin (Prx) 2 in red blood cells (RBCs) reacts with various reactive oxygen species and changes to hyperoxidized Prx2 (Prx2-SO2/3). Therefore, Prx2 may serve as an indicator of oxidative stress in vivo. This study aimed to analyze Prx2-SO2/3 levels in clinical samples to examine whether the oxidation state of Prx2 in human RBCs reflects the pathological condition of oxidative stress diseases. We first focused on obstructive sleep apnea (OSA), a hypoxic stress-induced disease of the respiratory system, and investigated the levels of Prx2-SO2/3 accumulated in the RBCs of OSA patients. In measurements on a small number of OSA patients and healthy subjects, levels of Prx2-SO2/3 accumulation in patients with OSA were clearly increased compared to those in healthy subjects. Hence, we proceeded to validate these findings with more samples collected from patients with OSA. The results revealed significantly higher levels of erythrocytic Prx2-SO2/3 in patients with OSA than in healthy subjects, as well as a positive correlation between the severity of OSA and Prx2-SO2/3 levels in the RBCs. Moreover, we performed a chromatographic study to show the structural changes of Prx2 due to hyperoxidation. Our findings demonstrated that the Prx2-SO2/3 molecules in RBCs from patients with OSA were considerably more hydrophilic than the reduced form of Prx2. These results implicate Prx2-SO2/3 as a promising candidate biomarker for OSA.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pseudocyst pancreas": {"__data__": {"id_": "pseudocyst pancreas", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pseudocyst pancreas", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "alcohol dependent": {"__data__": {"id_": "alcohol dependent", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "alcohol dependent", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "alcohol abuse": {"__data__": {"id_": "alcohol abuse", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "alcohol abuse", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid28515560": {"__data__": {"id_": "pmid28515560", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid28515560: Title: Pseudocyst Pancreas with Delirium in a Married Alcohol Dependent Male: A Rare Presentation.\n Abstract: We herein present a patient with a history of heavy alcohol abuse who developed pseudocyst Pancreas and delirium, who came to our hospital for treatment. The patient recovered well with treatment.\n.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "kanamycin": {"__data__": {"id_": "kanamycin", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "kanamycin", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "dying back": {"__data__": {"id_": "dying back", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "dying back", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "hair cell loss": {"__data__": {"id_": "hair cell loss", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "hair cell loss", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "degeneration": {"__data__": {"id_": "degeneration", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "degeneration", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cochlea": {"__data__": {"id_": "cochlea", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "cochlea", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "furosemide": {"__data__": {"id_": "furosemide", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "furosemide", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "efr3a": {"__data__": {"id_": "efr3a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "efr3a", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "spiral ganglion cell degeneration": {"__data__": {"id_": "spiral ganglion cell degeneration", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "spiral ganglion cell degeneration", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid25622037": {"__data__": {"id_": "pmid25622037", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid25622037: Title: Expression of EFR3A in the mouse cochlea during degeneration of spiral ganglion following hair cell loss. Abstract: Retrograde degeneration of spiral ganglion cells in the cochlea following hair cell loss is similar to dying back in pathology. The EFR3A gene has recently been discovered to be involved in the pathogenesis of dying back. The relationship of EFR3A and spiral ganglion degeneration, however, was rarely investigated. In this study, we destroyed the hair cells of the mouse cochlea by co-administration of kanamycin and furosemide and then investigated the EFR3A expression during the induced spiral ganglion cell degeneration. Our results revealed that co-administration of kanamycin and furosemide quickly induced hair cell loss in the C57BL/6J mice and then resulted in progressive degeneration of the spiral ganglion beginning at day 5 following drug administration. The number of the spiral ganglion cells began to decrease at day 15. The expression of EFR3A increased remarkably in the spiral ganglion at day 5 and then decreased to near normal level within the next 10 days. Our study suggested that the change of EFR3A expression in the spiral ganglion was coincident with the time of the spiral ganglion degeneration, which implied that high expression of EFR3A may be important to prompt initiation of spiral ganglion degeneration following hair cell loss.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "eosinophilic granulomatosis with polyangiitis": {"__data__": {"id_": "eosinophilic granulomatosis with polyangiitis", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "eosinophilic granulomatosis with polyangiitis", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "systemic vasculitis": {"__data__": {"id_": "systemic vasculitis", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "systemic vasculitis", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "conjunctivitis": {"__data__": {"id_": "conjunctivitis", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "conjunctivitis", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pulmonary renal syndrome": {"__data__": {"id_": "pulmonary renal syndrome", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pulmonary renal syndrome", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid36755295": {"__data__": {"id_": "pmid36755295", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid36755295: Title: Systemic vasculitis diagnosed during the post-partum period: case report and review of the literature.\n Abstract: INTRODUCTION: The vasculitis diagnosed specifically in the post-partum period are less well known. We report here such a case followed by a descriptive review of the literature. CASE REPORT: A 25 year-old French nurse reported abrupt-onset musculoskeletal pain 15 days after delivery of her first infant. Her first pregnancy was uneventful. The physical examination yielded only bilateral conjunctivitis and purpuric eruption of lower limbs, and complementary investigations evidenced pulmonary renal syndrome in connection with the diagnosis of Granulomatosis with Polyangiitis. METHODS: We screened previous articles in Medline database using keywords (i) \"post-partum\" or \"puerperium\" (ii)\"peripartum\" (iii) \"pregnancy\" associated with \"vasculitis\". Full texts were obtained from case reports or cases series whose title or abstract included keywords of interest (or synonyms). These references were secondarily excluded if the diagnosis of vasculitis was not confirmed or made before or more than 6 months after delivery and if vasculitis occurred only in the new born or affected only the cerebral vasculature or the retina. RESULTS: Fifty-six cases of vasculitis diagnosed in the post-partum period were included, 50 (89.3%) were secondary to an immunological process and 44 corresponded to primary vasculitis, 4 were secondary to Systemic Lupus Erythematosus, 1 to cryoglobulinaemia and 1 to cryoglobulinaemia associated with inflammatory bowel disease. The main primary vasculitis diagnosed were Takayasu Arteritis (n = 10), Eosinophilic granulomatosis with polyangiitis (n = 9), Granulomatosis with Polyangiitis (n = 7), Periarteritis Nodosa (n = 5) and Behcet's disease (n = 4). The first symptom occurred before delivery in 26 (59.1%) and maternal death occurred in 4 (9.1%) out of the 44 primary vasculitis cases. CONCLUSION: The vasculitis diagnosed in the post-partum period were mainly primary vasculitis among patients in whom the diagnosis had not been made during pregnancy. In less than half of cases and as described in ours, there were no reported symptoms before delivery. Therefore, the physicians should pay attention to symptoms and keep a high degree of suspicion for vasculitis before as well as after delivery.\n.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "vasculitis": {"__data__": {"id_": "vasculitis", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "vasculitis", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "inflammatory bowel disease": {"__data__": {"id_": "inflammatory bowel disease", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "inflammatory bowel disease", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "takayasu arteritis": {"__data__": {"id_": "takayasu arteritis", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "takayasu arteritis", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "behcet's disease": {"__data__": {"id_": "behcet's disease", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "behcet's disease", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "primary vasculitis": {"__data__": {"id_": "primary vasculitis", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "primary vasculitis", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "purpuric eruption": {"__data__": {"id_": "purpuric eruption", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "purpuric eruption", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "maternal death": {"__data__": {"id_": "maternal death", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "maternal death", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "periarteritis nodosa": {"__data__": {"id_": "periarteritis nodosa", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "periarteritis nodosa", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "musculoskeletal pain": {"__data__": {"id_": "musculoskeletal pain", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "musculoskeletal pain", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "systemic lupus erythematosus": {"__data__": {"id_": "systemic lupus erythematosus", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "systemic lupus erythematosus", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "amyotrophic lateral sclerosis": {"__data__": {"id_": "amyotrophic lateral sclerosis", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "amyotrophic lateral sclerosis", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cognitive, behavioral and psychomotor alterations": {"__data__": {"id_": "cognitive, behavioral and psychomotor alterations", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "cognitive, behavioral and psychomotor alterations", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "depression": {"__data__": {"id_": "depression", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "depression", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "poisoning": {"__data__": {"id_": "poisoning", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "poisoning", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "neurodegenerative disorders": {"__data__": {"id_": "neurodegenerative disorders", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "neurodegenerative disorders", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid28552054": {"__data__": {"id_": "pmid28552054", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid28552054: Title: Neurotoxicity of Insecticides. Abstract: BACKGROUND: Human exposure to insecticides raises serious public health concerns worldwide. Insecticides constitute a wide-ranging heterogeneous group of chemicals, most of which target the nervous system and disrupt neurometabolism and/or neurotransmission. Although the acute effects of insecticide poisoning in humans are well documented, the chronic and long-term effects remain difficult to investigate. OBJECTIVES AND METHOD: We sought to review the present state-of-knowledge of acute, chronic, neurodevelopmental and neurological consequences of human exposure to insecticides. RESULTS: Animal and epidemiologic studies indicate cognitive, behavioral and psychomotor alterations in mammals chronically exposed to insecticides. Parkinson's and Alzheimer's diseases, amyotrophic lateral sclerosis, and depression, have been regularly associated with insecticide exposure. Clinical studies, supported by experiments on animal models, demonstrate the neurotoxic impact of insecticide exposure during the period of cerebral development, the developing brain being particularly vulnerable to the action of insecticides. Moreover, detoxifying systems that are highly polymorph lead to great inter-individual variability in susceptibility to the neurotoxic effects of insecticides. CONCLUSION: Studies on mild chronic exposure to insecticides suggest significant involvement in the pathogenesis of multifactorial neurological diseases. However, the tardive appearance of neurodegenerative disorders and the large variability of inter-individual susceptibility to neurotoxicants make it difficult to assess the relative contribution of insecticide exposure. Close vigilance should therefore be exercised with regard to possible exposure to insecticides, particularly during the period of cerebral development.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "thrombophilia": {"__data__": {"id_": "thrombophilia", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "thrombophilia", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "inherited thrombophilia": {"__data__": {"id_": "inherited thrombophilia", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "inherited thrombophilia", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "lower extremity venous thrombosis": {"__data__": {"id_": "lower extremity venous thrombosis", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "lower extremity venous thrombosis", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "venous thromboembolism": {"__data__": {"id_": "venous thromboembolism", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "venous thromboembolism", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "inferior vena cava abnormalities": {"__data__": {"id_": "inferior vena cava abnormalities", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "inferior vena cava abnormalities", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid22454560": {"__data__": {"id_": "pmid22454560", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid22454560: Title: Lower extremity venous thrombosis in patients younger than 50 years of age. Abstract: AIM: Lower extremity deep venous thrombosis in the young adult is uncommon and has not been well studied in the literature. The aim of this study is to define risk factors for deep venous thrombosis among patients younger than 50 years of age, to compare them with a control group, and to suggest recommendations for the management and treatment of venous thrombosis in this particular group of patients. METHODS: From January 2003 to January 2011, 66 consecutive Lebanese patients (29 males and 37 females) younger than 50 years, diagnosed in an academic tertiary-care center with lower extremity deep venous thrombosis by color flow duplex scan, were retrospectively reviewed. Their age varied between 21 and 50 years (mean 38.7 years). The control group included 217 patients (86 males and 131 females) older than 50 years (range: 50-96 years; mean 72.9 years). RESULTS: The most commonly reported risk factors in the younger age group were inherited thrombophilia (46.9% compared with 13.8% in the control group; P < 0.001), pregnancy (18.2% compared with 0.5%; P < 0.001), treatment with estrogen drugs (13.6% compared with 2.3%; P = 0.001), and family history of venous thromboembolism (9.1% compared with 3.8%; P = 0.084). CONCLUSION: Inherited thrombophilia is the most commonly observed risk factor among patients younger than 50 years, with a prevalence of three times more than the control group. Young adults should be screened for thrombophilia even in the presence of transient acquired risk factors. Pregnancy and treatment with estrogen drugs essentially when associated with inherited thrombophilia represent a frequent cause of venous thrombosis among young female patients. Inferior vena cava abnormalities should be excluded in young patients with spontaneous proximal venous thrombosis especially when recurrent venous thrombosis or resistance to anticoagulation are observed.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "chronic periodontitis": {"__data__": {"id_": "chronic periodontitis", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "chronic periodontitis", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cancers": {"__data__": {"id_": "cancers", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "cancers", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "free radicals": {"__data__": {"id_": "free radicals", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "free radicals", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "8 hydroxydeoxyguanosine": {"__data__": {"id_": "8 hydroxydeoxyguanosine", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "8 hydroxydeoxyguanosine", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "inflammatory conditions": {"__data__": {"id_": "inflammatory conditions", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "inflammatory conditions", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "diabetes mellitus": {"__data__": {"id_": "diabetes mellitus", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "diabetes mellitus", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "periodontal disease": {"__data__": {"id_": "periodontal disease", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "periodontal disease", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "8 hydroxy 2' deoxiguanosine": {"__data__": {"id_": "8 hydroxy 2' deoxiguanosine", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "8 hydroxy 2' deoxiguanosine", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid38338704": {"__data__": {"id_": "pmid38338704", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid38338704: Title: Using 8-Hydroxy-2'-Deoxiguanosine (8-OHdG) as a Reliable Biomarker for Assessing Periodontal Disease Associated with Diabetes. Abstract: In recent years, research has shown that oxidative stress plays a significant role in chronic inflammatory conditions. The alteration of the oxidant/antioxidant balance leads to the appearance of free radicals, important molecules involved in both diabetes mellitus and periodontal disease. Diabetes is considered to be one of the major risk factors of periodontal disease and the inflammation characterizing this condition is associated with oxidative stress, implicitly resulting in oxidative damage to DNA. 8-Hydroxydeoxyguanosine (8-OHdG) is the most common stable product of oxidative DNA damage caused by reactive oxygen species, and its levels have been reported to increase in body fluids and tissues during inflammatory conditions. 8-OHdG emerges as a pivotal biomarker for assessing oxidative DNA damage, demonstrating its relevance across diverse health conditions, including neurodegenerative disorders, cancers, inflammatory conditions, and periodontal disease. Continued research in this field is crucial for developing more precise treatments and understanding the detailed link between oxidative stress and the progression of periodontitis. The use of the 8-OHdG biomarker in assessing and managing chronic periodontitis is an area of increased interest in dental research, with the potential to provide crucial information for diagnosis and treatment.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "tau": {"__data__": {"id_": "tau", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "tau", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "microtubule associated protein": {"__data__": {"id_": "microtubule associated protein", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "microtubule associated protein", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid7566342": {"__data__": {"id_": "pmid7566342", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid7566342: Title: Molecular dissection of the paired helical filament. Abstract: Abundant neurofibrillary tangles, neuropil threads and plaque neurites constitute the neurofibrillary pathology of Alzheimer's disease. They form in the nerve cells that undergo degeneration in the disease where their regional distribution correlates with the degree of dementia. Each lesion contains the paired helical filament (PHF) as its major fibrous component. Recent work has shown that PHFs are composed of the microtubule-associated protein tau in a hyperphosphorylated state. PHF-tau is hyperphosphorylated on six adult brain tau isoforms. As a consequence, tau is unable to bind to microtubules and is believed to self-assemble into the PHF. Current evidence suggests that protein kinases or protein phosphatases with a specificity for serine/threonine-proline residues play an important role in the hyperphosphorylation of tau. Candidate protein kinases include mitogen-activated protein kinase, glycogen synthase kinase-3 and cyclin-dependent kinase 5, whereas the trimeric form of protein phosphatase 2A is a candidate phosphatase.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid31882381": {"__data__": {"id_": "pmid31882381", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid31882381: Title: Intraoperative Optimization of Both Depth of Anesthesia and Cerebral Oxygenation in Elderly Patients Undergoing Coronary Artery Bypass Graft Surgery-A Randomized Controlled Pilot Trial.\n Abstract: OBJECTIVES: Does intraoperative optimization of both depth of anesthesia and regional cerebral tissue oxygenation (rScO2) in elderly patients reduce postoperative cognitive decline (primary outcome) or delirium (secondary outcome)? DESIGN: Prospective randomized controlled single blind trial. SETTING: A single major urban teaching and university hospital and tertiary referral center. PARTICIPANTS: Patients, 65 years of age and older, undergoing elective coronary artery bypass graft surgery on cardiopulmonary bypass. INTERVENTIONS: Intraoperative depth of anesthesia bispectral index (BIS) values were targeted at 50 +- 10. Regional cerebral tissue desaturations of more than 15% of the pre-induction value, or below 50%, were avoided. MEASUREMENTS AND MAIN RESULTS: Eighty-two patients were included, and mean depth of anesthesia values using BIS were significantly higher during surgery in the intervention group with 40.6 (7.3) versus 35.4 (6.7) in the control group, mean (standard deviation), p = 0.004. The cognitive function was similar between the treatment and control groups at 6 weeks postoperatively with a Mini Mental State Examination (MMSE) of 27 (26,29) in the intervention group and an MMSE of 29 (27,29) in the control group, median (interquartile range), with p = 0.12. The authors observed a reduction in the incidence of delirium, occurring in 2.4% (n = 1) of patients in the intervention group and in 20% (n = 8) in the control group (p = 0.01). CONCLUSIONS: This pilot trial demonstrates that noninvasive target-controlled depth of anesthesia monitoring is feasible. Cognitive function at 6 weeks showed no difference between the treatment and control groups; however, postoperative delirium was reduced in the intervention group.\n.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "heme": {"__data__": {"id_": "heme", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "heme", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "fe": {"__data__": {"id_": "fe", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "fe", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "human cerebral cortex": {"__data__": {"id_": "human cerebral cortex", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "human cerebral cortex", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cytochrome b": {"__data__": {"id_": "cytochrome b", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "cytochrome b", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pros": {"__data__": {"id_": "pros", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pros", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "amyloid beta (abeta) peptides": {"__data__": {"id_": "amyloid beta (abeta) peptides", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "amyloid beta (abeta) peptides", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "reduced oxygen species": {"__data__": {"id_": "reduced oxygen species", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "reduced oxygen species", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "his": {"__data__": {"id_": "his", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "his", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "amyloid": {"__data__": {"id_": "amyloid", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "amyloid", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid26816006": {"__data__": {"id_": "pmid26816006", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid26816006: Title: Peroxidase to Cytochrome b Type Transition in the Active Site of Heme-Bound Amyloid beta Peptides Relevant to Alzheimer's Disease. Abstract: Recent evidence has established the colocalization of amyloid-rich plaques and heme-rich deposits in the human cerebral cortex as a common postmortem feature in Alzheimer's disease (AD). The amyloid beta (Abeta) peptides have been shown to bind heme, and the resultant heme-Abeta complexes can generate toxic partially reduced oxygen species (PROS) and exhibit peroxidase activity. The heme-Abeta active site exhibits a concentration-dependent equilibrium between a high-spin mono-His-bound species similar to a peroxidase-type active site and a bis-His-bound six-coordinate low-spin species similar to that of a cytochrome b type active site. The nu(Fe-His) (241 cm(-1)) vibration has been identified in the high-spin heme-Abeta active site by resonance Raman spectroscopy. The formation of the low-spin heme-Abeta species is promoted by the His14 and noncoordinating second-sphere Arg5 residues. The high-spin state produces more PROS than the low-spin species. Nonbiological constructs modeling different forms of Abeta (oligomers, fibrils, etc.) suggest that the detrimental high-spin state is likely to dominate under most physiological conditions.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "spine toxicity": {"__data__": {"id_": "spine toxicity", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "spine toxicity", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid23860033": {"__data__": {"id_": "pmid23860033", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid23860033: Title: Dendritic spine density, morphology, and fibrillar actin content surrounding amyloid-beta plaques in a mouse model of amyloid-beta deposition. Abstract: Dendritic spines are the site of most excitatory synapses, the loss of which correlates with cognitive impairment in patients with Alzheimer disease. Substantial evidence indicates that amyloid-beta (Abeta) peptide, either insoluble fibrillar Abeta deposited into plaques or soluble nonfibrillar Abeta species, can cause spine loss but the concurrent contributions of fibrillar Abeta and nonfibrillar Abeta to spine loss has not been previously assessed. We used multiple-label immunohistochemistry to measure spine density, size, and F-actin content surrounding plaques in the cerebral cortex in the PSAPP mouse model of Abeta deposition. Our approach allowed us to measure fibrillar Abeta plaque content and an index of nonfibrillar Abeta species concurrently. We found that spine density was reduced within 6 mum of the plaque perimeter, remaining spines were more compact, and F-actin content per spine was increased. Measures of fibrillar Abeta plaque content were associated with reduced spine density near plaques, whereas measures of nonfibrillar Abeta species were associated with reduced spine density and size but not altered F-actin content. These findings suggest that strategies to preserve dendritic spines in AD patients may need to address both nonfibrillar and fibrillar forms of Abeta and that nonfibrillar Abeta may exert spine toxicity through pathways not mediated by depolymerization of F-actin.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "abeta": {"__data__": {"id_": "abeta", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "abeta", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ca2+": {"__data__": {"id_": "ca2+", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "ca2+", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "bapta am": {"__data__": {"id_": "bapta am", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "bapta am", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "u73122": {"__data__": {"id_": "u73122", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "u73122", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "phospholipase c": {"__data__": {"id_": "phospholipase c", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "phospholipase c", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "2 apb": {"__data__": {"id_": "2 apb", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "2 apb", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "corneal damage": {"__data__": {"id_": "corneal damage", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "corneal damage", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cornea": {"__data__": {"id_": "cornea", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "cornea", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ginseng gintonin": {"__data__": {"id_": "ginseng gintonin", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "ginseng gintonin", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "lpa1/3 receptor": {"__data__": {"id_": "lpa1/3 receptor", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "lpa1/3 receptor", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ki16425": {"__data__": {"id_": "ki16425", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "ki16425", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "corneal wound healing": {"__data__": {"id_": "corneal wound healing", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "corneal wound healing", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid27586470": {"__data__": {"id_": "pmid27586470", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid27586470: Title: Gintonin, an exogenous ginseng-derived LPA receptor ligand, promotes corneal wound healing. Abstract: Ginseng gintonin is an exogenous ligand of lysophosphatidic acid (LPA) receptors. Accumulating evidence shows LPA helps in rapid recovery of corneal damage. The aim of this study was to evaluate the therapeutic efficacy of gintonin in a rabbit model of corneal damage. We investigated the signal transduction pathway of gintonin in human corneal epithelium (HCE) cells to elucidate the underlying molecular mechanism. We next evaluated the therapeutic effects of gintonin, using a rabbit model of corneal damage, by undertaking histochemical analysis. Treatment of gintonin to HCE cells induced transient increases of [Ca2+]i in concentration-dependent and reversible manners. Gintonin-mediated mobilization of [Ca2+]i was attenuated by LPA1/3 receptor antagonist Ki16425, phospholipase C inhibitor U73122, inositol 1,4,5-triphosphate receptor antagonist 2-APB, and intracellular Ca2+ chelator BAPTA-AM. Gintonin facilitated in vitro wound healing in a concentration-dependent manner. When applied as an eye-drop to rabbits with corneal damage, gintonin rapidly promoted recovery. Histochemical analysis showed gintonin decreased corneal apoptosis and increased corneal cell proliferation. We demonstrated that LPA receptor activation by gintonin is linked to in vitro and in vivo therapeutic effects against corneal damage. Gintonin can be applied as a clinical agent for the rapid healing of corneal damage.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "evp 6124": {"__data__": {"id_": "evp 6124", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "evp 6124", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "alpha7 nicotinic acetylcholine receptor": {"__data__": {"id_": "alpha7 nicotinic acetylcholine receptor", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "alpha7 nicotinic acetylcholine receptor", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "encenicline": {"__data__": {"id_": "encenicline", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "encenicline", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "brain disease": {"__data__": {"id_": "brain disease", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "brain disease", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "brain": {"__data__": {"id_": "brain", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "brain", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid25495510": {"__data__": {"id_": "pmid25495510", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid25495510: Title: Safety and clinical effects of EVP-6124 in subjects with Alzheimer's disease currently or previously receiving an acetylcholinesterase inhibitor medication. Abstract: Alzheimer's disease (AD) is a prevalent and currently incurable brain disease whose impact will continue to rise as the population ages. With limited treatment options, a variety of experimental therapies are currently in clinical trials. EVP-6124 (encenicline) is an alpha7 nicotinic acetylcholine receptor partial agonist under investigation for the symptomatic treatment of AD. EVP-6124 activates the alpha7 nicotinic acetylcholine receptor at low nanomolar brain concentrations and improves memory performance in rats. Treatment with EVP-6124 in Phase I and II trials involving patients with mild-to-moderate AD was well tolerated and showed statistically significant improvements compared with placebo on cognitive and functional measures. Two Phase III trials under the title COGNITIV AD will assess the efficacy and tolerability of EVP-6124 in patients with mild-to-moderate AD. Based on the completed clinical trials and proposed mechanism of action, EVP-6124 would appear to be a good candidate for therapy in combination with cholinesterase inhibitors.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "tissue damage": {"__data__": {"id_": "tissue damage", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "tissue damage", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "glucose regulatory protein 78": {"__data__": {"id_": "glucose regulatory protein 78", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "glucose regulatory protein 78", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "glucagon like peptide 1 (glp 1) receptor": {"__data__": {"id_": "glucagon like peptide 1 (glp 1) receptor", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "glucagon like peptide 1 (glp 1) receptor", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "spinal cord injury": {"__data__": {"id_": "spinal cord injury", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "spinal cord injury", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "exenatide": {"__data__": {"id_": "exenatide", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "exenatide", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "hypoglycemia": {"__data__": {"id_": "hypoglycemia", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "hypoglycemia", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c/ebp homologous transcription factor protein": {"__data__": {"id_": "c/ebp homologous transcription factor protein", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "c/ebp homologous transcription factor protein", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "injury": {"__data__": {"id_": "injury", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "injury", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "contusive": {"__data__": {"id_": "contusive", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "contusive", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "injured spinal cord": {"__data__": {"id_": "injured spinal cord", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "injured spinal cord", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "diabetes": {"__data__": {"id_": "diabetes", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "diabetes", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid37822517": {"__data__": {"id_": "pmid37822517", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid37822517: Title: Administration of the GLP-1 receptor agonist exenatide in rats improves functional recovery after spinal cord injury by reducing endoplasmic reticulum stress. Abstract: After spinal cord injury (SCI), endoplasmic reticulum (ER) stress has been reported to be an integral part of the secondary injury process that causes apoptosis of glial cells, leading to remyelination failure. This report focuses on exenatide, a glucagon-like peptide-1 (GLP-1) receptor agonist widely used to treat diabetes, as a potential agent to improve functional outcome after SCI by improving the ER stress response. Exenatide administered subcutaneously immediately after injury and 7 days later in a rat model of moderate contusive SCI revealed significant improvement in hindlimb function without any hypoglycemia. Changes in the expression of glucose regulatory protein 78 (GRP78), an endoplasmic reticulum chaperone that protects against ER stress, and C/EBP homologous transcription factor protein (CHOP), a pro-apoptotic transcription factor in the apoptosis pathway were examined as indices of ER stress. We found that administration of exenatide after SCI suppressed CHOP while increasing GRP78 in the injured spinal cord, leading to a significant decrease in tissue damage and a significant increase in oligodendrocyte progenitor cell survival. This study suggests that administration of exenatide after SCI decreases ER stress and improves functional recovery without any apparent side-effects.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "protein misfolding disorders": {"__data__": {"id_": "protein misfolding disorders", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "protein misfolding disorders", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pancreatic damage": {"__data__": {"id_": "pancreatic damage", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pancreatic damage", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "hyperglycemia": {"__data__": {"id_": "hyperglycemia", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "hyperglycemia", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "insulin": {"__data__": {"id_": "insulin", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "insulin", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "islet amyloid polypeptide": {"__data__": {"id_": "islet amyloid polypeptide", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "islet amyloid polypeptide", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "prion diseases": {"__data__": {"id_": "prion diseases", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "prion diseases", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid28159831": {"__data__": {"id_": "pmid28159831", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid28159831: Title: Prion-Like Protein Aggregates and Type 2 Diabetes. Abstract: Type 2 diabetes (T2D) is a highly prevalent metabolic disease characterized by chronic insulin resistance and beta-cell dysfunction and loss, leading to impaired insulin release and hyperglycemia. Although the mechanism responsible for beta-cell dysfunction and death is not completely understood, recent findings suggest that the accumulation of misfolded aggregates of the islet amyloid polypeptide (IAPP) in the islets of Langerhans may play an important role in pancreatic damage. Misfolding and aggregation of diverse proteins and their accumulation as amyloid in different organs is the hallmark feature in a group of chronic, degenerative diseases termed protein misfolding disorders (PMDs). PMDs include highly prevalent human illnesses such as Alzheimer's and Parkinson's disease, as well as more than 25 rarer disorders. Among them, prion diseases are unique because the pathology can be transmitted by a proteinaceous infectious agent, termed a prion, which induces disease by propagating protein misfolding and aggregation. This phenomenon has a striking resemblance to the process of protein misfolding and aggregation in all of the PMDs, suggesting that misfolded aggregates have an intrinsic potential to be transmissible. Indeed, recent studies have shown that the pathological hallmarks of various PMDs can be induced in vivo under experimental conditions by inoculating tissue extracts containing protein aggregates into animal models. In this review, we describe our current understanding of the molecular mechanism underlying the prion-like transmission of protein aggregates and its possible role in T2D.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "amyloid deposits": {"__data__": {"id_": "amyloid deposits", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "amyloid deposits", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "familial british dementia": {"__data__": {"id_": "familial british dementia", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "familial british dementia", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "autosomal dominant condition": {"__data__": {"id_": "autosomal dominant condition", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "autosomal dominant condition", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "amyloid angiopathy": {"__data__": {"id_": "amyloid angiopathy", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "amyloid angiopathy", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "furin": {"__data__": {"id_": "furin", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "furin", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "abripp": {"__data__": {"id_": "abripp", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "abripp", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid12883829": {"__data__": {"id_": "pmid12883829", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid12883829: Title: Familial British dementia: colocalization of furin and ABri amyloid. Abstract: Familial British dementia (FBD) is an autosomal dominant condition caused by a point mutation in the stop codon of the BRI gene. This mutation extends the normal precursor protein (PP) of 266 amino acids to the next stop codon, which is at amino acid 277. Kim and colleagues demonstrated in vitro that furin can process both the normal protein BriPP and the extended protein ABriPP to produce C-terminal fragments of 23 and 34 amino acids. The abnormal C-terminal fragment, ABri, accumulates in FBD in the form of extracellular amyloid deposits. The objective of our study was to determine if furin is associated with ABri in FBD. Brain tissue of one case of FBD, four cases of Alzheimer's disease (AD) and two controls were studied by immunohistochemistry using antibodies against furin, beta-amyloid protein and ABri. In FBD, furin was found to be colocalized with ABri deposits and amyloid angiopathy in all areas examined. In contrast beta-amyloid deposits in AD were not immunostained by the furin antibody. In normal as well as pathological cases, clusters of neurons in the hippocampus and neocortex showed light to moderate furin immunostaining, while peptidergic neurons of the hypothalamus showed intense furin-immunostaining. These data suggest that furin may be involved in producing the pathological fragment of ABriPP in vivo and that inhibition of furin might be a method of treating this disorder.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "chronic": {"__data__": {"id_": "chronic", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "chronic", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "gfap": {"__data__": {"id_": "gfap", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "gfap", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "neurodegeneration": {"__data__": {"id_": "neurodegeneration", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "neurodegeneration", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "strawberry notch homolog 2": {"__data__": {"id_": "strawberry notch homolog 2", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "strawberry notch homolog 2", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "interleukin 6": {"__data__": {"id_": "interleukin 6", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "interleukin 6", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "gp130": {"__data__": {"id_": "gp130", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "gp130", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid35624480": {"__data__": {"id_": "pmid35624480", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid35624480: Title: Strawberry notch homolog 2 regulates the response to interleukin-6 in the central nervous system. Abstract: BACKGROUND: The cytokine interleukin-6 (IL-6) modulates a variety of inflammatory processes and, context depending, can mediate either pro- or anti-inflammatory effects. Excessive IL-6 signalling in the brain is associated with chronic inflammation resulting in neurodegeneration. Strawberry notch homolog 2 (Sbno2) is an IL-6-regulated gene whose function is largely unknown. Here we aimed to address this issue by investigating the impact of Sbno2 disruption in mice with IL-6-mediated neuroinflammation. METHODS: Mice with germline disruption of Sbno2 (Sbno2-/-) were generated and crossed with transgenic mice with chronic astrocyte production of IL-6 (GFAP-IL6). Phenotypic, molecular and transcriptomic analyses were performed on tissues and primary cell cultures to clarify the role of SBNO2 in IL-6-mediated neuroinflammation. RESULTS: We found Sbno2-/- mice to be viable and overtly normal. By contrast GFAP-IL6 x Sbno2-/- mice had more severe disease compared with GFAP-IL6 mice. This was evidenced by exacerbated neuroinflammation and neurodegeneration and enhanced IL-6-responsive gene expression. Cell culture experiments on primary astrocytes from Sbno2-/- mice further showed elevated and sustained transcript levels of a number of IL-6 stimulated genes. Notably, despite enhanced disease in vivo and gene expression both in vivo and in vitro, IL-6-stimulated gp130 pathway activation was reduced when Sbno2 is disrupted. CONCLUSION: Based on these results, we propose a role for SBNO2 as a novel negative feedback regulator of IL-6 that restrains the excessive inflammatory actions of this cytokine in the brain.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "resistin": {"__data__": {"id_": "resistin", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "resistin", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "obesity": {"__data__": {"id_": "obesity", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "obesity", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "diabetic mci": {"__data__": {"id_": "diabetic mci", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "diabetic mci", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "hyperlipidemia": {"__data__": {"id_": "hyperlipidemia", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "hyperlipidemia", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "type 2 diabetes mellitus": {"__data__": {"id_": "type 2 diabetes mellitus", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "type 2 diabetes mellitus", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "metabolic abnormalities": {"__data__": {"id_": "metabolic abnormalities", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "metabolic abnormalities", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid32333593": {"__data__": {"id_": "pmid32333593", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid32333593: Title: High Plasma Resistin Levels Portend the Insulin Resistance-Associated Susceptibility to Early Cognitive Decline in Patients with Type 2 Diabetes Mellitus. Abstract: BACKGROUND: Metabolic disorders, including insulin resistance, obesity, and hyperlipidemia occur frequently prior to hyperglycemia in patients with type 2 diabetes mellitus (T2DM) and cause mild cognitive impairment (MCI). OBJECTIVE: We investigated the involvement of resistin in these metabolic abnormalities contributes to MCI in patients with T2DM. METHODS: A total of 138 hospitalized patients with T2DM were enrolled and categorized into MCI and non-MCI groups according to the Montreal Cognitive Assessment (MoCA) score. Metabolic indicators and cognitive state were assessed, and plasma resistin levels were determined by ELISA. RESULTS: The resistin levels and homeostasis model assessment of insulin resistance (HOMA-IR) scores of MCI and gender-stratified subgroups were significantly higher than those of controls without MCI (all p < 0.01). Correlation analysis showed that the resistin level was negatively associated with majority of cognitive domains, e.g., MoCA (r = -0.693, p < 0.001) and Mini-Mental State Examination (r = -0.571, p < 0.001), and was related to HOMA-IR (r = 0.667, p < 0.001) but not to obesity and lipid indices. Multivariable regression analysis indicated that resistin (beta= -0.675, p < 0.001) and educational level (beta= 0.177, p = 0.003) were independent risk factors of MoCA in patients with T2DM. CONCLUSIONS: High plasma resistin levels portend the insulin resistance-related susceptibility to early cognitive decline in Chinese patients with T2DM. The involvement of this adipokine in other metabolic disorders leading to diabetic MCI and its clinical value for early disease screening must be further studied.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "aripiprazole": {"__data__": {"id_": "aripiprazole", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "aripiprazole", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "quetiapine": {"__data__": {"id_": "quetiapine", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "quetiapine", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "extrapyramidal symptoms": {"__data__": {"id_": "extrapyramidal symptoms", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "extrapyramidal symptoms", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "sertindole": {"__data__": {"id_": "sertindole", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "sertindole", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "clozapine": {"__data__": {"id_": "clozapine", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "clozapine", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "risperidone": {"__data__": {"id_": "risperidone", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "risperidone", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "haloperidol": {"__data__": {"id_": "haloperidol", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "haloperidol", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "zotepine": {"__data__": {"id_": "zotepine", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "zotepine", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "olanzapine": {"__data__": {"id_": "olanzapine", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "olanzapine", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "atypical antipsychotics": {"__data__": {"id_": "atypical antipsychotics", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "atypical antipsychotics", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "asenapine": {"__data__": {"id_": "asenapine", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "asenapine", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "paliperidone": {"__data__": {"id_": "paliperidone", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "paliperidone", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "lurasidone": {"__data__": {"id_": "lurasidone", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "lurasidone", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "amisulpiride": {"__data__": {"id_": "amisulpiride", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "amisulpiride", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid30181002": {"__data__": {"id_": "pmid30181002", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid30181002: Title: Efficacy and Tolerability of Atypical Antipsychotics in the Treatment of Delirium: A Systematic Review of the Literature.\n Abstract: BACKGROUND: Although haloperidol is the most widely used drug in the treatment of delirium, evidence on the relevance of atypical antipsychotics (AAPs) is growing. OBJECTIVE: To review the literature on the efficacy and tolerability of AAPs in the treatment of delirium. METHODS: A systematic search of the literature published before April 2018 was performed on PubMed using the following search strings: \"Delirium\" and \"Atypical antipsychotics\", \"Novel antipsychotics\", \"New antipsychotics\", \"Quetiapine\", \"Olanzapine\", \"Aripiprazole\", \"Risperidone\", \"Paliperidone\", \"Clozapine\", \"Asenapine\", \"Iloperidone\", \"Amisulpiride\", \"Ziprasidone\", \"Zotepine\", \"Sertindole\", \"Lurasidone\" or \"Perospirone\". RESULTS: Twelve randomized controlled trials (RCTs) and 22 open trials were considered. Despite an overall lack of large-scale RCTs, there is some evidence supporting the efficacy of olanzapine and quetiapine in placebo controlled trials. In a recent and large RCT in elderly patients, risperidone and/or haloperidol were associated with a significantly worse outcome than placebo. While preliminary, the current comparative studies suggest that haloperidol and the AAPs olanzapine, quetiapine and risperidone are similarly effective, although treatment with AAPs is associated with a reduced incidence of extrapyramidal symptoms. Ziprasidone was not shown to be effective. No RCTs are available for other AAPs. CONCLUSIONS: Although the current evidence of the efficacy and tolerability of AAPs in the treatment of delirium is limited and the heterogeneity of the data precluded a meta-analysis, olanzapine and quetiapine seem to be adequate alternatives to haloperidol, especially in patients who are vulnerable for extrapyramidal symptoms, who require sedation or who have a history of haloperidol intolerance. Evidently, larger-scale RCTs are urgently required.\n.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ziprasidone": {"__data__": {"id_": "ziprasidone", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "ziprasidone", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "perospirone": {"__data__": {"id_": "perospirone", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "perospirone", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "iloperidone": {"__data__": {"id_": "iloperidone", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "iloperidone", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "abeta1 42": {"__data__": {"id_": "abeta1 42", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "abeta1 42", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "dentate gyrus": {"__data__": {"id_": "dentate gyrus", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "dentate gyrus", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "app": {"__data__": {"id_": "app", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "app", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "abeta1 40": {"__data__": {"id_": "abeta1 40", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "abeta1 40", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "doublecortin": {"__data__": {"id_": "doublecortin", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "doublecortin", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "neurogenesis": {"__data__": {"id_": "neurogenesis", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "neurogenesis", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid19219917": {"__data__": {"id_": "pmid19219917", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid19219917: Title: Age effects on the regulation of adult hippocampal neurogenesis by physical activity and environmental enrichment in the APP23 mouse model of Alzheimer disease. Abstract: An active lifestyle is to some degree protective against Alzheimer's disease (AD), but the biological basis for this benefit is still far from clear. We hypothesize that physical and cognitive activity increase a reserve for plasticity by increasing adult neurogenesis in the hippocampal dentate gyrus (DG). We thus assessed how age affects the response to activity in the murine APP23 model of AD compared with wild type (WT) controls and studied the effects of physical exercise (RUN) and environmental enrichment (ENR) in comparison with standard housing (CTR) at two different ages (6 months and 18 months) and in both genotypes. At 18 months, both activity paradigms reduced the hippocampal human Abeta1-42/Abeta1-40 ratio when compared with CTR, despite a stable plaque load in the hippocampus. At this age, both RUN and ENR increased the number of newborn granule cells in the DG of APP23 mice when compared with CTR, whereas the levels of regulation were equivalent to those in WT mice under the same housing conditions. At 6 months, however, neurogenesis in ENR but not RUN mice responded like the WT. Quantifying the number of cells at the doublecortin-positive stage in relation to the number of cells on postmitotic stages we found that ENR overproportionally increased the number of the DCX-positive \"late\" progenitor cells, indicative of an increased potential to recruit even more new neurons. In summary, the biological substrates for activity-dependent regulation of adult hippocampal neurogenesis were preserved in the APP23 mice. We thus propose that in this model, ENR even more than RUN might contribute to a \"neurogenic reserve\" despite a stable plaque load and that age affects the outcome of an interaction based on \"activity.\"", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "brain disorders": {"__data__": {"id_": "brain disorders", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "brain disorders", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cardiovascular and metabolic disorders": {"__data__": {"id_": "cardiovascular and metabolic disorders", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "cardiovascular and metabolic disorders", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "brain damage": {"__data__": {"id_": "brain damage", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "brain damage", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid28711402": {"__data__": {"id_": "pmid28711402", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid28711402: Title: Beneficial effects of Angiotensin II receptor blockers in brain disorders. Abstract: A canonical brain Renin-Angiotensin System (RAS), like the canonical peripheral RAS, has long been proposed as a major regulator of brain function. Because of methodological limitations, however, this system is in urgent need of critical revision. The Angiotensin II AT1 receptors have been confirmed as key factors in the regulation of brain function, and AT1 receptor over activity has been established as a major and early injury factor in the development of many brain diseases. Consequently, Angiotensin Receptor Blockers (ARBs), compounds widely used to treat cardiovascular and metabolic disorders, are excellent candidates for repurposing for the treatment of brain disorders. This review will discuss some of the reasons why revisiting brain RAS is a pressing necessity, will present evidence for a participation of AT1 receptor over activity in the development of major brain disorders, and will present definite evidence of ARBs neuroprotective effects. The review will focus on the beneficial effects of ARB therapy in stroke, neurodegenerative disorders including Alzheimer's and Parkinson's diseases, traumatic brain injury, radiation- induced brain damage, stress and mood disorders.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cd44": {"__data__": {"id_": "cd44", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "cd44", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "melanoma": {"__data__": {"id_": "melanoma", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "melanoma", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "fgf2": {"__data__": {"id_": "fgf2", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "fgf2", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "spp1": {"__data__": {"id_": "spp1", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "spp1", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "amyloid plaques": {"__data__": {"id_": "amyloid plaques", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "amyloid plaques", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid37838728": {"__data__": {"id_": "pmid37838728", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid37838728: Title: Copper metabolism-related Genes in entorhinal cortex for Alzheimer's disease. Abstract: The pathological features of Alzheimer's disease are the formation of amyloid plaques and entanglement of nerve fibers. Studies have shown that Cu may be involved in the formation of amyloid plaques. However, their role has been controversial. The aim of this study was to explore the role of Cu in AD. We applied the \"R\" software for our differential analysis. Differentially expressed genes were screened using the limma package. Copper metabolism-related genes and the intersection set of differential genes with GSE5281 were searched; functional annotation was performed. The protein-protein interaction network was constructed using several modules to analyse the most significant hub genes. The hub genes were then qualified, and a database was used to screen for small-molecule AD drugs. We identified 87 DEGs. gene ontology analysis focused on homeostatic processes, response to toxic substances, positive regulation of transport, and secretion. The enriched molecular functions are mainly related to copper ion binding, molecular function regulators, protein-containing complex binding, identical protein binding and signalling receptor binding. The KEGG database is mainly involved in central carbon metabolism in various cancers, Parkinson's disease and melanoma. We identified five hub genes, FGF2, B2M, PTPRC, CD44 and SPP1, and identified the corresponding small molecule drugs. Our study identified key genes possibly related to energy metabolism in the pathological mechanism of AD and explored potential targets for AD treatment by establishing interaction networks.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ptprc": {"__data__": {"id_": "ptprc", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "ptprc", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b2m": {"__data__": {"id_": "b2m", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "b2m", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid31640836": {"__data__": {"id_": "pmid31640836", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid31640836: Title: Implementing dementia risk reduction in primary care: a preliminary conceptual model based on a scoping review of practitioners' views. Abstract: Primary care practitioners (PCPs) do not routinely promote dementia risk reduction. The purpose of this study was to map the published literature on the views of PCPs about dementia risk reduction, in order to identify implementation constructs and strategies crucial to the development of an implementation intervention to support dementia risk reduction in primary care. We undertook a scoping review of the PCPs' views about promoting brain health for reducing dementia risk. We searched MEDLINE, PsycINFO, CINAHL, and Embase for English-language articles published between 1995 and December 2017. We then applied the Consolidated Framework for Implementation Research (CFIR) and matched Expert Recommendations for Implementing Change to the scoping review findings in order to develop a preliminary implementation model. Eight articles reported views of PCPs about dementia prevention. Study findings were mapped to 5 of the 39 CFIR constructs: (i) knowledge and beliefs about dementia risk reduction, (ii) evidence strength and quality, (iii) relative priority, (iv) available resources, and (v) external policy and incentives. The findings suggest implementation strategies to consider in our preliminary model include (i) educational meetings, (ii) identifying and preparing champions, (iii) conducting local consensus discussions, (iv) altering incentive structures, and (v) capturing and sharing local knowledge. There have been few studies about the views of PCPs about dementia risk reduction. Implementation in the primary care setting is fundamental to early identification of risk and supporting preventive practices, but it needs to focus on more than just education for PCPs. We need more up-to-date and in-depth data on the views of PCPs about dementia risk reduction and context-specific analyses of implementation needs. Further research into effective primary care interventions to reduce dementia risk is expected to support implementation efforts.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "malnutrition": {"__data__": {"id_": "malnutrition", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "malnutrition", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid25565783": {"__data__": {"id_": "pmid25565783", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid25565783: Title: Preoperative assessment of the older surgical patient: honing in on geriatric syndromes.\n Abstract: Nearly 50% of Americans will have an operation after the age of 65 years. Traditional preoperative anesthesia consultations capture only some of the information needed to identify older patients (defined as >=65 years of age) undergoing elective surgery who are at increased risk for postoperative complications, prolonged hospital stays, and delayed or hampered functional recovery. As a catalyst to this review, we compared traditional risk scores (eg, cardiac-focused) to geriatric-specific risk measures from two older female patients seen in our preoperative clinic who were scheduled for elective, robotic-assisted hysterectomies. Despite having a lower cardiac risk index and Charlson comorbidity score, the younger of the two patients presented with more subtle negative geriatric-specific risk predictors - including intermediate or pre-frail status, borderline malnutrition, and reduced functional/mobility - which may have contributed to her 1-day-longer length of stay and need for readmission. Adequate screening of physiologic and cognitive reserves in older patients scheduled for surgery could identify at-risk, vulnerable elders and enable proactive perioperative management strategies (eg, strength, balance, and mobility prehabilitation) to reduce adverse postoperative outcomes and readmissions. Here, we describe our initial two cases and review the stress response to surgery and the impact of advanced age on this response as well as preoperative geriatric assessments, including frailty, nutrition, physical function, cognition, and mood state tests that may better predict postoperative outcomes in older adults. A brief overview of the literature on anesthetic techniques that may influence geriatric-related syndromes is also presented. \n.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "postoperative complications": {"__data__": {"id_": "postoperative complications", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "postoperative complications", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "geriatric syndromes": {"__data__": {"id_": "geriatric syndromes", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "geriatric syndromes", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "indole": {"__data__": {"id_": "indole", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "indole", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "amantadine": {"__data__": {"id_": "amantadine", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "amantadine", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "neurological disorders": {"__data__": {"id_": "neurological disorders", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "neurological disorders", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "nitric oxide": {"__data__": {"id_": "nitric oxide", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "nitric oxide", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "polycyclic compounds": {"__data__": {"id_": "polycyclic compounds", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "polycyclic compounds", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "aminoguanidine": {"__data__": {"id_": "aminoguanidine", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "aminoguanidine", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7 nitroindazole": {"__data__": {"id_": "7 nitroindazole", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "7 nitroindazole", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "nitric oxide synthase": {"__data__": {"id_": "nitric oxide synthase", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "nitric oxide synthase", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "indazole": {"__data__": {"id_": "indazole", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "indazole", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "l arginine": {"__data__": {"id_": "l arginine", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "l arginine", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "polycyclic": {"__data__": {"id_": "polycyclic", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "polycyclic", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "parkinson's and alzheimer's disease": {"__data__": {"id_": "parkinson's and alzheimer's disease", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "parkinson's and alzheimer's disease", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid18805011": {"__data__": {"id_": "pmid18805011", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid18805011: Title: Fluorescent polycyclic ligands for nitric oxide synthase (NOS) inhibition. Abstract: In recent years polycyclic compounds have been shown to exhibit pharmacological profiles of importance in the symptomatic and proposed curative treatment of neurodegenerative diseases (e.g., Parkinson's and Alzheimer's disease). These structures also show modification and improvement of the pharmacokinetic and pharmacodynamic properties of drugs in current use. Nitric oxide (NO) is a molecular messenger involved in a number of physiological processes in mammals. It is synthesised by nitric oxide synthase (NOS) from L-arginine and its overproduction could lead to a number of neurological disorders. The aim of this study was to synthesise a series of novel indazole, indole and other fluorescent derivatives conjugated to polycyclic structures for evaluation in NOS assays. NOS is a target system where fluorescent techniques and fluorescently labelled NOS inhibitors can be used for detecting the biophysical properties of enzyme-ligand interactions and thus facilitate development of novel inhibitors of neurodegeneration. This could lead to a greater insight into the neuroprotective mechanism and a possible cure/treatment for neurodegenerative diseases. A series of compounds incorporating polycyclic structures such as 3-hydroxy-4-aza-8-oxoheptacyclo[9.4.1.0.(2,10)0.(3,14)0.(4,9)0.(9,13)0(12,15)]tetradecane and amantadine as well as suitable fluorescent moieties were selected for synthesis. In the biological evaluation the oxyhaemoglobin (oxyHb) assay was employed to determine the activity of the novel compounds at an enzymatic level of NOS. IC(50) values of the novel fluorescent compounds were compared to that of aminoguanidine (AG) and 7-nitroindazole (7-NI), two known NOS inhibitors, and showed moderate to high affinity (IC(50) values ranging from 7.73 microM to 0.291 microM) for the NOS enzyme.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "otx2": {"__data__": {"id_": "otx2", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "otx2", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "visual cortex": {"__data__": {"id_": "visual cortex", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "visual cortex", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cortical plasticity": {"__data__": {"id_": "cortical plasticity", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "cortical plasticity", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "parvalbumin": {"__data__": {"id_": "parvalbumin", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "parvalbumin", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pnn": {"__data__": {"id_": "pnn", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pnn", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "sugars": {"__data__": {"id_": "sugars", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "sugars", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "glycosaminoglycan": {"__data__": {"id_": "glycosaminoglycan", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "glycosaminoglycan", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid26881132": {"__data__": {"id_": "pmid26881132", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid26881132: Title: Otx2-PNN Interaction to Regulate Cortical Plasticity. Abstract: The ability of the environment to shape cortical function is at its highest during critical periods of postnatal development. In the visual cortex, critical period onset is triggered by the maturation of parvalbumin inhibitory interneurons, which gradually become surrounded by a specialized glycosaminoglycan-rich extracellular matrix: the perineuronal nets. Among the identified factors regulating cortical plasticity in the visual cortex, extracortical homeoprotein Otx2 is transferred specifically into parvalbumin interneurons and this transfer regulates both the onset and the closure of the critical period of plasticity for binocular vision. Here, we review the interaction between the complex sugars of the perineuronal nets and homeoprotein Otx2 and how this interaction regulates cortical plasticity during critical period and in adulthood.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "gray matter loss": {"__data__": {"id_": "gray matter loss", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "gray matter loss", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid15925102": {"__data__": {"id_": "pmid15925102", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid15925102: Title: Voxel-based morphometry to discriminate early Alzheimer's disease from controls. Abstract: We assessed the accuracy of voxel-based morphometry (VBM) using a three-dimensional T1-weighted MRI in discriminating Alzheimer's disease (AD) in the very early stage of amnestic type of mild cognitive impairment and age-matched healthy controls. We randomly divided these subjects into two groups. The first group comprising 30 AD patients and 41 controls was used to identify the area with the most significant gray matter loss in patients compared to normal controls based on the voxel-based analysis of a group comparison. The second group comprising 31 patients and 41 controls was used to determine the discrimination accuracy of VBM. A Z-score map for a gray matter image of a subject was obtained by comparison with mean and standard deviation gray matter images of the controls for each voxel after anatomical standardization and voxel normalization to global mean using the following equation; Z-score=([control mean]-[individual value])/(control S.D.). Receiver operating characteristic curves for a Z-score in the bilateral medial temporal areas including the entorhinal cortex with the most significant loss in the first group showed a high discrimination accuracy of 87.8%. This result would open up a possibility for early diagnosis of AD using VBM.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid17170524": {"__data__": {"id_": "pmid17170524", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid17170524: Title: Hyponatremia, arginine vasopressin dysregulation, and vasopressin receptor antagonism.\n Abstract: Hyponatremia is often associated with arginine vasopressin (AVP) dysregulation that is regulated by the hypothalamo-neurohypophyseal tract in response to changes in plasma osmolality, commonly in patients with the syndrome of inappropriate antidiuretic hormone secretion (SIADH). Potentially lethal complications of hyponatremia most frequently involve the central nervous system and include anorexia, fatigue, lethargy, delirium, seizures, hypothermia and coma, and require prompt treatment. Chronic hyponatremia also complicates patient care and is associated with increased morbidity and mortality, particularly among patients with congestive heart failure. Conventional treatments for hyponatremia (e.g. fluid restriction, diuretic treatment, and sodium replacement) may not be effective in all patients and can lead to significant adverse events. Preclinical and clinical trial results have shown that AVP receptor antagonism is a promising approach to the treatment of hyponatremia that directly addresses the effects of increased AVP and consequent decreased aquaresis, the electrolyte-sparing excretion of free water. Agents that antagonize V(2) receptors promote aquaresis and can lead to increased serum sodium. Dual-receptor antagonism, in which both V(2) and V(1A) receptors are blocked, may provide additional benefits in patients with hyponatremia.\n.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "hypothermia": {"__data__": {"id_": "hypothermia", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "hypothermia", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "seizures": {"__data__": {"id_": "seizures", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "seizures", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "congestive heart failure": {"__data__": {"id_": "congestive heart failure", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "congestive heart failure", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "sodium": {"__data__": {"id_": "sodium", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "sodium", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "hyponatremia": {"__data__": {"id_": "hyponatremia", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "hyponatremia", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "lethargy": {"__data__": {"id_": "lethargy", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "lethargy", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "anorexia": {"__data__": {"id_": "anorexia", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "anorexia", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "water": {"__data__": {"id_": "water", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "water", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "premature death": {"__data__": {"id_": "premature death", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "premature death", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "movement disorders": {"__data__": {"id_": "movement disorders", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "movement disorders", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "dnj 14": {"__data__": {"id_": "dnj 14", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "dnj 14", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid26395859": {"__data__": {"id_": "pmid26395859", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid26395859: Title: Expression profile of a Caenorhabditis elegans model of adult neuronal ceroid lipofuscinosis reveals down regulation of ubiquitin E3 ligase components. Abstract: Cysteine string protein (CSP) is a chaperone of the Dnaj/Hsp40 family of proteins and is essential for synaptic maintenance. Mutations in the human gene encoding CSP, DNAJC5, cause adult neuronal ceroid lipofucinosis (ANCL) which is characterised by progressive dementia, movement disorders, seizures and premature death. CSP null models in mice, flies and worms have been shown to also exhibit similar neurodegenerative phenotypes. Here we have explored the mechanisms underlying ANCL disease progression using Caenorhaditis elegans mutant strains of dnj-14, the worm orthologue of DNAJC5. Transcriptional profiling of these mutants compared to control strains revealed a broad down-regulation of ubiquitin proteasome system (UPS)-related genes, in particular, components of multimeric RING E3 ubiquitin ligases including F-Box, SKR and BTB proteins. These data were supported by the observation that dnj-14 mutant worm strains expressing a GFP-tagged ubiquitin fusion degradation substrate exhibited decreased ubiquitylated protein degradation. The results indicate that disruption of an essential synaptic chaperone leads to changes in expression levels of UPS-related proteins which has a knock-on effect on overall protein degradation in C. elegans. The specific over-representation of E3 ubiquitin ligase components revealed in our study, suggests that proteins and complexes upstream of the proteasome itself may be beneficial therapeutic targets.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "neurodegenerative phenotypes": {"__data__": {"id_": "neurodegenerative phenotypes", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "neurodegenerative phenotypes", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "neuronal ceroid lipofuscinosis": {"__data__": {"id_": "neuronal ceroid lipofuscinosis", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "neuronal ceroid lipofuscinosis", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "dnajc5": {"__data__": {"id_": "dnajc5", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "dnajc5", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid38274839": {"__data__": {"id_": "pmid38274839", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid38274839: Title: \"Older people are weak\": perceptions and meanings of ageing and abuse against older people. Abstract: Introduction: This paper addresses the broader issue of elder abuse and seeks to analyse how victims and non-victims of abuse connect and explain the perception of ageing and the phenomenon of violence against older people. Methods: A qualitative study was conducted based on evidence gathered through 45 semi-structured interviews with people aged 60 or above who are part of the Portuguese EPIPorto population cohort. The interviews were analysed using grounded theory. Results/discussion: The results show that respondents link the ageist narratives that exist in our societies to the prevalence and naturalisation of violence against older people, that the risk of abuse increases with the weakening of family support networks, and that abuse is both a manifestation of asymmetrical power relations between victims and perpetrators and a severe violation of human rights. The findings also highlight the need to broaden the concept of violence against older people to include offences in the public sphere and not just in the context of the family and institutions.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "elder abuse": {"__data__": {"id_": "elder abuse", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "elder abuse", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "erk": {"__data__": {"id_": "erk", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "erk", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "axonal degeneration": {"__data__": {"id_": "axonal degeneration", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "axonal degeneration", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "sod1": {"__data__": {"id_": "sod1", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "sod1", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "huntington disease": {"__data__": {"id_": "huntington disease", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "huntington disease", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pridopidine": {"__data__": {"id_": "pridopidine", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pridopidine", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "muscle wasting": {"__data__": {"id_": "muscle wasting", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "muscle wasting", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "sigma 1 receptor": {"__data__": {"id_": "sigma 1 receptor", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "sigma 1 receptor", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "neurodegenerative disease": {"__data__": {"id_": "neurodegenerative disease", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "neurodegenerative disease", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "at deficits": {"__data__": {"id_": "at deficits", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "at deficits", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid30824685": {"__data__": {"id_": "pmid30824685", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid30824685: Title: Targeting the Sigma-1 Receptor via Pridopidine Ameliorates Central Features of ALS Pathology in a SOD1G93A Model. Abstract: Amyotrophic Lateral Sclerosis (ALS) is a fatal neurodegenerative disease affecting both the upper and lower motor neurons (MNs), with no effective treatment currently available. Early pathological events in ALS include perturbations in axonal transport (AT), formation of toxic protein aggregates and Neuromuscular Junction (NMJ) disruption, which all lead to axonal degeneration and motor neuron death. Pridopidine is a small molecule that has been clinically developed for Huntington disease. Here we tested the efficacy of pridopidine for ALS using in vitro and in vivo models. Pridopidine beneficially modulates AT deficits and diminishes NMJ disruption, as well as motor neuron death in SOD1G93A MNs and in neuromuscular co-cultures. Furthermore, we demonstrate that pridopidine activates the ERK pathway and mediates its beneficial effects through the sigma-1 receptor (S1R). Strikingly, in vivo evaluation of pridopidine in SOD1G93A mice reveals a profound reduction in mutant SOD1 aggregation in the spinal cord, and attenuation of NMJ disruption, as well as subsequent muscle wasting. Taken together, we demonstrate for the first time that pridopidine improves several cellular and histological hallmark pathologies of ALS through the S1R.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "alzheimer's": {"__data__": {"id_": "alzheimer's", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "alzheimer's", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "alpha synuclein": {"__data__": {"id_": "alpha synuclein", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "alpha synuclein", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "multiple system atrophy": {"__data__": {"id_": "multiple system atrophy", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "multiple system atrophy", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cerebral amyloid angiopathy": {"__data__": {"id_": "cerebral amyloid angiopathy", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "cerebral amyloid angiopathy", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cerebrovascular disease": {"__data__": {"id_": "cerebrovascular disease", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "cerebrovascular disease", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "neuronal loss": {"__data__": {"id_": "neuronal loss", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "neuronal loss", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid24752994": {"__data__": {"id_": "pmid24752994", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid24752994: Title: Neuropathological features of multiple system atrophy with cognitive impairment. Abstract: Cognitive impairment (CI) is an exclusion criterion for the diagnosis of multiple system atrophy (MSA), according to the second consensus statement. This view was recently challenged by patients with pathologically confirmed MSA who were reported to have dementia. With an aim to investigate the pathological substrate of CI in MSA, quantitative assessment of the glial and neuronal cytoplasmic inclusions and semiquantitative assessment of neuronal loss in the cortical and limbic regions was performed. No differences in the severity of these MSA-related pathological findings were identified between nine MSA cases with CI and nine MSA cases with normal cognition. Alzheimer's-related pathological changes, cerebral amyloid angiopathy, and cerebrovascular disease did not differ between the two MSA groups. MSA-specific alpha-synuclein and secondary pathological conditions were not more severe in MSA cases with CI, suggesting that although CI may be intrinsic to the MSA disease process, further investigation into the pathological basis of cognitive impairment in MSA is warranted.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "neuronal death": {"__data__": {"id_": "neuronal death", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "neuronal death", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "glutamate cytotoxicity": {"__data__": {"id_": "glutamate cytotoxicity", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "glutamate cytotoxicity", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "reactive nitrogen species": {"__data__": {"id_": "reactive nitrogen species", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "reactive nitrogen species", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "flavonoid": {"__data__": {"id_": "flavonoid", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "flavonoid", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "quercetin": {"__data__": {"id_": "quercetin", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "quercetin", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "infarction": {"__data__": {"id_": "infarction", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "infarction", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "trauma": {"__data__": {"id_": "trauma", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "trauma", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "glutamate": {"__data__": {"id_": "glutamate", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "glutamate", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ischemic stroke": {"__data__": {"id_": "ischemic stroke", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "ischemic stroke", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid36364448": {"__data__": {"id_": "pmid36364448", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid36364448: Title: Quercetin's Effects on Glutamate Cytotoxicity. Abstract: The potentially therapeutic effects of the naturally abundant plant flavonoid quercetin have been extensively studied. An extensive body of literature suggests that quercetin's powerful antioxidant effects may relate to its ability to treat disease. Glutamate excitotoxicity occurs when a neuron is overstimulated by the neurotransmitter glutamate and causes dysregulation of intracellular calcium concentrations. Quercetin has been shown to be preventative against many forms of neuronal cell death resulting from glutamate excitotoxicity, such as oncosis, intrinsic apoptosis, mitochondrial permeability transition, ferroptosis, phagoptosis, lysosomal cell death, parthanatos, and death by reactive oxygen species (ROS)/reactive nitrogen species (RNS) generation. The clinical importance for the attenuation of glutamate excitotoxicity arises from the need to deter the continuous formation of tissue infarction caused by various neurological diseases, such as ischemic stroke, seizures, neurodegenerative diseases, and trauma. This review aims to summarize what is known concerning glutamate physiology and glutamate excitotoxic pathophysiology and provide further insight into quercetin's potential to hinder neuronal death caused by cell death pathways activated by glutamate excitotoxicity. Quercetin's bioavailability may limit its use clinically, however. Thus, future research into ways to increase its bioavailability are warranted.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "spinocerebellar ataxia type 3": {"__data__": {"id_": "spinocerebellar ataxia type 3", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "spinocerebellar ataxia type 3", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ataxia": {"__data__": {"id_": "ataxia", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "ataxia", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "movement disorder": {"__data__": {"id_": "movement disorder", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "movement disorder", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cytosine adenine guanine (cag)": {"__data__": {"id_": "cytosine adenine guanine (cag)", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "cytosine adenine guanine (cag)", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid35478700": {"__data__": {"id_": "pmid35478700", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid35478700: Title: Network Reconfiguration Among Cerebellar Visual, and Motor Regions Affects Movement Function in Spinocerebellar Ataxia Type 3. Abstract: Background: Spinocerebellar ataxia type 3 (SCA3) is a rare movement disorder characterized with ataxia. Previous studies on movement disorders show that the whole-brain functional network tends to be more regular, and these reconfigurations correlate with genetic and clinical variables. Methods: To test whether the brain network in patients with SCA3 follows a similar reconfiguration course to other movement disorders, we recruited 41 patients with SCA3 (mean age = 40.51 +- 12.13 years; 23 male) and 41 age and sex-matched healthy individuals (age = 40.10 +- 11.56 years; 24 male). In both groups, the whole-brain network topology of resting-state functional magnetic resonance imaging (rs-fMRI) was conducted using graph theory, and the relationships among network topologies, cytosine-adenine-guanine (CAG) repeats, clinical symptoms, and functional connectivity were explored in SCA3 patients using partial correlation analysis, controlling for age and sex. Results: The brain networks tended to be more regular with a higher clustering coefficient, local efficiency, and modularity in patients with SCA3. Hubs in SCA3 patients were reorganized as the number of hubs increased in motor-related areas and decreased in cognitive areas. At the global level, small-worldness and normalized clustering coefficients were significantly positively correlated with clinical motor symptoms. At the nodal level, the clustering coefficient and local efficiency increased significantly in the visual (bilateral cuneus) and sensorimotor (right cerebellar lobules IV, V, VI) networks and decreased in the cognitive areas (right middle frontal gyrus). The clustering coefficient and local efficiency in the bilateral cuneus gyrus were negatively correlated with clinical motor symptoms. The functional connectivity between right caudate nucleus and bilateral calcarine gyrus were negatively correlated with disease duration, while connectivity between right posterior cingulum gyrus and left cerebellar lobule III, left inferior occipital gyrus and right cerebellar lobule IX was positively correlated. Conclusion: Our results demonstrate that a more regular brain network occurred in SCA3 patients, with motor and visual-related regions, such as, cerebellar lobules and cuneus gyrus, both forayed neighbor nodes as \"resource predators\" to compensate for normal function, with motor and visual function having the higher priority comparing with other high-order functions. This study provides new information about the neurological mechanisms underlying SCA3 network topology impairments in the resting state, which give a potential guideline for future clinical treatments. Clinical Trial Registration: [www.ClinicalTrials.gov], identifier [ChiCTR1800019901].", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "motion": {"__data__": {"id_": "motion", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "motion", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid31057348": {"__data__": {"id_": "pmid31057348", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid31057348: Title: Robust Motion Regression of Resting-State Data Using a Convolutional Neural Network Model. Abstract: Resting-state functional magnetic resonance imaging (rs-fMRI) based on the blood-oxygen-level-dependent (BOLD) signal has been widely used in healthy individuals and patients to investigate brain functions when the subjects are in a resting or task-negative state. Head motion considerably confounds the interpretation of rs-fMRI data. Nuisance regression is commonly used to reduce motion-related artifacts with six motion parameters estimated from rigid-body realignment as regressors. To further compensate for the effect of head movement, the first-order temporal derivatives of motion parameters and squared motion parameters were proposed previously as possible motion regressors. However, these additional regressors may not be sufficient to model the impact of head motion because of the complexity of motion artifacts. In addition, while using more motion-related regressors could explain more variance in the data, the neural signal may also be removed with increasing number of motion regressors. To better model how in-scanner motion affects rs-fMRI data, a robust and automated convolutional neural network (CNN) model is developed in this study to obtain optimal motion regressors. The CNN network consists of two temporal convolutional layers and the output from the network are the derived motion regressors used in the following nuisance regression. The temporal convolutional layer in the network can non-parametrically model the prolonged effect of head motion. The set of regressors derived from the neural network is compared with the same number of regressors used in a traditional nuisance regression approach. It is demonstrated that the CNN-derived regressors can more effectively reduce motion-related artifacts.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "oxygen": {"__data__": {"id_": "oxygen", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "oxygen", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "hypertension": {"__data__": {"id_": "hypertension", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "hypertension", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "death": {"__data__": {"id_": "death", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "death", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "malignant neoplasm": {"__data__": {"id_": "malignant neoplasm", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "malignant neoplasm", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "anaemia": {"__data__": {"id_": "anaemia", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "anaemia", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid28947447": {"__data__": {"id_": "pmid28947447", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid28947447: Title: Cohort profile: the National Health Insurance Service-National Health Screening Cohort (NHIS-HEALS) in Korea. Abstract: PURPOSE: The National Health Insurance Service-Health Screening Cohort (NHIS-HEALS) is a cohort of participants who participated in health screening programmes provided by the NHIS in the Republic of Korea. The NHIS constructed the NHIS-HEALS cohort database in 2015. The purpose of this cohort is to offer relevant and useful data for health researchers, especially in the field of non-communicable diseases and health risk factors, and policy-maker. PARTICIPANTS: To construct the NHIS-HEALS database, a sample cohort was first selected from the 2002 and 2003 health screening participants, who were aged between 40 and 79 in 2002 and followed up through 2013. This cohort included 514 866 health screening participants who comprised a random selection of 10% of all health screening participants in 2002 and 2003. FINDINGS TO DATE: The age-standardised prevalence of anaemia, diabetes mellitus, hypertension, obesity, hypercholesterolaemia and abnormal urine protein were 9.8%, 8.2%, 35.6%, 2.7%, 14.2% and 2.0%, respectively. The age-standardised mortality rate for the first 2 years (through 2004) was 442.0 per 100 000 person-years, while the rate for 10 years (through 2012) was 865.9 per 100 000 person-years. The most common cause of death was malignant neoplasm in both sexes (364.1 per 100 000 person-years for men, 128.3 per 100 000 person-years for women). FUTURE PLANS: This database can be used to study the risk factors of non-communicable diseases and dental health problems, which are important health issues that have not yet been fully investigated. The cohort will be maintained and continuously updated by the NHIS.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "amnestic": {"__data__": {"id_": "amnestic", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "amnestic", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cortical atrophy": {"__data__": {"id_": "cortical atrophy", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "cortical atrophy", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "visuospatial impairments": {"__data__": {"id_": "visuospatial impairments", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "visuospatial impairments", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "deficits in executive control and episodic memory": {"__data__": {"id_": "deficits in executive control and episodic memory", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "deficits in executive control and episodic memory", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "primary progressive aphasia": {"__data__": {"id_": "primary progressive aphasia", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "primary progressive aphasia", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cognitive impairments": {"__data__": {"id_": "cognitive impairments", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "cognitive impairments", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid25180158": {"__data__": {"id_": "pmid25180158", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid25180158: Title: Regional functional connectivity predicts distinct cognitive impairments in Alzheimer's disease spectrum. Abstract: Understanding neural network dysfunction in neurodegenerative disease is imperative to effectively develop network-modulating therapies. In Alzheimer's disease (AD), cognitive decline associates with deficits in resting-state functional connectivity of diffuse brain networks. The goal of the current study was to test whether specific cognitive impairments in AD spectrum correlate with reduced functional connectivity of distinct brain regions. We recorded resting-state functional connectivity of alpha-band activity in 27 patients with AD spectrum--22 patients with probable AD (5 logopenic variant primary progressive aphasia, 7 posterior cortical atrophy, and 10 early-onset amnestic/dysexecutive AD) and 5 patients with mild cognitive impairment due to AD. We used magnetoencephalographic imaging (MEGI) to perform an unbiased search for regions where patterns of functional connectivity correlated with disease severity and cognitive performance. Functional connectivity measured the strength of coherence between a given region and the rest of the brain. Decreased neural connectivity of multiple brain regions including the right posterior perisylvian region and left middle frontal cortex correlated with a higher degree of disease severity. Deficits in executive control and episodic memory correlated with reduced functional connectivity of the left frontal cortex, whereas visuospatial impairments correlated with reduced functional connectivity of the left inferior parietal cortex. Our findings indicate that reductions in region-specific alpha-band resting-state functional connectivity are strongly correlated with, and might contribute to, specific cognitive deficits in AD spectrum. In the future, MEGI functional connectivity could be an important biomarker to map and follow defective networks in the early stages of AD.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "charles bonnet syndrome": {"__data__": {"id_": "charles bonnet syndrome", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "charles bonnet syndrome", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid24379505": {"__data__": {"id_": "pmid24379505", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid24379505: Title: Atypical charles bonnet syndrome.\n Abstract: Charles Bonnet syndrome (CBS) is not uncommon disorder. It may not present with all typical symptoms and intact insight. Here, a case of atypical CBS is reported where antipsychotics were not effective. Patient improved completely after restoration of vision. \n.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "nicotinic acetylcholine receptors": {"__data__": {"id_": "nicotinic acetylcholine receptors", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "nicotinic acetylcholine receptors", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "alzheimer's diseases": {"__data__": {"id_": "alzheimer's diseases", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "alzheimer's diseases", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "hippocampus": {"__data__": {"id_": "hippocampus", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "hippocampus", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "synaptic plasticity": {"__data__": {"id_": "synaptic plasticity", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "synaptic plasticity", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cognitive deficits": {"__data__": {"id_": "cognitive deficits", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "cognitive deficits", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid11498056": {"__data__": {"id_": "pmid11498056", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid11498056: Title: Timing and location of nicotinic activity enhances or depresses hippocampal synaptic plasticity. Abstract: This study reveals mechanisms in the mouse hippocampus that may underlie nicotinic influences on attention, memory, and cognition. Induction of synaptic plasticity, arising via generally accepted mechanisms, is modulated by nicotinic acetylcholine receptors. Properly timed nicotinic activity at pyramidal neurons boosted the induction of long-term potentiation via presynaptic and postsynaptic pathways. On the other hand, nicotinic activity on interneurons inhibited nearby pyramidal neurons and thereby prevented or diminished the induction of synaptic potentiation. The synaptic modulation was dependent on the location and timing of the nicotinic activity. Loss of these synaptic mechanisms may contribute to the cognitive deficits experienced during Alzheimer's diseases, which is associated with a loss of cholinergic projections and with a decrease in the number of nicotinic receptors.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "amyloid precursor protein": {"__data__": {"id_": "amyloid precursor protein", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "amyloid precursor protein", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "vegf": {"__data__": {"id_": "vegf", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "vegf", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "lps": {"__data__": {"id_": "lps", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "lps", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cerebrovascular abnormalities": {"__data__": {"id_": "cerebrovascular abnormalities", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "cerebrovascular abnormalities", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid23684689": {"__data__": {"id_": "pmid23684689", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid23684689: Title: VEGF-releasing biodegradable nanospheres administered by craniotomy: a novel therapeutic approach in the APP/Ps1 mouse model of Alzheimer's disease. Abstract: This study attempts to develop a novel nanotechnology-based strategy to deliver vascular endothelial growth factor (VEGF) to the brain, as a possible therapeutic approach for AD. For this purpose, VEGF was encapsulated in biodegradable poly(lactic-co-glycolic acid) (PLGA) nanospheres (VEGF-NS). The nanosphere particle size was about 200 nm, with a narrow size distribution, and the zeta potential around -30 mV. The encapsulation efficiency of VEGF was 44.06+-5.61%, showing a biphasic release profile in vitro. The biological activity and neuroprotective effect of encapsulated VEGF were investigated in neuronal cell cultures, confirming the neuronal proliferative effect and the protection against Abeta42 induced neurotoxicity. In vivo studies were carried out in amyloid precursor protein/presenilin-1 (APP/Ps1) mice administering VEGF-NS through minimally invasive craniotomy. The results obtained showed that VEGF-NS were able to improve behavioral deficits, decrease Abeta deposits and promote angiogenesis, as well as reduce neuronal loss and cerebrovascular abnormalities. Furthermore, their ability to protect neuronal cultures against neuroinflammation induced by LPS provides new insight for future therapeutic approaches in other neurodegenerative disorders.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "sleep disruption": {"__data__": {"id_": "sleep disruption", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "sleep disruption", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid39982143": {"__data__": {"id_": "pmid39982143", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid39982143: Title: A Focused Update to the Clinical Practice Guidelines for the Prevention and Management of Pain, Anxiety, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU.\n Abstract: RATIONALE: Critically ill adults are at risk for a variety of distressing and consequential symptoms both during and after an ICU stay. Management of these symptoms can directly influence outcomes. OBJECTIVES: The objective was to update and expand the Society of Critical Care Medicine's 2018 Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU. PANEL DESIGN: The interprofessional inclusive guidelines task force was composed of 24 individuals including nurses, physicians, pharmacists, physiotherapists, psychologists, and ICU survivors. The task force developed evidence-based recommendations using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) approach. Conflict-of-interest policies were strictly followed in all phases of the guidelines, including task force selection and voting. METHODS: The task force focused on five main content areas as they pertain to adult ICU patients: anxiety (new topic), agitation/sedation, delirium, immobility, and sleep disruption. Using the GRADE approach, we conducted a rigorous systematic review for each population, intervention, control, and outcome question to identify the best available evidence, statistically summarized the evidence, assessed the quality of evidence, and then performed the evidence-to-decision framework to formulate recommendations. RESULTS: The task force issued five statements related to the management of anxiety, agitation/sedation, delirium, immobility, and sleep disruption in adults admitted to the ICU. In adult patients admitted to the ICU, the task force issued conditional recommendations to use dexmedetomidine over propofol for sedation, provide enhanced mobilization/rehabilitation over usual mobilization/rehabilitation, and administer melatonin. The task force was unable to issue recommendations on the administration of benzodiazepines to treat anxiety, and the use of antipsychotics to treat delirium. CONCLUSIONS: The guidelines task force provided recommendations for pharmacologic management of agitation/sedation and sleep, and nonpharmacologic management of immobility in critically ill adults. These recommendations are intended for consideration along with the patient's clinical status.\n.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "critically ill": {"__data__": {"id_": "critically ill", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "critically ill", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "agitation": {"__data__": {"id_": "agitation", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "agitation", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "propofol": {"__data__": {"id_": "propofol", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "propofol", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "melatonin": {"__data__": {"id_": "melatonin", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "melatonin", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "anxiety": {"__data__": {"id_": "anxiety", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "anxiety", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "dexmedetomidine": {"__data__": {"id_": "dexmedetomidine", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "dexmedetomidine", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid27169811": {"__data__": {"id_": "pmid27169811", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid27169811: Title: Dealing with daily challenges in dementia (deal-id study): effectiveness of the experience sampling method intervention 'Partner in Sight' for spousal caregivers of people with dementia: design of a randomized controlled trial. Abstract: BACKGROUND: There is an urgent need for psychosocial interventions that effectively support dementia caregivers in daily life. The Experience Sampling Methodology (ESM) offers the possibility to provide a more dynamic view of caregiver functioning. ESM-derived feedback may help to redirect caregivers' behavior towards situations that elicit positive emotions and to increase their feelings of competence in the caretaking process. This paper presents the design of a study that evaluates the process characteristics and effects of the ESM-based intervention 'Partner in Sight'. METHODS/DESIGN: A randomized controlled trial with 90 spousal caregivers of people with dementia will be conducted. Participants will be randomly assigned to the experimental (6-week ESM intervention including feedback), pseudo-experimental (6-week ESM intervention without feedback), or control group (care as usual). Assessments will be performed pre- and post-intervention and at 2-, and 6-month follow-up. Main outcomes will be sense of competence, perceived control, momentary positive affect, and psychological complaints (depressive symptoms, perceived stress, anxiety, momentary negative affect). In addition to the effect evaluation, a process and economic evaluation will be conducted to investigate the credibility and generalizability of the intervention, and its cost-effectiveness. DISCUSSION: The potential effects of the ESM intervention may help caregivers to endure their care responsibilities and prevent them from becoming overburdened. This is the first ESM intervention for caregivers of people with dementia. The results of this study, therefore, provide a valuable contribution to the growing knowledge on m-health interventions for dementia caregivers. TRIAL REGISTRATION: Dutch Trial Register NTR4847 ; date registered Oct 9, 2014.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "lung, liver, and central nervous system (cns) dysfunction": {"__data__": {"id_": "lung, liver, and central nervous system (cns) dysfunction", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "lung, liver, and central nervous system (cns) dysfunction", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid37175808": {"__data__": {"id_": "pmid37175808", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid37175808: Title: Inhibition of ITK Signaling Causes Amelioration in Sepsis-Associated Neuroinflammation and Depression-like State in Mice.\n Abstract: Sepsis affects millions of people worldwide and is associated with multiorgan dysfunction that is a major cause of increased morbidity and mortality. Sepsis is associated with several morbidities, such as lung, liver, and central nervous system (CNS) dysfunction. Sepsis-associated CNS dysfunction usually leads to several mental problems including depression. IL-17A is one of the crucial cytokines that is expressed and secreted by Th17 cells. Th17 cells are reported to be involved in the pathogenesis of depression and anxiety in humans and animals. One of the protein tyrosine kinases that plays a key role in controlling the development/differentiation of Th17 cells is ITK. However, the role of ITK in sepsis-associated neuroinflammation and depression-like symptoms in mice has not been investigated earlier. Therefore, this study investigated the efficacy of the ITK inhibitor, BMS 509744, in sepsis-linked neuroinflammation (ITK, IL-17A, NFkB, iNOS, MPO, lipid peroxides, IL-6, MCP-1, IL-17A) and a battery of depression-like behavioral tests, such as sucrose preference, tail suspension, and the marble burying test. Further, the effect of the ITK inhibitor on anti-inflammatory signaling (Foxp3, IL-10, Nrf2, HO-1, SOD-2) was assessed in the CNS. Our data show that sepsis causes increased ITK protein expression, IL-17A signaling, and neuroinflammatory mediators in the CNS that are associated with a depression-like state in mice. ITK inhibitor-treated mice with sepsis show attenuated IL-17A signaling, which is associated with the upregulation of IL-10/Nrf2 signaling and the amelioration of depression-like symptoms in mice. Our data show, for the first time, that the ITK inhibition strategy may counteract sepsis-mediated depression through a reduction in IL-17A signaling in the CNS.\n.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "il 6": {"__data__": {"id_": "il 6", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "il 6", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "multiorgan dysfunction": {"__data__": {"id_": "multiorgan dysfunction", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "multiorgan dysfunction", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid18300070": {"__data__": {"id_": "pmid18300070", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid18300070: Title: Herpes simplex virus type 1 and Alzheimer's disease: the autophagy connection. Abstract: The causes of Alzheimer's disease (AD) and of the characteristic pathological features - amyloid plaques and neurofibrillary tangles - of AD brain are unknown, despite the enormous resources provided over the years for their investigation. Indeed, the only generally accepted risk factors are age, Down syndrome, carriage of the type 4 allele of the apolipoprotein E gene (APOE-epsilon 4), and possibly brain injury. Following the authors' previous studies implicating herpes simplex virus type 1 (HSV1) in brain of APOE-epsilon 4 carriers as a major cause of AD, the authors propose here, on the basis of their and others' recent studies, that not only does HSV1 generate the main components of amyloid plaques and neurofibrillary tangles (NFTs) - beta-amyloid (A beta) and abnormally phosphorylated tau but also, by disrupting autophagy, it prevents degradation of these aberrant proteins, leading to their accumulation and deposition, and eventually to AD.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "down syndrome": {"__data__": {"id_": "down syndrome", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "down syndrome", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a beta": {"__data__": {"id_": "a beta", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "a beta", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "odc1": {"__data__": {"id_": "odc1", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "odc1", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ask1": {"__data__": {"id_": "ask1", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "ask1", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "mir 181": {"__data__": {"id_": "mir 181", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "mir 181", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "nuf2": {"__data__": {"id_": "nuf2", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "nuf2", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "mir 708": {"__data__": {"id_": "mir 708", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "mir 708", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid35729466": {"__data__": {"id_": "pmid35729466", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid35729466: Title: The Transcription Factor, alpha1ACT, Acts Through a MicroRNA Network to Regulate Neurogenesis and Cell Death During Neonatal Cerebellar Development. Abstract: MicroRNAs, a class of small RNA regulators, function throughout neurodevelopment, from neural stem cell neurogenesis to neuronal maturation, synaptic formation, and plasticity. alpha1ACT, a transcription factor (TF), plays a critical role in neonatal cerebellar development by regulating an ensemble of genes. Of these, ChIP-seq analysis matched near 50% genes directly regulated by alpha1ACT. Yet, more than half the regulated transcripts lacked direct interaction with alpha1ACT. To investigate whether alpha1ACT acts through a microRNA network, we studied alpha1ACT-associated simultaneous miRNA:mRNA transcriptome profiles, using miRNA-seq paired with RNA-seq. Thirty-one differentially expressed miRNAs (DEMs) associated with alpha1ACT-regulated differentially expressed genes (DEGs) were profiled in alpha1ACT-overexpressing PC12 cells and were further validated in neonatal transgenic mouse cerebellum overexpressing alpha1ACT in a context-dependent manner. Here, we also demonstrated that alpha1ACT facilitates neurogenesis and development of dendritic synapses and is partially a result of the downregulation of the miR-99 cluster, miR-143, miR-23, miR-146, miR-363, and miR-484. On the other hand, the miR-181, miR-125, and miR-708 clusters were upregulated by alpha1ACT, which inhibit MAPK signaling and cell death pathways by targeting Ask1, Odc1, Atf4, and Nuf2 for decreased expression. MiR-181a-5p was verified as the most abundant DEM in neonatal cerebellum, which was further induced by alpha1ACT. Overall, under alpha1ACT modulation, up-/downregulated miRNA clusters with their paired target genes may form a regulatory network controlling the balance between the neuronal proliferation, differentiation, and cell death in the cerebellum to promote neonatal development. Our findings concerning the alpha1ACT-related miRNA/mRNA expression profiles in neonatal cerebellum may inform future investigations for cerebellar development.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "headache": {"__data__": {"id_": "headache", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "headache", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "spermidine": {"__data__": {"id_": "spermidine", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "spermidine", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "migraine": {"__data__": {"id_": "migraine", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "migraine", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "aconitate": {"__data__": {"id_": "aconitate", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "aconitate", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "methionine sulfoxide": {"__data__": {"id_": "methionine sulfoxide", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "methionine sulfoxide", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "spermine": {"__data__": {"id_": "spermine", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "spermine", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "succinate": {"__data__": {"id_": "succinate", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "succinate", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid34615455": {"__data__": {"id_": "pmid34615455", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid34615455: Title: Identification of disease- and headache-specific mediators and pathways in migraine using blood transcriptomic and metabolomic analysis. Abstract: BACKGROUND: Recent data suggest that gene expression profiles of peripheral white blood cells can reflect changes in the brain. We aimed to analyze the transcriptome of peripheral blood mononuclear cells (PBMC) and changes of plasma metabolite levels of migraineurs in a self-controlled manner during and between attacks. METHODS: Twenty-four patients with migraine were recruited and blood samples were collected in a headache-free (interictal) period and during headache (ictal) to investigate disease- and headache-specific alterations. Control samples were collected from 13 age- and sex-matched healthy volunteers. RNA was isolated from PBMCs and single-end 75 bp RNA sequencing was performed using Illumina NextSeq 550 instrument followed by gene-level differential expression analysis. Functional analysis was carried out on information related to the role of genes, such as signaling pathways and biological processes. Plasma metabolomic measurement was performed with the Biocrates MxP Quant 500 Kit. RESULTS: We identified 144 differentially-expressed genes in PBMCs between headache and headache-free samples and 163 between symptom-free patients and controls. Network analysis revealed that enriched pathways included inflammation, cytokine activity and mitochondrial dysfunction in both headache and headache-free samples compared to controls. Plasma lactate, succinate and methionine sulfoxide levels were higher in migraineurs while spermine, spermidine and aconitate were decreased during attacks. CONCLUSIONS: It is concluded that enhanced inflammatory and immune cell activity, and oxidative stress can play a role in migraine susceptibility and headache generation.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "psychotic": {"__data__": {"id_": "psychotic", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "psychotic", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid8415899": {"__data__": {"id_": "pmid8415899", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid8415899: Title: Adverse psychic reactions to psychotropic drugs--a report from the AMUP study.\n Abstract: The AMUP study (AMUP = Arzneimitteluberwachung in der Psychiatrie (Drug Monitoring in Psychiatry)) was conducted from 1979 to 1989 in order to provide for a systematic and standardized assessment of all adverse reactions to psychotropic drugs under the conditions of routine clinical treatment at two psychiatric hospitals. This paper presents data from the AMUP study on the type and frequency of adverse psychic reactions to psychotropic drug groups and relevant single drugs. Psychic ADR leading to drug discontinuation were observed in 4.5% of 15,264 inpatients monitored over an eight-year period. Only neurological ADR were more frequent (4.9%). Neuroleptics and antidepressants were involved with similar frequencies in ADR that were at least \"probably\" drug-related (3.3 and 3.5%). Lithium salts and benzodiazepines were only rarely involved in psychic ADR. Toxic delirium (1.0%), agitation (0.9%), and sedation (0.8%) were the most frequent single events, usually rated as \"probably\" drug-related. Depression and psychotic states were next in frequency, but judged as only \"possibly\" drug-related in a considerable proportion of cases. Haloperidol, the most common high-potency neuroleptic, was imputed mainly for depression, sedation, agitation, and (malignant) neuroleptic syndrome; with medium-potency perazine, toxic delirium and sedation prevailed; among the most common antidepressants, amitriptyline was above all connected with toxic delirium, while with clomipramine agitation predominated. The paper discusses the particular difficulties encountered in the field of psychic ADR in psychiatric patients regarding causality assessment, and emphasizes the need for continuous ADR assessment studies including state hospitals.\n.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "clomipramine": {"__data__": {"id_": "clomipramine", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "clomipramine", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "neurological adr": {"__data__": {"id_": "neurological adr", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "neurological adr", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "perazine": {"__data__": {"id_": "perazine", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "perazine", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "lithium salts": {"__data__": {"id_": "lithium salts", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "lithium salts", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "amitriptyline": {"__data__": {"id_": "amitriptyline", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "amitriptyline", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "psychiatric": {"__data__": {"id_": "psychiatric", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "psychiatric", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "psychic adr": {"__data__": {"id_": "psychic adr", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "psychic adr", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "skin problems": {"__data__": {"id_": "skin problems", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "skin problems", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "edema": {"__data__": {"id_": "edema", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "edema", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "rash": {"__data__": {"id_": "rash", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "rash", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "vascular dementia": {"__data__": {"id_": "vascular dementia", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "vascular dementia", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid30741762": {"__data__": {"id_": "pmid30741762", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid30741762: Title: CE: Original Research: New Acute Symptoms in Older Adults with Cognitive Impairment: What Should Family Caregivers Do?\n Abstract: : Background: When older adults with cognitive impairment develop new physical or behavioral symptoms, their family caregivers face a difficult decision: whether and when to seek professional medical care. Most family caregivers lack formal training in assessment and may have difficulty making such decisions. The Veterans Health Administration's home-based primary care (HBPC) program, which is widely available, offers community-dwelling frail veterans and their family caregivers guidance, with the goal of reducing hospitalization and institutionalization in long-term care facilities. OBJECTIVE: This study sought to assess the frequency with which family caregivers of cognitively impaired older adults sought prehospital guidance from health care professionals when that resource was available to them, and to describe the characteristics of such events. METHODS: This study used a retrospective chart review of patients who were enrolled in the Orlando Veterans Affairs Medical Center HBPC program for at least one month between October 1, 2013, and September 30, 2014; had a diagnosis indicative of cognitive impairment (Alzheimer's disease, vascular dementia, or mild cognitive impairment); had a dedicated family caregiver; and were not enrolled in hospice care. Data were collected from data collection templates and nurses' narrative notes. Univariate descriptive analyses were conducted regarding the type of staff contacted by family caregivers, the presenting diagnoses, the guidance offered by staff, and the number of unplanned acute care encounters. RESULTS: Among the 215 patients studied, there were 254 unplanned acute care encounters (including ED visits followed by discharge to home and ED visits resulting in hospital admission). Family caregivers sought guidance from a health care professional 22% of the time before such an encounter. The presenting clinical issues were most often new problems (43%) that included falls, feeding tube problems, fever, new pain, rash or other skin problems, and unexplained edema. Overall, 25% of all unplanned acute care encounters were for reasons considered potentially avoidable. About half of the patients who were subsequently hospitalized had symptoms of delirium, indicating that their illness had significantly advanced before presentation. CONCLUSIONS: It's important for health care professionals to ensure that family caregivers of cognitively impaired older adults can access professional guidance readily when facing decisions about a loved one's care, especially when there is an acute onset of new symptoms. Teaching caregivers how to recognize such symptoms early in order to prevent exacerbations of chronic illness and subsequent hospitalization should be a high priority. Our findings underscore the need to do so, so that caregivers can best use the resources that HBPC programs have (or ought to have) in place, in particular 24/7 guidance and decision assistance.\n.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "fever": {"__data__": {"id_": "fever", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "fever", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "autism spectrum disorder": {"__data__": {"id_": "autism spectrum disorder", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "autism spectrum disorder", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "brain's genetic disorders": {"__data__": {"id_": "brain's genetic disorders", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "brain's genetic disorders", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "brain cancer": {"__data__": {"id_": "brain cancer", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "brain cancer", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid34616886": {"__data__": {"id_": "pmid34616886", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid34616886: Title: Genetic variations analysis for complex brain disease diagnosis using machine learning techniques: opportunities and hurdles. Abstract: BACKGROUND AND OBJECTIVES: This paper presents an in-depth review of the state-of-the-art genetic variations analysis to discover complex genes associated with the brain's genetic disorders. We first introduce the genetic analysis of complex brain diseases, genetic variation, and DNA microarrays. Then, the review focuses on available machine learning methods used for complex brain disease classification. Therein, we discuss the various datasets, preprocessing, feature selection and extraction, and classification strategies. In particular, we concentrate on studying single nucleotide polymorphisms (SNP) that support the highest resolution for genomic fingerprinting for tracking disease genes. Subsequently, the study provides an overview of the applications for some specific diseases, including autism spectrum disorder, brain cancer, and Alzheimer's disease (AD). The study argues that despite the significant recent developments in the analysis and treatment of genetic disorders, there are considerable challenges to elucidate causative mutations, especially from the viewpoint of implementing genetic analysis in clinical practice. The review finally provides a critical discussion on the applicability of genetic variations analysis for complex brain disease identification highlighting the future challenges. METHODS: We used a methodology for literature surveys to obtain data from academic databases. Criteria were defined for inclusion and exclusion. The selection of articles was followed by three stages. In addition, the principal methods for machine learning to classify the disease were presented in each stage in more detail. RESULTS: It was revealed that machine learning based on SNP was widely utilized to solve problems of genetic variation for complex diseases related to genes. CONCLUSIONS: Despite significant developments in genetic diseases in the past two decades of the diagnosis and treatment, there is still a large percentage in which the causative mutation cannot be determined, and a final genetic diagnosis remains elusive. So, we need to detect the variations of the genes related to brain disorders in the early disease stages.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid35129499": {"__data__": {"id_": "pmid35129499", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid35129499: Title: Public Opinions About Surgery in Older Adults: A Thematic Analysis.\n Abstract: OBJECTIVE: To examine public opinions of surgery in older adults. BACKGROUND: Increasing numbers of older adults are undergoing surgery. National healthcare organizations recognize the increased risks of postoperative complications and mortality in the older surgical population and have made efforts to improve the care of older adults undergoing surgery through hospital-level programs. However, limited research has explored the opinions and responses of the wider U.S. public regarding surgery in older adults. METHODS: We performed a qualitative, thematic analysis of reader comments posted in response to online newspaper articles relating to surgery in older adults. Articles were published in 2019-2020 and targeted for a popular press audience. RESULTS: Nine hundred eight reader comments posted in response to 6 articles relating to surgery in older adults were identified. Articles were published in online editions of print newspapers with a digital circulation between 1.3 and 5.7 million subscribers. Three themes were identified: (1) wariness/distrust towards healthcare: including general distrust of medicine and distrust of surgery, (2) problems experienced: ineffective communication and unrealistic expectations, and (3) recommended solutions: the need for multidisciplinary teams and patient-centered communication. CONCLUSIONS: Overall, the public viewed surgery in older adults with wariness/distrust due to ineffective communication and unrealistic expectations. Specialized surgical care tailored to the unique needs of older adults is needed. The public perspective suggests that U.S. health systems should strongly consider adopting programs that provide care to meet the unique needs of older adults undergoing surgery and ultimately improve both patient outcomes and their surgical experience.\n.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid39704609": {"__data__": {"id_": "pmid39704609", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid39704609: Title: Family Presence at the PICU Bedside and Pediatric Patient Delirium: Retrospective Analysis of a Single-Center Cohort, 2014-2017.\n Abstract: OBJECTIVES: To examine the association between family presence at the PICU bedside and daily positive delirium screening scores. DESIGN: Retrospective cohort study. SETTING: Tertiary children's hospital PICU. SUBJECTS: Children younger than 18 years old with PICU length of stay greater than 36 hours enrolled in the Seattle Children's Hospital Outcomes Assessment Program from 2014 to 2017. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: In the dataset, delirium screening had been performed bid using the Cornell Assessment of Pediatric Delirium, with scores greater than or equal to 9 classified as positive. Family presence was documented every 2 hours. Among 224 patients, 55% (n = 124/224) had positive delirium screening on 44% (n = 408/930) of PICU days. Family presence at the bedside during PICU stay (< 90% compared with >= 90%) was associated with higher proportion of ever (as opposed to never) being screened positive for delirium (26/37 vs. 98/187; difference, 17.9% [95% CI, 0.4-32.1%]; p = 0.046). On univariate analysis, each additional decile of increasing family presence was associated with lower odds of positive delirium screening on the same day (odds ratio [OR], 0.87 [95% CI, 0.77-0.97]) and subsequent day (OR, 0.84 [95% CI, 0.75-0.94]). On multivariable analysis after adjustments, including baseline Pediatric Cerebral Performance Category (PCPC), higher family presence was associated with lower odds of subsequent-day positive delirium screening (OR, 0.89 [95% CI, 0.81-0.98]). Among patients with PCPC less than or equal to 2, each additional decile of increasing family presence was independently associated with lower odds of both same-day (OR, 0.90 [95% CI, 0.81-0.99]) and subsequent-day (OR, 0.85 [95% CI, 0.76-0.95]) positive delirium screening. CONCLUSIONS: In our 2014-2017 retrospective cohort, greater family presence was associated with lower odds of delirium in PICU patients. Family presence is a modifiable factor that may mitigate the burden of pediatric delirium, and future studies should explore barriers and facilitators of family presence in the PICU.\n.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "tumorigenesis": {"__data__": {"id_": "tumorigenesis", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "tumorigenesis", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid34542930": {"__data__": {"id_": "pmid34542930", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid34542930: Title: Dependence receptors: new targets for cancer therapy. Abstract: Dependence receptors are known to promote survival and positive signaling such as proliferation, migration, and differentiation when activated, but to actively trigger apoptosis when unbound to their ligand. Their abnormal regulation was shown to be an important feature of tumorigenesis, allowing cancer cells to escape apoptosis triggered by these receptors while promoting in parallel major aspects of tumorigenesis such as proliferation, angiogenesis, invasiveness, and chemoresistance. This involvement in multiple cancer hallmarks has raised interest in dependence receptors as targets for cancer therapy. Although additional studies remain necessary to fully understand the complexity of signaling pathways activated by these receptors and to target them efficiently, it is now clear that dependence receptors represent very exciting targets for future cancer treatment. This manuscript reviews current knowledge on the contribution of dependence receptors to cancer and highlights the potential for therapies that activate pro-apoptotic functions of these proteins.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "early negative postoperative behavior": {"__data__": {"id_": "early negative postoperative behavior", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "early negative postoperative behavior", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "fentanyl": {"__data__": {"id_": "fentanyl", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "fentanyl", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "clonidine": {"__data__": {"id_": "clonidine", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "clonidine", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "emergence agitation": {"__data__": {"id_": "emergence agitation", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "emergence agitation", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "vomited": {"__data__": {"id_": "vomited", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "vomited", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "sevoflurane": {"__data__": {"id_": "sevoflurane", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "sevoflurane", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid24666767": {"__data__": {"id_": "pmid24666767", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid24666767: Title: The effect of fentanyl and clonidine on early postoperative negative behavior in children: a double-blind placebo controlled trial.\n Abstract: BACKGROUND: Early negative postoperative behavior (e-PONB) is common in children and manifests itself as emergence agitation (EA), emergence delirium (ED), and pain. The objective of this prospective double blind, randomized, placebo-controlled trial was to determine whether IV clonidine or IV fentanyl prior to surgery modifies e-PONB in children. METHODS: Ninety children scheduled for subumbilical surgery under sevoflurane anesthesia supplemented with regional anesthesia were randomized to either receive IV clonidine 2 mcg kg(-1) , IV fentanyl 2 mcg kg(-1) or placebo (IV saline) before surgery. Primary outcome measures were the incidence of EA, ED and pain during the first hour after awakening. Secondary outcome measures were side effects such as nausea and vomiting and delayed discharge from PACU. RESULTS: Eighty-seven children (n = 29 per group) completed the study. EA was present in 10 children (six clonidine, none fentanyl, and four placebo, P = 0.04) whereas ED was observed in 20 children (nine clonidine, three fentanyl, and eight placebo P = 0.13). Sixteen children who received placebo had a CHIPPS score of >=4 compared with nine children in fentanyl group and 18 children receiving clonidine (P = 0.04). Ten children receiving fentanyl vomited during the first postoperative day, compared with six children in placebo group and none in clonidine group (P = 0.003). Discharge from PACU was not affected. CONCLUSIONS: IV fentanyl before surgery but not IV clonidine modifies e-PONB in children undergoing lower abdominal surgery under general anesthesia supplemented with regional anesthesia. The use of fentanyl in this population was also associated with reduced pain scores after awakening but with significantly greater incidence of PONV.\n.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ganser syndrome": {"__data__": {"id_": "ganser syndrome", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "ganser syndrome", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "psychiatric conditions": {"__data__": {"id_": "psychiatric conditions", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "psychiatric conditions", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "disorganized psychosis": {"__data__": {"id_": "disorganized psychosis", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "disorganized psychosis", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "psychosis": {"__data__": {"id_": "psychosis", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "psychosis", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "hyperkinetic": {"__data__": {"id_": "hyperkinetic", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "hyperkinetic", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "hypokinetic": {"__data__": {"id_": "hypokinetic", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "hypokinetic", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "delirious mania": {"__data__": {"id_": "delirious mania", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "delirious mania", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid34392693": {"__data__": {"id_": "pmid34392693", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid34392693: Title: Pseudodelirium: Psychiatric Conditions to Consider on the Differential for Delirium.\n Abstract: OBJECTIVE: The phenotypes of several psychiatric conditions can very closely resemble delirium; the authors describe such presentations as pseudodelirium. However, because the clinical management of these conditions differs markedly from that of delirium, prompt differentiation is essential. The authors provide an educational review to assist clinicians in identifying and managing psychiatric conditions that may be especially challenging to differentiate from delirium. METHODS: Based on clinical experience, the authors identified four psychiatric conditions as among the most difficult to differentiate from delirium: disorganized psychosis, Ganser syndrome, delirious mania, and catatonia. An overview of each condition, description of clinical features, differentiation of specific phenotypes from delirium, and review of clinical management are also provided. RESULTS: The thought and behavioral disorganization in disorganized psychosis can be mistaken for the clouded sensorium and behavioral dysregulation encountered in delirium. The fluctuating alertness and apparent confusion in Ganser syndrome resemble delirium's altered arousal and cognitive features. As its name suggests, delirious mania presents as a mixture of hyperactive delirium and mania; additional features may include psychosis, autonomic activation, and catatonia. Both delirium and catatonia have hypokinetic and hyperkinetic variants, and the two syndromes can also co-occur. CONCLUSIONS: The clinical presentations of several psychiatric conditions can blend with the phenotype of delirium, at times even co-occurring with it. Detailed evaluation is often required to differentiate such instances of pseudodelirium from delirium proper.\n.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "behavioral dysregulation": {"__data__": {"id_": "behavioral dysregulation", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "behavioral dysregulation", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "catatonia": {"__data__": {"id_": "catatonia", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "catatonia", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "apoe*4": {"__data__": {"id_": "apoe*4", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "apoe*4", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid10081980": {"__data__": {"id_": "pmid10081980", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid10081980: Title: Genetic polymorphism in the persyn (gamma-synuclein) gene and the risk of Alzheimer's disease. Abstract: Alzheimer's disease (AD) is a complex disease with the possible involvement of several genes. Genetic studies on sporadic late-onset AD have determined APOE*4 to be the major risk factor. Members of the synuclein gene family are potential candidates for the risk of AD. The persyn gene (gamma-synuclein) has recently been characterized and a common polymorphism (Glu110Val) has been identified. In this study we investigated the association of this polymorphism with sporadic late-onset AD patients. We screened DNA samples of 313 late-onset cases and 352 controls. No significant association was observed between the missense mutation and AD. When the data were stratified by APOE*4 carriers and non-APOE*4 carriers, no difference was seen for the Glu110Val polymorphism. There was also no difference in genotype or allele frequency when stratified by the ACT*A allele. Although our data show no effect of this persyn polymorphism in AD, characterization of additional polymorphisms in this gene may provide more conclusive answers.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "n acetylglucosamine": {"__data__": {"id_": "n acetylglucosamine", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "n acetylglucosamine", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "diabetic complications": {"__data__": {"id_": "diabetic complications", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "diabetic complications", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "udp glcnac": {"__data__": {"id_": "udp glcnac", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "udp glcnac", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ogt": {"__data__": {"id_": "ogt", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "ogt", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "udp": {"__data__": {"id_": "udp", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "udp", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "udp n acetylglucosamine": {"__data__": {"id_": "udp n acetylglucosamine", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "udp n acetylglucosamine", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid21240259": {"__data__": {"id_": "pmid21240259", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid21240259: Title: Structure of human O-GlcNAc transferase and its complex with a peptide substrate. Abstract: The essential mammalian enzyme O-linked beta-N-acetylglucosamine transferase (O-GlcNAc transferase, here OGT) couples metabolic status to the regulation of a wide variety of cellular signalling pathways by acting as a nutrient sensor. OGT catalyses the transfer of N-acetylglucosamine from UDP-N-acetylglucosamine (UDP-GlcNAc) to serines and threonines of cytoplasmic, nuclear and mitochondrial proteins, including numerous transcription factors, tumour suppressors, kinases, phosphatases and histone-modifying proteins. Aberrant glycosylation by OGT has been linked to insulin resistance, diabetic complications, cancer and neurodegenerative diseases including Alzheimer's. Despite the importance of OGT, the details of how it recognizes and glycosylates its protein substrates are largely unknown. We report here two crystal structures of human OGT, as a binary complex with UDP (2.8 A resolution) and as a ternary complex with UDP and a peptide substrate (1.95 A). The structures provide clues to the enzyme mechanism, show how OGT recognizes target peptide sequences, and reveal the fold of the unique domain between the two halves of the catalytic region. This information will accelerate the rational design of biological experiments to investigate OGT's functions; it will also help the design of inhibitors for use as cellular probes and help to assess its potential as a therapeutic target.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "weight loss": {"__data__": {"id_": "weight loss", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "weight loss", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "hypothalamic dysfunction": {"__data__": {"id_": "hypothalamic dysfunction", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "hypothalamic dysfunction", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cognitive symptoms": {"__data__": {"id_": "cognitive symptoms", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "cognitive symptoms", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "disorders of body weight": {"__data__": {"id_": "disorders of body weight", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "disorders of body weight", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "memory loss": {"__data__": {"id_": "memory loss", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "memory loss", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid30568576": {"__data__": {"id_": "pmid30568576", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid30568576: Title: Disorders of Body Weight, Sleep and Circadian Rhythm as Manifestations of Hypothalamic Dysfunction in Alzheimer's Disease. Abstract: While cognitive decline and memory loss are the major clinical manifestations of Alzheimer's disease (AD), they are now recognized as late features of the disease. Recent failures in clinical drug trials highlight the importance of evaluating and treating patients with AD as early as possible and the difficulties in developing effective therapies once the disease progresses. Since the pathological hallmarks of AD including the abnormal aggregation of amyloid-beta (Abeta) and tau can occur decades before any significant cognitive decline in the preclinical stage of AD, it is important to identify the earliest clinical manifestations of AD and elucidate their underlying cellular and molecular mechanisms. Importantly, metabolic and non-cognitive manifestations of AD such as weight loss and alterations of peripheral metabolic signals can occur before the onset of cognitive symptoms and worsen with disease progression. Accumulating evidence suggests that the major culprit behind these early metabolic and non-cognitive manifestations of AD is AD pathology causing dysfunction of the hypothalamus, a brain region critical for integrating peripheral signals with essential homeostatic physiological functions. Here, we aim to highlight recent developments that address the role of AD pathology in the development of hypothalamic dysfunction associated with metabolic and non-cognitive manifestations seen in AD. Understanding the mechanisms underlying hypothalamic dysfunction in AD could give key new insights into the development of novel biomarkers and therapeutic targets.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "tuberous sclerosis complex": {"__data__": {"id_": "tuberous sclerosis complex", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "tuberous sclerosis complex", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "genetic disorder": {"__data__": {"id_": "genetic disorder", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "genetic disorder", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "nadph": {"__data__": {"id_": "nadph", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "nadph", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "nadh": {"__data__": {"id_": "nadh", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "nadh", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid30348864": {"__data__": {"id_": "pmid30348864", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid30348864: Title: A novel lysosome-to-mitochondria signaling pathway disrupted by amyloid-beta oligomers. Abstract: The mechanisms of mitochondrial dysfunction in Alzheimer's disease are incompletely understood. Using two-photon fluorescence lifetime microscopy of the coenzymes, NADH and NADPH, and tracking brain oxygen metabolism with multi-parametric photoacoustic microscopy, we show that activation of lysosomal mechanistic target of rapamycin complex 1 (mTORC1) by insulin or amino acids stimulates mitochondrial activity and regulates mitochondrial DNA synthesis in neurons. Amyloid-beta oligomers, which are precursors of amyloid plaques in Alzheimer's disease brain and stimulate mTORC1 protein kinase activity at the plasma membrane but not at lysosomes, block this Nutrient-induced Mitochondrial Activity (NiMA) by a mechanism dependent on tau, which forms neurofibrillary tangles in Alzheimer's disease brain. NiMA was also disrupted in fibroblasts derived from two patients with tuberous sclerosis complex, a genetic disorder that causes dysregulation of lysosomal mTORC1. Thus, lysosomal mTORC1 couples nutrient availability to mitochondrial activity and links mitochondrial dysfunction to Alzheimer's disease by a mechanism dependent on the soluble building blocks of the poorly soluble plaques and tangles.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "sleep wake cycle problems": {"__data__": {"id_": "sleep wake cycle problems", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "sleep wake cycle problems", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid21273032": {"__data__": {"id_": "pmid21273032", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid21273032: Title: Validation of the Intensive Care Delirium Screening Checklist in nonintubated intensive care unit patients in a resource-poor medical intensive care setting in South India.\n Abstract: OBJECTIVE: Delirium is a common, difficult-to-diagnose clinical condition in critical care units. The lack of recognition of delirium often results in increased morbidity and mortality. The study aimed to determine the validity and reliability of the Intensive Care Delirium Screening Checklist (ICDSC) in a resource-poor medical intensive care setting in South India. MATERIALS AND METHODS: Fifty-three patients admitted into the medical intensive care unit of a teaching hospital who were neither mute nor intubated were recruited for the study. Trained residents administered the ICDSC to screen for delirium. A consultant psychiatrist used the International Classification of Diseases, 10th Revision diagnostic criteria for research to determine the presence of delirium. RESULTS: The optimal threshold for screening, as ICDSC total score of 3 or more, was obtained by using a receiver operating characteristic curve. Although a sensitivity and specificity of 75% and 74%, respectively, were obtained at the original cutoff of 4, a sensitivity of 90% and specificity of 61.54% were achieved with a cutoff of 3. In a subsample of 21 patients, interrater reliability was evaluated and found to be 0.947 (95% confidence interval, 0.870-0.979). The ICDSC had good internal consistency, with Cronbach alpha of .754 and Guttman split-half coefficient of 0.71. Factor analysis revealed a 2-factor structure, namely, altered sensorium/psychopathology and sleep-wake cycle problems. CONCLUSIONS: Our findings indicate that in nonintubated intensive care unit patients, the ICDSC can be used to screen for delirium but should not be used as a diagnostic instrument in this patient population and that residents can be trained in the use of the instrument in resource-poor critical care settings. Using a different threshold for positivity of 3 rather than 4 appeared to offer improved screening characteristics in this resource-poor critical care setting.\n.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid34448431": {"__data__": {"id_": "pmid34448431", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid34448431: Title: Outcomes and measures of delirium interventional studies in palliative care to inform a core outcome set: A systematic review.\n Abstract: BACKGROUND: Trials of interventions for delirium in various patient populations report disparate outcomes and measures but little is known about those used in palliative care trials. A core outcome set promotes consistency of outcome selection and measurement. AIM: To inform core outcome set development by examining outcomes, their definitions, measures and time-points in published palliative care studies of delirium prevention or treatment delirium interventions. DESIGN: Prospectively registered systematic review adhering to Preferred Reporting Items for Systematic Reviews and Meta-Analyses. DATA SOURCES: We searched six electronic databases (1980-November 2020) for original studies, three for relevant reviews and the International Clinical Trials Registry Platform for unpublished studies and ongoing trials. We included randomised, quasi-randomised and non-randomised intervention studies of pharmacological and non-pharmacological delirium prevention and/or treatment interventions. RESULTS: From 13/3244 studies (2863 adult participants), we identified 9 delirium-specific and 13 non-delirium specific outcome domains within eight Core Outcome Measures in Effectiveness Trials (COMET) taxonomy categories. There were multiple and varied outcomes and time points in each domain. The commonest delirium specific outcome was delirium severity (n = 7), commonly using the Memorial Delirium Assessment Scale (6/8 studies, 75%). Four studies reported delirium incidence. Non-delirium specific outcomes included mortality, agitation, adverse events, other symptoms and quality of life. CONCLUSION: The review identified few delirium interventions with heterogeneity in outcomes, their definition and measurement, highlighting the need for a uniform approach. Findings will inform the next stage to develop consensus for a core outcome set to inform delirium interventional palliative care research.\n.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "head impact": {"__data__": {"id_": "head impact", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "head impact", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "american football": {"__data__": {"id_": "american football", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "american football", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "major depressive disorder": {"__data__": {"id_": "major depressive disorder", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "major depressive disorder", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid37396804": {"__data__": {"id_": "pmid37396804", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid37396804: Title: Suicide and depression in former contact sports participants: population-based cohort study, systematic review, and meta-analysis. Abstract: Background: Former participants in sports characterised by low intensity repetitive head impact appear to have elevated rates of later dementia, but links with other psychological health outcomes such as depression and suicide are uncertain. We quantified the occurrence of these endpoints in former contact sports athletes against general population controls using new data from a cohort study and a meta-analysis. Methods: The cohort study comprised 2004 retired male athletes, who had competed internationally as amateurs for Finland across a range of sports, and 1385 general population controls. All study members were linked to mortality and hospitalisation registries. In the PROSPERO-registered systematic review (CRD42022352780), we searched PubMed and Embase to October 31 2022 for cohort studies that reported standard estimates of association and precision. Study-specific estimates were aggregated in a random-effect meta-analysis. The Newcastle-Ottawa Scale was used to appraise the quality of each study. Findings: In survival analyses of the Finnish cohort data, former boxers (depression: hazard ratio 1.43 [95% CI 0.73, 2.78]; suicide: 1.75 [0.64, 4.38]), Olympic-style wrestlers (depression: 0.94 [0.44, 2.00]; suicide: 1.60 [0.64, 3.99]), and soccer players (depression: 0.62 [0.26, 1.48]; suicide: 0.50 [0.11, 2.16]) did not have statistically higher rates of major depressive disorder or suicide at follow-up relative to controls. In the systematic review, 7 cohort studies met inclusion criteria. After aggregating results with the Finnish cohort, retired soccer players appeared to have a lower risk of depression (summary risk ratio: 0.71 [0.54, 0.93]) relative to general population controls, while the rate of suicide was statistically the same across groups (0.70 [0.40, 1.23]). Past participation in American football seemed to be associated with some protection against suicide (0.58 [0.43, 0.80]) but there were insufficient studies of depression in this sport to facilitate aggregation. The aggregation of results from the soccer and American football studies showed directionally consistent relationships and there was no indication of inter-study heterogeneity (I2 = 0%). Interpretation: Based on a small cluster of studies exclusively comprising men, retired soccer players had a lower rate of later depression and former American football players had a lower risk of suicide relative to comparator groups. Whether these findings are generalisable to women requires testing. Funding: The preparation of this manuscript was unfunded.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "idiopathic tourette syndrome": {"__data__": {"id_": "idiopathic tourette syndrome", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "idiopathic tourette syndrome", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "tics": {"__data__": {"id_": "tics", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "tics", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid37215485": {"__data__": {"id_": "pmid37215485", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid37215485: Title: Mapping a network for tics in Tourette syndrome using causal lesions and structural alterations. Abstract: Tics are sudden stereotyped movements or vocalizations. Cases of lesion-induced tics are invaluable, allowing for causal links between symptoms and brain structures. While a lesion network for tics has recently been identified, the degree to which this network translates to Tourette syndrome has not been fully elucidated. This is important given that patients with Tourette syndrome make up a large portion of tic cases; therefore, existing and future treatments should apply to these patients. The aim of this study was to first localize a causal network for tics from lesion-induced cases and then refine and validate this network in patients with Tourette syndrome. We independently performed 'lesion network mapping' using a large normative functional connectome (n = 1000) to isolate a brain network commonly connected to lesions causing tics (n = 19) identified through a systematic search. The specificity of this network to tics was assessed through comparison to lesions causing other movement disorders. Using structural brain coordinates from prior neuroimaging studies (n = 7), we then derived a neural network for Tourette syndrome. This was done using standard anatomical likelihood estimation meta-analysis and a novel method termed 'coordinate network mapping', which uses the same coordinates, yet maps their connectivity using the aforementioned functional connectome. Conjunction analysis was used to refine the network for lesion-induced tics to Tourette syndrome by identifying regions common to both lesion and structural networks. We then tested whether connectivity from this common network is abnormal in a separate resting-state functional connectivity MRI data set from idiopathic Tourette syndrome patients (n = 21) and healthy controls (n = 25). Results showed that lesions causing tics were distributed throughout the brain; however, consistent with a recent study, these were part of a common network with predominant basal ganglia connectivity. Using conjunction analysis, coordinate network mapping findings refined the lesion network to the posterior putamen, caudate nucleus, globus pallidus externus (positive connectivity) and precuneus (negative connectivity). Functional connectivity from this positive network to frontal and cingulate regions was abnormal in patients with idiopathic Tourette syndrome. These findings identify a network derived from lesion-induced and idiopathic data, providing insight into the pathophysiology of tics in Tourette syndrome. Connectivity to our cortical cluster in the precuneus offers an exciting opportunity for non-invasive brain stimulation protocols.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "piperidine": {"__data__": {"id_": "piperidine", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "piperidine", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "il 18": {"__data__": {"id_": "il 18", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "il 18", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "il 1beta": {"__data__": {"id_": "il 1beta", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "il 1beta", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "muckle wells syndrome": {"__data__": {"id_": "muckle wells syndrome", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "muckle wells syndrome", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "kn3014": {"__data__": {"id_": "kn3014", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "kn3014", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cryopyrin associated periodic syndrome": {"__data__": {"id_": "cryopyrin associated periodic syndrome", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "cryopyrin associated periodic syndrome", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid32782316": {"__data__": {"id_": "pmid32782316", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid32782316: Title: KN3014, a piperidine-containing small compound, inhibits auto-secretion of IL-1beta from PBMCs in a patient with Muckle-Wells syndrome. Abstract: NLRP3, an intracellular pattern recognition receptor, recognizes numerous pathogens and/or its own damage-associated molecules, and forms complexes with the adaptor protein ASC. These complexes constitute the NLRP3 inflammasome, a platform for processing interleukin (IL)-1beta and/or IL-18. Several NLRP3 mutations result in constitutive activation of the NLRP3 inflammasome, causing cryopyrin-associated periodic syndrome (CAPS). To the best of our knowledge, small compounds that specifically inhibit inflammasome activation through the pyrin domain (PYD) have not yet been developed. This study describes an attempt to develop small compounds targeting the NLRP3 inflammasome. A core chemical library of 9,600 chemicals was screened against reconstituted NLRP3 inflammasome in a cell-free system with an amplified luminescence proximity homogeneous assay and a cell-based assay by human peripheral blood mononuclear cells (PBMCs). Inflammasome activation was evaluated by ASC-speck formation in human PBMCs, accompanied by IL-1beta secretion and processing, and by using IL-1beta-based dual operating luciferase (IDOL) mice. The activity of these compounds was evaluated clinically using PBMCs from a patient with Muckle-Wells syndrome (MWS), a type of CAPS, with an R260W mutation in NLRP3. Screening identified KN3014, a piperidine-containing compound targeting the interaction between NLRP3 and ASC through the PYD. KN3014 reduced ASC-speck formation in human PBMCs, luminescence from IDOL mice, and auto-secretion of IL-1beta by PBMCs from the patient with MWS. These findings suggest that KN3014 may be an attractive candidate for treatment of MWS, as well as other NLRP3 inflammasomopathies.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "sulfur": {"__data__": {"id_": "sulfur", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "sulfur", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "iron": {"__data__": {"id_": "iron", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "iron", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "atp": {"__data__": {"id_": "atp", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "atp", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid20463401": {"__data__": {"id_": "pmid20463401", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid20463401: Title: Mitochondrial iron metabolism and its role in neurodegeneration. Abstract: In addition to their well-established role in providing the cell with ATP, mitochondria are the source of iron-sulfur clusters (ISCs) and heme - prosthetic groups that are utilized by proteins throughout the cell in various critical processes. The post-transcriptional system that mammalian cells use to regulate intracellular iron homeostasis depends, in part, upon the synthesis of ISCs in mitochondria. Thus, proper mitochondrial function is crucial to cellular iron homeostasis. Many neurodegenerative diseases are marked by mitochondrial impairment, brain iron accumulation, and oxidative stress - pathologies that are inter-related. This review discusses the physiological role that mitochondria play in cellular iron homeostasis and, in so doing, attempts to clarify how mitochondrial dysfunction may initiate and/or contribute to iron dysregulation in the context of neurodegenerative disease. We review what is currently known about the entry of iron into mitochondria, the ways in which iron is utilized therein, and how mitochondria are integrated into the system of iron homeostasis in mammalian cells. Lastly, we turn to recent advances in our understanding of iron dysregulation in two neurodegenerative diseases (Alzheimer's disease and Parkinson's disease), and discuss the use of iron chelation as a potential therapeutic approach to neurodegenerative disease.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "sirt1": {"__data__": {"id_": "sirt1", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "sirt1", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "hsp27": {"__data__": {"id_": "hsp27", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "hsp27", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "nt4/5": {"__data__": {"id_": "nt4/5", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "nt4/5", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "multiple sclerosis": {"__data__": {"id_": "multiple sclerosis", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "multiple sclerosis", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "hsp70": {"__data__": {"id_": "hsp70", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "hsp70", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "bdnf": {"__data__": {"id_": "bdnf", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "bdnf", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid38003363": {"__data__": {"id_": "pmid38003363", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid38003363: Title: Exploring the mRNA and Plasma Protein Levels of BDNF, NT4, SIRT1, HSP27, and HSP70 in Multiple Sclerosis Patients and Healthy Controls. Abstract: Multiple sclerosis (MS) is a chronic, autoimmune neurodegenerative disease affecting the central nervous system. It is a major cause of non-traumatic neurological disability among young adults in North America and Europe. This study focuses on neuroprotective genes (BDNF, NT4/5, SIRT1, HSP70, and HSP27). Gene expression and protein levels of these markers were compared between MS patients and healthy controls. Blood samples were collected from 42 patients with multiple sclerosis (MS) and 48 control subjects without MS. Quantitative real-time PCR was performed to measure the expression of specific genes. The samples were analyzed in duplicate, and the abundance of mRNA was quantified using the 2-DeltaCt method. ELISA assay was used to measure the concentration of specific proteins in the plasma samples. The results show that a 3.5-fold decrease in the gene expression of BDNF corresponds to a 1.5-fold downregulation in the associated plasma protein concentration (p < 0.001). Similar trends were observed with NT-4 (five-fold decrease, slight elevation in protein), SIRT1 (two-fold decrease, two-fold protein decrease), HSP70 (four-fold increase, nearly two-fold protein increase), and HSP27 (four-fold increase, two-fold protein increase) (p < 0.001). This study reveals strong correlations between gene expression and protein concentration in MS patients, emphasizing the relevance of these neuroprotective markers in the disease.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "acute brain failure": {"__data__": {"id_": "acute brain failure", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "acute brain failure", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid28587754": {"__data__": {"id_": "pmid28587754", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid28587754: Title: Delirium screening in intensive care: A life saving opportunity.\n Abstract: BACKGROUND: Delirium is described as 'acute brain failure' and constitutes a medical emergency which presents a hazard for people cared for in intensive care units. The Scottish intensive care society audit group recommend that all people cared for in intensive care units be screened for signs of delirium so that treatment and management of complications can be implemented at an early stage. CLINICAL IMPLICATION: There is inconsistent evidence about when and how the assessment of delirium is carried out by nursing staff in the intensive care setting. AIM: This narrative review explores the pathophysiology and current practices of delirium screening in intensive care. Consideration is given to the role of the nurse in detecting and managing delirium and some barriers to routine daily delirium screening are critically debated. CONCLUSION: It is argued that routine delirium screening is an essential element of safe, effective and person centred nursing care which has potential to reduce morbidity and mortality.\n.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "folate": {"__data__": {"id_": "folate", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "folate", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "vitamin b12": {"__data__": {"id_": "vitamin b12", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "vitamin b12", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b12": {"__data__": {"id_": "b12", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "b12", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid31661337": {"__data__": {"id_": "pmid31661337", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid31661337: Title: Vitamin B12 and folate levels in progression of Alzheimer's disease - a short report. Abstract: Background: The status of vitamin B12 and folate has been implicated in the development and progression of Alzheimer's disease.Methods: The study explored this issue through a retrospective case-control study design, with follow up of the case group for 18 months. The case group (n = 136) comprised patients 65 years or older diagnosed with Alzheimer's disease and having a Mini-mental State Examination score (MMSE) of <= 27. The control group comprised healthy adults 65 years or older (n = 338) with a MMSE score of >27.Results: Vitamin B12 and folate levels were not found to differ between case and control groups. B12 and folate status at baseline was not predictive of disease progression in the case group.Discussion: This lack of association differs from other studies which have shown a protective effect of vitamin B12 and folate on cognitive decline.KEY POINTSThe findings of this study do not confirm evidence suggesting an effect of vitamin B12 and folate levels on development and progression of Alzheimer's disease.Folate and B12 levels were similar in the Alzheimer's group to those of healthy controls.Folate and B12 levels at initial assessment were not predictive of disease progression.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "caspase 7": {"__data__": {"id_": "caspase 7", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "caspase 7", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "amyloid beta peptide (abeta)": {"__data__": {"id_": "amyloid beta peptide (abeta)", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "amyloid beta peptide (abeta)", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "neuronal": {"__data__": {"id_": "neuronal", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "neuronal", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "caspase 8": {"__data__": {"id_": "caspase 8", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "caspase 8", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "caspase 6": {"__data__": {"id_": "caspase 6", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "caspase 6", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "caspase 3": {"__data__": {"id_": "caspase 3", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "caspase 3", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "neuronal apoptosis": {"__data__": {"id_": "neuronal apoptosis", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "neuronal apoptosis", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid11069945": {"__data__": {"id_": "pmid11069945", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid11069945: Title: Selective and protracted apoptosis in human primary neurons microinjected with active caspase-3, -6, -7, and -8. Abstract: We have shown previously that caspase-6 is activated in serum deprivation-mediated human neuronal cell death and correlates with increased production of Alzheimer's disease (AD) amyloid beta peptide (Abeta). Here, we show by direct microinjection of recombinant active enzymes that caspase-6 (>0.5 pg/cell) induces a protracted course of apoptosis in neurons in a caspase-specific, dose- and time-dependent manner in the presence of serum. Only transient activation of caspase-6 is required to initiate apoptosis. Caspase-6 induces apoptosis directly without the activation of other caspase effectors. Doses of caspase-6 of <0.25 pg/cell induce only 20% cell death within 16 d but render neurons vulnerable to oxidative stress, indicating that caspase activation affects neurons despite the absence of cell death. Caspase-3 induces neuronal apoptosis in 20% of the cells, whereas caspase-7 or -8 do not induce apoptosis. In contrast, astrocytes undergo apoptosis within 24 hr when microinjected with caspase-3 but not caspase-6, -7, or -8. These results show cell type-specific vulnerability to caspases in the CNS. The results suggest that activation of caspases in human neurons does not lead to an immediate and rapid process of cell death but provokes a protracted form of apoptosis. Activation of caspases in human neurons may participate in the long-term overproduction of Abeta and other potential toxic fragments resulting from caspase-mediated proteolysis. These results are consistent with the protracted and age-dependent nature of AD.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "stenosis of intracranial arteries": {"__data__": {"id_": "stenosis of intracranial arteries", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "stenosis of intracranial arteries", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid38585478": {"__data__": {"id_": "pmid38585478", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid38585478: Title: Psychiatric manifestations in moyamoya disease: more than a puff of smoke? a systematic review and a case-reports meta-analysis.\n Abstract: Introduction: Moyamoya disease (MMD) is a life-threatening condition characterized by stenosis of intracranial arteries. Despite the frequency and the impact of psychiatric symptoms on the long-term prognosis and quality of life of MMD patients, no systematic review on this topic exists. Methods: This systematic review and meta-analysis included 41 studies (29 being case reports), from PubMed, Scopus, Embase until 27/3/2023, on MMD patients exhibiting psychiatric symptoms. Results: Despite a fair average quality of the articles, quantitative synthesis through logistic regression was possible only for case reports, due to heterogeneity between the other studies. Psychosis, the most frequent psychiatric symptom reported in case reports, was more frequent in MMD patients with left hemisphere involvement. Neurological symptoms occurrence increased the odds of MMD diagnosis preceding psychiatric symptoms. Psychiatric symptoms are highly prevalent in MMD patients and are relatively often the only presenting symptoms. Discussion: We discuss the diagnostic, therapeutic, and prognostic implications of recognizing and characterizing specific psychiatric symptoms in MMD, outlining preliminary guidelines for targeted pharmacological and psychotherapeutic interventions. Lastly, we outline future research and clinical perspectives, striving to enhance the oft-overlooked psychiatric care for MMD patients and to ameliorate their long-term outcome. Systematic Review Registration: https://www.crd.york.ac.uk/PROSPERO/, identifier CRD42023406303.\n.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "moyamoya disease": {"__data__": {"id_": "moyamoya disease", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "moyamoya disease", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "psychiatric symptoms": {"__data__": {"id_": "psychiatric symptoms", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "psychiatric symptoms", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "high temperature requirement a": {"__data__": {"id_": "high temperature requirement a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "high temperature requirement a", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "mast cell related disorders": {"__data__": {"id_": "mast cell related disorders", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "mast cell related disorders", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "lung cancer": {"__data__": {"id_": "lung cancer", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "lung cancer", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "htra1, 2 and 3": {"__data__": {"id_": "htra1, 2 and 3", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "htra1, 2 and 3", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "breast cancer": {"__data__": {"id_": "breast cancer", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "breast cancer", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "allergy": {"__data__": {"id_": "allergy", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "allergy", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "interleukin 12": {"__data__": {"id_": "interleukin 12", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "interleukin 12", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pediatric asthma": {"__data__": {"id_": "pediatric asthma", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pediatric asthma", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "atopy": {"__data__": {"id_": "atopy", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "atopy", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "colon cancer": {"__data__": {"id_": "colon cancer", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "colon cancer", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "allergic rhinitis": {"__data__": {"id_": "allergic rhinitis", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "allergic rhinitis", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "acute lymphoblastic leukemia": {"__data__": {"id_": "acute lymphoblastic leukemia", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "acute lymphoblastic leukemia", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid32560402": {"__data__": {"id_": "pmid32560402", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid32560402: Title: Tumor Suppressors-HTRA Proteases and Interleukin-12-in Pediatric Asthma and Allergic Rhinitis Patients. Abstract: Background and objective: Allergy belongs to a group of mast cell-related disorders and is one of the most common diseases of childhood. It was shown that asthma and allergic rhinitis diminish the risk of various cancers, including colon cancer and acute lymphoblastic leukemia. On the other hand, asthma augments the risk of lung cancer and an increased risk of breast cancer in patients with allergy has been observed. Thus, the relation between allergy and cancer is not straightforward and furthermore, its biological mechanism is unknown. The HTRA (high temperature requirement A) proteases promote apoptosis, may function as tumor suppressors and HTRA1 is known to be released by mast cells. Interleukin-12 (Il-12) is an important cytokine that induces antitumor immune responses and is produced mainly by dendritic cells that co-localize with mast cells in superficial organs. Material and methods: In the present study we have assessed with ELISA plasma levels of the HTRA proteins, Il-12, and of the anti-HTRA autoantibodies in children with allergy (40) and in age matched controls (39). Children are a special population, since they usually do not have comorbidities and take not many drugs the processes we want to observe are not influenced by many other factors. Results: We have found a significant increase of HTRA1, 2 and 3, and of the Il-12 levels in the children with atopy (asthma and allergic rhinitis) compared to controls. Conclusion: Our results suggest that the HTRA1-3 and Il-12 levels might be useful in analyzing the pro- and antioncogenic potential in young atopic patients.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "aqueduct stenosis": {"__data__": {"id_": "aqueduct stenosis", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "aqueduct stenosis", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "tumours": {"__data__": {"id_": "tumours", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "tumours", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "post haemorrhagic hydrocephalus": {"__data__": {"id_": "post haemorrhagic hydrocephalus", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "post haemorrhagic hydrocephalus", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "peri  and intraventricular cysts": {"__data__": {"id_": "peri  and intraventricular cysts", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "peri  and intraventricular cysts", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "intracranial diseases": {"__data__": {"id_": "intracranial diseases", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "intracranial diseases", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid39669717": {"__data__": {"id_": "pmid39669717", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid39669717: Title: Assessment of the efficacy and safety of neuroendoscopic procedures for intracranial pathologies: A single-centre retrospective study with 318 intracranial endoscopic procedures.\n Abstract: Introduction: Neuroendoscopy has become a well-established procedure for treating various intracranial conditions. Research question: We evaluated the advantages of that technique, with focus on adverse events. Material and methods: Retrospective analysis included all patients who underwent neuroendoscopic procedures between January 2017 and December 2023. We conducted comparative analysis considering factors such as age, gender, follow-up duration, etiology, preoperative symptoms, clinical and radiological benefits, as well as surgical and nonsurgical adverse events rates. Results: Total of 318 neuroendoscopic procedures within 257 surgeries in 225 patients were included, with mean age of 18.8 +- 21.4 years. 170 cases (66.1%) were pediatric versus 87 cases adults (33.9%). Most common aetiologies were peri- and intraventricular cysts (27.2%), idiopathic aqueduct stenosis (24.9%), tumours (23.7%), and post-haemorrhagic hydrocephalus (17.1%). Procedures included endoscopic third ventriculostomy (51.0%), cyst fenestration (21.0%), and endoscopic-assisted ventricular catheter placements (19.5%). Headache was predominant preoperative symptom (42.0%). During follow-up, 84.8% and 82.5% of cases showed clinical and radiological improvement, respectively. Early surgical adverse events were observed in 5.4% of cases, while non-surgical adverse events occurred in 3.1%. There was no significant difference in the surgical adverse events rate between children and adults (4.7% vs. 6.9%, p = 0.563), compared to significant higher non-surgical adverse events in adults (6.9% vs 1.2%, p=0.020). Discussion and conclusion: Neuroendoscopy has demonstrated effectiveness and safety in treating intracranial diseases, boasting a low adverse events rate. Our study found no significant difference in the surgical adverse events rates between pediatric and adult groups.\n.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cyst": {"__data__": {"id_": "cyst", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "cyst", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid31998071": {"__data__": {"id_": "pmid31998071", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid31998071: Title: Untangling the Conformational Polymorphism of Disordered Proteins Associated With Neurodegeneration at the Single-Molecule Level. Abstract: A large fraction of the human genome encodes intrinsically disordered proteins/regions (IDPs/IDRs) that are involved in diverse cellular functions/regulation and dysfunctions. Moreover, several neurodegenerative disorders are associated with the pathological self-assembly of neuronal IDPs, including tau [Alzheimer's disease (AD)], alpha-synuclein [Parkinson's disease (PD)], and huntingtin exon 1 [Huntington's disease (HD)]. Therefore, there is an urgent and emerging clinical interest in understanding the physical and structural features of their functional and disease states. However, their biophysical characterization is inherently challenging by traditional ensemble techniques. First, unlike globular proteins, IDPs lack stable secondary/tertiary structures under physiological conditions and may interact with multiple and distinct biological partners, subsequently folding differentially, thus contributing to the conformational polymorphism. Second, amyloidogenic IDPs display a high aggregation propensity, undergoing complex heterogeneous self-assembly mechanisms. In this review article, we discuss the advantages of employing cutting-edge single-molecule fluorescence (SMF) techniques to characterize the conformational ensemble of three selected neuronal IDPs (huntingtin exon 1, tau, and alpha-synuclein). Specifically, we survey the versatility of these powerful approaches to describe their monomeric conformational ensemble under functional and aggregation-prone conditions, and binding to biological partners. Together, the information gained from these studies provides unique insights into the role of gain or loss of function of these disordered proteins in neurodegeneration, which may assist the development of new therapeutic molecules to prevent and treat these devastating human disorders.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "huntington's disease": {"__data__": {"id_": "huntington's disease", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "huntington's disease", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "huntingtin": {"__data__": {"id_": "huntingtin", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "huntingtin", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "translocator protein": {"__data__": {"id_": "translocator protein", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "translocator protein", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "metastases": {"__data__": {"id_": "metastases", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "metastases", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "brain metastases": {"__data__": {"id_": "brain metastases", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "brain metastases", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid35359488": {"__data__": {"id_": "pmid35359488", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid35359488: Title: Glial activation positron emission tomography imaging in radiation treatment of breast cancer brain metastases. Abstract: Brain metastases affect more breast cancer patients than ever before due to increased overall patient survival with improved molecularly targeted treatments. Approximately 25-34% of breast cancer patients develop brain metastases in their lifetime. Due to the blood-brain barrier (BBB), the standard treatment for breast cancer brain metastases (BCBM) is surgery, stereotactic radiosurgery (SRS) and/or whole brain radiation therapy (WBRT). At the cost of cognitive side effects, WBRT has proven efficacy in treating brain metastases when used with local therapies such as SRS and surgery. This review investigated the potential use of glial activation positron emission tomography (PET) imaging for radiation treatment of BCBM. In order to put these studies into context, we provided background on current radiation treatment approaches for BCBM, our current understanding of the brain microenvironment, its interaction with the peripheral immune system, and alterations in the brain microenvironment by BCBM and radiation. We summarized preclinical literature on the interactions between glial activation and cognition and clinical studies using translocator protein (TSPO) PET to image glial activation in the context of neurological diseases. TSPO-PET is not employed clinically in assessing and guiding cancer therapies. However, it has gained traction in preclinical studies where glial activation was investigated from primary brain cancer, metastases and radiation treatments. Novel glial activation PET imaging and its applications in preclinical studies using breast cancer models and glial immunohistochemistry are highlighted. Lastly, we discuss the potential clinical application of glial activation imaging to improve the therapeutic ratio of radiation treatments for BCBM.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "tau pet binding": {"__data__": {"id_": "tau pet binding", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "tau pet binding", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "phosphorylated tau181": {"__data__": {"id_": "phosphorylated tau181", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "phosphorylated tau181", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "apoe epsilon4": {"__data__": {"id_": "apoe epsilon4", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "apoe epsilon4", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "brain regions": {"__data__": {"id_": "brain regions", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "brain regions", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid35994280": {"__data__": {"id_": "pmid35994280", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid35994280: Title: Spatial Extent of Amyloid-beta Levels and Associations With Tau-PET and Cognition. Abstract: Importance: Preventive trials of anti-amyloid agents might preferably recruit persons showing earliest biologically relevant beta-amyloid (Abeta) binding on positron emission tomography (PET). Objective: To investigate the timing at which Abeta-PET binding starts showing associations with other markers of Alzheimer disease. Design, Setting, and Participants: This longitudinal multicentric cohort study included 3 independent cohorts: Presymptomatic Evaluation of Experimental or Novel Treatments for Alzheimer Disease (PREVENT-AD) (data collected from 2012-2020), Alzheimer Disease Neuroimaging Initiative (ADNI) (data collected from 2005-2019), and Harvard Aging Brain Study (HABS) (data collected from 2011-2019). In a 3-tiered categorization of Abeta-PET binding spatial extent, individuals were assigned as having widespread Abeta deposition if they showed positive signal throughout a designated set of brain regions prone to early Abeta accumulation. Those with binding in some but not all were categorized as having regional deposition, while those who failed to show any criterion Abeta signal were considered Abeta-negative. All participants who were cognitively unimpaired at their first Abeta PET scan. Main Outcomes and Measures: Differences in cerebrospinal fluid (CSF), genetics, tau-PET burden, and cognitive decline. Results: A total of 817 participants were included, including 129 from the PREVENT-AD cohort (mean [SD] age, 63.5 [4.7] years; 33 [26%] male; 126 [98%] White), 400 from ADNI (mean [SD] age, 73.6 [5.8] years; 190 [47%] male; 10 [5%] Hispanic, 338 [91%] White), and 288 from HABS (mean [SD] age, 73.7 [6.2] years; 117 [40%] male; 234 [81%] White). Compared with Abeta-negative persons, those with regional Abeta binding showed proportionately more APOE epsilon4 carriers (18 [64%] vs 22 [27%] in PREVENT-AD and 34 [31%] vs 38 [19%] in ADNI), reduced CSF Abeta1-42 levels (F = 24 and 71), and greater longitudinal Abeta-PET accumulation (significant beta = 0.019 to 0.056). Participants with widespread amyloid binding further exhibited notable cognitive decline (significant beta = -0.014 to -0.08), greater CSF phosphorylated tau181 (F = 5 and 27), and tau-PET binding (all F > 7.55). Using each cohort's specified dichotomous threshold for Abeta positivity or a visual read classification, most participants (56% to 100%, depending on classification method and cohort) with regional Abeta would have been classified Abeta-negative. Conclusions and Relevance: Regional Abeta binding appears to be biologically relevant and participants at this stage remain relatively free from CSF phosphorylated tau181, tau-PET binding, and related cognitive decline, making them ideal targets for anti-amyloid agents. Most of these individuals would be classified as negative based on classical thresholds of Abeta positivity.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "small vessel disease": {"__data__": {"id_": "small vessel disease", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "small vessel disease", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "white matter hyperintensities": {"__data__": {"id_": "white matter hyperintensities", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "white matter hyperintensities", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cognitive deterioration": {"__data__": {"id_": "cognitive deterioration", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "cognitive deterioration", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid34511497": {"__data__": {"id_": "pmid34511497", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid34511497: Title: Influence of White Matter Hyperintensities on Baseline and Longitudinal Amyloid-beta in Cognitively Normal Individuals. Abstract: BACKGROUND: The associations between small vessel disease (SVD) and cerebrospinal amyloid-beta1-42 (Abeta1-42) pathology have not been well-elucidated. OBJECTIVE: Baseline (BL) white matter hyperintensities (WMH) were examined for associations with month-24 (M24) and longitudinal Abeta1-42 change in cognitively normal (CN) subjects. The interaction of WMH and Abeta1-42 on memory and executive function were also examined. METHODS: This study included 72 subjects from the Alzheimer's Disease Neuroimaging Initiative. Multivariable linear regression models evaluated associations between baseline WMH/intracranial volume ratio, M24 and change in Abeta1-42 over two years. Linear mixed effects models evaluated interactions between BL WMH/ICV and Abeta1-42 on memory and executive function. RESULTS: Mean age of the subjects (Nmales = 36) = 73.80 years, SD = 6.73; mean education years = 17.1, SD = 2.4. BL WMH was significantly associated with M24 Abeta1-42 (p = 0.008) and two-year change in Abeta1-42 (p = 0.006). Interaction between higher WMH and lower Abeta1-42 at baseline was significantly associated with worse memory at baseline and M24 (p = 0.003). CONCLUSION: BL WMH was associated with M24 and longitudinal Abeta1-42 change in CN. The interaction between higher WMH and lower Abeta1-42 was associated with poorer memory. Since SVD is associated with longitudinal Abeta1-42 pathology, and the interaction of both factors is linked to poorer cognitive outcomes, the mitigation of SVD may be correlated with reduced amyloid pathology and milder cognitive deterioration in Alzheimer's disease.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "esr1": {"__data__": {"id_": "esr1", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "esr1", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "mapk1": {"__data__": {"id_": "mapk1", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "mapk1", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "nicotine": {"__data__": {"id_": "nicotine", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "nicotine", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "egfr": {"__data__": {"id_": "egfr", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "egfr", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "abl1": {"__data__": {"id_": "abl1", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "abl1", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cuscohygrine": {"__data__": {"id_": "cuscohygrine", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "cuscohygrine", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "anahygrine": {"__data__": {"id_": "anahygrine", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "anahygrine", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "prkcd": {"__data__": {"id_": "prkcd", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "prkcd", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "isopelletierine": {"__data__": {"id_": "isopelletierine", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "isopelletierine", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "gsk3b": {"__data__": {"id_": "gsk3b", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "gsk3b", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "hspa4": {"__data__": {"id_": "hspa4", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "hspa4", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid34278961": {"__data__": {"id_": "pmid34278961", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid34278961: Title: Network pharmacological evaluation of Withania somnifera bioactive phytochemicals for identifying novel potential inhibitors against neurodegenerative disorder. Abstract: Neurodegenerative disorders are illnesses that are responsible for neuronal cell death and resulting in lifelong cognitive problems. Due to their unclear mechanism, there are no effective drugs available for the treatment. For a long time, herbal drugs have been used as a role model in the field of the drug discovery process. Withania somnifera (Ashwagandha) in the Indian medicinal system (Ayurveda) is used for several neuronal disorders like insomnia and memory loss for decades. This study aims to identify active components of W. somnifera (WS) as potential inhibitors for the treatment of neurodegenerative diseases (ND). To fulfill this objective, Network pharmacology approach, gene ontology, pharmacokinetics analysis, molecular docking, and molecular dynamics simulation (MDS) studies were performed. A total of 77 active components in WS, 175 predicted neurodegenerative targets of WS, and 8085 ND-related targets were identified from different databases. The network analysis showed that the top ten targets APP, EGFR, MAPK1, ESR1, HSPA4, PRKCD, MAPK3, ABL1, JUN, and GSK3B were found as significant target related to ND. On the basis of gene ontology and topology analysis results, APP was found as a significant target related to Alzheimer's disease pathways. Molecular docking results found that Anahygrine, Cuscohygrine, Isopelletierine, and Nicotine showed the best binding affinities -5.55, -4.73, -4.04, and -4.11 Kcal/mol. Further, MDS results suggested that Isopelletierine and Nicotine could be used as potential inhibitors against APP protein and could be useful for the treatment of Alzheimer's disease.Communicated by Ramaswamy H. Sarma.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cognitive problems": {"__data__": {"id_": "cognitive problems", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "cognitive problems", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "mapk3": {"__data__": {"id_": "mapk3", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "mapk3", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "nfat5": {"__data__": {"id_": "nfat5", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "nfat5", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "strokes": {"__data__": {"id_": "strokes", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "strokes", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cerebral hypoperfusion": {"__data__": {"id_": "cerebral hypoperfusion", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "cerebral hypoperfusion", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid39710754": {"__data__": {"id_": "pmid39710754", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid39710754: Title: Adequate post-ischemic reperfusion of the mouse brain requires endothelial NFAT5. Abstract: Severity and outcome of strokes following cerebral hypoperfusion are significantly influenced by stress responses of the blood vessels. In this context, brain endothelial cells (BEC) regulate inflammation, angiogenesis and the vascular resistance to rapidly restore perfusion. Despite the relevance of these responses for infarct volume and tissue recovery, their transcriptional control in BEC is not well characterized. We revealed that oxygen and nutrient-deprived BEC activate nuclear factor of activated T-cells 5 (NFAT5)-a transcription factor that adjusts the cellular transcriptome to cope with environmental stressors. We hypothesized that NFAT5 controls the expression of genes regulating the response of BEC in the ischemic brain. The functional relevance of NFAT5 was assessed in mice, allowing the conditional EC-specific knock-out of Nfat5 (Nfat5(EC)-/-). Cerebral ischemia was induced by transient middle cerebral artery occlusion (MCAO) followed reperfusion up to 28 days. While loss of endothelial Nfat5 did not evoke any phenotypic abnormalities in mice under control conditions, infarct volumes, neurological deficits and the degree of brain atrophy were significantly pronounced following MCAO as compared to control animals (Nfat5fl/fl). In contrast, MCAO-induced edema formation, inflammatory processes and angiogenesis were not altered in Nfat5(EC)-/- mice. RNAseq analyses of cultured BEC suggested that loss of NFAT5 impairs the expression of Kcnj2 encoding a potassium channel that may affect reperfusion. In fact, lower levels of KCNJ2 were detected in arterial endothelial cells of Nfat5(EC)-/- versus Nfat5fl/fl mice. Laser speckle contrast imaging of the brain revealed an impaired perfusion recovery in Nfat5(EC)-/- versus Nfat5fl/fl mice after MCAO.Collectively, NFAT5 in arterial BEC is required for an adequate reperfusion response after brain ischemia that is presumably dependent on the maintenance of Kcnj2 expression. Consequently, impairment of the protective role of endothelial NFAT5 results in enlarged infarct sizes and more severe functional deficits of brain functions.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "kcnj2": {"__data__": {"id_": "kcnj2", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "kcnj2", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "neurological deficits": {"__data__": {"id_": "neurological deficits", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "neurological deficits", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "post ischemic": {"__data__": {"id_": "post ischemic", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "post ischemic", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ischemic brain": {"__data__": {"id_": "ischemic brain", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "ischemic brain", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "infarct": {"__data__": {"id_": "infarct", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "infarct", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cerebral ischemia": {"__data__": {"id_": "cerebral ischemia", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "cerebral ischemia", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "middle cerebral artery occlusion": {"__data__": {"id_": "middle cerebral artery occlusion", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "middle cerebral artery occlusion", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "brain atrophy": {"__data__": {"id_": "brain atrophy", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "brain atrophy", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "kidney hypofunction": {"__data__": {"id_": "kidney hypofunction", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "kidney hypofunction", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "hypofunction": {"__data__": {"id_": "hypofunction", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "hypofunction", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "coldness": {"__data__": {"id_": "coldness", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "coldness", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "frailty": {"__data__": {"id_": "frailty", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "frailty", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ketsu": {"__data__": {"id_": "ketsu", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "ketsu", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "locomotor disease": {"__data__": {"id_": "locomotor disease", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "locomotor disease", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "hoki": {"__data__": {"id_": "hoki", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "hoki", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "anti oketsu": {"__data__": {"id_": "anti oketsu", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "anti oketsu", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cutaneous dryness": {"__data__": {"id_": "cutaneous dryness", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "cutaneous dryness", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "microcirculation disorder": {"__data__": {"id_": "microcirculation disorder", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "microcirculation disorder", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid29755984": {"__data__": {"id_": "pmid29755984", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid29755984: Title: Kampo Medicines for Frailty in Locomotor Disease. Abstract: Frailty is a syndrome that includes broad problems of senility and consists of three domains: physical, psychological, and social. Kampo medicine is used for intervention in cases of hypofunction in a mental or physical state. Kampo treatment, using Hojin formulations such as Hachimijiogan and Gosyajinkigan, is useful in patients with \"jinkyo,\" or kidney hypofunction. Ketsu includes both blood and its metabolic products that circulate throughout the body. Oketsu is a disturbance of ketsu and is considered to be a microcirculation disorder. Anti-oketsu formulations, such as Keishibukuryogan and Jidabokuippo, are useful in the treatment of trauma patients who are experiencing swelling and pain. \"Ki\" is the universal energy that exists in the world. Hoki formulations, such as Rikkunshito and Hochuekkito, are useful in patients with poor appetites for reinforcing vital energy. Juzentaihoto and Ninjinyoeito are useful in patients with hypofunction of ki and ketsu, which are accompanying symptoms of coldness or cutaneous dryness. Thus, Kampo medicines can be used as a superior approach for the management of frailty.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "degenerative disorder": {"__data__": {"id_": "degenerative disorder", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "degenerative disorder", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cognitive & intellectual impairments": {"__data__": {"id_": "cognitive & intellectual impairments", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "cognitive & intellectual impairments", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid35751201": {"__data__": {"id_": "pmid35751201", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid35751201: Title: Early detection of Alzheimer's disease using single nucleotide polymorphisms analysis based on gradient boosting tree. Abstract: Alzheimer's disease (AD) is a degenerative disorder that attacks nerve cells in the brain. AD leads to memory loss and cognitive & intellectual impairments that can influence social activities and decision-making. The most common type of human genetic variation is single nucleotide polymorphisms (SNPs). SNPs are beneficial markers of complex gene-disease. Many common and serious diseases, such as AD, have associated SNPs. Detection of SNP biomarkers linked with AD could help in the early prediction and diagnosis of this disease. The main objective of this paper is to predict and diagnose AD based on SNPs biomarkers with high classification accuracy in the early stages. One of the most concerning problems is the high number of features. Thus, the paper proposes a comprehensive framework for early AD detection and detecting the most significant genes based on SNPs analysis. Usage of machine learning (ML) techniques to identify new biomarkers of AD is also suggested. In the proposed system, two feature selection techniques are separately checked: the information gain filter and Boruta wrapper. The two feature selection techniques were used to select the most significant genes related to AD in this system. Filter methods measure the relevance of features by their correlation with dependent variables, while wrapper methods measure the usefulness of a subset of features by training a model on it. Gradient boosting tree (GBT) has been applied on all AD genetic data of neuroimaging initiative phase 1 (ADNI-1) and Whole-Genome Sequencing (WGS) datasets by using two feature selection techniques. In the whole-genome approach ADNI-1, results revealed that the GBT learning algorithm scored an overall accuracy of 99.06% in the case of using Boruta feature selection. Using information gain feature selection, the proposed system achieved an average accuracy of 94.87%. The results show that the proposed system is preferable for the early detection of AD. Also, the results revealed that the Boruta wrapper feature selection is superior to the information gain filter technique.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "frontotemporal dementia": {"__data__": {"id_": "frontotemporal dementia", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "frontotemporal dementia", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "affective disorder": {"__data__": {"id_": "affective disorder", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "affective disorder", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "major depression": {"__data__": {"id_": "major depression", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "major depression", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid18368677": {"__data__": {"id_": "pmid18368677", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid18368677: Title: [Differentiating early dementia from major depression with the Spanish version of the Addenbrooke's Cognitive Examination]. Abstract: INTRODUCTION: In clinical practice it is often difficult to establish whether cognitive impairment is secondary to an affective disorder or a dementing process. AIM: To describe the cognitive performance on the Spanish version of the Addenbrooke's Cognitive Examination (ACE) of patients with early dementia and depression. SUBJECTS AND METHODS: 77 patients with early dementia (53 Alzheimer disease; 24 frontotemporal dementia), 17 patients with major depression and 54 healthy volunteers were tested with the Spanish version of the ACE. RESULTS: Alzheimer disease and frontotemporal dementia groups were significantly lower than the control group and the major depression group. When the major depression group was compared with the control group no significant differences were found. CONCLUSIONS: The cognitive performance in the ACE is different in patients with early dementia and patient with depression.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "curcumin": {"__data__": {"id_": "curcumin", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "curcumin", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "tetrahydrocurcumin": {"__data__": {"id_": "tetrahydrocurcumin", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "tetrahydrocurcumin", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid30766658": {"__data__": {"id_": "pmid30766658", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid30766658: Title: Subchronic and Reproductive/Developmental Toxicity Studies of Tetrahydrocurcumin in Rats. Abstract: Tetrahydrocurcumin (THC) is a major metabolite of curcumin, which is obtained from Curcuma longa. THC has various benefits and overcomes the bioavailability issue of curcumin. To establish it as a pharmacologically active molecule, its safety profile has to be determined. Thus, the present study aimed to determine the preclinical safety profile of THC in a 90-day subchronic and reproductive/developmental toxicity study in Wistar rats. THC at oral doses of 100, 200, and 400 mg/kg was administered daily for 90 days. Rats in the recovery group were kept for 14 days after treatment termination. The animals were observed for treatment-related morbidity, mortality, and changes in clinical signs, clinical pathology, and histopathology. In the reproductive/developmental toxicity study, THC at 100, 200, and 400 mg/kg was administered orally to rats and the reproductive/developmental parameters in adult male and female rats and pups were observed. THC at up to 400 mg/kg/day of did not have any significant effect on all parameters in male and female rats in both toxicity studies. Thus, 400 mg/kg/day can be considered as the no-observed-adverse-effect-level of THC in rats.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid37452841": {"__data__": {"id_": "pmid37452841", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid37452841: Title: Characterization of N-glycome profile in mouse brain tissue regions by MALDI-TOF/MS. Abstract: Glycosylation is one of the most common types of post-translational modifications in mammals. It is well known that N-glycans play a key role in cell adhesion, differentiation, synapsis, and myelination during the development of the mammalian central nervous system (CNS). Neuropathological symptoms (such as epilepsy and Alzheimer's disease) are usually accompanied by N-glycosylation changes. In this study, we extracted N-glycan chains from eight regions of the mouse brain, and combined high-throughput, high-resolution matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF/MS) with the Fmoc N-hydroxysuccinimide ester (Fmoc-OSU) derivatization method to improve the sensitivity of glycan detection to characterize the total N-glycans in the mouse brain. A total of 96 N-glycan moieties were detected. An exhaustive examination of the relative abundance of N-glycans, coupled with a comparative analysis of differences, has uncovered discernible variations of statistical significance, including high mannose, fucosylated, sialylated, and galactosylated N-glycans. According to our investigations, a thorough and regionally specific cartography of glycans within the brain can facilitate the investigation of glycan-mediated mechanisms related to both the developmental trajectory and functional output of the brain. Additionally, this approach may serve as a basis for identifying potential biomarkers that are relevant to various brain-associated pathologies.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "glycan": {"__data__": {"id_": "glycan", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "glycan", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "epilepsy": {"__data__": {"id_": "epilepsy", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "epilepsy", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "n glycan": {"__data__": {"id_": "n glycan", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "n glycan", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "fmoc osu": {"__data__": {"id_": "fmoc osu", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "fmoc osu", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "mannose": {"__data__": {"id_": "mannose", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "mannose", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "periodontal diseases": {"__data__": {"id_": "periodontal diseases", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "periodontal diseases", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "maresins": {"__data__": {"id_": "maresins", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "maresins", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "lipid mediators": {"__data__": {"id_": "lipid mediators", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "lipid mediators", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "rheumatoid arthritis": {"__data__": {"id_": "rheumatoid arthritis", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "rheumatoid arthritis", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "chronic inflammatory diseases": {"__data__": {"id_": "chronic inflammatory diseases", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "chronic inflammatory diseases", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "omega 3 fatty acids": {"__data__": {"id_": "omega 3 fatty acids", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "omega 3 fatty acids", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid37446190": {"__data__": {"id_": "pmid37446190", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid37446190: Title: Maresin: Macrophage Mediator for Resolving Inflammation and Bridging Tissue Regeneration-A System-Based Preclinical Systematic Review. Abstract: Maresins are lipid mediators derived from omega-3 fatty acids with anti-inflammatory and pro-resolving properties, capable of promoting tissue regeneration and potentially serving as a therapeutic agent for chronic inflammatory diseases. The aim of this review was to systematically investigate preclinical and clinical studies on maresin to inform translational research. Two independent reviewers performed comprehensive searches with the term \"Maresin (NOT) Review\" on PubMed. A total of 137 studies were included and categorized into 11 human organ systems. Data pertinent to clinical translation were specifically extracted, including delivery methods, optimal dose response, and specific functional efficacy. Maresins generally exhibit efficacy in treating inflammatory diseases, attenuating inflammation, protecting organs, and promoting tissue regeneration, mostly in rodent preclinical models. The nervous system has the highest number of original studies (n = 25), followed by the cardiovascular system, digestive system, and respiratory system, each having the second highest number of studies (n = 18) in the field. Most studies considered systemic delivery with an optimal dose response for mouse animal models ranging from 4 to 25 mug/kg or 2 to 200 ng via intraperitoneal or intravenous injection respectively, whereas human in vitro studies ranged between 1 and 10 nM. Although there has been no human interventional clinical trial yet, the levels of MaR1 in human tissue fluid can potentially serve as biomarkers, including salivary samples for predicting the occurrence of cardiovascular diseases and periodontal diseases; plasma and synovial fluid levels of MaR1 can be associated with treatment response and defining pathotypes of rheumatoid arthritis. Maresins exhibit great potency in resolving disease inflammation and bridging tissue regeneration in preclinical models, and future translational development is warranted.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "gi": {"__data__": {"id_": "gi", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "gi", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "hydroxycarboxylic acid receptor 2": {"__data__": {"id_": "hydroxycarboxylic acid receptor 2", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "hydroxycarboxylic acid receptor 2", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "mk 6892": {"__data__": {"id_": "mk 6892", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "mk 6892", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "niacin": {"__data__": {"id_": "niacin", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "niacin", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "dyslipidemia": {"__data__": {"id_": "dyslipidemia", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "dyslipidemia", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "skin flushing": {"__data__": {"id_": "skin flushing", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "skin flushing", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid36973264": {"__data__": {"id_": "pmid36973264", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid36973264: Title: Structural insights into the human niacin receptor HCA2-Gi signalling complex. Abstract: The hydroxycarboxylic acid receptor 2 (HCA2) agonist niacin has been used as treatment for dyslipidemia for several decades albeit with skin flushing as a common side-effect in treated individuals. Extensive efforts have been made to identify HCA2 targeting lipid lowering agents with fewer adverse effects, despite little being known about the molecular basis of HCA2 mediated signalling. Here, we report the cryo-electron microscopy structure of the HCA2-Gi signalling complex with the potent agonist MK-6892, along with crystal structures of HCA2 in inactive state. These structures, together with comprehensive pharmacological analysis, reveal the ligand binding mode and activation and signalling mechanisms of HCA2. This study elucidates the structural determinants essential for HCA2 mediated signalling and provides insights into ligand discovery for HCA2 and related receptors.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "neuronal damage": {"__data__": {"id_": "neuronal damage", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "neuronal damage", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "impaired cognitive function": {"__data__": {"id_": "impaired cognitive function", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "impaired cognitive function", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid23339742": {"__data__": {"id_": "pmid23339742", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid23339742: Title: Single molecule characterization of the interactions between amyloid-beta peptides and the membranes of hippocampal cells. Abstract: Oligomers of the 40 and 42 residue amyloid-beta peptides (Abeta40 and Abeta42) have been implicated in the neuronal damage and impaired cognitive function associated with Alzheimer's disease. However, little is known about the specific mechanisms by which these misfolded species induce such detrimental effects on cells. In this work, we use single-molecule imaging techniques to examine the initial interactions between Abeta monomers and oligomers and the membranes of live cells. This highly sensitive method enables the visualization of individual Abeta species on the cell surface and characterization of their oligomerization state, all at biologically relevant, nanomolar concentrations. The results indicate that oligomers preferentially interact with cell membranes, relative to monomers and that the oligomers become immobilized on the cell surface. Additionally, we observe that the interaction of Abeta species with the cell membrane is inhibited by the presence of ATP-independent molecular chaperones. This study demonstrates the power of this methodology for characterizing the interactions between protein aggregates and the membranes of live neuronal cells at physiologically relevant concentrations and opens the door to quantitative studies of the cellular responses to potentially pathogenic oligomers.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "endothelial dysfunction": {"__data__": {"id_": "endothelial dysfunction", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "endothelial dysfunction", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "amyloid beta1 40": {"__data__": {"id_": "amyloid beta1 40", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "amyloid beta1 40", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "superoxide": {"__data__": {"id_": "superoxide", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "superoxide", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "vasoactivity": {"__data__": {"id_": "vasoactivity", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "vasoactivity", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cu/zn superoxide dismutase": {"__data__": {"id_": "cu/zn superoxide dismutase", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "cu/zn superoxide dismutase", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "superoxide radicals": {"__data__": {"id_": "superoxide radicals", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "superoxide radicals", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "beta amyloid1 40 peptide": {"__data__": {"id_": "beta amyloid1 40 peptide", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "beta amyloid1 40 peptide", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "mn(iii)tetrakis(4 benzoic acid) porphyrin": {"__data__": {"id_": "mn(iii)tetrakis(4 benzoic acid) porphyrin", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "mn(iii)tetrakis(4 benzoic acid) porphyrin", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "peroxynitrite": {"__data__": {"id_": "peroxynitrite", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "peroxynitrite", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "nitrotyrosine": {"__data__": {"id_": "nitrotyrosine", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "nitrotyrosine", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid9682018": {"__data__": {"id_": "pmid9682018", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid9682018: Title: Role of peroxynitrite in the vasoactive and cytotoxic effects of Alzheimer's beta-amyloid1-40 peptide. Abstract: Increasing evidence implicates oxidative stress as partially responsible for the neurodegenerative process of Alzheimer's disease (AD). Recent reports show an increased production of nitrotyrosine in AD brains, suggesting that peroxynitrite is produced in excess in this disease. Furthermore, incidence of cerebral amyloid angiopathy in AD cases is very frequent (83%), strongly suggesting a vascular component of AD pathogenesis. We have evaluated the hypothesis that peroxynitrite could be responsible for mediating the cytotoxicity and vasoactivity induced by the amyloid-beta1-40 (Abeta) peptide. Rat brain endothelial cells (RBE-4) appear to be sensitive to Abeta-induced toxicity but not to the cytotoxicity induced by peroxynitrite. Addition of Cu/Zn superoxide dismutase to cell culture media, which is only able to clear extracellular superoxide, was not effective in blocking Abeta-induced toxicity. However, we were able to partially block Abeta-induced cytotoxicity by using Mn(III)tetrakis(4-benzoic acid) porphyrin (MnTBAP) which dismutes superoxide intracellularily. Yet, MnTBAP was not able to prevent the vasoactivity triggered by Abeta. Moreover, addition of peroxynitrite to rat aortae did not modulate the vasotension induced by Abeta. We conclude that intracellular superoxide radicals may contribute to Abeta-induced cytotoxicity. Our results also indicate that peroxynitrite does not significantly contribute to Abeta-induced cytotoxicity in rat brain endothelial cells (RBE-4) or vasoactivity in rat aortae. These results suggest that therapeutic efforts aimed at removal of reactive oxygen species with SOD is unlikely to be beneficial for treatment of Abeta-induced endothelial dysfunction. However, compounds that clear free radicals intracellularly may well be beneficial.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "epileptic seizures": {"__data__": {"id_": "epileptic seizures", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "epileptic seizures", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "disorder of the brain": {"__data__": {"id_": "disorder of the brain", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "disorder of the brain", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid28149289": {"__data__": {"id_": "pmid28149289", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid28149289: Title: Pore-Forming Proteins as Mediators of Novel Epigenetic Mechanism of Epilepsy. Abstract: Epilepsy is a disorder of the brain characterized by an enduring predisposition to generate epileptic seizures. In the last two decades, numerous gene defects underlying different forms of epilepsy have been identified with most of these genes encoding ion channel proteins. Despite these developments, the etiology of majority of non-familial epilepsies has no known associated genetic mutations and cannot be explained by defects in identified ion channels alone. We hypothesize that de novo formation of ion channels by naturally unfolded proteins (NUPs) increases neuronal excitability. Altered ionic homeostasis may initiate/contribute to cellular cascades related to epileptogenesis in susceptible individuals. Here, we consider two small proteins, namely, alpha-synuclein and stefin B, as prototypical candidates to illustrate the underlying mechanism(s). Previous work points to an association between epilepsy and alpha-synuclein or stefin B, but the mechanism(s) underlying such association remains elusive. We review the evidence to link the structure-function of these proteins with disease processes. Epigenetic mechanisms unrelated to altered DNA sequence(s) that may affect epileptogenesis include transcriptional or posttranscriptional regulation. Such epigenetic mechanisms or their combination(s) enhance the levels of these proteins and as a result the ability to form annular structures, which upon incorporation into membrane form novel ion channels and disturb intracellular ion homeostasis. Alternative epigenetic mechanisms may change amyloidogenic proteins by posttranslational modifications, thereby increasing their propensity to form channels. Further research elucidating the details about the formation of ion channels through these mechanisms and their role in epileptogenesis may define new molecular targets and guide the development of new drug targets.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "neuropsychiatric symptoms": {"__data__": {"id_": "neuropsychiatric symptoms", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "neuropsychiatric symptoms", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid35863150": {"__data__": {"id_": "pmid35863150", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid35863150: Title: Neuropsychiatric symptoms influence differently cognitive decline in older women and men. Abstract: OBJECTIVE: The potential impact of sex on cognitive performance in normal aging and participants with Alzheimer's disease (AD) has been outlined previously. Nevertheless, differences in neuropsychiatric symptoms (NPS) have been also outlined. We aimed to study a potential association between NPS and cognitive performances according to sex, in older individuals with and without cognitive impairment. METHODS: Demographic, neuropsychiatric and neuropsychological data from the ADNI and NACC databases were merged into a dataset of 506 participants with healthy cognitive performance, 467 patients with mild cognitive impairment, and 238 patients with AD. Cognitive performance in each group was evaluated according to sex and the presence of NPS. RESULTS: Based on sex, cognitive performance differed according to clinical stage: in the healthy controls and AD groups, women had better fluency performance, while in the mild cognitive impairment group, women had better working memory and men better oral naming. Regardless of sex, depression showed a negative effect on processing speed in AD. Finally, there was an interaction between sex and NPS in mild cognitive impairment, where women with apathy had better working memory performance, and in AD, women with depression had better fluency performance. The opposite pattern being was observed in men, where men with depression have worse focused attention. CONCLUSION: Cognitive performance is influenced by sex, yet this influence has different manifestations at normal cognition, MCI or AD. Furthermore, apathy and depression seem to influence differently women and men at different types of cognitive decline.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "alpha lipoic acid": {"__data__": {"id_": "alpha lipoic acid", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "alpha lipoic acid", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "calpain1": {"__data__": {"id_": "calpain1", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "calpain1", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "tauopathies": {"__data__": {"id_": "tauopathies", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "tauopathies", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "iron overload": {"__data__": {"id_": "iron overload", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "iron overload", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid29126071": {"__data__": {"id_": "pmid29126071", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid29126071: Title: alpha-Lipoic acid improves abnormal behavior by mitigation of oxidative stress, inflammation, ferroptosis, and tauopathy in P301S Tau transgenic mice. Abstract: Alzheimer's disease (AD) is the most common neurodegenerative disease and is characterized by neurofibrillary tangles (NFTs) composed of Tau protein. alpha-Lipoic acid (LA) has been found to stabilize the cognitive function of AD patients, and animal study findings have confirmed its anti-amyloidogenic properties. However, the underlying mechanisms remain unclear, especially with respect to the ability of LA to control Tau pathology and neuronal damage. Here, we found that LA supplementation effectively inhibited the hyperphosphorylation of Tau at several AD-related sites, accompanied by reduced cognitive decline in P301S Tau transgenic mice. Furthermore, we found that LA not only inhibited the activity of calpain1, which has been associated with tauopathy development and neurodegeneration via modulating the activity of several kinases, but also significantly decreased the calcium content of brain tissue in LA-treated mice. Next, we screened for various modes of neural cell death in the brain tissue of LA-treated mice. We found that caspase-dependent apoptosis was potently inhibited, whereas autophagy did not show significant changes after LA supplementation. Interestingly, Tau-induced iron overload, lipid peroxidation, and inflammation, which are involved in ferroptosis, were significantly blocked by LA administration. These results provide compelling evidence that LA plays a role in inhibiting Tau hyperphosphorylation and neuronal loss, including ferroptosis, through several pathways, suggesting that LA may be a potential therapy for tauopathies.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "schizophrenia": {"__data__": {"id_": "schizophrenia", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "schizophrenia", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cns diseases": {"__data__": {"id_": "cns diseases", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "cns diseases", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid30195932": {"__data__": {"id_": "pmid30195932", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid30195932: Title: Electrophysiological assessment methodology of sensory processing dysfunction in schizophrenia and dementia of the Alzheimer type. Abstract: Schizophrenia and Alzheimer's disease impacts on various sensory processings are extensively reviewed in the present publication. This article describes aspects of a research project whose aim is to delineate the neurobiology that may underlie Social Withdrawal in Alzheimer's disease, Schizophrenia and Major Depression. This is a European-funded IMI 2 project, identified as PRISM (Psychiatric Ratings using Intermediate Stratified Markers). This paper focuses specifically on the selected electrophysiological paradigms chosen based on a comprehensive review of all relevant literature and practical constraints. The choice of the electrophysiological biomarkers were fundamentality based their metrics and capacity to discriminate between populations. The selected electrophysiological paradigms are resting state EEG, auditory mismatch negativity, auditory and visual based oddball paradigms, facial emotion processing ERP's and auditory steady-state response. The primary objective is to study the effect of social withdrawal on various biomarkers and endophenotypes found altered in the target populations. This has never been studied in relationship to social withdrawal, an important component of CNS diseases.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "hematopoietic diseases": {"__data__": {"id_": "hematopoietic diseases", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "hematopoietic diseases", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "acute myeloid leukemia": {"__data__": {"id_": "acute myeloid leukemia", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "acute myeloid leukemia", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "transforming growth factor beta1": {"__data__": {"id_": "transforming growth factor beta1", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "transforming growth factor beta1", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid37332612": {"__data__": {"id_": "pmid37332612", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid37332612: Title: Cell-cell interactome of the hematopoietic niche and its changes in acute myeloid leukemia. Abstract: The bone marrow (BM) is a complex microenvironment, coordinating the production of billions of blood cells every day. Despite its essential role and its relevance to hematopoietic diseases, this environment remains poorly characterized. Here we present a high-resolution characterization of the niche in health and acute myeloid leukemia (AML) by establishing a single-cell gene expression database of 339,381 BM cells. We found significant changes in cell type proportions and gene expression in AML, indicating that the entire niche is disrupted. We then predicted interactions between hematopoietic stem and progenitor cells (HSPCs) and other BM cell types, revealing a remarkable expansion of predicted interactions in AML that promote HSPC-cell adhesion, immunosuppression, and cytokine signaling. In particular, predicted interactions involving transforming growth factor beta1 (TGFB1) become widespread, and we show that this can drive AML cell quiescence in vitro. Our results highlight potential mechanisms of enhanced AML-HSPC competitiveness and a skewed microenvironment, fostering AML growth.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "neurologic complications": {"__data__": {"id_": "neurologic complications", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "neurologic complications", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid35192952": {"__data__": {"id_": "pmid35192952", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid35192952: Title: Delirium severity in critical patients with COVID-19 from an Infectious Disease Intensive Care Unit.\n Abstract: BACKGROUND: COVID-19 is mainly characterized by respiratory manifestations. Nevertheless, neurologic complications have been described, including delirium, which appears to be frequent, prolonged, and severe. METHODS: We conducted a retrospective analysis of demographic, clinical, and laboratory data of two cohorts: patients with COVID-19 admitted to the infectious disease intensive care unit (ID-ICU) and patients admitted to the ID-ICU with other respiratory infections in 2018-2019. Outcomes were defined as the presence, duration, and severity of delirium. Doses of antipsychotics used to control delirium were converted to equivalents and used as delirium severity. Logistics regression models were used to correlate COVID-19 with the outcomes. RESULTS: Ninety-nine patients with COVID-19 and 40 patients without COVID-19 were included. The mean age of the COVID-19 cohort was 63 years, with a male predominance. Delirium developed in 42%, with a median duration of 3 days and an equivalent dose of olanzapine use of 10 mg/day. In univariate analysis, COVID-19 was not associated with the development or different duration of delirium when compared with patients without COVID-19. There was an association between COVID-19 and severity of delirium in a binary logistic regression model controlled to confounding variables. CONCLUSION: COVID-19 is not associated with a higher prevalence or duration of delirium than in cohorts without COVID-19. However, it is associated with more severe forms of delirium.\n.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "infectious disease": {"__data__": {"id_": "infectious disease", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "infectious disease", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "respiratory infections": {"__data__": {"id_": "respiratory infections", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "respiratory infections", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "3 methylhistidine": {"__data__": {"id_": "3 methylhistidine", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "3 methylhistidine", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "phenyl isothiocyanate": {"__data__": {"id_": "phenyl isothiocyanate", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "phenyl isothiocyanate", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "balenine": {"__data__": {"id_": "balenine", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "balenine", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "imidazole peptides": {"__data__": {"id_": "imidazole peptides", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "imidazole peptides", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid35206066": {"__data__": {"id_": "pmid35206066", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid35206066: Title: Detection of Balenine in Mouse Plasma after Administration of Opah-Derived Balenine by HPLC with PITC Pre-Column Derivatization. Abstract: We examined the absorption of balenine (Bal) in mouse blood after the administration of a high-purity Bal prepared from opah muscle. Using HPLC with phenyl isothiocyanate pre-column derivatization, we successfully isolated imidazole peptides and their constituents. We detected Bal and 3-methylhistidine (3-Me-His) in mouse blood 1 h after the administration of opah-derived Bal. The concentrations of Bal and 3-Me-His significantly increased to 128.27 and 69.09 nmol/mL in plasma, respectively, but were undetectable in control and carnosine (Car)-administrated mice. In contrast, beta-alanine and histidine did not increase in mouse plasma 1 h after the administration of Car and opah-derived Bal. The present study is the first report on the absorption of food-derived Bal in mouse blood and serves as a pilot study for future clinical trials.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "19f": {"__data__": {"id_": "19f", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "19f", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "1h": {"__data__": {"id_": "1h", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "1h", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid37953866": {"__data__": {"id_": "pmid37953866", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid37953866: Title: How to 19F MRI: applications, technique, and getting started. Abstract: Magnetic resonance imaging (MRI) plays a significant role in the routine imaging workflow, providing both anatomical and functional information. 19F MRI is an evolving imaging modality where instead of 1H, 19F nuclei are excited. As the signal from endogenous 19F in the body is negligible, exogenous 19F signals obtained by 19F radiofrequency coils are exceptionally specific. Highly fluorinated agents targeting particular biological processes (i.e., the presence of immune cells) have been visualised using 19F MRI, highlighting its potential for non-invasive and longitudinal molecular imaging. This article aims to provide both a broad overview of the various applications of 19F MRI, with cancer imaging as a focus, as well as a practical guide to 19F imaging. We will discuss the essential elements of a 19F system and address common pitfalls during acquisition. Last but not least, we will highlight future perspectives that will enhance the role of this modality. While not an exhaustive exploration of all 19F literature, we endeavour to encapsulate the broad themes of the field and introduce the world of 19F molecular imaging to newcomers. 19F MRI bridges several domains, imaging, physics, chemistry, and biology, necessitating multidisciplinary teams to be able to harness this technology effectively. As further technical developments allow for greater sensitivity, we envision that 19F MRI can help unlock insight into biological processes non-invasively and longitudinally.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "delusions": {"__data__": {"id_": "delusions", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "delusions", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid37637517": {"__data__": {"id_": "pmid37637517", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid37637517: Title: Acute Psychosis Related to Primary Hyperparathyroidism in a Patient With Bipolar Disorder.\n Abstract: Primary hyperparathyroidism (PHPT) can cause hypercalcemia secondary to high parathyroid hormone secretion. Hyperparathyroidism- and hypercalcemia-related acute psychotic symptoms can be challenging to diagnose in patients with mental health-related disorders, and it should be considered a possible differential in these patients besides medications. It can sometimes be the first manifestation of the disease, and diagnosis can be challenging, especially in patients with a previous psychiatric history without checking their biochemistry profile. The hypercalcemia severity can vary from mild to severe, and signs and symptoms may also vary depending on the calcium levels. Hypercalcemia can cause neuropsychiatric dysfunction, and patients may present with confusion, agitation, delusions, and hallucinations. We present a case of a 54-year-old patient with a previous history of bipolar disorder and a recent diagnosis of depression and schizophreniform disorder, who presented to the emergency department with acute agitation, violent behavior, and disorientation. She was being managed by the community mental health team at a local behavioral health hospital for new onset psychosis over the past few months. She was refusing blood tests prior to hospital admission. Calcium level on laboratory tests was 3.54 mmol/l, and parathyroid hormone level was 45 pg/ml. She was managed with intravenous fluids initially, followed by zoledronic acid (4 mg intravenously over 15 minutes). She was then commenced on cinacalcet 30 mg twice daily initially, which was later increased to 60 mg twice daily. Ultrasound of the neck demonstrated a large left parathyroid mass, and she underwent left parathyroidectomy as an urgent outpatient. She has remained asymptomatic, and her psychiatry symptoms resolved following parathyroidectomy.\n.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "bipolar disorder": {"__data__": {"id_": "bipolar disorder", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "bipolar disorder", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "neuropsychiatric dysfunction": {"__data__": {"id_": "neuropsychiatric dysfunction", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "neuropsychiatric dysfunction", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "disorientation": {"__data__": {"id_": "disorientation", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "disorientation", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "hypercalcemia": {"__data__": {"id_": "hypercalcemia", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "hypercalcemia", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "schizophreniform disorder": {"__data__": {"id_": "schizophreniform disorder", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "schizophreniform disorder", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "zoledronic acid": {"__data__": {"id_": "zoledronic acid", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "zoledronic acid", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "hallucinations": {"__data__": {"id_": "hallucinations", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "hallucinations", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cinacalcet": {"__data__": {"id_": "cinacalcet", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "cinacalcet", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "primary hyperparathyroidism": {"__data__": {"id_": "primary hyperparathyroidism", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "primary hyperparathyroidism", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "parathyroid hormone": {"__data__": {"id_": "parathyroid hormone", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "parathyroid hormone", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid31496063": {"__data__": {"id_": "pmid31496063", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid31496063: Title: Implementation of a model of care for hospitalised older persons with cognitive impairment (the Confused Hospitalised Older Persons program) in six New South Wales hospitals.\n Abstract: OBJECTIVE: To evaluate the implementation of a model of care known as the Confused Hospitalised Older Persons (CHOPs) program to improve recognition, assessment and management of older persons with cognitive impairment (delirium and/or dementia) admitted to acute hospitals. METHODS: The model of care was implemented in six selected hospitals across New South Wales. Pre- and postimplementation medical record audits, environmental audits, and staff knowledge and care confidence surveys were performed. Interviews with clinical leads postimplementation identified enablers and barriers. RESULTS: There were significant increases in cognitive screening within 24 hours (OR = 3.32 [2.50-4.91]), delirium risk identification (OR = 4.04 [2.89-5.64]), assessment of cognitive impairment (OR = 2.55 [1.90-3.43]) and interaction with families (OR = 2.81 [2.09-3.79]). Staff education and care confidence were improved, and positive environmental changes occurred in all hospitals. Barriers and enablers to implementation were identified. CONCLUSION: The CHOPs program improved identification, risk assessment and management of cognitive impairment in older hospitalised patients.\n.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "coagulation disorders": {"__data__": {"id_": "coagulation disorders", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "coagulation disorders", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "organ damage": {"__data__": {"id_": "organ damage", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "organ damage", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid36002211": {"__data__": {"id_": "pmid36002211", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid36002211: Title: COVID-19 postacute care major organ damage: a systematic review. Abstract: BACKGROUND: Major organ complications have been reported in patients hospitalised for COVID-19; most studies lacked controls. OBJECTIVE: Examine major organ damage postdischarge among adults hospitalised for COVID-19 versus non-COVID-19 controls. DATA SOURCES: MEDLINE, Embase and Cochrane Library from 1 January 2020 to 19 May 2021. STUDY ELIGIBILITY CRITERIA: English language studies of adults discharged from hospital for COVID-19; reporting major organ damage. Single review of abstracts; independent dual review of full text. STUDY APPRAISAL AND SYNTHESIS METHODS: Study quality was assessed using the Joanna Briggs Institute Appraisal Checklist for Cohort Studies. Outcome data were not pooled due to heterogeneity in populations, study designs and outcome assessment methods; findings are narratively synthesised. RESULTS: Of 124 studies in a full evidence report, 9 included non-COVID controls and are described here. Four of the nine (three USA, one UK) used large administrative databases. Four of the remaining five studies enrolled <600 COVID-19 patients. Mean or median age ranged from 49 to 70 years with 46%-94% male and 48%-78% White race; 10%-40% had been in intensive care units. Follow-up ranged from 4 weeks to 22 weeks postdischarge. Four used hospitalised controls, three non-hospitalised controls and two were unclear. Studies used various definitions of, and methods to assess, major organ damage outcomes. While the magnitude of effect differed across studies, incident cardiac, pulmonary, liver, acute and chronic kidney, stroke, diabetes, and coagulation disorders were consistently greater in adults hospitalised for COVID-19 compared with non-COVID-19 controls. LIMITATIONS: Applicability to subgroups (age, gender, COVID-19 severity, treatment, vaccination status) and non-hospitalised patients is unknown. CONCLUSIONS AND IMPLICATIONS OF KEY FINDINGS: Postacute COVID-19 major organ damage is common and likely higher than controls. However, there is substantial uncertainty. More consistent reporting of clinical outcomes and pre-COVID health status along with careful selection of control groups are needed to address evidence gaps. PROSPERO REGISTRATION NUMBER: CRD42020204788.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid29299599": {"__data__": {"id_": "pmid29299599", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid29299599: Title: Association of Integrated Care Coordination With Postsurgical Outcomes in High-Risk Older Adults: The Perioperative Optimization of Senior Health (POSH) Initiative.\n Abstract: Importance: Older adults undergoing elective surgery experience higher rates of preventable postoperative complications than younger patients. Objective: To assess clinical outcomes for older adults undergoing elective abdominal surgery via a collaborative intervention by surgery, geriatrics, and anesthesia focused on perioperative health optimization. Design, Setting, and Participants: Perioperative Optimization of Senior Health (POSH) is a quality improvement initiative with prospective data collection. Participants in an existing geriatrics-based clinic within a single-site academic health center were included if they were at high risk for complications (ie, older than 85 years or older than 65 years with cognitive impairment, recent weight loss, multimorbidity, or polypharmacy) undergoing elective abdominal surgery. Outcomes were compared with a control group of patients older than 65 years who underwent similar surgeries by the same group of general surgeons immediately before implementation of POSH. Main Outcomes and Measures: Primary outcomes included length of stay, 7- and 30-day readmissions, and level of care at discharge. Secondary outcomes were delirium and other major postoperative complications. Outcomes data were derived from institutional databases linked with electronic health records and billing data sets. Results: One hundred eighty-three POSH patients were compared with 143 patients in the control group. On average, patients in the POSH group were older compared with those in the control group (75.6 vs 71.9 years; P < .001; 95% CI, 2.27 to 5.19) and had more chronic conditions (10.6 vs 8.5; P = .001; 95% CI, 0.86 to 3.35). Median length of stay was shorter among POSH patients (4 days vs 6 days; P < .001; 95% CI, -1.06 to -4.21). Patients in the POSH group had lower readmission rates at 7 days (5 of 180 [2.8%] vs 14 of 142 [9.9%]; P = .007; 95% CI, 0.09 to 0.74) and 30 days (14 of 180 [7.8%] vs 26 of 142 [18.3%]; P = .004; 95% CI, 0.19 to 0.75) and were more likely to be discharged home with self-care (114 of 183 [62.3%] vs 73 of 143 [51.1%]; P = .04; 95% CI, 1.02 to 2.47). Patients in the POSH group experienced fewer mean number of complications (0.9 vs 1.4; P < .001; 95% CI, -0.13 to -0.89) despite higher rates of documented delirium (52 of 183 [28.4%] vs 8 of 143 [5.6%]; P < .001; 95% CI, 3.06 to 14.65). A greater proportion of POSH patients underwent laparoscopic procedures (92 of 183 [50%] vs 55 of 143 [38.5%]; P = .001; 95% CI, 1.04 to 2.52). Tests for interactions between POSH patients and procedure type were insignificant for all outcomes. Conclusions and Relevance: Despite higher mean age and morbidity burden, older adults who participated in an interdisciplinary perioperative care intervention had fewer complications, shorter hospitalizations, more frequent discharge to home, and fewer readmissions than a comparison group.\n.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "abeta(1 42)": {"__data__": {"id_": "abeta(1 42)", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "abeta(1 42)", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "neuritic degeneration": {"__data__": {"id_": "neuritic degeneration", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "neuritic degeneration", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "abeta(1 40)": {"__data__": {"id_": "abeta(1 40)", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "abeta(1 40)", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid19175671": {"__data__": {"id_": "pmid19175671", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid19175671: Title: A facile method for expression and purification of the Alzheimer's disease-associated amyloid beta-peptide. Abstract: We report the development of a high-level bacterial expression system for the Alzheimer's disease-associated amyloid beta-peptide (Abeta), together with a scaleable and inexpensive purification procedure. Abeta(1-40) and Abeta(1-42) coding sequences together with added ATG codons were cloned directly into a Pet vector to facilitate production of Met-Abeta(1-40) and Met-Abeta(1-42), referred to as Abeta(M1-40) and Abeta(M1-42), respectively. The expression sequences were designed using codons preferred by Escherichia coli, and the two peptides were expressed in this host in inclusion bodies. Peptides were purified from inclusion bodies using a combination of anion-exchange chromatography and centrifugal filtration. The method described requires little specialized equipment and provides a facile and inexpensive procedure for production of large amounts of very pure Abeta peptides. Recombinant peptides generated using this protocol produced amyloid fibrils that were indistinguishable from those formed by chemically synthesized Abeta1-40 and Abeta1-42. Formation of fibrils by all peptides was concentration-dependent, and exhibited kinetics typical of a nucleation-dependent polymerization reaction. Recombinant and synthetic peptides exhibited a similar toxic effect on hippocampal neurons, with acute treatment causing inhibition of MTT reduction, and chronic treatment resulting in neuritic degeneration and cell loss.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "retrograde and anterograde amnesia": {"__data__": {"id_": "retrograde and anterograde amnesia", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "retrograde and anterograde amnesia", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "atrial fibrillation": {"__data__": {"id_": "atrial fibrillation", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "atrial fibrillation", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "postoperative amnesia": {"__data__": {"id_": "postoperative amnesia", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "postoperative amnesia", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid25429367": {"__data__": {"id_": "pmid25429367", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid25429367: Title: Postoperative amnesia in a patient undergoing general anesthesia for electro-physiologic (EP) catheter ablation of an irritable atrial focus.\n Abstract: This case report describes the anesthetic management of a 67-year-old who underwent a catheter based pulmonary vein isolation (PVI) of long-standing, persistent atrial fibrillation. When the patient awoke from the 6.5 hour procedure, he was found to have a transient retrograde and anterograde amnesia that persisted for 18-24 hours postoperatively. This is a unique instance of global amnesia following a cardiac ablation procedure under prolonged general anesthesia. This case study highlights important topics in postoperative cognitive deficits including the differential diagnosis, risk factors, and strategies for optimizing patient outcomes in high risk procedures.\n.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "appetite dysfunction": {"__data__": {"id_": "appetite dysfunction", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "appetite dysfunction", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cholesterol": {"__data__": {"id_": "cholesterol", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "cholesterol", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "lipids": {"__data__": {"id_": "lipids", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "lipids", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c reactive protein": {"__data__": {"id_": "c reactive protein", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "c reactive protein", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "psychiatric and cognitive abnormalities": {"__data__": {"id_": "psychiatric and cognitive abnormalities", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "psychiatric and cognitive abnormalities", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "glucagon": {"__data__": {"id_": "glucagon", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "glucagon", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "prolactin": {"__data__": {"id_": "prolactin", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "prolactin", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "involuntary body movements": {"__data__": {"id_": "involuntary body movements", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "involuntary body movements", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "growth hormone": {"__data__": {"id_": "growth hormone", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "growth hormone", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "inherited neurodegenerative disorder": {"__data__": {"id_": "inherited neurodegenerative disorder", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "inherited neurodegenerative disorder", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ldl c": {"__data__": {"id_": "ldl c", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "ldl c", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid25002850": {"__data__": {"id_": "pmid25002850", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid25002850: Title: Metabolic and hormonal signatures in pre-manifest and manifest Huntington's disease patients. Abstract: Huntington's disease (HD) is an inherited neurodegenerative disorder typified by involuntary body movements, and psychiatric and cognitive abnormalities. Many HD patients also exhibit metabolic changes including progressive weight loss and appetite dysfunction. Here we have investigated metabolic function in pre-manifest and manifest HD subjects to establish an HD subject metabolic hormonal plasma signature. Individuals at risk for HD who have had predictive genetic testing showing the cytosine-adenine-guanine (CAG) expansion causative of HD, but who do not yet present signs and symptoms sufficient for the diagnosis of manifest HD are said to be \"pre-manifest.\" Pre-manifest and manifest HD patients, as well as both familial and non-familial controls, were evaluated for multiple peripheral metabolism signals including circulating levels of hormones, growth factors, lipids, and cytokines. Both pre-manifest and manifest HD subjects exhibited significantly reduced levels of circulating growth factors, including growth hormone and prolactin. HD-related changes in the levels of metabolic hormones such as ghrelin, glucagon, and amylin were also observed. Total cholesterol, HDL-C, and LDL-C were significantly decreased in HD subjects. C-reactive protein was significantly elevated in pre-manifest HD subjects. The observation of metabolic alterations, even in subjects considered to be in the pre-manifest stage of HD, suggests that in addition, and prior, to overt neuronal damage, HD affects metabolic hormone secretion and energy regulation, which may shed light on pathogenesis, and provide opportunities for biomarker development.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "toxicities": {"__data__": {"id_": "toxicities", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "toxicities", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "car t": {"__data__": {"id_": "car t", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "car t", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "chimeric antigen receptor": {"__data__": {"id_": "chimeric antigen receptor", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "chimeric antigen receptor", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "hemophagocytic lymphohistiocytosis": {"__data__": {"id_": "hemophagocytic lymphohistiocytosis", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "hemophagocytic lymphohistiocytosis", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid32801727": {"__data__": {"id_": "pmid32801727", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid32801727: Title: Spotlight on Tocilizumab in the Treatment of CAR-T-Cell-Induced Cytokine Release Syndrome: Clinical Evidence to Date.\n Abstract: Immune-based therapies such as chimeric antigen receptor (CAR)-T-cell therapy have revolutionized the landscape of cancer treatment in recent years. Although this class of therapy has demonstrated impressive clinical efficacy against cancers that were once thought to be incurable, its success is in part limited by unique toxicities which can be severe or even fatal. Cytokine release syndrome (CRS) is the most commonly observed toxicity and occurs as a result of non-antigen specific immune activation. Similar to macrophage activation syndrome (MAS)/hemophagocytic lymphohistiocytosis (HLH), CRS is associated with elevated levels of several cytokines including interleukin-6 (IL-6) that serve as a driver for host immune dysregulation. As a direct anti-cytokine drug, tocilizumab has been a cornerstone in the treatment of CAR-T-associated CRS through its ability to dampen CRS without compromising CAR-T-cell function. However, optimal timing of administration is yet unknown. Here, we review the use of tocilizumab in the management of CAR-T-associated CRS, emphasizing on the clinical efficacy across various CAR constructs and its role in current CRS management algorithms. We also discuss alternative therapies that may be considered for refractory CRS therapy and the use of tocilizumab in the current COVID-19 global pandemic.\n.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "immune dysregulation": {"__data__": {"id_": "immune dysregulation", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "immune dysregulation", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "tocilizumab": {"__data__": {"id_": "tocilizumab", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "tocilizumab", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cytokine release syndrome": {"__data__": {"id_": "cytokine release syndrome", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "cytokine release syndrome", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "macrophage activation syndrome": {"__data__": {"id_": "macrophage activation syndrome", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "macrophage activation syndrome", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid23716899": {"__data__": {"id_": "pmid23716899", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid23716899: Title: Ofloxacin-induced hallucinations.\n Abstract: Drug-induced hallucinations are not uncommon, and may be misdiagnosed as psychiatric illness leading to unnecessary treatment with antipsychotics. If a temporal association of use of a drug having the potential to cause hallucinations is present, mere withdrawal of the drug causes complete improvement in the symptoms. There are reports of various untoward central nervous system adverse events following administration of fluoroquinolones, including delirium, hallucinations and psychosis, even after a single dose. We describe a 5-year-old girl who suffered visual hallucinations following ofloxacin use.\n.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "fluoroquinolones": {"__data__": {"id_": "fluoroquinolones", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "fluoroquinolones", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ofloxacin": {"__data__": {"id_": "ofloxacin", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "ofloxacin", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "psychiatric illness": {"__data__": {"id_": "psychiatric illness", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "psychiatric illness", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid25291460": {"__data__": {"id_": "pmid25291460", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid25291460: Title: Variability in Obstacle Clearance May (Not) Indicate Cognitive Disorders in Alzheimer Disease. Abstract: The aim of this study was to investigate obstacle clearance and its variability in individuals with Alzheimer dementia (AD) as well as healthy elderly individuals while they approached and crossed an obstacle in their path. Fifteen people with AD and 15 age-matched/sex-matched healthy individuals (control group) participated in this study. Clinical assessment of both groups was performed by a neuropsychiatrist. Spatial-temporal parameters of 5 trials of unobstructed walking and 5 trials of obstacle crossing during walking (approach and crossing phases) were measured using a 3-dimensional optoelectronic system. The results indicated that individuals with AD showed higher variability in the approach phase for stride length and the horizontal distance from their trailing limb foot to the obstacle. However, their gait variability in the crossing phase was similar to the control group. In addition, the individuals with AD were found to walk slowly and with a short stride length in both conditions. In conclusion, individuals with AD had increased gait variability while approaching an obstacle during walking, indicating a deficit in planning to avoid obstacles that could be related to cognitive disorders. However, gait variability during the crossing phase may not be indicative of cognitive disorders in AD.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "tryptophan": {"__data__": {"id_": "tryptophan", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "tryptophan", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid38916729": {"__data__": {"id_": "pmid38916729", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid38916729: Title: Tryptophan Metabolism in Alzheimer's Disease with the Involvement of Microglia and Astrocyte Crosstalk and Gut-Brain Axis. Abstract: Alzheimer's disease (AD) is an age-dependent neurodegenerative disease characterized by extracellular Amyloid Abeta peptide (Abeta) deposition and intracellular Tau protein aggregation. Glia, especially microglia and astrocytes are core participants during the progression of AD and these cells are the mediators of Abeta clearance and degradation. The microbiota-gut-brain axis (MGBA) is a complex interactive network between the gut and brain involved in neurodegeneration. MGBA affects the function of glia in the central nervous system (CNS), and microbial metabolites regulate the communication between astrocytes and microglia; however, whether such communication is part of AD pathophysiology remains unknown. One of the potential links in bilateral gut-brain communication is tryptophan (Trp) metabolism. The microbiota-originated Trp and its metabolites enter the CNS to control microglial activation, and the activated microglia subsequently affect astrocyte functions. The present review highlights the role of MGBA in AD pathology, especially the roles of Trp per se and its metabolism as a part of the gut microbiota and brain communications. We (i) discuss the roles of Trp derivatives in microglia-astrocyte crosstalk from a bioinformatics perspective, (ii) describe the role of glia polarization in the microglia-astrocyte crosstalk and AD pathology, and (iii) summarize the potential of Trp metabolism as a therapeutic target. Finally, we review the role of Trp in AD from the perspective of the gut-brain axis and microglia, as well as astrocyte crosstalk, to inspire the discovery of novel AD therapeutics.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "minutuminolate": {"__data__": {"id_": "minutuminolate", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "minutuminolate", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "umbelliferone": {"__data__": {"id_": "umbelliferone", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "umbelliferone", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "tumor necrosis factor alpha": {"__data__": {"id_": "tumor necrosis factor alpha", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "tumor necrosis factor alpha", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "alpha acyloxyenone": {"__data__": {"id_": "alpha acyloxyenone", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "alpha acyloxyenone", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "coumarin": {"__data__": {"id_": "coumarin", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "coumarin", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "palladium": {"__data__": {"id_": "palladium", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "palladium", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "coumarin 3": {"__data__": {"id_": "coumarin 3", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "coumarin 3", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "muralatin i": {"__data__": {"id_": "muralatin i", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "muralatin i", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7 methoxy 8 (2 acetoxy 3 methyl 1 oxobut 2 enyl) coumarin": {"__data__": {"id_": "7 methoxy 8 (2 acetoxy 3 methyl 1 oxobut 2 enyl) coumarin", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "7 methoxy 8 (2 acetoxy 3 methyl 1 oxobut 2 enyl) coumarin", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid37970054": {"__data__": {"id_": "pmid37970054", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid37970054: Title: Syntheses of Minutuminolate and Related Coumarin Natural Products and Evaluation of Their TNF-alpha Inhibitory Activities. Abstract: The concise syntheses of the coumarin natural product, minutuminolate (1), and its related natural products, 7-methoxy-8-(2-acetoxy-3-methyl-1-oxobut-2-enyl) coumarin (2) and muralatin I (3), were accomplished for the first time in 4-5 steps from the commercially available umbelliferone. The key step involves a palladium-catalyzed oxidative rearrangement reaction to assemble the alpha-acyloxyenone moiety in 1 and 2. The incorporation of this functionality enables the successful synthesis of coumarin 3 through an acidic hydrolysis reaction. The anti-inflammatory activities of the compounds were also evaluated against tumor necrosis factor-alpha production in lipopolysaccharides-stimulated RAW264.7 cells. Our developed synthetic route will facilitate the development of analogues and derivatives of 1-3 with potent anti-inflammatory activities.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid33799196": {"__data__": {"id_": "pmid33799196", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid33799196: Title: The Effects of the 1st National COVID 19 Lockdown on Emergency Psychiatric Visit Trends in a Tertiary General Hospital in Israel.\n Abstract: OBJECTIVE: To examine whether the 1st COVID-19 lockdown in Israel affected emergency psychiatric presentations in a general hospital. METHOD: We studied files of patients who underwent psychiatric consultation in the emergency-room (ER) at the Tel-Aviv Sourasky Medical Center during a lockdown imposed in 2020. Parallel data were obtained from 2017-2019, as control. RESULTS: The number of psychiatric consultations dropped during the lockdown period; an increased relative number of compulsory psychiatric hospitalizations was documented and a decreased rate of consented psychiatric hospitalizations. DISCUSSION: Less psychiatric patients approached the ER during the lockdown period, pointing to an urgent need to facilitate access to psychiatric care in future times of crisis.\n.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "muscle aging": {"__data__": {"id_": "muscle aging", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "muscle aging", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid35328652": {"__data__": {"id_": "pmid35328652", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid35328652: Title: The Role of MicroRNAs in Proteostasis Decline and Protein Aggregation during Brain and Skeletal Muscle Aging. Abstract: Aging can be defined as the progressive deterioration of cellular, tissue, and organismal function over time. Alterations in protein homeostasis, also known as proteostasis, are a hallmark of aging that lead to proteome imbalances and protein aggregation, phenomena that also occur in age-related diseases. Among the various proteostasis regulators, microRNAs (miRNAs) have been reported to play important roles in the post-transcriptional control of genes involved in maintaining proteostasis during the lifespan in several organismal tissues. In this review, we consolidate recently published reports that demonstrate how miRNAs regulate fundamental proteostasis-related processes relevant to tissue aging, with emphasis on the two most studied tissues, brain tissue and skeletal muscle. We also explore an emerging perspective on the role of miRNA regulatory networks in age-related protein aggregation, a known hallmark of aging and age-related diseases, to elucidate potential miRNA candidates for anti-aging diagnostic and therapeutic targets.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "short peptides": {"__data__": {"id_": "short peptides", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "short peptides", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "balance disorders": {"__data__": {"id_": "balance disorders", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "balance disorders", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid33467522": {"__data__": {"id_": "pmid33467522", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid33467522: Title: A Global Review on Short Peptides: Frontiers and Perspectives. Abstract: Peptides are fragments of proteins that carry out biological functions. They act as signaling entities via all domains of life and interfere with protein-protein interactions, which are indispensable in bio-processes. Short peptides include fundamental molecular information for a prelude to the symphony of life. They have aroused considerable interest due to their unique features and great promise in innovative bio-therapies. This work focusing on the current state-of-the-art short peptide-based therapeutical developments is the first global review written by researchers from all continents, as a celebration of 100 years of peptide therapeutics since the commencement of insulin therapy in the 1920s. Peptide \"drugs\" initially played only the role of hormone analogs to balance disorders. Nowadays, they achieve numerous biomedical tasks, can cross membranes, or reach intracellular targets. The role of peptides in bio-processes can hardly be mimicked by other chemical substances. The article is divided into independent sections, which are related to either the progress in short peptide-based theranostics or the problems posing challenge to bio-medicine. In particular, the SWOT analysis of short peptides, their relevance in therapies of diverse diseases, improvements in (bio)synthesis platforms, advanced nano-supramolecular technologies, aptamers, altered peptide ligands and in silico methodologies to overcome peptide limitations, modern smart bio-functional materials, vaccines, and drug/gene-targeted delivery systems are discussed.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid37173788": {"__data__": {"id_": "pmid37173788", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid37173788: Title: Intraoperative pleth variability index-based fluid management therapy and gastrointestinal surgical outcomes in elderly patients: a randomised controlled trial.\n Abstract: BACKGROUND: Intraoperative goal-directed fluid therapy (GDFT) has been reported to reduce postoperative complications of patients undergoing major abdominal surgery. The clinical benefits of pleth variability index (PVI)-directed fluid management for gastrointestinal (GI) surgical patients remain unclear. Therefore, this study aimed to evaluate the impact of PVI-directed GDFT on GI surgical outcomes in elderly patients. METHODS: This randomised controlled trial was conducted in two university teaching hospitals from November 2017 to December 2020. In total, 220 older adults undergoing GI surgery were randomised to the GDFT or conventional fluid therapy (CFT) group (n = 110 each). The primary outcome was a composite of complications within 30 postoperative days. The secondary outcomes were cardiopulmonary complications, time to first flatus, postoperative nausea and vomiting, and postoperative length of stay. RESULTS: The total volumes of fluid administered were less in the GDFT group than in the CFT group (2.075 L versus [vs.] 2.5 L, P = 0.008). In intention-to-treat analysis, there was no difference in overall complications between the CFT group (41.3%) and GDFT group (43.0%) (odds ratio [OR] = 0.935; 95% confidence interval [CI], 0.541-1.615; P = 0.809). The proportion of cardiopulmonary complications was higher in the CFT group than in the GDFT group (19.2% vs. 8.4%; OR = 2.593, 95% CI, 1.120-5.999; P = 0.022). No other differences were identified between the two groups. CONCLUSIONS: Among elderly patients undergoing GI surgery, intraoperative GDFT based on the simple and non-invasive PVI did not reduce the occurrence of composite postoperative complications but was associated with a lower cardiopulmonary complication rate than usual fluid management. TRIAL REGISTRATION: This trial was registered with the Chinese Clinical Trial Registry (ChiCTR-TRC-17012220) on 1 August 2017.\n.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "postoperative nausea and vomiting": {"__data__": {"id_": "postoperative nausea and vomiting", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "postoperative nausea and vomiting", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cardiopulmonary complications": {"__data__": {"id_": "cardiopulmonary complications", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "cardiopulmonary complications", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ros pathway": {"__data__": {"id_": "ros pathway", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "ros pathway", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ros": {"__data__": {"id_": "ros", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "ros", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "neuronal toxicity": {"__data__": {"id_": "neuronal toxicity", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "neuronal toxicity", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "neurotoxin damage": {"__data__": {"id_": "neurotoxin damage", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "neurotoxin damage", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pgk1": {"__data__": {"id_": "pgk1", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pgk1", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "neurite outgrowth": {"__data__": {"id_": "neurite outgrowth", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "neurite outgrowth", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pgk1 t378p": {"__data__": {"id_": "pgk1 t378p", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pgk1 t378p", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "epgk1": {"__data__": {"id_": "epgk1", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "epgk1", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "mptp": {"__data__": {"id_": "mptp", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "mptp", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "methyl 4 phenyl 1,2,3,6 tetrahydropyridine": {"__data__": {"id_": "methyl 4 phenyl 1,2,3,6 tetrahydropyridine", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "methyl 4 phenyl 1,2,3,6 tetrahydropyridine", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ventral diencephalon": {"__data__": {"id_": "ventral diencephalon", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "ventral diencephalon", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "apoptosis": {"__data__": {"id_": "apoptosis", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "apoptosis", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid35456967": {"__data__": {"id_": "pmid35456967", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid35456967: Title: Cerebroventricular Injection of Pgk1 Attenuates MPTP-Induced Neuronal Toxicity in Dopaminergic Cells in Zebrafish Brain in a Glycolysis-Independent Manner. Abstract: Parkinson's disease (PD) is characterized by the degeneration of dopaminergic neurons. While extracellular Pgk1 (ePgk1) is reported to promote neurite outgrowth, it remains unclear if it can affect the survival of dopaminergic cells. To address this, we employed cerebroventricular microinjection (CVMI) to deliver Pgk1 into the brain of larvae and adult zebrafish treated with methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) as a PD-like model. The number of dopamine-producing cells in ventral diencephalon clusters of Pgk1-injected, MPTP-treated embryos increased over that of MPTP-treated embryos. Swimming distances of Pgk1-injected, MPTP-treated larvae and adult zebrafish were much longer compared to MPTP-treated samples. The effect of injected Pgk1 on both dopamine-producing cells and locomotion was time- and dose-dependent. Indeed, injected Pgk1 could be detected, located on dopamine neurons. When the glycolytic mutant Pgk1, Pgk1-T378P, was injected into the brain of MPTP-treated zebrafish groups, the protective ability of dopaminergic neurons did not differ from that of normal Pgk1. Therefore, ePgk1 is functionally independent from intracellular Pgk1 serving as an energy supplier. Furthermore, when Pgk1 was added to the culture medium for culturing dopamine-like SH-SY5Y cells, it could reduce the ROS pathway and apoptosis caused by the neurotoxin MPP+. These results show that ePgk1 benefits the survival of dopamine-producing cells and decreases neurotoxin damage.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cecal": {"__data__": {"id_": "cecal", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "cecal", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "uncoupling protein 2": {"__data__": {"id_": "uncoupling protein 2", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "uncoupling protein 2", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cpt1a": {"__data__": {"id_": "cpt1a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "cpt1a", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "lung injury": {"__data__": {"id_": "lung injury", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "lung injury", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "liver and kidney injury": {"__data__": {"id_": "liver and kidney injury", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "liver and kidney injury", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "5' amp activated protein kinase (ampk)": {"__data__": {"id_": "5' amp activated protein kinase (ampk)", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "5' amp activated protein kinase (ampk)", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cytokine production": {"__data__": {"id_": "cytokine production", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "cytokine production", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "toll like receptors": {"__data__": {"id_": "toll like receptors", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "toll like receptors", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "systemic inflammatory response syndrome": {"__data__": {"id_": "systemic inflammatory response syndrome", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "systemic inflammatory response syndrome", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "non esterified fatty acids (nefa)": {"__data__": {"id_": "non esterified fatty acids (nefa)", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "non esterified fatty acids (nefa)", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "oa": {"__data__": {"id_": "oa", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "oa", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "non esterified fatty acids": {"__data__": {"id_": "non esterified fatty acids", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "non esterified fatty acids", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "na+/k+ atpase": {"__data__": {"id_": "na+/k+ atpase", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "na+/k+ atpase", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "olive oil": {"__data__": {"id_": "olive oil", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "olive oil", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "monounsaturated fatty acid": {"__data__": {"id_": "monounsaturated fatty acid", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "monounsaturated fatty acid", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "omega 9 oleic acid induces fatty acid": {"__data__": {"id_": "omega 9 oleic acid induces fatty acid", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "omega 9 oleic acid induces fatty acid", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "weight gain": {"__data__": {"id_": "weight gain", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "weight gain", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "oxidative stress": {"__data__": {"id_": "oxidative stress", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "oxidative stress", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "carnitine palmitoyltransferase ia (cpt1a)": {"__data__": {"id_": "carnitine palmitoyltransferase ia (cpt1a)", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "carnitine palmitoyltransferase ia (cpt1a)", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "organ dysfunction": {"__data__": {"id_": "organ dysfunction", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "organ dysfunction", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "metabolic dysfunction": {"__data__": {"id_": "metabolic dysfunction", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "metabolic dysfunction", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "omega 9 oleic acid": {"__data__": {"id_": "omega 9 oleic acid", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "omega 9 oleic acid", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid27078880": {"__data__": {"id_": "pmid27078880", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid27078880: Title: Omega-9 Oleic Acid Induces Fatty Acid Oxidation and Decreases Organ Dysfunction and Mortality in Experimental Sepsis. Abstract: Sepsis is characterized by inflammatory and metabolic alterations, which lead to massive cytokine production, oxidative stress and organ dysfunction. In severe systemic inflammatory response syndrome, plasma non-esterified fatty acids (NEFA) are increased. Several NEFA are deleterious to cells, activate Toll-like receptors and inhibit Na+/K+-ATPase, causing lung injury. A Mediterranean diet rich in olive oil is beneficial. The main component of olive oil is omega-9 oleic acid (OA), a monounsaturated fatty acid (MUFA). We analyzed the effect of OA supplementation on sepsis. OA ameliorated clinical symptoms, increased the survival rate, prevented liver and kidney injury and decreased NEFA plasma levels in mice subjected to cecal ligation and puncture (CLP). OA did not alter food intake and weight gain but diminished reactive oxygen species (ROS) production and NEFA plasma levels. Carnitine palmitoyltransferase IA (CPT1A) mRNA levels were increased, while uncoupling protein 2 (UCP2) liver expression was enhanced in mice treated with OA. OA also inhibited the decrease in 5' AMP-activated protein kinase (AMPK) expression and increased the enzyme expression in the liver of OA-treated mice compared to septic animals. We showed that OA pretreatment decreased NEFA concentration and increased CPT1A and UCP2 and AMPK levels, decreasing ROS production. We suggest that OA has a beneficial role in sepsis by decreasing metabolic dysfunction, supporting the benefits of diets high in monounsaturated fatty acids (MUFA).", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cerebral small vessel disease": {"__data__": {"id_": "cerebral small vessel disease", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "cerebral small vessel disease", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cerebellar abnormalities": {"__data__": {"id_": "cerebellar abnormalities", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "cerebellar abnormalities", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cognitive dysfunction": {"__data__": {"id_": "cognitive dysfunction", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "cognitive dysfunction", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid34248601": {"__data__": {"id_": "pmid34248601", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid34248601: Title: The Cerebellum Is Related to Cognitive Dysfunction in White Matter Hyperintensities. Abstract: OBJECTIVE: White matter hyperintensities (WMHs) on magnetic resonance imaging (MRI) is frequently presumed to be secondary to cerebral small vessel disease (CSVD) and associated with cognitive decline. The cerebellum plays a key role in cognition and has dense connections with other brain regions. Thus, the aim of this study was to investigate if cerebellar abnormalities could occur in CSVD patients with WMHs and the possible association with cognitive performances. METHODS: A total of 104 right-handed patients with WMHs were divided into the mild WMHs group (n = 39), moderate WMHs group (n = 37), and severe WMHs group (n = 28) according to the Fazekas scale, and 36 healthy controls were matched for sex ratio, age, education years, and acquired resting-state functional MRI. Analysis of voxel-based morphometry of gray matter volume (GMV) and seed-to-whole-brain functional connectivity (FC) was performed from the perspective of the cerebellum, and their correlations with neuropsychological variables were explored. RESULTS: The analysis revealed a lower GMV in the bilateral cerebellum lobule VI and decreased FC between the left- and right-sided cerebellar lobule VI with the left anterior cingulate gyri in CSVD patients with WMHs. Both changes in structure and function were correlated with cognitive impairment in patients with WMHs. CONCLUSION: Our study revealed damaged GMV and FC in the cerebellum associated with cognitive impairment. This indicates that the cerebellum may play a key role in the modulation of cognitive function in CSVD patients with WMHs.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pp2a": {"__data__": {"id_": "pp2a", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pp2a", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "glycogen synthase kinase 3beta": {"__data__": {"id_": "glycogen synthase kinase 3beta", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "glycogen synthase kinase 3beta", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "protein kinase b": {"__data__": {"id_": "protein kinase b", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "protein kinase b", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pp2ac": {"__data__": {"id_": "pp2ac", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pp2ac", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid19542610": {"__data__": {"id_": "pmid19542610", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid19542610: Title: Interactions between glycogen synthase kinase 3beta, protein kinase B, and protein phosphatase 2A in tau phosphorylation in mouse N2a neuroblastoma cells. Abstract: In this study, we investigated how tau phosphorylation is regulated by protein kinase glycogen synthase kinase 3beta (GSK3 beta), protein kinase B (PKB), and protein phosphatase 2A (PP2A) in mouse N2a neuroblastoma cells. Results showed that GSK3 beta overexpression significantly increased PKB phosphorylation at the S473 site but not the T308 site. Neither GSK3 beta nor PKB overexpression could reduce the PP2AC phosphorylation at the Y307 site. In contrast, either PKB or GSK3 beta knockdown could increase PP2A phosphorylation at the Y307 site. PP2AC knockdown increased GSK3 beta phosphorylation at the S9 site but not at the Y216 site, and PKB phosphorylation at the T308 site but not at the S473 site. Tau phosphorylation at the S396 site was increased by GSK3 beta or PKB overexpression. Tau phosphorylation at the S214 site was only induced by PKB overexpression in the study. While GSK3 beta knockdown decreased tau phosphorylation at the S396 site, PKB knockdown increased tau phosphorylation at both the S396 and S214 sites. PP2AC knockdown decreased tau phosphorylation at the S396 and S214 sites. These findings suggest that tau phosphorylation at the S396 and S214 sites is differentially regulated by GSK3 beta, PKB, and PP2A in N2a cells. The final phosphorylation state of tau is possibly caused by the synergic action of the three enzymes.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "microvascular network": {"__data__": {"id_": "microvascular network", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "microvascular network", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "mir126 3p": {"__data__": {"id_": "mir126 3p", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "mir126 3p", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "mir126": {"__data__": {"id_": "mir126", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "mir126", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "melty cpg binding protein 2": {"__data__": {"id_": "melty cpg binding protein 2", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "melty cpg binding protein 2", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "etv2": {"__data__": {"id_": "etv2", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "etv2", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "vascular integrity": {"__data__": {"id_": "vascular integrity", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "vascular integrity", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "doxycycline": {"__data__": {"id_": "doxycycline", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "doxycycline", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "neurodevelopmental disorder": {"__data__": {"id_": "neurodevelopmental disorder", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "neurodevelopmental disorder", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "rett syndrome": {"__data__": {"id_": "rett syndrome", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "rett syndrome", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid39415995": {"__data__": {"id_": "pmid39415995", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid39415995: Title: miR126-mediated impaired vascular integrity in Rett syndrome. Abstract: Rett syndrome (RTT) is a neurodevelopmental disorder that is caused by mutations in melty-CpG binding protein 2 (MeCP2). MeCP2 is a non-cell type-specific DNA binding protein, and its mutation influences not only neural cells but also non-neural cells in the brain, including vasculature associated with endothelial cells. Vascular integrity is crucial for maintaining brain homeostasis, and its alteration may be linked to the pathology of neurodegenerative disease, but a non-neurogenic effect, especially the relationship between vascular alternation and Rett syndrome pathogenesis, has not been shown. Here, we recapitulate a microvascular network using Rett syndrome patient-derived induced pluripotent stem (iPS) cells that carry MeCP2[R306C] mutation to investigate early developmental vascular impact. To expedite endothelial cell differentiation, doxycycline (DOX)-inducible ETV2 expression vectors were inserted into the AAVS1 locus of Rett syndrome patient-derived iPS cells and its isogenic control by CRISPR/Cas9. With these endothelial cells, we established a disease microvascular network (Rett-dMVNs) and observed higher permeability in the Rett-dMVNs compared to isogenic controls, indicating altered barrier function by MeCP2 mutation. Furthermore, we unveiled that hyperpermeability is involved in the upregulation of miR126-3p in Rett syndrome patient-derived endothelial cells by microRNA profiling and RNAseq, and rescue of miR126-3p level can recover their phenotype. We discover miR126-3p-mediated vascular impairment in Rett syndrome patients and suggest the potential application of these findings for translational medicine.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "macrophage inflammation": {"__data__": {"id_": "macrophage inflammation", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "macrophage inflammation", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "nox2": {"__data__": {"id_": "nox2", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "nox2", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "oxidative signaling": {"__data__": {"id_": "oxidative signaling", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "oxidative signaling", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "nadph oxidase": {"__data__": {"id_": "nadph oxidase", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "nadph oxidase", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "adiposity": {"__data__": {"id_": "adiposity", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "adiposity", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "metabolic and neurologic decline": {"__data__": {"id_": "metabolic and neurologic decline", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "metabolic and neurologic decline", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "visceral inflammation": {"__data__": {"id_": "visceral inflammation", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "visceral inflammation", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "metabolic and physiologic impairment": {"__data__": {"id_": "metabolic and physiologic impairment", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "metabolic and physiologic impairment", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "brain injury": {"__data__": {"id_": "brain injury", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "brain injury", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid28771483": {"__data__": {"id_": "pmid28771483", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid28771483: Title: Myeloid-specific deletion of NOX2 prevents the metabolic and neurologic consequences of high fat diet. Abstract: High fat diet-induced obesity is associated with inflammatory and oxidative signaling in macrophages that likely participates in metabolic and physiologic impairment. One key factor that could drive pathologic changes in macrophages is the pro-inflammatory, pro-oxidant enzyme NADPH oxidase. However, NADPH oxidase is a pleiotropic enzyme with both pathologic and physiologic functions, ruling out indiscriminant NADPH oxidase inhibition as a viable therapy. To determine if targeted inhibition of monocyte/macrophage NADPH oxidase could mitigate obesity pathology, we generated mice that lack the NADPH oxidase catalytic subunit NOX2 in myeloid lineage cells. C57Bl/6 control (NOX2-FL) and myeloid-deficient NOX2 (mNOX2-KO) mice were given high fat diet for 16 weeks, and subject to comprehensive metabolic, behavioral, and biochemical analyses. Data show that mNOX2-KO mice had lower body weight, delayed adiposity, attenuated visceral inflammation, and decreased macrophage infiltration and cell injury in visceral adipose relative to control NOX2-FL mice. Moreover, the effects of high fat diet on glucose regulation and circulating lipids were attenuated in mNOX2-KO mice. Finally, memory was impaired and markers of brain injury increased in NOX2-FL, but not mNOX2-KO mice. Collectively, these data indicate that NOX2 signaling in macrophages participates in the pathogenesis of obesity, and reinforce a key role for macrophage inflammation in diet-induced metabolic and neurologic decline. Development of macrophage/immune-specific NOX-based therapies could thus potentially be used to preserve metabolic and neurologic function in the context of obesity.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "swcnt": {"__data__": {"id_": "swcnt", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "swcnt", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pegylated": {"__data__": {"id_": "pegylated", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pegylated", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "swcnts": {"__data__": {"id_": "swcnts", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "swcnts", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "carbon nanotubes": {"__data__": {"id_": "carbon nanotubes", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "carbon nanotubes", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "polyethylene glycol": {"__data__": {"id_": "polyethylene glycol", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "polyethylene glycol", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "carbon nanomaterials": {"__data__": {"id_": "carbon nanomaterials", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "carbon nanomaterials", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "sulforhodamine b": {"__data__": {"id_": "sulforhodamine b", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "sulforhodamine b", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid30347680": {"__data__": {"id_": "pmid30347680", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid30347680: Title: Designed Functional Dispersion for Insulin Protection from Pepsin Degradation and Skeletal Muscle Cell Proliferation: In Silico and In Vitro Study. Abstract: Functionalized single-walled carbon nanotubes with polyethylene glycol (PEGylated SWCNTs) are a promising nanomaterial that recently has emerged as the most attractive \"cargo\" to deliver chemicals, peptides, DNA and RNAs into cells. Insulin therapy is a recommended therapy to treat diabetes mellitus despite its side effects. Recently, functional dispersion made up of bioactive peptides, bioactive compounds and functionalized carbon nanomaterials such as PEGylated SWCNTs have proved to possess promising applications in nanomedicine. In the present study, molecular modeling simulations are utilized to assist in designing insulin hormone-PEGylated SWCNT composites, also called functional dispersion; to achieve this experimentally, an ultrasonication tool was utilized. Enzymatic degradation assay revealed that the designed functional dispersion protects about 70% of free insulin from pepsin. In addition, sulforhodamine B (SRB) assay, the quantification of insulin and glucose levels in differentiated skeletal muscle cell supernatants, reveals that functional dispersion regulates glucose and insulin levels to promote skeletal muscle cell proliferation. These findings offer new perspectives for designed functional dispersion, as potential pharmaceutical preparations to improve insulin therapy and promote skeletal muscle cell health.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid15816783": {"__data__": {"id_": "pmid15816783", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid15816783: Title: Incidence of delirium in older adults newly prescribed lithium or valproate: a population-based cohort study.\n Abstract: BACKGROUND: The use of lithium carbonate for the treatment of mood disorders in old age has decreased at a dramatic rate in favor of valproate. Because of lithium's narrow therapeutic range, neurotoxicity can be an important complication in lithium therapy and potentially influence prescription patterns. Therefore, we compared the incidence of delirium in older adults with mood disorders who were newly dispensed either lithium or valproate. METHOD: Using 4 population-based administrative databases from the province of Ontario, Canada (the Ontario Drug Benefit program, the Canadian Institute for Health Information, the Ontario Health Insurance Plan, and the Registered Persons Data Base), we were able to identify a cohort of mood disorder patients 66 years and older who were newly dispensed lithium or valproate over an 8-year period (1993-2001). Measures were taken to ensure that the sample was composed of mood disorder patients. As a comparator, we included a known deliriogenic drug, benztropine. The main outcome measure was a new diagnosis of delirium on a hospitalization record during 1 year of follow-up. RESULTS: Our study cohort consisted of 2422 new users of lithium and 2918 new users of valproate over an 8-year period. There was no statistically significant difference in the incidence of delirium between lithium (2.8 per 100 person-years) and valproate (4.1 per 100 person-years). Compared with patients who received lithium, patients who received benztropine had a significantly higher risk of delirium (p < .001). CONCLUSION: The incidence of hospitalizations with delirium was similar in patients treated with lithium and valproate. These findings add to the evidence suggesting that the shift away from the use of lithium carbonate to manage mood disorders in older adults is not justified on the basis of concerns of neurotoxicity.\n.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "mood disorders": {"__data__": {"id_": "mood disorders", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "mood disorders", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "lithium carbonate": {"__data__": {"id_": "lithium carbonate", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "lithium carbonate", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "valproate": {"__data__": {"id_": "valproate", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "valproate", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "benztropine": {"__data__": {"id_": "benztropine", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "benztropine", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "angina pectoris": {"__data__": {"id_": "angina pectoris", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "angina pectoris", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cardiac diseases": {"__data__": {"id_": "cardiac diseases", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "cardiac diseases", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "glaucoma": {"__data__": {"id_": "glaucoma", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "glaucoma", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cerebrovascular accident": {"__data__": {"id_": "cerebrovascular accident", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "cerebrovascular accident", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "osteoarthrosis": {"__data__": {"id_": "osteoarthrosis", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "osteoarthrosis", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "chronic diseases": {"__data__": {"id_": "chronic diseases", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "chronic diseases", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid7477540": {"__data__": {"id_": "pmid7477540", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid7477540: Title: [Prevalence of chronic diseases in the elderly; the ERGO study (Erasmus Rotterdam Health and the Elderly)]. Abstract: In the Rotterdam Study, prevalence and determinants of chronic diseases in the elderly (age > or = 55 years), were investigated in inhabitants of Ommoord, a suburb of Rotterdam. The study focused on cardiac diseases (myocardial infarction, angina pectoris, cardiovascular risk factors), glaucoma, macular degeneration, osteoporosis, osteoarthrosis and invalidity, dementia (Alzheimer's disease, vascular dementia, Parkinson's disease), epilepsy, cerebrovascular accident. The number of participants was 7983 (3105 men, 4878 women), a response of 78%. The participants were interviewed and were twice examined in an out-patient clinic. The results will be described in subsequent issues of this journal.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "2beta carbomethoxy 3beta (4 iodophenyl) n (3 fluoropropyl) nortropane": {"__data__": {"id_": "2beta carbomethoxy 3beta (4 iodophenyl) n (3 fluoropropyl) nortropane", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "2beta carbomethoxy 3beta (4 iodophenyl) n (3 fluoropropyl) nortropane", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "dopaminergic degeneration": {"__data__": {"id_": "dopaminergic degeneration", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "dopaminergic degeneration", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "idiopathic tremor": {"__data__": {"id_": "idiopathic tremor", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "idiopathic tremor", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "iodine 123": {"__data__": {"id_": "iodine 123", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "iodine 123", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "non": {"__data__": {"id_": "non", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "non", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "degenerative parkinsonism": {"__data__": {"id_": "degenerative parkinsonism", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "degenerative parkinsonism", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "123i fp cit": {"__data__": {"id_": "123i fp cit", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "123i fp cit", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid34191214": {"__data__": {"id_": "pmid34191214", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid34191214: Title: Single-site 123I-FP-CIT reference values from individuals with non-degenerative parkinsonism-comparison with values from healthy volunteers. Abstract: PURPOSE: Iodine 123-radiolabeled 2beta-carbomethoxy-3beta-(4-iodophenyl)-N-(3-fluoropropyl) nortropane (123I-FP-CIT) SPECT can be performed to distinguish degenerative forms of movement disorders/parkinsonism/tremor from other entities such as idiopathic tremor or drug-induced parkinsonism. For equivocal cases, semi-quantification and comparison to reference values are a necessary addition to visual interpretation of 123I-FP-CIT scans. To overcome the challenges of multi-center recruitment and scanning of healthy volunteers, we generated 123I-FP-CIT reference values from individuals with various neurological conditions but without dopaminergic degeneration, scanned at a single center on the same SPECT-CT system following the same protocol, and compared them to references from a multi-center database built using healthy volunteers' data. METHODS: From a cohort of 1884 patients, we identified 237 subjects (120 men, 117 women, age range 16-88 years) through a two-stage selection process. Every patient had a final clinical diagnosis after a mean follow-up of 4.8 +- 1.3 years. Images were reconstructed using (1) Flash3D with scatter and CT-based attenuation corrections (AC) and (2) filtered back projection with Chang AC. Volume-of-interest analysis was performed using a commercial software to calculate specific binding ratios (SBRs), caudate-to-putamen ratios, and asymmetry values on different striatal regions. Generated reference values were assessed according to age and gender and compared with those from the ENC-DAT study, and their robustness was tested against a cohort of patients with different diagnoses. RESULTS: Age had a significant negative linear effect on all SBRs. Overall, the reduction rate per decade in SBR was between 3.80 and 5.70%. Women had greater SBRs than men, but this gender difference was only statistically significant for the Flash3D database. Linear regression was used to correct for age-dependency of SBRs and to allow comparisons to age-matched reference values and \"normality\" limits. Generated regression parameters and their 95% confidence intervals (CIs) were comparable to corresponding European Normal Control Database of DaTscan (ENC-DAT) results. For example, 95% CI mean slope for the striatum in women is - 0.015 ([- 0.019, - 0.011]) for the Flash3D database versus - 0.015 ([- 0.021, - 0.009]) for ENC-DAT. Caudate-to-putamen ratios and asymmetries were not influenced by age or gender. CONCLUSION: The generated 123I-FP-CIT references values have similar age-related distribution, with no increase in variance due to comorbidities when compared to values from a multi-center study with healthy volunteers. This makes it possible for sites to build their 123I-FP-CIT references from scans acquired during routine clinical practice.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid30002953": {"__data__": {"id_": "pmid30002953", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid30002953: Title: Automatic analysis of treadmill running to estimate times to fatigue and exhaustion in rodents.\n Abstract: INTRODUCTION: The determination of fatigue and exhaustion in experimental animals is complicated by the subjective nature of the measurement. Typically, it requires an observer to watch exercising animals, e.g. rats running on the treadmill, and to identify the time of the event. In this study, we hypothesized that automatic analysis of the time-averaged position of a rat on a treadmill could be an objective way for estimating times to fatigue and exhaustion. To test this hypothesis, we compared these times measured by a human observer to the results of an automated video tracking system. METHODS: Rats, previously familiarized to running on the treadmill, ran at a fixed speed with zero incline, until exhaustion. The experiments were performed at either room temperature (24  C) or in a hot environment (32  C). Each experiment was video recorded. A trained observer estimated the times to fatigue and exhaustion. Then, video tracking software was used to determine the position of the animals on the treadmill belt. The times to fatigue and exhaustion were determined, based on the position on the treadmill using predefined criteria. RESULTS: Manual scores and the average position on the treadmill had significant correlation. Both the observer and the automated video tracking determined that exercise in a hot environment, compared with the exercise at room temperature, results in shorter times to exhaustion and fatigue. Also, estimates of times made by the observer and the automated video tracking were not statistically different from each other. DISCUSSION: A similarity between the estimates of times to fatigue and exhaustion made by the observer and the automated technique suggests that video tracking of rodents running on a treadmill can be used to determine both parameters in experimental studies. Video tracking technique allows for a more objective measure and would allow for an increased performance in experimentation. The Supplemental information to this manuscript contains an Excel file, which includes the code in Virtual Basic with freeware license, to process and visualize running data and automatically estimate the times to fatigue and exhaustion. Instructions for the software are also included.\n.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "depressive": {"__data__": {"id_": "depressive", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "depressive", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "bio922": {"__data__": {"id_": "bio922", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "bio922", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "glua2": {"__data__": {"id_": "glua2", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "glua2", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid24713001": {"__data__": {"id_": "pmid24713001", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid24713001: Title: Synapto-depressive effects of amyloid beta require PICK1. Abstract: Amyloid beta (Abeta), a key component in the pathophysiology of Alzheimer's disease, is thought to target excitatory synapses early in the disease. However, the mechanism by which Abeta weakens synapses is not well understood. Here we showed that the PDZ domain protein, protein interacting with C kinase 1 (PICK1), was required for Abeta to weaken synapses. In mice lacking PICK1, elevations of Abeta failed to depress synaptic transmission in cultured brain slices. In dissociated cultured neurons, Abeta failed to reduce surface alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor subunit 2, a subunit of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors that binds with PICK1 through a PDZ ligand-domain interaction. Lastly, a novel small molecule (BIO922) discovered through structure-based drug design that targets the specific interactions between GluA2 and PICK1 blocked the effects of Abeta on synapses and surface receptors. We concluded that GluA2-PICK1 interactions are a key component of the effects of Abeta on synapses.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "protein interacting with c kinase 1": {"__data__": {"id_": "protein interacting with c kinase 1", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "protein interacting with c kinase 1", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "metabolic dysfunctions": {"__data__": {"id_": "metabolic dysfunctions", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "metabolic dysfunctions", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid33003412": {"__data__": {"id_": "pmid33003412", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid33003412: Title: Metabolic Defects Caused by High-Fat Diet Modify Disease Risk through Inflammatory and Amyloidogenic Pathways in a Mouse Model of Alzheimer's Disease. Abstract: High-fat diet (HFD) has been shown to accelerate Alzheimer's disease (AD) pathology, but the exact molecular and cellular mechanisms remain incompletely understood. Moreover, it is unknown whether AD mice are more susceptible to HFD-induced metabolic dysfunctions. To address these questions, we used 5xFAD mice as an Alzheimer's disease model to study the physiological and molecular underpinning between HFD-induced metabolic defects and AD pathology. We systematically profiled the metabolic parameters, the gut microbiome composition, and hippocampal gene expression in 5xFAD and wild type (WT) mice fed normal chow diet and HFD. HFD feeding impaired energy metabolism in male 5xFAD mice, leading to increased locomotor activity, energy expenditure, and food intake. 5xFAD mice on HFD had elevated circulating lipids and worsened glucose intolerance. HFD caused profound changes in gut microbiome compositions, though no difference between genotype was detected. We measured hippocampal mRNAs related to AD neuropathology and neuroinflammation and showed that HFD elevated the expression of apoptotic, microglial, and amyloidogenic genes in 5xFAD mice. Pathway analysis revealed that differentially regulated genes were involved in insulin signaling, cytokine signaling, cellular stress, and neurotransmission. Collectively, our results showed that 5xFAD mice were more susceptible to HFD-induced metabolic dysregulation and suggest that targeting metabolic dysfunctions can ameliorate AD symptoms via effects on insulin signaling and neuroinflammation in the hippocampus.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "glucose intolerance": {"__data__": {"id_": "glucose intolerance", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "glucose intolerance", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "5xfad": {"__data__": {"id_": "5xfad", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "5xfad", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "short chain fatty acid": {"__data__": {"id_": "short chain fatty acid", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "short chain fatty acid", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "butyric acid": {"__data__": {"id_": "butyric acid", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "butyric acid", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "acetic acid": {"__data__": {"id_": "acetic acid", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "acetic acid", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "5 ht": {"__data__": {"id_": "5 ht", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "5 ht", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "labh": {"__data__": {"id_": "labh", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "labh", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "iso butyric acid": {"__data__": {"id_": "iso butyric acid", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "iso butyric acid", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "claudin 5": {"__data__": {"id_": "claudin 5", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "claudin 5", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "propanoic acid": {"__data__": {"id_": "propanoic acid", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "propanoic acid", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ampicillin": {"__data__": {"id_": "ampicillin", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "ampicillin", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid37189686": {"__data__": {"id_": "pmid37189686", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid37189686: Title: Suppressive Effects of Lactobacillus on Depression through Regulating the Gut Microbiota and Metabolites in C57BL/6J Mice Induced by Ampicillin. Abstract: Depression is a medical and social problem. Multiple metabolites and neuroinflammation regulate it. Modifying the gut microbiota with probiotics to reduce depression through the gut-brain axis is a potential treatment strategy. In this study, three anti-depressive potentials of Lactobacillus spp. (LAB), including L. rhamnosus GMNL-74, L. acidophilus GMNL-185 and L. plantarum GMNL-141, which combined to produce low dosage LAB (1.6 x 108 CFU/mouse, LABL) and high dosage LAB (4.8 x 108 CFU/mouse, LABH), were administered to C57BL/6 mice induced depression by ampicillin (Amp). A behavioral test of depression, 16S ribosomal RNA gene amplicon sequencing, bioinformatic analysis, and short-chain fatty acid (SCFA) content measurement were executed to investigate the gut microbiota composition, activation of nutrient metabolism pathways, levels of inflammatory factors, gut-derived 5-HT biosynthesis genes, and SCFA levels in C57BL/6 mice. Results showed that after mice were induced by Amp, both LAB groups recovered from depressive behaviors, decreased the abundance of Firmicutes, and increased the abundance of Actinobacteria and Bacteroidetes in the mouse ileum. The prediction of metabolism pathways of microbes revealed the activation of arginine and proline metabolism, cyanoamino acid metabolism, and nicotinate and nicotinamide metabolism were increased, and fatty acid synthesis was decreased in both LAB groups. The LABH groups showed increased levels of acetic acid, propanoic acid, and iso-butyric acid and decreased butyric acid levels in the cecum. LABH treatment increased claudin-5 and reduced IL-6 mRNA expression. Both LAB groups also reduced monoamine oxidase, and the LABH group increased vascular endothelial growth factor mRNA expression. These results showed that the composite of three LAB exerts antidepressant effects by regulating the gut microbiota and modifying the levels of depression-related metabolites in C57BL/6J Amp-treated mice.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "4 mptc": {"__data__": {"id_": "4 mptc", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "4 mptc", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "store operated ca2+ entry": {"__data__": {"id_": "store operated ca2+ entry", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "store operated ca2+ entry", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "stim1": {"__data__": {"id_": "stim1", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "stim1", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "stim2": {"__data__": {"id_": "stim2", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "stim2", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid33959394": {"__data__": {"id_": "pmid33959394", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid33959394: Title: A Novel Modulator of STIM2-Dependent Store-Operated Ca2+ Channel Activity. Abstract: Store-operated Ca2+ entry is one of the main pathways of calcium influx into non-excitable cells, which entails the initiation of many intracellular processes. The endoplasmic reticulum Ca2+ sensors STIM1 and STIM2 are the key components of store-operated Ca2+ entry in mammalian cells. Under physiological conditions, STIM proteins are responsible for store-operated Ca2+ entry activation. The STIM1 and STIM2 proteins differ in their potency for activating different store-operated channels. At the moment, there are no selective modulators of the STIM protein activity. We screened a library of small molecules and found the 4-MPTC compound, which selectively inhibited STIM2-dependent store-operated Ca2+ entry (IC50 = 1 muM) and had almost no effect on the STIM1-dependent activation of store-operated channels.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "mes": {"__data__": {"id_": "mes", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "mes", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pyrido pentapeptide": {"__data__": {"id_": "pyrido pentapeptide", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pyrido pentapeptide", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "agcl": {"__data__": {"id_": "agcl", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "agcl", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cu2+": {"__data__": {"id_": "cu2+", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "cu2+", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "copper(ii)": {"__data__": {"id_": "copper(ii)", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "copper(ii)", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid35480650": {"__data__": {"id_": "pmid35480650", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid35480650: Title: Low-cost potentiometric paper-based analytical device based on newly synthesized macrocyclic pyrido-pentapeptide derivatives as novel ionophores for point-of-care copper(ii) determination. Abstract: A simple, cost-effective, portable and disposable paper-based analytical device is designed and fabricated for copper(ii) determination. All solid-state ion-selective electrodes (ISEs) for copper and a Ag/AgCl reference electrode were constructed and optimized on the paper substrate. The copper electrodes were built using carbon nano-tube ink as a conductive substrate and an ion-to electron transducer. A suitable polymeric membrane is drop-cast on the surface of the conductive carbon ink window. The copper-sensing membrane is based on newly synthesized macrocyclic pyrido-pentapeptide derivatives as novel ionophores for copper detection. Under the optimized conditions, the presented all-solid-state paper-based Cu2+-ISEs showed a Nernstian response toward Cu2+ ions in 30 mM MES buffer, pH 7.0 over the linear range of 5.0 x 10-7-1.0 x 10-3 M with a limit of detection of 8.0 x 10-8 M. The copper-based sensors exhibited rapid detection of Cu2+ ions with a short response time (<10 s). The selectivity pattern of these new ionophores towards Cu2+ ions over many common mono-, di- and trivalent cations was evaluated using the modified separate solution method (MSSM). The presented paper-based analytical device exhibited good intra-day and inter day precision. The presented tool was successfully applied for trace Cu2+ detection in real samples of serum and whole blood collected from different children with autism spectrum disorder. The data obtained by the proposed potentiometric method were compared with those obtained by the inductively-coupled plasma (ICP) as a reference method. The presented copper paper-based analytical-device can be considered as an attractive tool for point-of-care copper determination because of its affordability, vast availability, and self-pumping ability, particularly when combined with potentiometric detection.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid31822300": {"__data__": {"id_": "pmid31822300", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid31822300: Title: Operationalizing Impaired Performance in Neuropsychological Assessment: A Comparison of the Use of Published Versus Sample-Based Normative Data for the Prediction of Dementia. Abstract: OBJECTIVES: To compare the sensitivity, specificity, and predictive value of published versus sample-based norms to detect early dementia in the Uniform Data Set (UDS). METHODS: The UDS was administered to 526 nondemented participants from the Alzheimer's Disease Neuroimaging Initiative (ADNI). Baseline scores were standardized using published norms and healthy control data from ADNI corrected for age, education, and sex. Subjects obtaining two scores < -1 SD (determined separately using published and sample norms) were labeled \"at risk for dementia.\" Both methods were compared on sensitivity, specificity, and positive/negative predictive value (PPV/NPV) for dementia at follow-up. RESULTS: Risk scores derived from published data had 86.1% sensitivity, 62.0% specificity, 68.6% accuracy, 46.1% PPV, and 92.2% NPV. Those from sample norms were more sensitive (91.0%), less specific (52.9%), and less accurate (63.3%), with worse PPV (42.1%) and similar NPV (94.0%). Sample norms were better at identifying incident dementia cases with relatively lower education than those with higher education. Discrepancies between both methods were more common in women. CONCLUSIONS: Sample norms are marginally more sensitive than published norms for predicting dementia, while published norms are slightly more accurate. Accuracy of risk estimates for women and those with lower education may be increased using locally generated norms.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "transthyretin": {"__data__": {"id_": "transthyretin", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "transthyretin", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid34445655": {"__data__": {"id_": "pmid34445655", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid34445655: Title: OTX2 Homeoprotein Functions in Adult Choroid Plexus. Abstract: The choroid plexus is an important blood barrier that secretes cerebrospinal fluid, which essential for embryonic brain development and adult brain homeostasis. The OTX2 homeoprotein is a transcription factor that is critical for choroid plexus development and remains highly expressed in adult choroid plexus. Through RNA sequencing analyses of constitutive and conditional knockdown adult mouse models, we reveal putative functional roles for OTX2 in adult choroid plexus function, including cell signaling and adhesion, and show that OTX2 regulates the expression of factors that are secreted into the cerebrospinal fluid, notably transthyretin. We also show that Otx2 expression impacts choroid plexus immune and stress responses, and affects splicing, leading to changes in the mRNA isoforms of proteins that are implicated in the oxidative stress response and DNA repair. Through mass spectrometry analysis of OTX2 protein partners in the choroid plexus, and in known non-cell-autonomous target regions, such as the visual cortex and subventricular zone, we identify putative targets that are involved in cell adhesion, chromatin structure, and RNA processing. Thus, OTX2 retains important roles for regulating choroid plexus function and brain homeostasis throughout life.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "end stage cancer": {"__data__": {"id_": "end stage cancer", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "end stage cancer", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid30380977": {"__data__": {"id_": "pmid30380977", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid30380977: Title: Intravenous Chlorpromazine for the Short-Term Treatment of Insomnia in End-Stage Cancer Patients With Difficulty in Oral Administration.\n Abstract: The objective of the study was to evaluate effectiveness and safety of intravenous chlorpromazine for the short-term treatment of insomnia in end-stage cancer patients. Insomnia occurs as one of distressing symptoms in 70% of end-stage cancer patients. End-stage cancer patients often have difficulty in oral administration because of disease progress. We retrospectively evaluated 30 end-stage cancer patients with difficulty in oral administration who received intravenous chlorpromazine for the short-term treatment of insomnia. A primary end point was sleep quality based on St. Mary's Hospital Sleep Questionnaire 3 days after the treatment. Improved sleep quality was observed on the day after the treatment and later (P < .001), and the effective rate mean was 0.63 (95% confidential interval: 0.45-0.81) 3 days after the treatment. Increased total sleep time and decreased sleep latency time were observed 3 days after the treatment (P < .001); however, no improvement in depth of sleep was achieved (P = .231). There was no adverse event except for two delirium cases. The study indicated that intravenous chlorpromazine can be applied safely and effectively for the short-term treatment of insomnia in end-stage cancer patients with difficulty in oral administration.\n.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "chlorpromazine": {"__data__": {"id_": "chlorpromazine", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "chlorpromazine", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "insomnia": {"__data__": {"id_": "insomnia", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "insomnia", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "gabexate": {"__data__": {"id_": "gabexate", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "gabexate", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "amidine": {"__data__": {"id_": "amidine", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "amidine", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "camostat": {"__data__": {"id_": "camostat", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "camostat", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "nafamostat": {"__data__": {"id_": "nafamostat", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "nafamostat", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "diminazene": {"__data__": {"id_": "diminazene", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "diminazene", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cp": {"__data__": {"id_": "cp", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "cp", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "sepimostat": {"__data__": {"id_": "sepimostat", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "sepimostat", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "serine protease": {"__data__": {"id_": "serine protease", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "serine protease", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid39444609": {"__data__": {"id_": "pmid39444609", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid39444609: Title: The diversity of AMPA receptor inhibition mechanisms among amidine-containing compounds. Abstract: Amidine-containing compounds are primarily known as antiprotozoal agents (pentamidine, diminazene, furamidine) or as serine protease inhibitors (nafamostat, sepimostat, camostat, gabexate). DAPI is widely recognized as a fluorescent DNA stain. Recently, it has been shown that these compounds also act as NMDA receptor inhibitors. In this study, we examined the activity of these compounds and analyzed the mechanisms of action in relation to another important class of ionotropic glutamate receptors-calcium-permeable AMPA receptors (CP-AMPARs) and calcium-impermeable AMPA receptors (CI-AMPARs) - using the whole-cell patch-clamp method on isolated male Wistar rat brain neurons. Gabexate and camostat were found to be inactive. Other compounds preferentially inhibited calcium-permeable AMPA receptors with IC50 values of 30-60 microM. DAPI and furamidine were also active against CI-AMPARs with IC50s of 50-60 muM, while others showed poor activity. All active compounds acted as channel blockers, which are able for permeating into the cytoplasm on both CP- and CI-AMPARs. Specifically, sepimostat showed trapping in the closed CP-AMPAR channel. Furamidine and DAPI demonstrated a voltage-independent action on CI-AMPARs, indicating binding to an additional superficial site. While the majority of compounds inhibited glutamate-activated steady-state currents as well as kainate-activated currents on CI-AMPARs, pentamidine significantly potentiated glutamate-induced steady-state responses. The potentiating effect of pentamidine resembles the action of the positive allosteric modulator cyclothiazide although the exact binding site remains unclear. Thus, this study, together with our previous research on NMDA receptors, provides a comprehensive overview of this novel group of ionotropic glutamate receptors inhibitors with a complex pharmacological profile, remarkable diversity of effects and mechanisms of action.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "yoda1": {"__data__": {"id_": "yoda1", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "yoda1", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "piezo1": {"__data__": {"id_": "piezo1", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "piezo1", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "gsmtx4": {"__data__": {"id_": "gsmtx4", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "gsmtx4", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "mouse cerebellum": {"__data__": {"id_": "mouse cerebellum", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "mouse cerebellum", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "neuronal illnesses": {"__data__": {"id_": "neuronal illnesses", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "neuronal illnesses", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid37305437": {"__data__": {"id_": "pmid37305437", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid37305437: Title: Inflammation condition sensitizes Piezo1 mechanosensitive channel in mouse cerebellum astrocyte. Abstract: Piezo1 mechanosensitive ion channel (MSC) plays a significant role in human physiology. Despite several research on the function and expression of Piezo1 in the nervous system, its electrophysiological properties in neuroinflammatory astrocytes remain unknown. We tested whether astrocytic neuroinflammatory state regulates Piezo1 using electrical recordings, calcium imaging, and wound healing assays on cultured astrocytes. In this study, we determined whether neuroinflammatory condition regulates astrocytic Piezo1 currents in astrocytes. First, we performed electrophysiological recordings on the mouse cerebellum astrocytes (C8-S) under lipopolysaccharide (LPS)-induced neuroinflammatory condition. We found that LPS treatment significantly increased MSC currents in C8-S. The half-maximal pressure of LPS treated MSC currents was left-shifted but the slope sensitivity was not altered by LPS treatment. LPS-induced increase of MSC currents were further augmented by Piezo1 agonist, Yoda1 but were normalized by Piezo1 inhibitor, GsMTx4. Furthermore, silencing Piezo1 in LPS treated C8-S normalized not only MSC currents but also calcium influx and cell migration velocity. Together, our results show that LPS sensitized Piezo1 channel in C8-S astrocytes. These findings will suggest that astrocytic Piezo1 is a determinant of neuroinflammation pathogenesis and may in turn become the foundation of further research into curing several neuronal illnesses and injury related inflammation of neuronal cells.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "chitinase 3 like protein 1": {"__data__": {"id_": "chitinase 3 like protein 1", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "chitinase 3 like protein 1", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid30617377": {"__data__": {"id_": "pmid30617377", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid30617377: Title: Chitinase-3-like protein 1 levels in bipolar disorder. Abstract: OBJECTIVES: To evaluate the relationship between the expression level and biologic role of YKL-40 in bipolar disorder (BD). METHODS: This case-control study was conducted in the Faculty of Medicine, Canakkale Onsekiz Mart University, Canakkale, Turkey in 2015. One hundred and four patients diagnosed as having bipolar disorder (DSM5 criteria), and 96 participants were included as healthy controls in this study. A human YKL-40 enzyme-linked immunosorbent assay (ELISA) kit was used to measure the serum YKL-40 levels. As independent variables, we collected data on C-reactive protein (CRP), demographic variables, and medications. Results: The mean YLK-40 levels for the BD was 2723.5+-543.8 pg/ml and control groups was 2132.5+-576.3 pg/ml (t=7.42, p less than 0.001). The mean CRP levels for the BD was 0.4+-0.6 mg/dl and control groups was 0.4+-0.7 mg/dl (t=0.02, p=0.985). The receiver operating characteristics (ROC) analysis revealed an area under the curve (AUC) of YKL-40 in the diagnosis of BD as 0.79 (95% confidence interval [CI]: 0.72-0.85) with a sensitivity of 82.7% and specificity of 68.1% at a cutoff level of 2307.1 pg/ml. The use of antidepressants, antipsychotics, mood modifiers, and the presence of any comorbidity was not related to the YKL-40 levels (p greater than 0.05). Conclusion: With acceptable sensitivity and specificity levels, the YKL-40 can be utilized as a marker in the diagnosis and follow-up of BD.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "huntington's": {"__data__": {"id_": "huntington's", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "huntington's", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid21683788": {"__data__": {"id_": "pmid21683788", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid21683788: Title: The regulation of mitochondrial morphology: intricate mechanisms and dynamic machinery. Abstract: Mitochondria typically form a reticular network radiating from the nucleus, creating an interconnected system that supplies the cell with essential energy and metabolites. These mitochondrial networks are regulated through the complex coordination of fission, fusion and distribution events. While a number of key mitochondrial morphology proteins have been identified, the precise mechanisms which govern their activity remain elusive. Moreover, post translational modifications including ubiquitination, phosphorylation and sumoylation of the core machinery are thought to regulate both fusion and division of the network. These proteins can undergo several different modifications depending on cellular signals, environment and energetic demands of the cell. Proteins involved in mitochondrial morphology may also have dual roles in both dynamics and apoptosis, with regulation of these proteins under tight control of the cell to ensure correct function. The absolute reliance of the cell on a functional mitochondrial network is highlighted in neurons, which are particularly vulnerable to any changes in organelle dynamics due to their unique biochemical requirements. Recent evidence suggests that defects in the shape or distribution of mitochondria correlate with the progression of neurodegenerative diseases such as Alzheimer's, Huntington's and Parkinson's disease. This review focuses on our current understanding of the mitochondrial morphology machinery in cell homeostasis, apoptosis and neurodegeneration, and the post translational modifications that regulate these processes.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "tissue plasminogen activator": {"__data__": {"id_": "tissue plasminogen activator", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "tissue plasminogen activator", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "tissue plasminogen activator (tpa)": {"__data__": {"id_": "tissue plasminogen activator (tpa)", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "tissue plasminogen activator (tpa)", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "amyloid accumulation": {"__data__": {"id_": "amyloid accumulation", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "amyloid accumulation", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "nmda receptors (nmdars)": {"__data__": {"id_": "nmda receptors (nmdars)", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "nmda receptors (nmdars)", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "nmdar": {"__data__": {"id_": "nmdar", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "nmdar", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "acetylcholine": {"__data__": {"id_": "acetylcholine", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "acetylcholine", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "plasminogen inhibitor 1": {"__data__": {"id_": "plasminogen inhibitor 1", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "plasminogen inhibitor 1", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "vascular amyloid deposition": {"__data__": {"id_": "vascular amyloid deposition", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "vascular amyloid deposition", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "amyloid beta (abeta)": {"__data__": {"id_": "amyloid beta (abeta)", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "amyloid beta (abeta)", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "functional hyperemia": {"__data__": {"id_": "functional hyperemia", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "functional hyperemia", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "plasminogen inhibitor 1 (pai 1)": {"__data__": {"id_": "plasminogen inhibitor 1 (pai 1)", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "plasminogen inhibitor 1 (pai 1)", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "neurovascular coupling dysfunction": {"__data__": {"id_": "neurovascular coupling dysfunction", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "neurovascular coupling dysfunction", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cerebral": {"__data__": {"id_": "cerebral", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "cerebral", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid32928888": {"__data__": {"id_": "pmid32928888", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid32928888: Title: tPA Deficiency Underlies Neurovascular Coupling Dysfunction by Amyloid-beta. Abstract: The amyloid-beta (Abeta) peptide, a key pathogenic factor in Alzheimer's disease, attenuates the increase in cerebral blood flow (CBF) evoked by neural activity (functional hyperemia), a vital homeostatic response in which NMDA receptors (NMDARs) play a role through nitric oxide, and the CBF increase produced by endothelial factors. Tissue plasminogen activator (tPA), which is reduced in Alzheimer's disease and in mouse models of Abeta accumulation, is required for the full expression of the NMDAR-dependent component of functional hyperemia. Therefore, we investigated whether tPA is involved in the neurovascular dysfunction of Abeta. tPA activity was reduced, and the tPA inhibitor plasminogen inhibitor-1 (PAI-1) was increased in male mice expressing the Swedish mutation of the amyloid precursor protein (tg2576). Counteracting the tPA reduction with exogenous tPA or with pharmacological inhibition or genetic deletion of PAI-1 completely reversed the attenuation of the CBF increase evoked by whisker stimulation but did not ameliorate the response to the endothelium-dependent vasodilator acetylcholine. The tPA deficit attenuated functional hyperemia by suppressing NMDAR-dependent nitric oxide production during neural activity. Pharmacological inhibition of PAI-1 increased tPA activity, prevented neurovascular uncoupling, and ameliorated cognition in 11- to 12-month-old tg2576 mice, effects associated with a reduction of cerebral amyloid angiopathy but not amyloid plaques. The data unveil a selective role of the tPA in the suppression of functional hyperemia induced by Abeta and in the mechanisms of cerebral amyloid angiopathy, and support the possibility that modulation of the PAI-1-tPA pathway may be beneficial in diseases associated with amyloid accumulation.SIGNIFICANCE STATEMENT Amyloid-beta (Abeta) peptides have profound neurovascular effects that may contribute to cognitive impairment in Alzheimer's disease. We found that Abeta attenuates the increases in blood flow evoked by neural activation through a reduction in tissue plasminogen activator (tPA) caused by upregulation of its endogenous inhibitor plasminogen inhibitor-1 (PAI-1). tPA deficiency prevents NMDA receptors from triggering nitric oxide production, thereby attenuating the flow increase evoked by neural activity. PAI-1 inhibition restores tPA activity, rescues neurovascular coupling, reduces amyloid deposition around blood vessels, and improves cognition in a mouse model of Abeta accumulation. The findings demonstrate a previously unappreciated role of tPA in Abeta-related neurovascular dysfunction and in vascular amyloid deposition. Restoration of tPA activity could be of therapeutic value in diseases associated with amyloid accumulation.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid25515653": {"__data__": {"id_": "pmid25515653", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid25515653: Title: Development and validation of a new performance-based measurement of instrumental activities of daily living in Taiwan. Abstract: BACKGROUND: The performance-based instrumental activities of daily living (IADL) measurement is thought to improve the validity and reliability of conventional tools that rely on proxy reports. The aims of this study were to develop and validate a performance-based measurement of IADL for use in elderly patients with cognitive impairment in Taiwan and other Chinese-speaking communities. METHODS: Referring to current versions of performance-based IADL, we developed the new Taiwan Performance-Based IADL (TPIADL) measurement to minimize literacy dependency and render it compatible with local culture. Participants performed tasks, including finding a telephone number, calculating the correct amount of change, reading the ingredients on a tin of food, finding food items on a shelf, and reading instructions on a medicine container. The internal consistency and convergent and criteria validity of the TPIADL were examined. RESULTS: Altogether, 117 elderly subjects were invited to participate in this study, including 39 patients with dementia due to Alzheimer's disease, 29 with amnestic mild cognitive impairment, and 49 without cognitive impairment. The internal consistency of the TPIADL was 0.82. The TPIADL scores were significantly correlated with the Lawton Instrumental Activities of Daily Living Scale (r = 0.76, P < 0.001). The area under the relative operating characteristic curve was 0.90 (95% confidence interval = 0.84-0.97) to differentiate dementia due to Alzheimer's disease and others. The optimal cut-off point for the TPIADL was 6/7, which gives a sensitivity of 84.6% and a specificity of 75.6%. CONCLUSIONS: The TPIADL is a validated instrument for the measurement of IADL in elderly subjects. It might replace conventional assessment as a valid and easily administered measurement.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "amnestic mild cognitive impairment": {"__data__": {"id_": "amnestic mild cognitive impairment", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "amnestic mild cognitive impairment", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid28465867": {"__data__": {"id_": "pmid28465867", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid28465867: Title: Differences in Antipsychotic-Related Adverse Events in Adult, Pediatric, and Geriatric Populations.\n Abstract: In recent years, antipsychotic medications have increasingly been used in pediatric and geriatric populations, despite the fact that many of these drugs were approved based on clinical trials in adult patients only. Preliminary studies have shown that the \"off-label\" use of these drugs in pediatric and geriatric populations may result in adverse events not found in adults. In this study, we utilized the large-scale U.S. Food and Drug Administration (FDA) Adverse Events Reporting System (AERS) database to look at differences in adverse events from antipsychotics among adult, pediatric, and geriatric populations. We performed a systematic analysis of the FDA AERS database using MySQL by standardizing the database using structured terminologies and ontologies. We compared adverse event profiles of atypical versus typical antipsychotic medications among adult (18-65), pediatric (age < 18), and geriatric (> 65) populations. We found statistically significant differences between the number of adverse events in the pediatric versus adult populations with aripiprazole, clozapine, fluphenazine, haloperidol, olanzapine, quetiapine, risperidone, and thiothixene, and between the geriatric versus adult populations with aripiprazole, chlorpromazine, clozapine, fluphenazine, haloperidol, paliperidone, promazine, risperidone, thiothixene, and ziprasidone (p < 0.05, with adjustment for multiple comparisons). Furthermore, the particular types of adverse events reported also varied significantly between each population for aripiprazole, clozapine, haloperidol, olanzapine, quetiapine, risperidone, and ziprasidone (Chi-square, p < 10-6). Diabetes was the most commonly reported side effect in the adult population, compared to behavioral problems in the pediatric population and neurologic symptoms in the geriatric population. We also found discrepancies between the frequencies of reports in AERS and in the literature. Our analysis of the FDA AERS database shows that there are significant differences in both the numbers and types of adverse events among these age groups and between atypical and typical antipsychotics. It is important for clinicians to be mindful of these differences when prescribing antipsychotics, especially when prescribing medications off-label.\n.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "neurologic symptoms": {"__data__": {"id_": "neurologic symptoms", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "neurologic symptoms", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "behavioral problems": {"__data__": {"id_": "behavioral problems", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "behavioral problems", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "donepezil": {"__data__": {"id_": "donepezil", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "donepezil", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid24436135": {"__data__": {"id_": "pmid24436135", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid24436135: Title: The effects of combine treatment of memantine and donepezil on Alzheimer's disease patients and its relationship with cerebral blood flow in the prefrontal area. Abstract: BACKGROUND: In this study, we evaluated the effect on cognitive function of memantine, behavioral and psychological symptoms of dementia, and the care burden, in patients with moderate-to-severe Alzheimer's disease (AD). Furthermore, with near-infrared spectroscopy (NIRS), we examined the association between effect of memantine and brain blood flow. METHODS: We evaluated the effect of memantine administration from baseline on Clinical Global Impression-Improvement scale, mini mental state examination (MMSE), Clock Drawing Test (CDT), Neuropsychiatric Inventory (NPI), Japanese version of the Zarit Burden Interview (J-ZBI) and NIRS in two groups, donepezil administration memantine combination group (combination group, n = 19) donepezil administration memantine non-administration group (control group, n = 18) were assessed at weeks 0, 4, 12, and 24. RESULTS: Significant difference was found between the combination group and the control group in the score variation of Clinical Global Impression-Improvement scale, MMSE, CDT, NPI, and J-ZBI. In the NIRS measurements, trend oxyhemoglobin reduced suppression was observed in some channels centered on the superior frontal gyrus. A significant correlation was observed in the scores of MMSE, CDT, NPI, and J-ZBI. In addition, a significant positive correlation was also observed between the number of words in NIRS and scores of MMSE and CDT. CONCLUSIONS: In this study, by administering memantine in AD patients that inhibit the reduction of cerebral blood flow in the prefrontal area and improve clinical symptoms overall cognitive function, behavioral and psychological symptoms of dementia, thereby reducing the care burden of caregivers was suggested.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "tnf alpha": {"__data__": {"id_": "tnf alpha", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "tnf alpha", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "il 10": {"__data__": {"id_": "il 10", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "il 10", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "brain dysfunction": {"__data__": {"id_": "brain dysfunction", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "brain dysfunction", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "il 8": {"__data__": {"id_": "il 8", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "il 8", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid30027347": {"__data__": {"id_": "pmid30027347", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid30027347: Title: Neuroimaging Findings in Sepsis-Induced Brain Dysfunction: Association with Clinical and Laboratory Findings.\n Abstract: BACKGROUND: Incidence and patterns of brain lesions of sepsis-induced brain dysfunction (SIBD) have been well defined. Our objective was to investigate the associations between neuroimaging features of SIBD patients and well-known neuroinflammation and neurodegeneration factors. METHODS: In this prospective observational study, 93 SIBD patients (45 men, 48 women; 50.6 +- 12.7 years old) were enrolled. Patients underwent a neurological examination and brain magnetic resonance imaging (MRI). Severity-of-disease scoring systems (APACHE II, SOFA, and SAPS II) and neurological outcome scoring system (GOSE) were used. Also, serum levels of a panel of mediators [IL-1beta, IL-6, IL-8, IL-10, IL-12, IL-17, IFN-gamma, TNF-alpha, complement factor Bb, C4d, C5a, iC3b, amyloid-beta peptides, total tau, phosphorylated tau (p-tau), S100b, neuron-specific enolase] were measured by ELISA. Voxel-based morphometry (VBM) was employed to available patients for assessment of neuronal loss pattern in SIBD. RESULTS: MRI of SIBD patients were normal (n = 27, 29%) or showed brain lesions (n = 51, 54.9%) or brain atrophy (n = 15, 16.1%). VBM analysis showed neuronal loss in the insula, cingulate cortex, frontal lobe, precuneus, and thalamus. Patients with abnormal MRI findings had worse APACHE II, SOFA, GOSE scores, increased prevalence of delirium and mortality. Presence of MRI lesions was associated with reduced C5a and iC3b levels and brain atrophy was associated with increased p-tau levels. Regression analysis identified an association between C5a levels and presence of lesion on MRI and p-tau levels and the presence of atrophy on MRI. CONCLUSIONS: Neuronal loss predominantly occurs in limbic and visceral pain perception regions of SIBD patients. Complement breakdown products and p-tau stand out as adverse neuroimaging outcome markers for SIBD.\n.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "visceral pain": {"__data__": {"id_": "visceral pain", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "visceral pain", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "atrophy": {"__data__": {"id_": "atrophy", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "atrophy", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ifn gamma": {"__data__": {"id_": "ifn gamma", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "ifn gamma", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "neurodegenerative and neuropsychiatric disorders": {"__data__": {"id_": "neurodegenerative and neuropsychiatric disorders", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "neurodegenerative and neuropsychiatric disorders", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "memory impairments": {"__data__": {"id_": "memory impairments", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "memory impairments", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid35705176": {"__data__": {"id_": "pmid35705176", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid35705176: Title: Deep brain stimulation of fornix for memory improvement in Alzheimer's disease: A critical review. Abstract: Memory reflects the brain function in encoding, storage and retrieval of the data or information, which is a fundamental ability for any live organism. The development of approaches to improve memory attracts much attention due to the underlying mechanistic insight and therapeutic potential to treat neurodegenerative diseases with memory loss, such as Alzheimer's disease (AD). Deep brain stimulation (DBS), a reversible, adjustable, and non-ablative therapy, has been shown to be safe and effective in many clinical trials for neurodegenerative and neuropsychiatric disorders. Among all potential regions with access to invasive electrodes, fornix is considered as it is the major afferent and efferent connection of the hippocampus known to be closely associated with learning and memory. Indeed, clinical trials have demonstrated that fornix DBS globally improved cognitive function in a subset of patients with AD, indicating fornix can serve as a potential target for neurosurgical intervention in treating memory impairment in AD. The present review aims to provide a better understanding of recent progresses in the application of fornix DBS for ameliorating memory impairments in AD patients.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "infections": {"__data__": {"id_": "infections", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "infections", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "acute b cell lymphoblastic leukemia": {"__data__": {"id_": "acute b cell lymphoblastic leukemia", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "acute b cell lymphoblastic leukemia", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cd19": {"__data__": {"id_": "cd19", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "cd19", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "hematological toxicity": {"__data__": {"id_": "hematological toxicity", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "hematological toxicity", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "hyperinflammatory syndrome": {"__data__": {"id_": "hyperinflammatory syndrome", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "hyperinflammatory syndrome", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b cell malignancies": {"__data__": {"id_": "b cell malignancies", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "b cell malignancies", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "immune effector cell associated neurotoxicity syndrome": {"__data__": {"id_": "immune effector cell associated neurotoxicity syndrome", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "immune effector cell associated neurotoxicity syndrome", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid36891576": {"__data__": {"id_": "pmid36891576", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid36891576: Title: Management of adverse events in young adults and children with acute B-cell lymphoblastic leukemia receiving anti-CD19 chimeric antigen receptor (CAR) T-cell therapy.\n Abstract: With impressive clinical advancements in immune effector cell therapies targeting CD19, chimeric antigen receptor (CAR) T-cell therapy has emerged as a new paradigm for treating relapsed/refractory B-cell malignancies. Currently, three second-generation CAR T-cell therapies have been approved, of which only tisagenlecleucel (tisa-cel) is approved for treating children and young adults with B-cell acute lymphoblastic leukemia (ALL) with durable remission rates of approximately 60-90%. Although CAR T-cell therapies are considered to treat refractory B-ALL, they are associated with unique toxicities such as cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS). The severity of CAR T-cell therapy toxicities can vary according to several clinical factors. In rare cases, severe CRS can progress to a fulminant hyperinflammatory syndrome known as hemophagocytic lymphohistiocytosis, which has a poor prognosis. The first-line treatments for CRS/ICANS include tocilizumab and corticosteroids. When severe CAR T-cell toxicity is resistant to first-line treatment, an additional approach is required to manage the persistent inflammation. In addition to CRS/ICANS, CAR T-cell therapy can cause early and delayed hematological toxicity, which can predispose patients to severe infections. The use of growth factors and anti-infective prophylaxis should follow institutional guidelines according to patient-specific risk factors. This review provides a thorough summary of updated practical recommendations for managing acute and delayed adverse effects following anti-CD19 CAR T-cell therapy in adults and children.\n.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "kynurenic acid": {"__data__": {"id_": "kynurenic acid", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "kynurenic acid", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "kynurenine pathway": {"__data__": {"id_": "kynurenine pathway", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "kynurenine pathway", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "quinolinic acid": {"__data__": {"id_": "quinolinic acid", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "quinolinic acid", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "kynurenine": {"__data__": {"id_": "kynurenine", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "kynurenine", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "indoleamine 2,3 dioxygenase": {"__data__": {"id_": "indoleamine 2,3 dioxygenase", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "indoleamine 2,3 dioxygenase", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "hypoactive delirium": {"__data__": {"id_": "hypoactive delirium", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "hypoactive delirium", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid36982655": {"__data__": {"id_": "pmid36982655", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid36982655: Title: Altered Tryptophan-Kynurenine Pathway in Delirium: A Review of the Current Literature. Abstract: Delirium, a common form of acute brain dysfunction, is associated with increased morbidity and mortality, especially in older patients. The underlying pathophysiology of delirium is not clearly understood, but acute systemic inflammation is known to drive delirium in cases of acute illnesses, such as sepsis, trauma, and surgery. Based on psychomotor presentations, delirium has three main subtypes, such as hypoactive, hyperactive, and mixed subtype. There are similarities in the initial presentation of delirium with depression and dementia, especially in the hypoactive subtype. Hence, patients with hypoactive delirium are frequently misdiagnosed. The altered kynurenine pathway (KP) is a promising molecular pathway implicated in the pathogenesis of delirium. The KP is highly regulated in the immune system and influences neurological functions. The activation of indoleamine 2,3-dioxygenase, and specific KP neuroactive metabolites, such as quinolinic acid and kynurenic acid, could play a role in the event of delirium. Here, we collectively describe the roles of the KP and speculate on its relevance in delirium.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "neurofilament light chain": {"__data__": {"id_": "neurofilament light chain", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "neurofilament light chain", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid36409557": {"__data__": {"id_": "pmid36409557", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid36409557: Title: Cerebrospinal fluid quinolinic acid is strongly associated with delirium and mortality in hip-fracture patients.\n Abstract: BACKGROUNDThe kynurenine pathway (KP) has been identified as a potential mediator linking acute illness to cognitive dysfunction by generating neuroactive metabolites in response to inflammation. Delirium (acute confusion) is a common complication of acute illness and is associated with increased risk of dementia and mortality. However, the molecular mechanisms underlying delirium, particularly in relation to the KP, remain elusive.METHODSWe undertook a multicenter observational study with 586 hospitalized patients (248 with delirium) and investigated associations between delirium and KP metabolites measured in cerebrospinal fluid (CSF) and serum by targeted metabolomics. We also explored associations between KP metabolites and markers of neuronal damage and 1-year mortality.RESULTSIn delirium, we found concentrations of the neurotoxic metabolite quinolinic acid in CSF (CSF-QA) (OR 2.26 [1.78, 2.87], P < 0.001) to be increased and also found increases in several other KP metabolites in serum and CSF. In addition, CSF-QA was associated with the neuronal damage marker neurofilament light chain (NfL) (beta 0.43, P < 0.001) and was a strong predictor of 1-year mortality (HR 4.35 [2.93, 6.45] for CSF-QA >= 100 nmol/L, P < 0.001). The associations between CSF-QA and delirium, neuronal damage, and mortality remained highly significant following adjustment for confounders and multiple comparisons.CONCLUSIONOur data identified how systemic inflammation, neurotoxicity, and delirium are strongly linked via the KP and should inform future delirium prevention and treatment clinical trials that target enzymes of the KP.FUNDINGNorwegian Health Association and South-Eastern Norway Regional Health Authorities.\n.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "hip fracture": {"__data__": {"id_": "hip fracture", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "hip fracture", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid36647830": {"__data__": {"id_": "pmid36647830", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid36647830: Title: The kynurenine pathway implicated in patient delirium: possible indications for indoleamine 2,3 dioxygenase inhibitors.\n Abstract: Tryptophan (Trp) metabolism plays a central role in sleep, mood, and immune system regulation. The kynurenine pathway (KP), which is regulated by the enzymes tryptophan 2,3-dioxygenase (TDO) and indoleamine 2,3 dioxygenase (IDO), which catalyze the conversion of Trp to kynurenine (Kyn), facilitates immune regulation and influences neurocognition. Notably, Kyn metabolites bind the N-methyl-d-aspartate receptor (NMDAR), essential for memory encoding, and in turn, cognition. Aberrant NMDAR activity through agonist binding influences excitability and cell death. In this issue of the JCI, Watne and authors demonstrate that KP pathway end products were elevated in the serum and the cerebrospinal fluid (CSF) of subjects with delirium. This observation provides insight regarding the basis of a variety of commonly observed clinical conditions including sundowning, abnormal sleep-wake cycles in hospitalized patients, neurodegenerative cognitive impairment, radiation-induced cognitive impairment, neurocognitive symptomatology related to COVID-19, and clinical outcomes observed in patients with CNS tumors, such as gliomas.\n.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "tryptophan 2,3 dioxygenase": {"__data__": {"id_": "tryptophan 2,3 dioxygenase", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "tryptophan 2,3 dioxygenase", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "neurodegenerative cognitive impairment": {"__data__": {"id_": "neurodegenerative cognitive impairment", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "neurodegenerative cognitive impairment", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "gliomas": {"__data__": {"id_": "gliomas", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "gliomas", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "neurodegenerative conditions": {"__data__": {"id_": "neurodegenerative conditions", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "neurodegenerative conditions", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "trp 2,3 dioxygenase": {"__data__": {"id_": "trp 2,3 dioxygenase", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "trp 2,3 dioxygenase", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid28469468": {"__data__": {"id_": "pmid28469468", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid28469468: Title: Kynurenine Pathway of Tryptophan Metabolism: Regulatory and Functional Aspects.\n Abstract: Regulatory and functional aspects of the kynurenine (K) pathway (KP) of tryptophan (Trp) degradation are reviewed. The KP accounts for ~95% of dietary Trp degradation, of which 90% is attributed to the hepatic KP. During immune activation, the minor extrahepatic KP plays a more active role. The KP is rate-limited by its first enzyme, Trp 2,3-dioxygenase (TDO), in liver and indoleamine 2,3-dioxygenase (IDO) elsewhere. TDO is regulated by glucocorticoid induction, substrate activation and stabilization by Trp, cofactor activation by heme, and end-product inhibition by reduced nicotinamide adenine dinucleotide (phosphate). IDO is regulated by IFN-gamma and other cytokines and by nitric oxide. The KP disposes of excess Trp, controls hepatic heme synthesis and Trp availability for cerebral serotonin synthesis, and produces immunoregulatory and neuroactive metabolites, the B3 \"vitamin\" nicotinic acid, and oxidized nicotinamide adenine dinucleotide. Various KP enzymes are undermined in disease and are targeted for therapy of conditions ranging from immunological, neurological, and neurodegenerative conditions to cancer.\n.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "pmid7145182": {"__data__": {"id_": "pmid7145182", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "pmid7145182: Title: [Hypopotassemia during delirium tremens. Pathogenesis and clinical significance].\n Abstract: The authors have investigated the changes of kalemia and kaluria levels in 40 patients suffering from delirium tremens, and have observed during the acute stage of the illness, a swift fall of kalemia level without an increase of the kaluric excretion. The kalemic values quickly rise up again at the end of the delirium.. The authors think that an adrenergic mechanism is responsible for this quick and transient hypokalemia. The significance of this adrenergic mechanism in the alcohol withdrawal syndrome is at present widely proved.\n.", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "hypopotassemia": {"__data__": {"id_": "hypopotassemia", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "hypopotassemia", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "alcohol withdrawal syndrome": {"__data__": {"id_": "alcohol withdrawal syndrome", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "alcohol withdrawal syndrome", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "delirium tremens": {"__data__": {"id_": "delirium tremens", "embedding": null, "metadata": {}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "delirium tremens", "mimetype": "text/plain", "start_char_idx": null, "end_char_idx": null, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}}, "docstore/metadata": {"cognitive impairment": {"doc_hash": "f63f32a6cc16b8e6f628320e133ad1d5fab485f041ea22a7117c738dc35aaea6"}, "apolipoprotein e": {"doc_hash": "0be0ed3e3fa15ed7ea985402d28864c9bc62e95dbcca15657f14cd40ce1f1936"}, "dementia": {"doc_hash": "1b357c9c21a3997e2556c321bf8ae40786e48d642d17fe32569c7a460603ab7c"}, "alzheimer's disease": {"doc_hash": "f91b77cbb675f0b18b1243aec7ba8322e5a7ae97979ba4cf879a7ce0d092ec03"}, "pmid22815080": {"doc_hash": "9ceffd0b9e16dfdf79df565e767ac617261f1944ff2c51b7ced56fa783836a66"}, "coma": {"doc_hash": "97c999ee8f9dd747bb0160416b77cf002ea79690280afde31610f9092f5a6400"}, "infection": {"doc_hash": "365c47bf48215ec0c92a3a6ef67dc01402b82ab4b0aebbf5764fdeda95de9b30"}, "pmid33849471": {"doc_hash": "40a7190f47243ece83883ced401da2f859454fc04edd3259844c69636ac8eaf8"}, "sepsis": {"doc_hash": "bf49d5fbcf16c936dd2efffc0fb312cea705e4e06acb99878f84a51c9a853760"}, "septic shock": {"doc_hash": "3bf71acfd6fb8af198da74160e086c99b46817299f440ee3c1e3a022adea27c0"}, "delirium": {"doc_hash": "aba54347c630553858cc6608a4a7d06461affbbd1a7f04c84d648fea63a42343"}, "cognitive disorders": {"doc_hash": "df268e09abe2d98cf3da48de6af97035d22fc28264eb68cadd80c511b3f060c1"}, "gsk 3beta": {"doc_hash": "ab9777a15ea879dede268f7bc53f4d877b79402469a8089f51eacac08e88ee91"}, "inflammation": {"doc_hash": "37822852b8056fff651719c303396bb292ec530b5717b4fdea19f87be89c2ea2"}, "dopamine": {"doc_hash": "2e0c313d3333b3fcff8aaced0a43eeb7916928822147c725d6f9de860b7b8893"}, "parkinson's disease": {"doc_hash": "33c5687b6dfb7921bb56718c83a10d711fdd6a2c0b7e07b1d90830f9f9c3cea7"}, "neurodegenerative diseases": {"doc_hash": "0086d940056da3f4dd03cd7bba44c05be7df75a6cbd7b087163ccd05dc132949"}, "lithium": {"doc_hash": "2b71b9008e0ddce8ad7eeac38b89905d8d012278355dd7e5208ce9c56f8ea051"}, "pmid33503974": {"doc_hash": "806e5d7d015af474298136c0a9c3f8bbd63c42e2565554e267dd5783e1c668ee"}, "rapamycin": {"doc_hash": "04b41f2ea5404bde492e3fbacbf5ab3878092ff907bf19e0a472ccd6988806a5"}, "h2o2": {"doc_hash": "0a45f9bdb56ee3e71ab623bff5b30d56be3bf9ad7395d3a79c0c03f69638bd6e"}, "3 ma": {"doc_hash": "047a0077b725979c44901094009f27795f7bd083226f17a50644515c2c94e841"}, "reactive oxygen species": {"doc_hash": "33928cbd2ef2dbc3504e6ab2518023f6a52b9a152cd00e02e7af68cf666687f6"}, "hypoxic": {"doc_hash": "3bbee07422912592e81f72133716f16c00c6b851142d49c72a02af0a26bec375"}, "neurological diseases": {"doc_hash": "dd2d064c7de4eac766814cc93228f9cb91e1c5769091c48c2cc4fa91c16f95cb"}, "p53": {"doc_hash": "d956a8c4eaa1a73b13dbb9485aa09f07fdd78c56ad20311be0e44fa4c9b4af7e"}, "pmid29871517": {"doc_hash": "ad6affdbbf4ef56abd482fcbdfd63f16f073d888001f2ef21a495a2336f4dc2d"}, "covid 19": {"doc_hash": "fd6c3b67cd66e20a2144cc6773c3c2151153a71c7a9963794d1672d340eeddb5"}, "trd": {"doc_hash": "7d870d2fdf0f3ce234bce81614d843b0535219a5f672a96676b24316f954f120"}, "depressive symptoms": {"doc_hash": "ec4f80d7caf8f83e43872f71130e989a0e0774ff60b1067a4c0f3db2d3390a3d"}, "pmid36968708": {"doc_hash": "25db6fc00e79f29984e9c1b9ebf1d063fff0a7f37a86cdabf7910306857a1a58"}, "baclofen": {"doc_hash": "fdc5bd0de7e4a3ec7c0d314873e379f7dabcd0bbffd1df3821ceacad8618b43f"}, "pmid29198063": {"doc_hash": "8430c505c01564e83acdab9e3b50f2766afbdeb7231ca53cc0ba11d9916c24cd"}, "gamma hydroxybutyrate": {"doc_hash": "6ae04e1467551bc16de502c96af38aa1dc6308f0652585c866afd07b9da8d129"}, "withdrawal symptoms": {"doc_hash": "756c1533118ab35e1e11466d6c7b0131253a9b1ccfb8171a28acda96f1bcacad"}, "benzodiazepines": {"doc_hash": "d583edefbf59b377eec60e4cce56916232346276d25635e61a605338db192748"}, "learning impairment": {"doc_hash": "20404b5aa0ee208491948e49ed3266bb71c4035178a9af35ee875f5d97746212"}, "entorhinal cortex lesions": {"doc_hash": "e85fbe7e637657b555347f8396b917543850237a5d9dc25eb2af86033b4f60b9"}, "traumatic brain injury": {"doc_hash": "39b12727ff5360fc18f02e85e6cdf32a4352994d10016485d0aae7dbb776077c"}, "behavioral deficits": {"doc_hash": "6386a21ff9a5006d23a491c24c532c220ca194eedd2c1721c50a027c4375a0f0"}, "damage to the entorhinal cortex": {"doc_hash": "b1e1c518a21fdff6c7325aaa711f6f7b119faef9d47cff4fa5b89554ca2b56c0"}, "integration deficits": {"doc_hash": "53d9bca3b2a6df3ee13c23ce5bedec8e9b70e73eb981b23ee5483282c063278a"}, "stroke": {"doc_hash": "7b497d18e2228f444d68a50daec821d2a0c056fedc97489f7f93db05ea654c79"}, "pmid11302296": {"doc_hash": "3c4ee17aa30444f964152414c3fadbbebd02e5f9248911fb977f7c8b158a0a94"}, "neurofibrillary tangles": {"doc_hash": "a382cb7e4d711d8a8f73132faaa6a18095e15912caf5a150136ef0846292a6b6"}, "pmid1407551": {"doc_hash": "9f2bf5d4b4460cff76ed0f21f37dc87379732e082bb2e4c8fa2e4c0da4c6faf8"}, "multi infarct dementia": {"doc_hash": "ecdfbafc5a06a4c98bf5914e0211c4f42c5bc4b0fbf7319edf70c6b2487e349e"}, "pmid11336076": {"doc_hash": "d7277a29e0234cbe1627d027247202bf16a21db0ee8e2262232aa48781b0af2f"}, "deaths": {"doc_hash": "e1bcd95c1fdda77004c83f346e44dd9eabeaddc710715a37e6bac7ef7a23f5b4"}, "pmid30559156": {"doc_hash": "5eaee638c6baa7b57e3693e522974d0a5edddf6ac1893c143997def053f3d0df"}, "terminal cancer": {"doc_hash": "ba7f8d8bae497806494913570ad41fb9a9eae9c48f23f2f7df1a7d7367e8dfd9"}, "pmid36104140": {"doc_hash": "9faf125a6041b003beefbafc24a437e4caf28e9b050908522e2af42fda49e034"}, "fatigue": {"doc_hash": "99c36c12d7bb0372adb0e3a0b56df2ee01188304456a0ba13be699694b71c0cb"}, "constipation": {"doc_hash": "6ae818c5bc8112361f8ca1e05b08bb7f553872b8710a83c0cb3449e6970b0417"}, "pain": {"doc_hash": "e0bcf6b6d1985182cfcee1986c4735f45e2118c4270f9d536880d8b8a12f0341"}, "nausea and vomiting": {"doc_hash": "fac1c0667c23a718bcc51cad2c18dc1f4cdecd3ccb502bcbace15e2795363c8b"}, "skin disorders": {"doc_hash": "29b5dbbee2fa2576c5fd9efd79dd0d232e11eae7c33e558d5f997744deb89faa"}, "hypotension": {"doc_hash": "ad29bc179b6a646e31fbc2750196988f50f792b1e067819521efb0ee142fc112"}, "blood loss": {"doc_hash": "8b955d408e9a5f182e07fa14967e7ed9fb48be90cd92483f84946dfd6ee427fd"}, "impairment of cognitive functions": {"doc_hash": "abecd86fbd616a716848031faa43370d5608c4ab988617173f890448ab7e58d2"}, "pmid26991989": {"doc_hash": "1df375912bff4d432f64cdc1ce2e1a98c4693f179cdc608df1a7737983935e86"}, "pmid34281087": {"doc_hash": "95305a1d1efc0945c696e9d02ea76a548ea4c655a11bcb0018c509b9f66e16b0"}, "kidney disease": {"doc_hash": "9a97f0549d33194b7dc277ce787925b74bb2505d50f07f8c14003e2790f3835e"}, "renal failure": {"doc_hash": "7a0a4a94eb9c744307c17b6db319418a5ad5095ab427a5d6b3109f538e3bf857"}, "chronic kidney disease": {"doc_hash": "681c420edfa43a158f87cee597311f329b6cae10317f79670578342e735631b6"}, "vascular disease": {"doc_hash": "ff420b901d5ffb5caacba9e0efad17dde39d32c6b2ca6b8bca922bcf49b8d0d6"}, "cerebral white matter": {"doc_hash": "dc360a10f550d73198cb73b3d62873d7c16c535162b5e6af62a1265341f29e62"}, "pmid32747970": {"doc_hash": "ec668ca175e26fbbd22a9a84028fc6942d985b152f4411c0cee381fd8c3823fe"}, "alzheimer's amyloidosis": {"doc_hash": "4aba96a5def1bd828c3914a66c75d0da992464fbd56f693cf8d9249df09037e7"}, "d pinitol": {"doc_hash": "683a4f41dca2a6473b10e59dbbaadf0bb924f57c04d2cb64bc55e2fa22a14500"}, "insulin resistance": {"doc_hash": "fdb7098a02494badac50eda539c02c7a20b45f1dd614a54e9de11a47a1496369"}, "leptin": {"doc_hash": "f58de103307e91171eab7564f04a364aa0109f5715c30cfae1eb7101d8335dff"}, "claudin 3": {"doc_hash": "5b409e6afcad0a449b828174b5b7a3894893951bb6215462cbd581bf35b38e36"}, "cognitive decline": {"doc_hash": "28d2e8705de4ace4f83e44a6d4009cf25d004e4289fb77b6919d3dbc93ab978b"}, "ghrelin": {"doc_hash": "8ab7bc382b2f610e0b333de5fd7c67401db1a21853cc3e9ecfe0829bbcb7a694"}, "lipopolysaccharide": {"doc_hash": "21690f86a26376ad867bd58cf5ec01345d3f2657b21dbcf09251cb81275595dd"}, "cyclin dependent kinase 5": {"doc_hash": "84cbf6415cb577dbbc4d860d803559de490ab6bff177962dcaca7ff1ed1fc2ec"}, "pmid39683582": {"doc_hash": "a0e6c8c0fd0d620cd23470bfc67dfa7318a9aca66763b3abe9cb85e1846478ec"}, "acute myelogenous leukemia": {"doc_hash": "bc26119bd62008ce93e5db87e793a944060f1998258d08271124f315ad5a33f8"}, "pmid35836706": {"doc_hash": "2a9b643d492dddf80e3be7518ca4c83ca673a4ff780e7a594d962373b45e049b"}, "disseminated intravascular coagulation": {"doc_hash": "728e07e025f224c938ffcfab3e0822c6502c4ae555d413ac14e80bdd89d6991a"}, "non promyelocytic acute myelogenous leukemia": {"doc_hash": "763de1a70207a9a45e5bf233e3fb4df62693259ff4d19c36fa04c0d34fb5cadc"}, "acute liver failure": {"doc_hash": "35214d9eaf634925b33042c6906e45729b984cc74ca35b2fb99a700685740c19"}, "hepatic venous outflow tract obstruction": {"doc_hash": "5bd37129cb68abcc55ab62ebd18e4a9a2b1d082f4217ca6abb8c61bd4ce92fa6"}, "malignancy": {"doc_hash": "9fd4a14483780f48fa5dd8247150fc5a4fac764e94f14ffa283efb5d66a9efcd"}, "thrombophilic disorder": {"doc_hash": "4076d22de8b83e70634efa35961cdcdfdd075f3966ea515eedf80534b6845d52"}, "cumic alcohol": {"doc_hash": "b437232c6029a347c880c117a4954ffc91c6f2440a210e84bcdde3ae71f23ce8"}, "trans,trans 2,4 hexadienol": {"doc_hash": "cb7bc8f39f6c89fc3e11e1782c00374b23d1183df74e662c507e7428706d9430"}, "piperonal": {"doc_hash": "04da3b85aacb242b9c26175bb2dff28d574c5d08d0c5f38b117f5d85a13c248b"}, "cuminaldehyde": {"doc_hash": "d8659d48663ad8accc7fa8398885962ef178cedf8fbf45de68724347aeffae4d"}, "carbon": {"doc_hash": "c02ecea136195c73fd07c703eed31abba92fcc5ba36892f2da6c2ac40c1722da"}, "piperonyl alcohol": {"doc_hash": "f8e6a27a383330717cb4972b9f53bea0b50ed84b534a323619ef14c3c9766c4f"}, "peaao2": {"doc_hash": "45e8d02253ce7b2fb10a13422f2a97f51afb92bdfda70e377e03d72933998c2c"}, "p anisyl alcohol": {"doc_hash": "b3af846f4e00ae5289408d0f87f21b06333b51095b836782d114bc643c440109"}, "veratryl alcohol": {"doc_hash": "1144773c7707d1cc15ab4521c8f6516a1cefb2d8173c48732d5f7a2d86142521"}, "benzyl alcohol": {"doc_hash": "43fbaf0c6ab2e1291969a00b0f24e7f0320ad998e8b926fc6113384b3e52a046"}, "pmid32949280": {"doc_hash": "5b9751e48d41e85f318d2becf2c694b5fd52cac166b02e76971b1130128872ce"}, "cytotoxicity": {"doc_hash": "ffa6b921b73ffe11a3951757be6e43b4fded85539a610f1d4c65e4db17c87b95"}, "mtt": {"doc_hash": "7f025054c3dcb082ae7e1e234655315093f02ee5812a5eb72fc1b28304efcc77"}, "hng": {"doc_hash": "03e983cd4a3d73d7c921de3368939a2236b7966c533691bf36cf67c1b9c5419e"}, "pmid23349038": {"doc_hash": "2266d41ff58f58aca98f140b5d0b08f00801fbf369ce305f0bfe88c0d2855cbc"}, "deep vein thrombosis": {"doc_hash": "7aa73428c8781c94006959c2bd49f42589ca239f618e9e850db8665470d7e4a3"}, "end stage knee osteoarthritis": {"doc_hash": "55d330a46290ded56f808a2390aa18e6885aa472feeec09e052a0afa5b02f998"}, "pmid34635383": {"doc_hash": "5247fed5d54d2fd9cb6f50e68c08189b3203fadbecc7fc02b975eaba24f2086f"}, "bleeding": {"doc_hash": "f05e0e3f9cc076c688b35adb61e5c7b14ad8612e668f06e890789eff56f3262c"}, "ps2": {"doc_hash": "09b02a765ee70451d34077d8173fc4027fcda675012a89f2377a5cfc5db9cb7f"}, "presenilin 1": {"doc_hash": "ceb554cd6743a6a0622079819bac6393441741ab348f8dfb7990fd7fea2f644b"}, "calcium": {"doc_hash": "0f519279b9a4747cef27771218bfe0c1e8f7998c7175acea851ebdbf097ebca8"}, "presenilin (ps) 1, 2": {"doc_hash": "776679676dcb222f4a1bc84f5480eac9e4e4e8c647885b62bb4a08f4fc5930bf"}, "alzheimer disease": {"doc_hash": "ce4f268f71b893b47441378095bb14fa4d5c58938efdc1afd945f4dc8e98f9b5"}, "m calpain": {"doc_hash": "cb650350c1d08cef6dc15a0c4ac6b1ae1355c378b011a990e99ca3ffad980f43"}, "pmid10677567": {"doc_hash": "5c189506185e10c6e941f0fca1f3652ad895b672b88f0105a699228f26efa9ea"}, "atherosclerosis": {"doc_hash": "3b56dd5696b0dac64e9adcf79665debdc93dd68907826fd4271f7c199203e5ea"}, "monocyte chemoattractant protein 1": {"doc_hash": "0724c98fcb07e24a1b3f651d174619d8e31a3d4745073eadd95fb5847cc91368"}, "elastin": {"doc_hash": "b3f91cc074942241bfc2b3bd488e0a4f0bf6595b35365057cceeacff29113f92"}, "pitava nps": {"doc_hash": "d816ca16c2595bb37876499510431111b579263124d46045b99980ce96bf2128"}, "abdominal aorta": {"doc_hash": "3f7dcf9bcc5d23e5d4d1901df4371d3fd6ec072bbb66abe80f288c5d2c341230"}, "abdominal aortic aneurysm (aaa)": {"doc_hash": "79707a741b96413a5430f82474cf7a08a9c360889a44f90e2a44bf0024cab364"}, "abdominal aortic aneurysm": {"doc_hash": "667126de6da5a3a8bda35b83d96a6ed7b6908be0d353e1dda74ab1545a796775"}, "rupture": {"doc_hash": "0d29dfc8afd44493d0823008a9b1bcb019a9c405052b403de94a4bb909a231d0"}, "macrophage accumulation": {"doc_hash": "0a78cdc4c88988c0eaad9fa1235371dddd88133fbba7d7a42d28fa94f49e3113"}, "pmid33455994": {"doc_hash": "70b7bcb7f4804d936754ac78b78357de49c70d7ac151ac177f2b6ca15b90b864"}, "poly(lactic co glycolic acid)": {"doc_hash": "8dac2fd3cc26802281bebe6a8c76cc03754f35c6564be005ff3dbb5a143e9072"}, "apoe": {"doc_hash": "af7a94ebfd082d651aaa315127c9602079ac1963c8d59c241da290907fb2ee40"}, "pitavastatin": {"doc_hash": "37eadeca4113ebc4e22236e3d96a9fcd225a55a33b7f8a2677bab8ccefe6df72"}, "lipofuscin": {"doc_hash": "ad2db299327cb305068f2b0c0c1703ec45dbe166848606b917bb981dd534f11e"}, "amyloid formation": {"doc_hash": "47c7dbed6a2b687ea376d7a88a9687817323a698c1d0eaab1430c366a7c1bc35"}, "amylin": {"doc_hash": "87280ffa3f7b4339a123ab356176c83d71971c5bcf9949f4250e1e61596e8e64"}, "type 2 diabetes": {"doc_hash": "b75063a57b7f9b04cb04596eac946bcc8ea9dde8cc1fc4f58dc460877e8218b1"}, "age related degenerative diseases": {"doc_hash": "70b11009febf21784f021907247b44b78f9c7092a325f45aa79f17cb822a5193"}, "pmid29580826": {"doc_hash": "51ff0556ed6bc8fed342aeaac2f7b41fd9a4524aaa7ce149990a499cf635aa5a"}, "inflammatory": {"doc_hash": "9bd6dc83f25189f641e35c3f6c9f0398fe356a69e3dc5d599b5f1fe4f9caefc3"}, "central nervous system diseases": {"doc_hash": "e837f717e3beef5c01ba2958ef332b2b08a3cd861d248524bee31998fe80a847"}, "ppargamma": {"doc_hash": "9da19bb09523c24897317511091e1d642124449425d3ae08c76327d182018e64"}, "pparbeta/delta": {"doc_hash": "0bc47d095be9ff483fa8249c8375d5fb56f5a920f7ea6d7114c0296859a73ef1"}, "pparalpha": {"doc_hash": "5018afe2c1facb11ac5c585c45b1453b44d4fb62716f0126ecc260967b87fad9"}, "pmid34833044": {"doc_hash": "7708645e22b86365b57f144d81f6e8d8aaf134cd1b0455a382c5af9ce725fbf5"}, "guanidine": {"doc_hash": "1ab74e60d55110b0f46e988d190d4b9a4a6d96b53d057721935b1ac7a4826101"}, "barbital": {"doc_hash": "3caf7926008e3899e553600a5af3218510b3bd5425b5261e78dc4379cefd3d54"}, "hydrogen": {"doc_hash": "379fcc40d7fcb8dc8dae9210800fb6a68fc098f246971d6baabb9a94d951fe7e"}, "ureide": {"doc_hash": "f9d2dc45d6056a56245890dcf4d04e360faf3305bbde9cb2b48034bd7758f44f"}, "metformin": {"doc_hash": "e91bd2c13cb2308b808ef4fe83e51c5cc9b385155cbeab2117ebcda662987885"}, "pmid34299653": {"doc_hash": "f009775db9843401f31678f5b83caf6abebb9b5a282717aeff9ec428107aa0c6"}, "neuroinflammation": {"doc_hash": "d0d454cdb56c9c61c6abcdfd81816945347255b44d8d13c7f2b215162b9e5d73"}, "nervous system": {"doc_hash": "ffd5a474b22000536335b2bf20881f7bee4fc575010ab5e687fab2fd2b3bd5bd"}, "oral infection": {"doc_hash": "42d41362a5ad6a7dcc2e9d2b44810fce265aacee7150a235a520ecaceced8250"}, "periodontitis": {"doc_hash": "99595b88a096f513bcf7130f0247335130749a8f22bbde98c8ae1b35002e4753"}, "pmid24919005": {"doc_hash": "52e9b9fc8c2274b83c6435eeab83addfe8ad7d07ff5060ef2ece11b55be48d17"}, "1,3 linked pyrimidine quinolone hybrids": {"doc_hash": "64a84ab939d049b38022507f6f695673511f6463afb18bc17c951014efb3446f"}, "lactate dehydrogenase a": {"doc_hash": "e483351148e3b1a1dd903510fc7c19cbd634ba40088a47228d4f17996bd45dc2"}, "4 aryl 2 chloropyrimidines": {"doc_hash": "a7d3e4e0f1353f07d8e8ce5a8f8d25b9ec2f83cfb3463b574abf730bb5524cd0"}, "aminophenylsulfide": {"doc_hash": "0b6a02a17da56f54da85ee33500b7258ca27d020debe20a7f4646ed4c69200bb"}, "3 (((2/4 aminophenyl)thio)methyl)quinolin 2(1h) ones 22/": {"doc_hash": "7ddfa27a9e596f03d41515b861ac3996ebb205d186dbf64e945f416fe1fc77d9"}, "2 aminophenylsulfide": {"doc_hash": "ebd67721ff90879a85aa131b00ae6536a4f180750c6aa4547beb59a69e9745c2"}, "pyrimidine quinolone": {"doc_hash": "d8d97f6ee233907feb46fc6a8809d93bcdb5f1f5ba13cc788395f85f04977532"}, "quinolone": {"doc_hash": "f767ccabc1f8efb34dafb7c296c6247a558582da5d5e0a44d2a3c6f7c86495d8"}, "pmid35890090": {"doc_hash": "4b8ca2105bf61b094ef6d5d3f52b8f776f912064ddefb7beefd6bae4f9c73c0c"}, "25a, 25b, and 35a": {"doc_hash": "ccdd8ddd4c8c76a2b585296ca944a513ad92db26bf3cf06f042682d9432af9a5"}, "pyrimidine": {"doc_hash": "8966dc5884e7ef352b1659a59cd45a4857f5230d1da9e469924f64abe3c384b4"}, "calretinin": {"doc_hash": "757a70b5ca84bf6116695d69ac09843f8644ae1971ee9b931446ff0b4027fded"}, "toxicity": {"doc_hash": "20f548497c6dcdee3e5e94a8b2356075a46ab30ba2d2730f82c1d83e817a3ceb"}, "neurotoxicity": {"doc_hash": "2639f79694e0373fdd948e38da39acc2cad840cdc197bb5b8ebe6dd59d82534f"}, "pmid7743217": {"doc_hash": "cad4b74dc37ebc6e92b1c2d7cb2def7b400799a80a35f085b72f7b516759b1fe"}, "amyloid beta": {"doc_hash": "a3800e3af76b4629326400ccea0b0a6265459e3910079f9f31483a8ef35c74f0"}, "metabolic dysregulation": {"doc_hash": "cc2b9f17f506c07e5e83230f1947e40c944bc800d24dc50460d701ebe4fad6ec"}, "tau tangle": {"doc_hash": "447931e8832a70a8efce6d499fd193c34a1a416c6f7fda6b1ba3ef38902dba1e"}, "cholesterol and phospholipid transporter": {"doc_hash": "2482a2435c34bfe69ad7219a21e452a5981e5e8d559212bf74f23c2454970676"}, "mci": {"doc_hash": "78cc38ffa2f407a0e14fedd7d19e2075490aa97ed500516707fe7a90aa6b2957"}, "lipid": {"doc_hash": "a57315055159c3ac0302dc45b99b48eed5b94873dfd322915f92ebc84bea8256"}, "pmid38938596": {"doc_hash": "4b5c4cdb858299458905fa66fbb4caed239ec7c37a2e6c9edbbf8d305a877e8f"}, "pmid18599956": {"doc_hash": "024bcfadd3ee0d1fcd53bb6ff60ad49a33b8963d92f4fc8e05e31e9b929703f8"}, "phospholipid": {"doc_hash": "fa406e3624b6c7676b5860972094d7288b0a5574d4a6d17f94f9d4c01579ec05"}, "coenzyme q": {"doc_hash": "cc9844812a07b0fc64ff5289cefbfb684084ac0b92d6a85203b3fb0625a9f8fa"}, "age related diseases": {"doc_hash": "97d32db906747e366239f4db792a956eb7a493d99c003a5226938e5eae2f1438"}, "pmid26999099": {"doc_hash": "2bb6734ad4ccfbcd5b1c8a9e1c8b27eeca0eba49882391569396b83c5b223544"}, "crenezumab": {"doc_hash": "e651403c5f6ea7723494e3c478a51b005578ce3bdc113ada7faa84963114be8e"}, "psen1": {"doc_hash": "c15de3421054dbe3a7599ea4fdc018b6f8e28a1984c961e2df418ac87fb8fc8d"}, "pmid30090848": {"doc_hash": "8ece5c70561a178987bb6fc7a026d5bd6ba6a94359880f004cb70cc4acdac8bf"}, "polyglutamate": {"doc_hash": "5aafcff5c9fd564b425c80121cf8a9d1cd599317c4cdea55eb6504b2d463a9e7"}, "mefox": {"doc_hash": "c7d4af2a1102f398608ec7812de18f797a588854bb1deba6f960ef2839209365"}, "formyl folate": {"doc_hash": "21690174fe23af6f3044c51bc05fb492c6942aa912f76e9e7f051a6b5fefc25d"}, "s pyrazino triazine": {"doc_hash": "92e2294386bb5caa2128c5a9e81d1174df34eba7b172154a0342a640ae229463"}, "folate mono  and polyglutamates": {"doc_hash": "eeac0d0b5dbb81f085b0b6a395a7d22d694d274d3ea07cf3810aa85e3961fc00"}, "b9 vitamins": {"doc_hash": "c85fc7f26545d562040361b04060a245b00a64cbae079b5b793ef035aa9a3f01"}, "pmid32717862": {"doc_hash": "960effa260207a33ece452872cee6c22540e97ccc7a8b33a671ff9d304e91cbe"}, "renal tubular injury and dysfunction": {"doc_hash": "cd1f8fc7123084c8006e234e7b657da9b8bfed454a2895877eb469d35f927e52"}, "rhabdomyolysis": {"doc_hash": "731e96a24268fa54ca31e2caa49ee98ab3fc00131575205076053547c23b87e7"}, "nlrp3": {"doc_hash": "c0f5237344995c598b29f85e2f4f28046970c697ea0d272980d9b43481d180b4"}, "glycerol": {"doc_hash": "1fc062c5b3dbd724e62ec681afa8dffdb100a116dee66fa7bedaeae09b23e4ab"}, "rhabdomyolysis induced aki": {"doc_hash": "1d0315987a13ba4d90ba5c0a7eba9057e8d09692602007282dd4cb79c8dbb9aa"}, "interleukin (il) 1beta": {"doc_hash": "fd3fd9399b4dc4be38142b56ba0596bd48ae9b9226d1b8681e77a85ac8fe3a8b"}, "asc": {"doc_hash": "bf5ea5cb1cd15253504c58628ccca8aba30dd26d78db89eb31ef92a8e7ddc3bc"}, "caspase 1": {"doc_hash": "f8235323d904f21ee9fe7eb302c403c7a0bd84d25763a1b7aa136a3f4adcf729"}, "pmid26045078": {"doc_hash": "8b4134d6bbc89fa19298c976161aff4aa015d5d0f56713325cf8b73571ccd7cc"}, "estrogen receptor": {"doc_hash": "b7ece6f2d41ed779f034e70122a3a6dd80b7a195c407121044f1f4c3fef8138b"}, "sirtuin 1": {"doc_hash": "efc8cf5b4a04d239c16ee6d2e5c1df4f6e856188dfb8f749c5f9a127b6dcebe9"}, "27 hydroxycholesterol": {"doc_hash": "23bfe6563576f900c1fb364061a1177468833137932f99f3a9caa6c3aa9916db"}, "locomotor behavior disorder": {"doc_hash": "c1e2a620f12826133627898f96e369ac11dffd46887644e2cf875a02b7300580"}, "resveratrol": {"doc_hash": "cd97f8a761c50b0fab1bb2bee482190a14a8d542a4d668e156a4cb855e4711ea"}, "17beta estradiol": {"doc_hash": "7097e5c05cfe15ef0825268c9c5bcc7be680682ca791edf6189cbfc72f6f1dfb"}, "pmid34239694": {"doc_hash": "3c328a722fa765257e2dcf2c44638a9eb46d37901e53d222cd27d00e5154a1a4"}, "nuclear factor of activated t cells, cytoplasmic 1": {"doc_hash": "7dfeac78e8bccb686ecc9414f11f10a82a3968ea97f7d40b7d51d8ec8b950a34"}, "cilostazol": {"doc_hash": "5d6119ed317f85d71069876f43028a2c577a78b5b4b8cc4788df8e15ed7e5f99"}, "receptor activator of nuclear factor kappab ligand": {"doc_hash": "de5f301a281aa07cbfd1f2a4be3f56e98193b8e6e7e48cfafbee9ce83abfe337"}, "adenosine 3',5' cyclic monophosphate": {"doc_hash": "7b511eadd018eeb7095a01830cd07226682ea46003120e1dc139304a406ab87c"}, "bone loss": {"doc_hash": "eb55b5e127b88ee31a9632526ddaade420558193f611fa09864635986376e977"}, "metabolic syndrome": {"doc_hash": "ca4fda9cc8fc95cf018ae21c0c8c3d0383825e08d003e415ae20ddac1cf69e79"}, "loss of ovarian function": {"doc_hash": "e597ad395dd7f4162ebc9bd4c74f4a7578fcf09fe78a8d9e85f5ef4745100e12"}, "pmid25992691": {"doc_hash": "6167b42699c471c9c8e210493e0c090b3bcb1710641d3996ce990c53a0695dcb"}, "abdominal pain": {"doc_hash": "7143398eabb3178838b55fc9093d67e35a54c63d8337489dfb3574e3aabeea63"}, "diarrhoea": {"doc_hash": "d80b2c130f5a8c7d0652d46a6853917a0a0c8345a2c94927eadf9d6088434d10"}, "gastrointestinal dysmotility": {"doc_hash": "3a9165d43bb3ef8f3d5246924d9901a424adde5057d6aa327bbfba3023817f04"}, "vomiting": {"doc_hash": "b9dc8663de740d07a02293081bccad42afbb06e333ad15f241157cbc44ae1f68"}, "drop of power": {"doc_hash": "370cf0cded327338a5939d6027ef69f846c67721a6ce0ef13f59b6b463632f1a"}, "memantine": {"doc_hash": "04201c9914a76065727868a1ff7e038983ced51aa8b67e40f9ef4c5c0a585018"}, "magnesium": {"doc_hash": "43f0fa7d4b5ea0467b77541be132473eb2051878b7e6466fcd99550bed70c6c3"}, "gastric myoelectric": {"doc_hash": "dbe32baf1f102e42b10d8188ef99fa35df0ea0e2a58c555b0273ca83b9df884a"}, "gastric arrhythmia": {"doc_hash": "e39eea484395839f56262fb4991b28ffe7e4979cd43517363a2ae1ee5ba2d3c1"}, "pmid31978146": {"doc_hash": "871eaa382290647ee92251fe616d563fbc890adebed13e3c7d05e5fe7dbdd745"}, "motility disorders": {"doc_hash": "f4930037683b9dc903a27858b6f20145cefeddbcab933fe6072a4ef8c2b4bbc5"}, "tor pathway": {"doc_hash": "3931eb00be7df4dcf9828a1169df3fdad5182402db2fb6f2b0f46fb2e31eb3c6"}, "whi2": {"doc_hash": "65cf04b27bc3aa95a85418fd941858ab03bd96cc522a262366bca1cbff5aaafa"}, "msn2": {"doc_hash": "ca1b10bb7996b50aa58474d07afb9d19425bcb3c0e949afbf382b9715e6b0540"}, "cancer": {"doc_hash": "b446a28dccf2cf8cd69459678adc1ce83f3910b1fadd4dd9e0669d9eafb3ca6c"}, "pmid28646136": {"doc_hash": "8341cba09d60004ab5bd830ec612b77f951c698f18c0ab9e64ccccb08d10328b"}, "pmid25875657": {"doc_hash": "7803c5818a438206bda579ce249368e351eeefe37a99666c0b7c1ae24f5509ef"}, "delta4": {"doc_hash": "db9e200cd9c581d21265b18f3e6bafa82cfe0e30f99002944295718d4a169358"}, "neurological disorders and stroke": {"doc_hash": "6092dc40c6c6951e251f543bc65a3d1c35f98c7db8090d2bc9f6072bbf79d8db"}, "pmid16917086": {"doc_hash": "3db9c97c75b45ef23689839804b1991c9c871acc8dae3e672204bfd3a9231f64"}, "mesencephalic astrocyte derived neurotrophic factor": {"doc_hash": "d584e472459878883799f719c978a1964ef73d63fff0be510bcef8e15b15d5d2"}, "pmid34234505": {"doc_hash": "77f2a1ae9a286e4d2b0084db53c4c9ec4a5e353869a1e66cd8a04d631cb7bff9"}, "sensory deprivation": {"doc_hash": "6aa44e65493e5f2c8d48e184742593c1fd6ac52e30278ecd1508401a86dda745"}, "pmid2872139": {"doc_hash": "8c1320aca15416da2dd1e58e32e76d01625c8928a0da35e8c25e242faad5c472"}, "impaired vision or hearing": {"doc_hash": "184b41cf6753276d242c81878d09cb6c9dd3939bc097fc359e6c836856af126b"}, "glucose": {"doc_hash": "0af4217903896df52b629b2f9ce8a43e96ecd40c07d9c52a2da24760eddee74c"}, "pmid35740018": {"doc_hash": "dbc0c1d203054024894ee8c878f228a35c09b205cc4a7110bf4054e5f00d0f16"}, "adenosine triphosphate": {"doc_hash": "48be411f6d66ea2813a912ab0e65c963135a9d5d4f6744ddc48345e393e35fd6"}, "autoimmune and neoplastic diseases": {"doc_hash": "d129798fe7b52216bfe54852b4fcd90ab1dee4c48d28be068caf97fdddccf020"}, "mitochondrial dysfunction": {"doc_hash": "345fb9ae4e2bdbad4ce225bb25e07e65da9a94f7fc480a182f8c4db53078b7b6"}, "copper": {"doc_hash": "ddf9b173674b2f1bc064757d8e20f62c2a6e317383229ffb9b64bca5ccc376d8"}, "protein misfolding diseases": {"doc_hash": "6dac660998730a9a292152be8c9d1e7038332a960ccd99467992c4b7da01fd07"}, "metal chaperones": {"doc_hash": "203342999db68a99ae813f92656110d83d920f28bfaa90624ef1d69bab06af1b"}, "pmid20536399": {"doc_hash": "8b6cbd9616840abaf03f6a6b5e30793bc21b8858918c2b8479fba4e5f86b4465"}, "pmid23662612": {"doc_hash": "7d4652cc414adacb2a529668a00d7f3e9dc80ae64eeb3b727eca82cc64505df5"}, "polyphenols": {"doc_hash": "656e05cb9db32c84b20fe30594038dde63cc422f1a4d6d754c77bedcfaf24994"}, "hispidins": {"doc_hash": "23d00f378801e3017f3a3b70c11b817987062563f771cf9e99dea331060ed438"}, "polysaccharides": {"doc_hash": "d3464384c4a271c62db949baf78877ef94c82f1b7e4c0a5ee12a9729927f9190"}, "alcohol dependence": {"doc_hash": "b1278f8bd77b856a3a5bf38ee1c5ca022f9af8a0324f5ca189ffa031460854c4"}, "addiction medicine": {"doc_hash": "31d817ae4b800e2a17c4a83d73fc68213bdff0f69ddc61d27c956ddfd7efb1a7"}, "calcium acetylhomotaurine": {"doc_hash": "79b565a45e3f4f026fb9aa66705daa7a13076384eb8f808d42e686b32d8a4e78"}, "pmid23399877": {"doc_hash": "187bea60d8d63c90f582d24c12cb1a470c077e04a4e52aa45253e41701486424"}, "alcohol": {"doc_hash": "05c02af18655f41cb9f7007d465027168493c1022191dfddbfdf59b1a2ba0e14"}, "wrinkles": {"doc_hash": "838431947c2bd9f5e488fbdeb23896952aaeb968b2c208340f739e8d9449b20c"}, "laxity": {"doc_hash": "29dd3b3bb1404c9a390bbf56ac5098957fcede1e0c335aa43fb60033d64f02ce"}, "elastosis": {"doc_hash": "e5bcea815bdda22dff3147a24f09a47519a4f500b5b4ce6bc674e414b81dbcdc"}, "osteoporosis": {"doc_hash": "95a2f0c58d4ecfe66079728364ce3ca0cc6f82276f4e3c7b3559ccfcf59de747"}, "aberrant pigmentation": {"doc_hash": "231d0a0fc705f92aebc858dd34ad1388017471fe1f575e7527b801c10dcd3dd2"}, "aged skin": {"doc_hash": "8aab9a6267d9dafe1ddf275767995615e3bd0a28244eb7c5c164ca865a62504d"}, "telangiectasia": {"doc_hash": "4e568f6766db9c323fe61bd5b1b8c79adb39451e33f23624639c7fdca4d5882b"}, "degenerative diseases": {"doc_hash": "5115d8aeccc12cfc0e511b8b2445417f8495016bfadade5a6fc15ec759993dba"}, "pmid36698629": {"doc_hash": "023511d78ca53bfa5bc8e9688a484ad3472ef381f9c8060cca57c3fdb56225c6"}, "myocardial infarction": {"doc_hash": "7393576cb52c26f9132b8142fd93a02b6d3ac60dba658e4f44d95eb669df262c"}, "antiplatelet": {"doc_hash": "102b0151e35ab45284adc6e9f203f9571f18049caf1508f075c315d1218da29a"}, "coronary artery disease": {"doc_hash": "54cb91e67030bef5cde744e9e05a6d26a66ea98d4abde468e47c015f6a57f9d7"}, "pmid36130806": {"doc_hash": "565d834b2b3b0913c8c408c68fcecf022afc859c798e862a27f60b4a69690cb6"}, "decisional impairment": {"doc_hash": "c77bf477a904d5bdff8860cf66c6856fe50c1128835d18d3cc650bad7b57c0a4"}, "pmid11986134": {"doc_hash": "a3a4e7b1595ee21166f1fe179c1897d564be2db803f16476ee32848e0e87705d"}, "so2/3": {"doc_hash": "731335a9b7312a253eb34ba1dd1882cda64456e5c3ff4de21b2caff29d46eaca"}, "obstructive sleep apnea": {"doc_hash": "75bfbda21632324fef0a193e5602209de29713c14aaff135eeff6eec7cf07fb0"}, "pmid36552694": {"doc_hash": "9a235f977e4839f7bd60efe820e0cd429a87e68f64e8a99969a45eb7804a9b04"}, "pseudocyst pancreas": {"doc_hash": "2223d0ef604419265b2ceb4798e3ce763ade0ee82aba8b6d780a3efb30316235"}, "alcohol dependent": {"doc_hash": "b0279f4f6ed5e26c2a1cc668b7ddf6605a8d58de9bfd51efde15f3074a9dd468"}, "alcohol abuse": {"doc_hash": "641942208c96b61470618f1a1d1e5425c9e646a306bebedae01e31728bab1f5f"}, "pmid28515560": {"doc_hash": "82847804f63e3b54bbb9c3d772e196f2f5449eb0dd203275f384d65ece829f33"}, "kanamycin": {"doc_hash": "4709c7ae752c580c3554aab74335905d1eee9139a99ea7d390fa315ada799471"}, "dying back": {"doc_hash": "e2a1435f1e57b0ad7ec251588c25730db8a9a35bb3a9acba0990932865dfb18c"}, "hair cell loss": {"doc_hash": "87f37cf18d18a5bf96210c3312115b37af8fe5b7b61c3bbc700d1af006ef639e"}, "degeneration": {"doc_hash": "94602d51299f7848697c3c2fe78bf9f75df0c4fd885b71b5efadb28b24ec7918"}, "cochlea": {"doc_hash": "6f5d3fb0e686b7af0327e1508940ce579f66dfdcc2245b57095f36f06355cc15"}, "furosemide": {"doc_hash": "04998f636ecf4d74d184c434828392094191c341a346c7636d71362628fc02e5"}, "efr3a": {"doc_hash": "4cf38cb50a96e40f7b7c39f8c013e7655fb79efa7c18b23b16b580bbf1ea1a6e"}, "spiral ganglion cell degeneration": {"doc_hash": "485ebd05fae6a43aa87f3d3f8b18d02e2a4384d517bc0ea77436a0b9b33f41d8"}, "pmid25622037": {"doc_hash": "da8f14b9bb9fe9135b45ca98694ec00ded42a39b41e8cc1c4c865fe1cdfcca52"}, "eosinophilic granulomatosis with polyangiitis": {"doc_hash": "454cf5b4da47e11f6edc292000f32a425adaf31e5b595b440fcb88301d1d8753"}, "systemic vasculitis": {"doc_hash": "e9b687e7af6b7df28de94ec70b217c32a5863de229f5ccaa01c893702db527b0"}, "conjunctivitis": {"doc_hash": "9cc74703cd0607c44d4f81d7f29925f0a86d8323a106e2e4989062d11b42a8b9"}, "pulmonary renal syndrome": {"doc_hash": "4ae605546e3cdfd9600e5beb8d6c4584f8023a12799ad49ae73954c8dde6bf8f"}, "pmid36755295": {"doc_hash": "4cfb8ffc3c322074b351e9128727af979ed5a1891973c64a4b87223611e23ff8"}, "vasculitis": {"doc_hash": "9ca7fb9208ede9766a62894e24b60345be3bd1a7818d8a2d29ccfa66d3f7a67a"}, "inflammatory bowel disease": {"doc_hash": "85bc072c838f44d00ccc51f5c451e222503e3134968667975c142fe4d9bbf7ba"}, "takayasu arteritis": {"doc_hash": "32813213d2e7f54581790a778f9bf403875759f41b848baa8439e1706374e853"}, "behcet's disease": {"doc_hash": "d6d28e6e4147259ca4a58d1138082ba213db3c92d1ca1c5970dec802c730590b"}, "primary vasculitis": {"doc_hash": "e8a8e0763dd13ad4cbbdade110bc2de76c1ca45a1818af1f36e781e5b1d7d89b"}, "purpuric eruption": {"doc_hash": "2b7fb8d15cf9815e3f4db906a4efd54d5a3e25548bb96fad7701a6e99bdc4288"}, "maternal death": {"doc_hash": "65d4b9a511bda9e92ccc3c2d8e953034dbb276102895e83cb9745475dcfbd669"}, "periarteritis nodosa": {"doc_hash": "4e8b2c864775cff404d26fce793ecd58a075269b61c29168c4e0818265872cbd"}, "musculoskeletal pain": {"doc_hash": "2955786fb652e6c2c907cd5804ae8f6ca23429fbe3c5176dc0bb0fe43a5bbf55"}, "systemic lupus erythematosus": {"doc_hash": "15d275b68ca0480de2d29e4bc9f3a25d262920cc5ab85820d0e98947d98492ab"}, "amyotrophic lateral sclerosis": {"doc_hash": "f5bd684f2b0345f2564eff8e65b86055e8807891b9c937319e967314ceed633d"}, "cognitive, behavioral and psychomotor alterations": {"doc_hash": "be8dcba62706747efc9693ac081fd29d089b61e38bab59b44e9bcbed93b00cf9"}, "depression": {"doc_hash": "9d6f6e4b8bd5884595c0cd04d42d380d5a4971cafb84676f2b52d9205929568f"}, "poisoning": {"doc_hash": "28163c8a1ea31c5b077cbc7a83e2e910e259bf094e0a34ba21bb28be519e61f4"}, "neurodegenerative disorders": {"doc_hash": "e49ea516df604bc7c08c45be4b7e2740b5b3c5f462a35bd129ce364230be06d3"}, "pmid28552054": {"doc_hash": "cac9e70de4cbbbce2b98eec84fd64e07869cd484905b493776a5f794e15a74b0"}, "thrombophilia": {"doc_hash": "13eba4e6eef3bc89d221ca3692f6a43d35ed9745d8c09440cc9ff322efcbec37"}, "inherited thrombophilia": {"doc_hash": "2c7d041d76f32567c8b45c392595443445553483f92e8310e01088af35c157e8"}, "lower extremity venous thrombosis": {"doc_hash": "40036f9323d94f426b5700a2e632f8b4c696e5b600c497404faffbdd2e2bdbf4"}, "venous thromboembolism": {"doc_hash": "22df8c30ba061dc557ebf98a0984f152538d783d74430a2be72c1c71d2b89682"}, "inferior vena cava abnormalities": {"doc_hash": "4ec60b8295874a2eec8017ff3e647609634194907f1f199000ae920a46d779d4"}, "pmid22454560": {"doc_hash": "35df9c16bcc93076e0fd58e790da02999951143686f5e13f3bd50770a057a843"}, "chronic periodontitis": {"doc_hash": "f8e44fd12cc66a46bd0e9e8b74d32e2578e8cba5dedff8535b75ded4ec27e7ae"}, "cancers": {"doc_hash": "19096d07b539f69e2c89d19f04195a19569fceead42360b3c15dfb3dd516d902"}, "free radicals": {"doc_hash": "b93b2ee39624a1fdac449ffe3ea8be504ef6a3f4fd355880d1d5a42b6087039e"}, "8 hydroxydeoxyguanosine": {"doc_hash": "e9eb7a07ae742d6d74e9b42d937782dff46d80eff1be1d294482d31677a5f6c2"}, "inflammatory conditions": {"doc_hash": "0e8bfd872547f1f36611bdd671d991ba01580d10fdc5309c669c4354d7bb3118"}, "diabetes mellitus": {"doc_hash": "d816700463b75ed51d2733d1062a7270b4ca2eebfe7c2c24ab5396eeead9fc4a"}, "periodontal disease": {"doc_hash": "45eda06ecf018dec2bab0443771a4355c03a3c4538c279d3bb670a341a935bdb"}, "8 hydroxy 2' deoxiguanosine": {"doc_hash": "a812e5d0069d1b4d1b0db62e751c649a8d17c0d1719acdd7bf517015212fb8a3"}, "pmid38338704": {"doc_hash": "f297881c77d961d2bfa215778ad78abaf46c6e123d6fa0f85e40a9f3228ba013"}, "tau": {"doc_hash": "a8bafd05c804bb2a0657195e89aeb7b397a1c8f84164a15a4ad9f94cec94cf3e"}, "microtubule associated protein": {"doc_hash": "2392db36a122bb471007d9f9883b36f57ff73a0f4c9dbf6a31a2e0cc03c042d9"}, "pmid7566342": {"doc_hash": "696cb2d85fee52b1d11c0b6c004cedc9b5bc9ccf7cdae3b51b31ccf65e9f0d3d"}, "pmid31882381": {"doc_hash": "d6d0f2c308a9214ccc8d673439b04d9a60849e144fb69290c14516282e57f943"}, "heme": {"doc_hash": "867c443769dbe9dd203085be0dc93ca29d6c0902e31b5901125bcadc4e719e1f"}, "fe": {"doc_hash": "c3839191ae10db3c49172725cdd523fc625fec22debce846ec4e50f6d3ee5abf"}, "human cerebral cortex": {"doc_hash": "dcda64604716ffcf2ea01a20179b73f1f5d541db498a2ed8a484958ce666026a"}, "cytochrome b": {"doc_hash": "d99b65a71d4ffd6af5eeed11659d4810ba4b4664239eeed942fe37178a4104c3"}, "pros": {"doc_hash": "23f1d5d0702ffe0b0e22a24686c372e6588eafe937b6c65b76eb1bc66ba3f0e5"}, "amyloid beta (abeta) peptides": {"doc_hash": "08a3a3519999c114a6cc2046e70e56376bcdca10a00b9806c24b4777dd7329b7"}, "reduced oxygen species": {"doc_hash": "0d9f8b8a0a3d5d8e849a6253ad1a3025cb20a961af9ec4a6b2c236c9fc13406d"}, "his": {"doc_hash": "ad5df23662d21ac0ec0f18024ab1801709f7812f2869d1eeffddf22c110cc3dc"}, "amyloid": {"doc_hash": "0b7c537b4ef1c46d415965978833ef54ca3aa321d6f9fd4b5c4c78d86e420e41"}, "pmid26816006": {"doc_hash": "e9ec1fe9672d75588b7a6d173553efa4761a6c1c52de2377a0238f72ac4707e0"}, "spine toxicity": {"doc_hash": "68218150aaab0c1cfd31ea5e7f13bbbc83b3d06d7c62d072fa1088cf301657fa"}, "pmid23860033": {"doc_hash": "2b823de17cec405b5c662d00a8132f61e083c5e057b7a0d02a43169ca0be23cb"}, "abeta": {"doc_hash": "a3fe46671720d220268a39702f5cdd61451bf9b6465d17e9432d9a8d39049b97"}, "ca2+": {"doc_hash": "b18ec52037090b985d8760e08110e2b97d47f72ba01e078e0ce5bc064a649f21"}, "bapta am": {"doc_hash": "22f51252d46e4ff31144c7043de93e0d5a9b4f518c8d9f495cb80bcebf412e55"}, "u73122": {"doc_hash": "c379e7c85922fe74d3f4ff7a51e78a993ca90d471d5ac20b0894cf79a44f66eb"}, "phospholipase c": {"doc_hash": "41558762ca4d82288f1b11f5afecb059381c0affd78c0e8b26589c576c679621"}, "2 apb": {"doc_hash": "441c7aa2e97cd5bad9aec7206ca5845f02118bddde686dec90e2026bbdc988a6"}, "corneal damage": {"doc_hash": "f0a1998b84d773ab42b9397e742dd59d10a833f40812e3e8df66b862ec77f53e"}, "cornea": {"doc_hash": "f77fd179c932e6380240590cf6db3dcea13cbb5c94a4c2610c13669137a8db7e"}, "ginseng gintonin": {"doc_hash": "a3c337062b269cc415f5cef76ec032c7279037665494d05fd22fb27aef09231e"}, "lpa1/3 receptor": {"doc_hash": "f621e418455d1354795c254f30834e3fc6108fb4f84d3b558a5d18a603e825b9"}, "ki16425": {"doc_hash": "063f66a6d02fcfffec8d87d461329a8b7543815feeba9c5c6becebdb51aae88b"}, "corneal wound healing": {"doc_hash": "0d74fff83185d76f8c44ec350c48ae9bc915cde37dff48c395297c9984603458"}, "pmid27586470": {"doc_hash": "47a6e5c3e8d312266cf6863e6f544e766c367c5e12fea21a8397e9278260c313"}, "evp 6124": {"doc_hash": "8c43365c0d34e7ef4c102b4de740f9e9b469d894dbb1f0df17daa62aba0f54c2"}, "alpha7 nicotinic acetylcholine receptor": {"doc_hash": "6c2ccae12a117721cd346eff2aa49192a20b79009c439f83e4dd03cd1906abd9"}, "encenicline": {"doc_hash": "5697140f2b03cd44dea32bbfdd959adb416a9b93c6d80898c5da6c6fb1ec4b9f"}, "brain disease": {"doc_hash": "166add9bc8310c591d537d649087ef3f3bfa30a973318c10d68ef76c1dfdcd68"}, "brain": {"doc_hash": "0e39f52f6e3de9e3f2f960e5adf7714485eb0e38871a98b981865c5a15d107ee"}, "pmid25495510": {"doc_hash": "7184df4acf5f620653fca1dfef6c5f0a219f8a627dff54d5124f9320ba5f31c4"}, "tissue damage": {"doc_hash": "561042673589525f8821ab381ca9b0f3357a78529456a7076d5dff880cc45d36"}, "glucose regulatory protein 78": {"doc_hash": "b822ad6b91fc3aad036eaa8d7a57882deba4a52f3c2884495318cae934aa0202"}, "glucagon like peptide 1 (glp 1) receptor": {"doc_hash": "f22f36d6a7f3e97b6750150279a799274e4436c4ea519844d806b97404b695e7"}, "spinal cord injury": {"doc_hash": "1568648696a1f3893ae690c31c98e5b17eceaba73bcb4b3a417197b8c7902d5b"}, "exenatide": {"doc_hash": "77536bf3b6ebf19aa4af7183d0b599ac1f87ef1265274645ff963ca8d22baac5"}, "hypoglycemia": {"doc_hash": "ea89011721d113e0093121d0fc8493d7e26d4d45b27fe800f43ad1d286bcba83"}, "c/ebp homologous transcription factor protein": {"doc_hash": "b6f0421d451dbc2b320c7fc97a2919bd3a4d5b44d71343ee86383e9fbf95f359"}, "injury": {"doc_hash": "954df94bc4de14fab5a69aa1738a191f48c3dcc2d7f4a2bfd8dce73d5a7a2bdd"}, "contusive": {"doc_hash": "66dc27e209cd47a0baeedc23ee92db7bbf9bb9e96be07b2606f663b442e6d17d"}, "injured spinal cord": {"doc_hash": "d1e15818d27abc43e5346c6827606a353fd32973f7ac83f17986e57b45b34d92"}, "diabetes": {"doc_hash": "09632f1576614b49334b2c37760fc3d7c07b4a6c79e1217a129b64e4b636e8c0"}, "pmid37822517": {"doc_hash": "c116067fc19b3d715fe2f8c91ce1b19cc3eeb3335cb69af4098bee4e97d37894"}, "protein misfolding disorders": {"doc_hash": "fe2264f3411afc2a2ec9d4c0abc4196547d45a6d59d174326cc8622e5c4080a0"}, "pancreatic damage": {"doc_hash": "fe3f4b1d242dd7c633f2696a3e07e1da1e0c0021c61c208498c3958d45ec7136"}, "hyperglycemia": {"doc_hash": "79df3fe9d74613b74dded8f2a01daae0c502f5552e75eb4a5d005eed066ae7a1"}, "insulin": {"doc_hash": "03a2a3ead373697f63c98a710c591c8686ffbc177e282b041b44b1161738576f"}, "islet amyloid polypeptide": {"doc_hash": "e10da49e3426cad085da28f77bff026e18866321d595a70c7bd17e40df98a9c3"}, "prion diseases": {"doc_hash": "d4bc1149cf819dff9e2278cb387ae4f2432a738947d2000df88fda1712fc06d0"}, "pmid28159831": {"doc_hash": "5f628c543bb3b3c05643a475681b7cfe9382435e3d9acca60d4c2510bcfb1c9b"}, "amyloid deposits": {"doc_hash": "5aaadf07b616476e732f06128383a146d2c7a72a9b25ec6df3a830af25db3b1c"}, "familial british dementia": {"doc_hash": "0e686b198fe037f0b44f7d105ba7c28ecdf211659605a20c2a8bc3439d9f1745"}, "autosomal dominant condition": {"doc_hash": "b4cfd5c6f96fc5f3f24e541e0712cc443b4f2c6d8bf0f9bd012d2852abcb5e77"}, "amyloid angiopathy": {"doc_hash": "ce80df9937fd845a5acf8eb980c521e982242386f82ae0a09ad6cb788082d5d8"}, "furin": {"doc_hash": "5a3e7dc991d76da747571ffb2e8ab38721a8fd1f62f595137455b14947b37dc9"}, "abripp": {"doc_hash": "5d604cea867c8e6101ed42e47783f842cf79fce898aa5282843482c1b2091a11"}, "pmid12883829": {"doc_hash": "ffcfc2f946b46261659abaf6b336d4d63ed66be6652eb587542cefa3829b852b"}, "chronic": {"doc_hash": "e38e7bbdb96d2a48b5e6cb08706803f04dff8da5c41d1496df3f2116a239ba12"}, "gfap": {"doc_hash": "9e125dc8feebd9f762421c59763ecf129aab7d1ee46e4d7002022b0b1a066200"}, "neurodegeneration": {"doc_hash": "8bcdd5c7e52dfe683c3de7bccaf9afb4fa44a0e4edfc93c864050b59300e6e0f"}, "strawberry notch homolog 2": {"doc_hash": "35c57f7796838eeb5cb553c5646288a2a11189ffec8c66d2c213d811c469908a"}, "interleukin 6": {"doc_hash": "4a382c9c3741259052652ce4d79f013de4d0a847eb0265727921697c3bce8a37"}, "gp130": {"doc_hash": "7a9a066e75cf2f9171914314880cfbcab61b0c17de50049f4421368311bbe729"}, "pmid35624480": {"doc_hash": "fd01bd87ec4d57f67ec56d89c5fc597f6e1c87ab21c13ba5a35d3bbb9d21c2eb"}, "resistin": {"doc_hash": "086a4d04b486e19702b2a80e40b2f4691087c1aded968a67cca5b7ffe3101445"}, "obesity": {"doc_hash": "12a4c059d1abc978c4224abca513538636ce5970d6572302444400b5368769e7"}, "diabetic mci": {"doc_hash": "e2b07b4b6ac7a88b6ababac543b2267eee47e71a1618e9d9d8e45c0028672ecd"}, "hyperlipidemia": {"doc_hash": "e02c9bcc2c7d18219f9048d7ae3fac39c0d6a0f955117e79128842f9f28e65d9"}, "type 2 diabetes mellitus": {"doc_hash": "869a3622486614a5d5313fad8259ecc742567ba55da261e335d543e4e1d69dd0"}, "metabolic abnormalities": {"doc_hash": "1c384434f16f99e96be8c91f71ab8356aab833275c781c4bed7c173841f716d6"}, "pmid32333593": {"doc_hash": "4dec003ce697d86607b60141e324ab37514588cc025d20b2a75b52f12c0d6e3a"}, "aripiprazole": {"doc_hash": "750eb4fb287b7de0db599eb2378d04d81734dc939f3fcaebb73270aff1ef08ef"}, "quetiapine": {"doc_hash": "24bbe9b1ed3dc03a1db6e6343cb8e2f78d4058739ad1901dc33cd852cea315fb"}, "extrapyramidal symptoms": {"doc_hash": "356addcc9f8925586e8ae066c24642e3065fc0c3f39fb64f82f27d1f622c9d12"}, "sertindole": {"doc_hash": "9f59c12e6f0f6a5ba190fb56e14556bae262bede1fba9545d6a836023d2395c6"}, "clozapine": {"doc_hash": "f8e4bbabab2a6a0af5b270bc1e4f450e91b480c99fc15a181ea1c71ff7033506"}, "risperidone": {"doc_hash": "37ae0e7de13528ecccbe7f114f51b0baa108386535509adf1775b9ffd86e7e9c"}, "haloperidol": {"doc_hash": "d668e92e30460c3a7d17880eacc4241153af34b364c6d6ce07cf39c8c4bd9b90"}, "zotepine": {"doc_hash": "2e5eb81d2881baeb39ed0ac4753a792cfe4404d842bee8050f382e72d680be19"}, "olanzapine": {"doc_hash": "96fc43c6763ff036abcaab4d5e59500a0a93530a5de7f543d63a3fc4f9c528e6"}, "atypical antipsychotics": {"doc_hash": "64d92df0c9fd4eb3aee6cd5ed910d2e60566f039b3d5a101fc8784bf8a4a24e4"}, "asenapine": {"doc_hash": "3c29532054d77e053d6c8dc88156053e84e0a0722dd54b32b41c8a80a531b4ab"}, "paliperidone": {"doc_hash": "143010c29ff7ac938b1dc255a861ccad5b703671eb4b9f92395a6d6577c9c7a3"}, "lurasidone": {"doc_hash": "dc3006ce703a814809f6ba4b08618652f8e5cf325d7f7ff907454efbea8ad7fe"}, "amisulpiride": {"doc_hash": "389eb53fe8566f3ff89a0157dd440de853b75a74c53877c61a2006c8d588cd1a"}, "pmid30181002": {"doc_hash": "1701f9f287b2c630c97a9a31c497dfdf2466c4622ecf488619918fcd625d1728"}, "ziprasidone": {"doc_hash": "7323b47499811f175889b34bbdde9ac3c268ef064900dc0eb2074cfbcd202a32"}, "perospirone": {"doc_hash": "f7f9fd116ec2fdd2b1b6a22eb35a8b6f3f3ea7734ef38b1d9ed3ad14612cebf9"}, "iloperidone": {"doc_hash": "bd079c9c1a0ddfc948e63a7a89bbc5076b7fa06161000394dc8f8c6ec270a205"}, "abeta1 42": {"doc_hash": "4f2eebdb2dfd44e43aa573fc1ef29bb3be2aed00eef56d7c1060dbfe95eb3e23"}, "dentate gyrus": {"doc_hash": "1f524f99abc43b7c8c90e7313691b47eb50cefe7c8dfeb02c853320e47af3c90"}, "app": {"doc_hash": "f3793590504d66a3d0c1c6de6f635961d3b2cc1ca7fc5756d7bba41a30ec2f2f"}, "abeta1 40": {"doc_hash": "59468e018a2650ea145e33eec83e984f05dff543fa20bb438449011b54a44a9c"}, "doublecortin": {"doc_hash": "2acd7ab254cf84b09d8405174451e07c1a65f7460b1c2498c16fed0ba58b9d8f"}, "neurogenesis": {"doc_hash": "75435b4ad7f09dbd15c4e14c91173336a1635c963f1498e7940661e7a7f940b2"}, "pmid19219917": {"doc_hash": "07e61e81cd14551d37a24f1ae21710b81ccaf060b749f410f7baebfe4f5d2c2a"}, "brain disorders": {"doc_hash": "7a1a39d45aad813afd48ed28c26f347942438fa50796ae35e961eaeef02dd283"}, "cardiovascular and metabolic disorders": {"doc_hash": "a2dad763bace9983593aec363c7bdf5873977366b954600427d243aec7882dae"}, "brain damage": {"doc_hash": "ec078301dbe73a5c84cd4c523ceb922da117f2aabf29b1799f127cc6f2827d6a"}, "pmid28711402": {"doc_hash": "8a97f6921d49e76715a890aeff98ae678560ba546bdeca3a2025f4e4223a3192"}, "cd44": {"doc_hash": "1fcdafffa6e76efc806f64a51946741cb5cb7d63c0bd2fa35d38be09a8d8a8fd"}, "melanoma": {"doc_hash": "95221d6272932ab6608aa610e8a6378786301c06e7241165b351113891d989c6"}, "fgf2": {"doc_hash": "4708513b367fdf9a9be130876042f8ffa501e3ef55598adbb18f620a7e71c689"}, "spp1": {"doc_hash": "cdd43348c40013db43e153aab0de05da67e0f87caf2fdde40ee03cc3e68ecbf1"}, "amyloid plaques": {"doc_hash": "6f72ef2077e30691035de32fabab39d01ee637950a1dbb879cd3d3783a3f7862"}, "pmid37838728": {"doc_hash": "21edf5d72f65327ed7944b999a9e1fff6cecbab781c2abedfe599551dc951489"}, "ptprc": {"doc_hash": "3dc5c3b7ae44480ae0046f143889d66d986a71194185ca7d04ed278d78d2da63"}, "b2m": {"doc_hash": "3f522a257e138951bce09e331fe177401b795bcc90fed03813973584495dd54e"}, "pmid31640836": {"doc_hash": "99be1d2858d2670c3902998333d408034fc8c35f814f2dc2f47a7361eb84f3a3"}, "malnutrition": {"doc_hash": "327f40589911346ff946b73365a5b392486a77156e13246634fd39d2ff5cc028"}, "pmid25565783": {"doc_hash": "41a9b3534346f96fb6658b4f32c2561d5c9b8d72e97c0dc0fd50ff5e108c07bc"}, "postoperative complications": {"doc_hash": "5c0115bf5a8dc947ca00da54d2124e995405a3d2a3149f8eb9cc69fe2ca725a2"}, "geriatric syndromes": {"doc_hash": "b9adf56fee6be4f1a6987aa2a6c5fafed3f2c6be7f75cd8296f39639561725b9"}, "indole": {"doc_hash": "0c2a9d482d224f66a1729f10eba30e9168d85ee6bb8e4e32714e21eeac5f1ac1"}, "amantadine": {"doc_hash": "7c64e4999496093184283bf973db4b38c56d589584ee90170f8b5153805de79a"}, "neurological disorders": {"doc_hash": "2ebbde80cd44798e85e2ca75641a0eec16ac75f9909933096e3f068c0068be1c"}, "nitric oxide": {"doc_hash": "f056f7045089533fe9003ee4375928ef8ab7fcd2bc8ae31acdb7f5f76ce535c6"}, "polycyclic compounds": {"doc_hash": "e2f6e3c3e7735447d9a753a714118b90e34b0d121e27e9b093277be12a9b9e8b"}, "aminoguanidine": {"doc_hash": "231dce63f33f44f1f7421017153fe6ceee459f9b2afcd692adcd050a5b06c0b8"}, "7 nitroindazole": {"doc_hash": "c55b4cb2f75071a4e375ad661fe6faa5511de917988d7db547c671e6083aa885"}, "nitric oxide synthase": {"doc_hash": "d43a9e1eced0c361195cd45f1838bb346aa7818bea2cf92714a7e2a5a9738ac4"}, "indazole": {"doc_hash": "6735ca8df91b73861ca68f6568bf638ca5ba7a435707a7d758cf09aa023c7b7c"}, "l arginine": {"doc_hash": "c7a1ed04f8e01e836b700d656c658e5f32c0beaaaa238d3c94ede5ce28eae482"}, "polycyclic": {"doc_hash": "dfca09f37c11b86e5da82bb4c6fbe6990428e42c25d6825dfdbde6152c0ffe45"}, "parkinson's and alzheimer's disease": {"doc_hash": "4dad7e7b086bfc0bc3b28148f7fa1bc2e4449a8ca6abe6ea875fb3c8203970d8"}, "pmid18805011": {"doc_hash": "d0250815aa497dde3c5fbfdd3ac9e5f246110d054660b8ca78cd6cbb09bfabd3"}, "otx2": {"doc_hash": "f294110dcbfb83f710787839736741dff47deb794c1c256d53931f527c87ff5a"}, "visual cortex": {"doc_hash": "c98c33d829cd46a3a136c2e98984cf63f278815746cdf82449ef8baa11b621f7"}, "cortical plasticity": {"doc_hash": "f3566f747066e43da7e1d58ea30d5d7d45bb803d41408977e0d0238a41bd77b4"}, "parvalbumin": {"doc_hash": "b5502ba51c94413740fd91657e0f76e26d6678bfbd2f28a865b5dc308977046e"}, "pnn": {"doc_hash": "d5b551f8a4b85ca1436eda2020c13319427175c7eeb1af0793bfa196af5e4aa1"}, "sugars": {"doc_hash": "9ecbb4ba93b4e8ea0c7dadfa95f97900171dde95a3498e77007179dfc547d43b"}, "glycosaminoglycan": {"doc_hash": "138817fb81dada4b11cb5243b598a5402dbe3581b47ac470dae6defafcec0366"}, "pmid26881132": {"doc_hash": "3be1ea5535fa35545f63c433b11c2b2adbd2e1e960ce2bd6707a5a2fa2e3f273"}, "gray matter loss": {"doc_hash": "69ec974277bc080d1a9970c1295393f3795257881922e93bef51092dfdd91ce2"}, "pmid15925102": {"doc_hash": "8b59c9c7aa49b6195146b9b21589559861051e2192699c379b3c9be09978aa4b"}, "pmid17170524": {"doc_hash": "15cac4e841a8c02335ba8a64a9592f8844dc8d800a12de2c82b28b17cb83fec2"}, "hypothermia": {"doc_hash": "df876079b62d9d73804081783e0fcd4c8d52a83729f8ef3f73e29135da8ce227"}, "seizures": {"doc_hash": "4b6fa88ed5e5661d0c4691d812348ad9dcfa054f707335f37d408d45d560b320"}, "congestive heart failure": {"doc_hash": "3e3af30a07d353967557f5c6281374b9a5ee59f51887d763c9260ad3d172d1c5"}, "sodium": {"doc_hash": "c23f787d0ef1ca6155ab48d1beb5ebbec89d76d88cfdb1fffae2938fc367ef04"}, "hyponatremia": {"doc_hash": "e9b4b433053ab1422f1b91fcdc989f9b2271c3fe314f6b4952a4797121302795"}, "lethargy": {"doc_hash": "acf60c58892cfd8927d1709d440eb08fcc71a4123d47f750a8c97b88f9cdbdf6"}, "anorexia": {"doc_hash": "862faeb3a3d790fd720f8aa4635ccbb679ab6e457133d484a47210c7e9003a6a"}, "water": {"doc_hash": "654ed6bf8f08aee52018a6c64ab4713f499f064e92fdd0f613bc0f514f3f2106"}, "premature death": {"doc_hash": "ea61526718c54df30ddaa12ed542a442c428208c62355718da0e2f63ba9afd81"}, "movement disorders": {"doc_hash": "d628cdcbb27aeb66ea6d48029ad287d89db2ee73e560d561eefe9e6cf373f7e6"}, "dnj 14": {"doc_hash": "08cc60e58dfd5eefa42fd9e90e2aa619d2cfdabf818b7c805d723bc65a07e47a"}, "pmid26395859": {"doc_hash": "d9ef897e305dc596ae9f35cbaedbfb5794c56478e912db0f6811e783f885ba55"}, "neurodegenerative phenotypes": {"doc_hash": "b74b0056ae9d18dc8ea95a50b21971f6a71fe78218d4f19a62b97cc0a299810d"}, "neuronal ceroid lipofuscinosis": {"doc_hash": "d57e3466bb6ca2b949af7b1d9f303413d4229f603c4e6fd8553eb5937034ec5d"}, "dnajc5": {"doc_hash": "c68e8ead077b8669476b79835ec688a024ae57ab05db2767cfb7294bddf1ff8a"}, "pmid38274839": {"doc_hash": "c2ce2dbadfc65e7b475b995ac1e22881c9c4e6199938865a3fd1daa6925659d2"}, "elder abuse": {"doc_hash": "d050d86d22818a3f61f9332dc2785493fa8186d3c3729b8f53c5b1256e6cebc9"}, "erk": {"doc_hash": "45f1d590b60aecce1d266d310448b26a70dcc695b40f309ccd8af9ec3a15fa79"}, "axonal degeneration": {"doc_hash": "597427eb5cf2319cd85c2741710593281b7190ed337eeddde2152ce6e506bb71"}, "sod1": {"doc_hash": "8079b05d09caef99c8f7a71cf04b37a8fe2edbab674ef544ffd539eafb587e58"}, "huntington disease": {"doc_hash": "e87584ca3b57ce83ae315f7dea7ec956726b254aae1a1ab86538d6b5903e5d41"}, "pridopidine": {"doc_hash": "22c0448237212a2d4a00cc1e19653311c1936feb79604371b2efbc669aeb89f3"}, "muscle wasting": {"doc_hash": "f5ee093993cc25c6b7af528e758400491709e2e9071990fc89ba63d95bc47b9a"}, "sigma 1 receptor": {"doc_hash": "1c17136058240bdfa08bebfae843a00f0c3c5963ceb64c83c1a058c2d967edb5"}, "neurodegenerative disease": {"doc_hash": "61c5ea4b327ac88b9aec8ed15ccdac1a91566c81246819dbb8cf23a1c8b3610d"}, "at deficits": {"doc_hash": "8111329932a3babd3f3331c4972db9996565bb114c54acfe65573a38402a0398"}, "pmid30824685": {"doc_hash": "37b34dad4f388e21fbde68905ad8eddb33660da9ec71828a7faa93409ae2a049"}, "alzheimer's": {"doc_hash": "cfc8972992c97ef8cb01333a02c4ec92d0e6e5bf460bcd905104f2996204884c"}, "alpha synuclein": {"doc_hash": "2edea65b8196474d50d7bd67b0f3cb5556cb52e2f19ef0f9bce2895ca70f8a54"}, "multiple system atrophy": {"doc_hash": "a5af377e5033825ed37dbdb9a128436e5c91cda1948a5bd80b3585f061bd75dc"}, "cerebral amyloid angiopathy": {"doc_hash": "0230a67b318c6d99fa138671bfaf1fd4f0571474f54c477d5ffb9ca99f861ce8"}, "cerebrovascular disease": {"doc_hash": "5c10c3df9c3d8df0d093e0d017d1d366b794b9e53de5b8adfd09743602701885"}, "neuronal loss": {"doc_hash": "ff2a424660cf3dc377a6ec6497c087310f7596a7ac943b336dd2849959915278"}, "pmid24752994": {"doc_hash": "c59eb7223b86661bd905b61935f86835ffcc0974c2009f0c76301f66df02d090"}, "neuronal death": {"doc_hash": "c42f5a5e091b6791dde84c2c7c6a4bd48e73bfa04d50592a896d70cbc6df3368"}, "glutamate cytotoxicity": {"doc_hash": "6028d77e37e9425afcc2ead4d2741208b0e943c9710113bc9a3aff27d65bd76b"}, "reactive nitrogen species": {"doc_hash": "a883b6edf1ef7fa2c2f21b21e9f286230f6e05ab2a5bd71ebb7cdd3d94b79f34"}, "flavonoid": {"doc_hash": "25b3e106dfe6006800181521b746722a44459b47c70d00fee64709c145b711d3"}, "quercetin": {"doc_hash": "53b6cf17e3ce5257f48c509cd23c7ae6d215d6e07719e4f18fa9df21984ddba3"}, "infarction": {"doc_hash": "b9894f5a1abc07e1714f2e640e4f22bb126450fe319940ca399f885be1eab68b"}, "trauma": {"doc_hash": "e919ae319fded6b2161794253486272991648638c06dc3a1fde816e1e86f4bcf"}, "glutamate": {"doc_hash": "a9925f1930a2a440acafcabfbb100c4afc59651f7452433496e9df46d0ba0fd4"}, "ischemic stroke": {"doc_hash": "6b23b096a998221403cff1ec904c2cba6e84d38d6ad38d34c4fa00e03e9e4f71"}, "pmid36364448": {"doc_hash": "e84647723b215ce2c5d813d1d0e01ce9b11eb0cb2ca57a6b776c5a924221cbd4"}, "spinocerebellar ataxia type 3": {"doc_hash": "ee05723cb45b8773982ec677124ad2c31f494d45c3bf62310232aabd48cc8f56"}, "ataxia": {"doc_hash": "4d80ff9997aceeb0a20d882946b69f93e1d397ab0b8cb2da464a5c45c6c20124"}, "movement disorder": {"doc_hash": "27aad22aa50d8f773997dfe4034fa9abbfd9f711ae352b71f92c6aed4e8fd986"}, "cytosine adenine guanine (cag)": {"doc_hash": "4ce5ff92ef27af76b173946be4c0fbd8b27ee33b40d6f15d9eb1828bb81492cc"}, "pmid35478700": {"doc_hash": "7581d2bc06fc2f885722e98c8c5ff9a6cca2aa436bda14cfeda7d4fe57e02da2"}, "motion": {"doc_hash": "ed21f6430aa298392e6893ac3a99fffbee8e881de9ba3f66aef4969f39cb5e0c"}, "pmid31057348": {"doc_hash": "4f18d7bac19f57ddef5cdec9006ce4b90c880296e0d91b5bcf56c183ee7636f4"}, "oxygen": {"doc_hash": "6389324a65a90c2a24e18a5857dc72229377615a999fb9f99fc6d1a3f8556fa1"}, "hypertension": {"doc_hash": "18a8ff55d7f893d0a872eae5876ffe9cc6a2725ce8e7da2d2005b18a253efb63"}, "death": {"doc_hash": "c2afef51e7b3712523de1538af3d86f4e5b9e6740c4bba78e9d509b524927508"}, "malignant neoplasm": {"doc_hash": "128bb55d3012b9bc09447f507b3ead760a88ce5fddb6cf7bedb87cc8c60591bb"}, "anaemia": {"doc_hash": "2279b80a6b1ce52201e8913c3bfcccf140738bd6e8ffaaf139eeb7d113f94714"}, "pmid28947447": {"doc_hash": "1fb6fb1438eccfb26add1ac11aac3ec06727eaee8e4c82310243335d8b4e6740"}, "amnestic": {"doc_hash": "9e72c429b40550539ca77c504e0b22d7e9bd1931f0f1b78299fa300ebf85c45d"}, "cortical atrophy": {"doc_hash": "36e84eacfa334552c536be6159ec3b5542985776c8cb14129629335d213583a2"}, "visuospatial impairments": {"doc_hash": "38692b29e14254021f458632e6f10619a532a44bdb0efd12058a45823572e80a"}, "deficits in executive control and episodic memory": {"doc_hash": "82716647ee92fe714d5c70566978fc264a173b9c63b1fe82457cac0db9795d80"}, "primary progressive aphasia": {"doc_hash": "e24412db86f9e65ccfe240970a8b9707dc5d05136a9f71ded05f6b12bfac9ab2"}, "cognitive impairments": {"doc_hash": "4a8818fd9a7b13ec77dcfd5b3bbfb5ccb339131f37be9b5d654c888e122b2b8d"}, "pmid25180158": {"doc_hash": "b488b04c9f669ed7645c8221a57895027a60bcc97031ddb9525dd00861e8208d"}, "charles bonnet syndrome": {"doc_hash": "6e1090109820298f54e727c2995f090861d111db290e5fae9a0c7ea20b7abe03"}, "pmid24379505": {"doc_hash": "1eb081ceacd7d12af72859b00d65eb0d99081f852a11c56ada79b6aab49ee9ef"}, "nicotinic acetylcholine receptors": {"doc_hash": "2014688eb5a9ac4c11ca939a2478bb2b62ab47d6c945ace63f5d7e8f63373f29"}, "alzheimer's diseases": {"doc_hash": "9982ea0999958aa934e4584ec5707de8b2e630db078efa01619353ad6bcb4b7e"}, "hippocampus": {"doc_hash": "21daa26bfa2f41180c656d21ed9f6b3f8ffeb3fb1c6e32f512e730c10562da51"}, "synaptic plasticity": {"doc_hash": "59e6d5bbc04ba76a0c5f05ac82f1bb520db1519a75f17e09f6b012f1ceae8cce"}, "cognitive deficits": {"doc_hash": "d1da033c3b55dff723839160366f49edc8330bd78543e2dba81daa733416b015"}, "pmid11498056": {"doc_hash": "02b4dcacdb6e8d0a9fe15605e42612bfa2f72a45bcd63e0e1f1f8114db4f9c11"}, "amyloid precursor protein": {"doc_hash": "13dff79f4195579a6fbc3d334b4544a4cf21f06de033aaf947b5644346d68fda"}, "vegf": {"doc_hash": "2ae11a4f408f7e996c0befad6c423557688f742b2ec1628a5f4e273ca65586dc"}, "lps": {"doc_hash": "cefc5779ae87ed2deafd6f1c1b728626c45883f491dd278594be3da1fbdacb19"}, "cerebrovascular abnormalities": {"doc_hash": "35ee3ba0d7e1011d1d18e4e6843ad61ecc990d273c7b4f0ff155cf06de41a561"}, "pmid23684689": {"doc_hash": "386138a64bc8b4a868a24d33f735ccc73bedcefceb1584712b253efc0c67240d"}, "sleep disruption": {"doc_hash": "45dd4e9f800f1677f83f450fb06d937cb7d15fd534ad6f407581134d2a56f600"}, "pmid39982143": {"doc_hash": "48fad88e29c489c90c9d0b1ab09ff2c92fbace9e3bff3af0f84d5f000afc077f"}, "critically ill": {"doc_hash": "5f8652933d93e0411910d920bc883c055e6fca5958c30f9aab275f1b24be5c09"}, "agitation": {"doc_hash": "90674fe319c1fd2c0a6939392802a6e2c6406f4b0c602d5845371ea1c1c091e1"}, "propofol": {"doc_hash": "8f49a740f024b94ba9b133669ca07b88cdb5257dd42bed84f0fc9c503d97b70c"}, "melatonin": {"doc_hash": "90bba29af8c57d34b37e7298088164118760cb43e72f3eefdd4c4540cdb87283"}, "anxiety": {"doc_hash": "03a35a250b4f75c291ca66d0444a53824c0c28b7a1e50cd1f8322e8fa606d738"}, "dexmedetomidine": {"doc_hash": "1cc9aae8442ebb80a99fa01cb93bf6d1d7d2a3097b20af616c975cb95c8200af"}, "pmid27169811": {"doc_hash": "f51b5c60e4d4dc6b364738990f7d298d661ec0ee96808d4cb571c7568246ff4f"}, "lung, liver, and central nervous system (cns) dysfunction": {"doc_hash": "408e0a9beecb9571dd2061a77f4aec02d54515c73d087a4e107d165fa1ba3d09"}, "pmid37175808": {"doc_hash": "bb99c0025093cda7a1d076ac91d438d5fda95174cea07f102cbade3026977922"}, "il 6": {"doc_hash": "1fff2639be8cbb6c4f6f99c3ea252bef748efb8dba03791c3d77d64a1a40754a"}, "multiorgan dysfunction": {"doc_hash": "04ffc64766d7e4bcf4b1985deb34b2cfd28f86d36f10a6448a3a1558e9e1456f"}, "pmid18300070": {"doc_hash": "73a6b698480b00bf7bb6b71a4075e108554cb67d5b67ef1fbf03332756267741"}, "down syndrome": {"doc_hash": "bce561a452941a428529ee9841575d581860e89ffe52e09f6544757bde22be79"}, "a beta": {"doc_hash": "4fc020f43d199411cc5de9adafeb5955f4cf731f63e2ac91a59f8ffe328ce466"}, "odc1": {"doc_hash": "093a0c5133c0741022130111e91f901d0cee8b9cc292cfe91603e2fc07e343ea"}, "ask1": {"doc_hash": "995890f06f6d2875fac6ecc2422bd74c89845aa8d8d70823b1cc228d10fd18b9"}, "mir 181": {"doc_hash": "3ffc679c280001919db46cb1fdf92d69b419cec633c159bdbf916e6d291ca927"}, "nuf2": {"doc_hash": "f61b7cbd5e2928d0b3ccf014e169d387ba91c588a7687db58519cda0d9c37bb0"}, "mir 708": {"doc_hash": "8e11e8f73ae62aa84c03fd73dda97386420a9f347d14b8cf3e7484e196d411f7"}, "pmid35729466": {"doc_hash": "b948d17eff49a4c5238f7786554a9a2f3c2e1a2de70af491beda57ee1fd95a49"}, "headache": {"doc_hash": "79c5445f39337583048ca82aa10801aa51232bd5882bd4aea0cc3bc98405e7f6"}, "spermidine": {"doc_hash": "3faa29b897fb4e7c9660dad6645a9ab2d5b4f4761e020157dc8c41974d8f8a95"}, "migraine": {"doc_hash": "6f0408481a505a453694152fd3c984a7e1fb9d7dee28e50dfb511ed2aaa9f726"}, "aconitate": {"doc_hash": "c0ebe529b270b9d9aa249602552d4d92ddd357594536eec19cae9678751c52b1"}, "methionine sulfoxide": {"doc_hash": "f992e9252a9df01b1731f491f0cd773622cfe2632d0375159dbb37e15b7a2db4"}, "spermine": {"doc_hash": "7c68f5758e2513fa350ef13406e3f724bc02f52679c4ea2a2e69583452bdf889"}, "succinate": {"doc_hash": "88957263702b14d26d063f30135190009b50d9d2441f66a6b67ad8b42cd6bc73"}, "pmid34615455": {"doc_hash": "4e42160a2ead71dabe49f4e5ac9cb31869c40520ea63fa72e1e012bcf1f54765"}, "psychotic": {"doc_hash": "e9ddd5bae1b4a55c5896749f143a18a4c81490d70a34cc582357d8eea20bea24"}, "pmid8415899": {"doc_hash": "6100a0444a06cf4f1ef29bdc21b7f44fd02edc674b43a7b0bbe1ab93af575d1b"}, "clomipramine": {"doc_hash": "f8ebae39c593811bf1a427ee95d7476bc83c3da27cfa4e669696644d4c23e1b1"}, "neurological adr": {"doc_hash": "28d179e1f3ae68c18a0c97595342efb1f734993be8f8853bd4d5bc9eb79f274c"}, "perazine": {"doc_hash": "8a2e72533134059a56f2ea952f617cbb16781428ab307d607ac632955d56689e"}, "lithium salts": {"doc_hash": "acc9ae36706cbb6380c5b6ea1c052045daae5c2443bb5f4754e93fb27762125f"}, "amitriptyline": {"doc_hash": "06fb61e9aca105d9422ba0e679277f2d4cbb9df7acef01cbbc40140565913ea4"}, "psychiatric": {"doc_hash": "cc36e123b32e64286114a156487b5303f30863a742ce83113dda12d37344c984"}, "psychic adr": {"doc_hash": "d9e6eee186c93b73cbf63da27c3c1bc31e6a72bf1a970a5140ce1731f474596e"}, "skin problems": {"doc_hash": "3ff461fd057d1be690ef50b2d5d4b1a64a5bfa0b30173f221a25be1072820011"}, "edema": {"doc_hash": "44e9ed0270464bcb03ea74a71f1ea9b4441f49a946ccf91de0420c227bae7125"}, "rash": {"doc_hash": "dbccbdd69c7c6d1d478cf7ba4342df427d1a2c7cbc8ee16db00d0d7343e404d9"}, "vascular dementia": {"doc_hash": "90a60681aace78cd9dc50c0ba7e1d5f781042778b87043936c0024170d9bf002"}, "pmid30741762": {"doc_hash": "136d81b68937774400ee76d13ee7899bc55961e5502961e077457f7a631eea69"}, "fever": {"doc_hash": "b1f8b038a5d7e0f587498f428c59bd9ca8ebdbad8ee3d2a78dd569280bb1dcc0"}, "autism spectrum disorder": {"doc_hash": "3cfebeb5fb74f53ac8b3bd1fc3a6e6a0fbcf5d477015a01099d874673bd3c0b2"}, "brain's genetic disorders": {"doc_hash": "1584b2b7cbe79247316a1509503311d9810ab9bc41f4089868c9f244bf1b87b0"}, "brain cancer": {"doc_hash": "2109594f9fd60a529ac9796124936c970ea645ca7d2745691c17e7e25c64125c"}, "pmid34616886": {"doc_hash": "8cfad6068d50d0fbb92e16a9340edf9681dcaf2f1cbca1f5ac6c7aecf95fc03e"}, "pmid35129499": {"doc_hash": "4432780ed54cb6216a5ae5fb8c36d419f09dc31e350673bac4bcbe969e1cf0e4"}, "pmid39704609": {"doc_hash": "0c4a62f166282a071dad138e3b1b3913985230a04450d966036da3fe58368515"}, "tumorigenesis": {"doc_hash": "6a325a4426a6b2c7f2d0cd643bd0c76fb7e334ea07b6875a4f9693aab4d9813f"}, "pmid34542930": {"doc_hash": "894c3cf078da3ee12c25309052df2efe06891e7d3a9317a0027765124096a23a"}, "early negative postoperative behavior": {"doc_hash": "fd4709399758ac4de15afff165877e635331e8b307fa8b7dea7bacdc8b03f2ee"}, "fentanyl": {"doc_hash": "a4dbb749e432792d9e3ce3d259cae7efba4eb900e467db9e157352ed805a592b"}, "clonidine": {"doc_hash": "1bdcd17eae705741244c80acb2538773863f38541fe8cc8a824600a0313ec4d2"}, "emergence agitation": {"doc_hash": "6ae50cba58b106601f06d7e6961522f6c4d401a5a80fd48d2acf728f1d41fac7"}, "vomited": {"doc_hash": "ff26f0500834d545e572600c65ad35a72980e42cba90b5a16ff2ec2d5d3053f1"}, "sevoflurane": {"doc_hash": "1633633fcdab3a986fd6cb100c23321d2a9a0fd8f93b9083f775ea93ad183c26"}, "pmid24666767": {"doc_hash": "b64b8ffbef23168014c68ad827e62e564c488f13df1818a86df861b3228ea2ab"}, "ganser syndrome": {"doc_hash": "b6f7d8a32615df6a7527fa77d84c01ab2ec3737eb977589c3ad07e0799f50289"}, "psychiatric conditions": {"doc_hash": "03111bdca69e0b4725ce648cdc75166902fdb3128d46291b682bd319ae9fb533"}, "disorganized psychosis": {"doc_hash": "0dc2b15baca6c27e0aebee2d33f6cfb1fd9dfc93d752fccfb60077d64a864b66"}, "psychosis": {"doc_hash": "31c2fabd087370d29b2bbdb4524134a0e236c418ecd963b57a28a3d8f3ebf6a1"}, "hyperkinetic": {"doc_hash": "d6c550881fcd607a757839a0ead8ac324bbac0a9c7e83f1f029ffcffb98b3d78"}, "hypokinetic": {"doc_hash": "84d983907d271550aade3060db97a826bfd0112d8085db188b6721ec7da33c86"}, "delirious mania": {"doc_hash": "58afc0b9b6caeeaf3f97d5d2df033b3d4fdbcd360215f4deaf3b454ace7f151f"}, "pmid34392693": {"doc_hash": "1c2b5cf6e14aa1f3cbf958d6204c9a7cf1d447f6798d01edcf12bad84e90183f"}, "behavioral dysregulation": {"doc_hash": "e66ed6b1c7cab4ab100f91337d1b2a4ca53bd9fe156ddf9cdecedea839f4eeba"}, "catatonia": {"doc_hash": "fc45651beee121410ca8d7a9bd565465e040ebedf94df4f0d2afbdccaf52c9b5"}, "apoe*4": {"doc_hash": "435b4d100897179467472840e52cfda8a8360fcf0752f07c6fc40b7cd96b4225"}, "pmid10081980": {"doc_hash": "203532c78f99e8c9740a687722daa076fa60b5c6efd94fce120a305801cb96c3"}, "n acetylglucosamine": {"doc_hash": "4bebf722cf4fa9bfec883950c3d5311ad80468ef6481309034ca922d1ee4d6f2"}, "diabetic complications": {"doc_hash": "9ac1dc9830776f1678789f38e8b04dd1a02331eec8b63abea41e5b98ef0b098a"}, "udp glcnac": {"doc_hash": "b06b0276aa775526f997f0104a57ef7dff1b69416571706daa72eb6f80cd589d"}, "ogt": {"doc_hash": "e1dffd062f63fb16c27205a0312d8303851bed7d983e857ef0fcf5c5556249a0"}, "udp": {"doc_hash": "3d915d42d0728626dcec609ca257584a851153e24b8486eaca95471fab69487b"}, "udp n acetylglucosamine": {"doc_hash": "28eb6bb43b34f95ba1bbe6d07c53e8f6650b0cf6a6c929cb6a148eb46381e816"}, "pmid21240259": {"doc_hash": "63eb2e6868e8bb8bb751a1fb7ad7450793cbffd4bef165d368d8fc0aab3651e2"}, "weight loss": {"doc_hash": "8c7ddaa84fd1313d4305cba6000c1f65ad69b2be3d0f4d5b4c9116af2dc6bb2a"}, "hypothalamic dysfunction": {"doc_hash": "3aef8da7851cbb1a80d710059ac9a7251bc6a4f2e7b08cdf62b2f5c007e34bfe"}, "cognitive symptoms": {"doc_hash": "a4691155b4c83380a269a3ce663a7986fdb0a115b6587d29b438820f89610ed9"}, "disorders of body weight": {"doc_hash": "1d129eaab42ee815fde52444b19455dc43e93bde834ede14f02b6976245e7c80"}, "memory loss": {"doc_hash": "08260d1108f706bb00f875c3195e8319ce1e7c7e8116ddc99d006defc5afe5a3"}, "pmid30568576": {"doc_hash": "784cf5bc99a63804bc7e41bf753e0c5279dd36ab5e2ae79229062685297bf550"}, "tuberous sclerosis complex": {"doc_hash": "4466b0f4c8186615522f55807ea5201fe4c427b3b2e667833738dbf367aec785"}, "genetic disorder": {"doc_hash": "97f797ce834066deae2a62720bc9f57c216d8e44edaa15904094cda153ac54de"}, "nadph": {"doc_hash": "a6db61d85aef853ea95b801bea1c99e2d8f96da8a879b9b8e3c299ad96d526d8"}, "nadh": {"doc_hash": "a289826b6c9a1366a3194af38e843acc43acc3d7511bb98727fb801e8e341df2"}, "pmid30348864": {"doc_hash": "e6f65bae98e4294c9f524821e907f71efcde0a7d74bcdbbb642e1468ded17b0b"}, "sleep wake cycle problems": {"doc_hash": "367dcb986a58547758c7bb7094db9adf62ac4feba07f28dba304bfcd38a97de7"}, "pmid21273032": {"doc_hash": "8194de8d60cceca700ac210fb5f8143d74052ba054234fb592ba932fd6d6a9bb"}, "pmid34448431": {"doc_hash": "19b2e41ee5675fa92b62e206c35fcbdad71fd4c988f8f61e0100e3fc31c72272"}, "head impact": {"doc_hash": "76fee273e4351398e5a3d5157e50ec478d100a21f1dc494bd545516267047135"}, "american football": {"doc_hash": "c65159dbb082363226529da99a95436ae53e532a23f9e7482f74cc49857440a6"}, "major depressive disorder": {"doc_hash": "6cd3ca750cf4f943922fc8d4ea785bce76704a7b72cffa6a1a88598365614e50"}, "pmid37396804": {"doc_hash": "9815160e190501026e91f68e9f3ee9dc14beb86db1ebd250589c8b73d295f15a"}, "idiopathic tourette syndrome": {"doc_hash": "a7a18b7b047fa190d5beed1dcfdd985b5cddc8e38f7c3c5401df185feffb4aa1"}, "tics": {"doc_hash": "015400f2efb4516c6501f16ed889a27920db59d8a8d5c90463b1d4e0daeb6892"}, "pmid37215485": {"doc_hash": "93338c239cfe9d90ddd524ae52d4b682ff3203f81b0708b518c160ba285d67b3"}, "piperidine": {"doc_hash": "37dfe43fe4191b976273698832316237a7974d3efda4000dc706236aafd3fe56"}, "il 18": {"doc_hash": "6cf76de1b38c1610ddb83dc703c663a6583769806850811865212f5ffbbd6db2"}, "il 1beta": {"doc_hash": "f4e6e405828dbd0fa252abe1c8486df4d2aeb40d6298e2d5e2a165b6ec4d99c7"}, "muckle wells syndrome": {"doc_hash": "052479ae407f3d4b5fab5d457f0b571b707bdab3ab89bc6bd9a11a55a130081f"}, "kn3014": {"doc_hash": "fd57281f63983c6c3cf74d73fa31272fafd74217f1410045129ac6c70801fa0a"}, "cryopyrin associated periodic syndrome": {"doc_hash": "1a5086d374a5339846e61e250fedc16554498e348c4a91daf97b389b5cd2d98d"}, "pmid32782316": {"doc_hash": "14f3676a664627eef74597988128490174b237d8935543182e679515c087240a"}, "sulfur": {"doc_hash": "c13e37f6aca977e287cc8b02df28930ee9b00f52fd2d6a2d97ce85a3f5ff82e1"}, "iron": {"doc_hash": "56950edd76cb850cefe01b9a3aa1dba5e33b3ed2a75d15b49c9382e224aa5d0b"}, "atp": {"doc_hash": "44798f7330d393532680654fb9fb9c27b6ea991a1756a16775cf3e66fc4924c6"}, "pmid20463401": {"doc_hash": "a9f590e86cbd2bc772dc8d2e1275807e18ce4016899ea1795ac199b3acdb4a36"}, "sirt1": {"doc_hash": "11e86dbe122db88b8cb159d5561fe62296009f6affa3d4c9015a6ad254042ea2"}, "hsp27": {"doc_hash": "81fdd63f3a402a5cd97015898dc0d4c2bec21fe7caf4a207dfc2f4fd6ecd332b"}, "nt4/5": {"doc_hash": "9c1c3be3204f289be348179f2170b44ce74e8f120c0038fc9a1955ad2450f17d"}, "multiple sclerosis": {"doc_hash": "5ca557b823bf72e7a7c1815e05a03b40993857d140d8c127a10c1430d2a4473d"}, "hsp70": {"doc_hash": "8c9a80fbee5bd789127ca394539458853828ea4725f75bf5d6e9eb579ecaed54"}, "bdnf": {"doc_hash": "2036f739cdab8b10a54526dfb2ebb0ed71b4bd40558ce3faad8a703f451b452f"}, "pmid38003363": {"doc_hash": "4a64794bcff39a134ef87fee33f92230ae3750a4e703614dc267ce08e93704ee"}, "acute brain failure": {"doc_hash": "086be8be31735133ed7759903d557e55ac4ad02ca2e6e4d766637f587d1fdca5"}, "pmid28587754": {"doc_hash": "caf079686d92c6c3bfeef15a872e44212263e0e4df03145ecc8b589981308358"}, "folate": {"doc_hash": "6350075de2c1f329607a4c6aef534f5e1fb3e9e46d62188490a2e84387053429"}, "vitamin b12": {"doc_hash": "ca9e13419c07a3101ca3786d30efeb791bc8e27adae90df4218de6ba6c657db2"}, "b12": {"doc_hash": "6cc3cc0e1278f5adf38d92b6aa9712a48ca1c3097e1fb47aa4816327239e1cc8"}, "pmid31661337": {"doc_hash": "1b9e6eed558b542d06471dd67393eb098b4aa8244a29a62360c74ef019ddc274"}, "caspase 7": {"doc_hash": "5fbbd636e13886efcd3ce1c2d7b46d1c2a6a2ab9578c56226164d1691bce41b6"}, "amyloid beta peptide (abeta)": {"doc_hash": "b7f665c55f42e6a4d5bace898b15250f7057ab200f1abb0e2fdbd07832ba37b7"}, "neuronal": {"doc_hash": "ba94c1bd6f63ebd6bc10fcc8ab2d8f3ca74c0ffa86f729eeb6f1c3050c26c0b3"}, "caspase 8": {"doc_hash": "800681c45c561677bc70f4b02ca8798c82a3650189689688280a1e946e01793b"}, "caspase 6": {"doc_hash": "c84a64e15fa19b3b2b10c83a26bf69f848e0213cb37b9c198e8e9fa430de8301"}, "caspase 3": {"doc_hash": "4cf04c627109b303988fc3da0628267124f14cc99594275ed4491b7e44f6e8b1"}, "neuronal apoptosis": {"doc_hash": "33a14bfcdc9866e962af3cf4660ac400d3c3488a95be17f311a77f529cf123be"}, "pmid11069945": {"doc_hash": "24103bc214772d02f3f378c1527076d09b3282ccd22f8def33069e9235ddcc2d"}, "stenosis of intracranial arteries": {"doc_hash": "9aadc76c934db6419c31e0f2ddbfa133665ca7987e425ccfa6ed36fb5050a878"}, "pmid38585478": {"doc_hash": "3cd54683c3c1f39e1db0b0a3b9cd203ef84a033cb48f677ceaddfda9fb02679d"}, "moyamoya disease": {"doc_hash": "153a91cf1b8c84a8256aff105ab36522293bdcbe17ab4d4009838e588935a4a4"}, "psychiatric symptoms": {"doc_hash": "4fc7cd8e6400feeac5d6f4684e64739d11fc2ad7d3fdaf621c9494a3151fc09d"}, "high temperature requirement a": {"doc_hash": "27bd750032267b875e638d5d01638a11f6f68ce6ad338c88cdaedf2f1d0c575e"}, "mast cell related disorders": {"doc_hash": "ef25b9b9e3c484fedc030d1c4202e45e760b1c6302b775d14fb0ebe15becd536"}, "lung cancer": {"doc_hash": "b57d767276b0598335b1fa382adef6ad1a39728bcd738215a062406fb5ca509a"}, "htra1, 2 and 3": {"doc_hash": "87d67d7cdeb6751134a8f6f557cca86cf2246c5882b0f94b893a704bd030a1ab"}, "breast cancer": {"doc_hash": "13bfa2971dc39729fcd932ef1836081444591932aeb4db454a8381be2c3ea2c5"}, "allergy": {"doc_hash": "83808bc9cb42ca75653f7ddad7b2b29ffffd82eabcf7c77581ff5e81954be95d"}, "interleukin 12": {"doc_hash": "b68edc0a28f756ac1c21f084171ed1470c3ca43d370f0f84a14c4903e05d2b20"}, "pediatric asthma": {"doc_hash": "8a6bb3f14b1311af2e9677189ed9792387e46a9b5de5cd346779bf4cc7928046"}, "atopy": {"doc_hash": "8ac0a865cde915fe385985635cb9574011f9398dd9b4156fd41dc1eb535cdd99"}, "colon cancer": {"doc_hash": "8e5f505d3ab772494635a1060e016f0db9bb65a12ba64a75c5ea03616e07fe55"}, "allergic rhinitis": {"doc_hash": "79f43e4f2a5e3b96209ffa46e904980f5e0129ddc5734d5f7051fa3390cff09f"}, "acute lymphoblastic leukemia": {"doc_hash": "fa83c77c191cbbce2651874c7cf835c06fcbfc34f38a8681188d83dee34262e7"}, "pmid32560402": {"doc_hash": "fc295db64114a7ed392118cc083644b77913eff20b95ac850c482e2ff4520a16"}, "aqueduct stenosis": {"doc_hash": "c67fb59034ef7d4da0ffa8e7416fe09c1ac619d6533f678ba5ad990ce3df1171"}, "tumours": {"doc_hash": "e3aa8c17d4b2f2490c8b364d70b0251af11160817bd2f83bd5513209da110aaa"}, "post haemorrhagic hydrocephalus": {"doc_hash": "14869e8e2efcc371e6db1c755feffa2248b3c76cef5fdea8ca23f3a770a32290"}, "peri  and intraventricular cysts": {"doc_hash": "06a7e8d67b185ab9d9bdd8881e9ebd982892898f0c211822198e3c121cfb3567"}, "intracranial diseases": {"doc_hash": "6f11ea3994391d7e769c2b250af93d05809df29f770f2ccb835f860a639ee9aa"}, "pmid39669717": {"doc_hash": "0c2068ca100ea2e39e81c8ad5e9f5a70fa799d688f2738b4b76c874a4e6bc7d0"}, "cyst": {"doc_hash": "c69279c0c08abd506032f0dfa286a9e48031ddd968685ebe984e5dfc8b8d037b"}, "pmid31998071": {"doc_hash": "69245038f9599c79a6ceaba2a08a98a3071f3e50d590b8383506c7c86f179d2c"}, "huntington's disease": {"doc_hash": "2f83b726a9572cfe5854807065d55a784c13449096043fe723362b4bda807ef3"}, "huntingtin": {"doc_hash": "86fad1059c507d35a2d3560389adf36d86a6c6d48ab43575f2c075c4a4105442"}, "translocator protein": {"doc_hash": "5b1f5ae5dbf86f659d10951d97b4463fa5cc6aff3be5565a09d80448bee7bc1a"}, "metastases": {"doc_hash": "2a8c07bf5d79831f6033c6ddb2e62aa0e7fd8f00d985499a03b1d38767e65443"}, "brain metastases": {"doc_hash": "302b7f4b57b07fb13c61944821717f49e26e2ddf78a21d75245c2f29e10fa177"}, "pmid35359488": {"doc_hash": "83ea4e57864e2a05e8af6fb65e60a4e80cbd113f06cd4690c055391c70d3f1c9"}, "tau pet binding": {"doc_hash": "9357e4c5a3cb0f72faecf63c2e324f7c1ad7f91dbe236dfef644523ba9eeb1ee"}, "phosphorylated tau181": {"doc_hash": "ab68723ca8077fa29832a736eaaed46ac404fe5ae2a5d2c778fb8d780f47d3ed"}, "apoe epsilon4": {"doc_hash": "8c6a647a727561607bb1dc325a1f57bc2b2e4a59f0d75eca69966a8787c4a926"}, "brain regions": {"doc_hash": "f5f6957489b6343c8145c4e6ca494be4bdd10be67cca26e5440cc1b8618bac1a"}, "pmid35994280": {"doc_hash": "853b8d136833cf8dbca856a3d3bfa259d6a6d46622d0ff2fcf89ab9ec578545b"}, "small vessel disease": {"doc_hash": "fb2155a973eddf5a69a095d37d33d1f3e0e0373230bcfa8c06594eff9f6575c6"}, "white matter hyperintensities": {"doc_hash": "03eb4ab9a010f665556f9cb6fc973506fc342694f0c3ec8b6272cc0aa194a00d"}, "cognitive deterioration": {"doc_hash": "411009d19c0ea9fcedee3ab026de004b4b3ba8eead091d88e94f72230b3bd746"}, "pmid34511497": {"doc_hash": "ff985fea94e4289c6bef15b27747f9e55dc9d944d7524c92bdb6ca45ac35497e"}, "esr1": {"doc_hash": "e6108b542266eeecaf227b51750541fc39ad55df012dd7be28af967d5c87c240"}, "mapk1": {"doc_hash": "f947586a33421404bed846e9fd6f4d3e50b263e526aa340264a32f625adae27b"}, "nicotine": {"doc_hash": "e6e97a5e6df57d238bb6323107c048d7aceb3b71485d18dd23bbe2c5e0c1c261"}, "egfr": {"doc_hash": "770bc384fbed8928f3e223f2a367da9f16d56c9c54538bb1d820daa01d0090ae"}, "abl1": {"doc_hash": "8af43c14590cf452f6d2de03cf414807e248d03fa30cfc89a64de0b5453fa4a6"}, "cuscohygrine": {"doc_hash": "f500e7e61abd0fc3e2c49e382c996717e37d66ebc6e410d823d5dce346cf72a9"}, "anahygrine": {"doc_hash": "eb45d0aed818f5f30e2b1cc0930f73ba8479df4a9c941a16221591a113ae3631"}, "prkcd": {"doc_hash": "8389e5703beb125424b5e4d947833885b2b28a39830ecc778b8199c02ffcf1a5"}, "isopelletierine": {"doc_hash": "22c4bb6c1495b230d3f9184adb2a54aef6ac45fe2cd77891660c8d7e77ca5521"}, "gsk3b": {"doc_hash": "7f3c67d61df0195a189a9ae09742d4a5425bfe90d0929a95cfbc2db5f311b97a"}, "hspa4": {"doc_hash": "83ccff5cbba68a6ce95bc98be521b9f1cb109d8d1a2f5aa1887e8d98b00aeb6b"}, "pmid34278961": {"doc_hash": "fe66c09268bb4c5dcbe27118027dc56aea61ad4e0d8bd2252729ba6a8cedd0b3"}, "cognitive problems": {"doc_hash": "ffbde4a0768872ddd48261033fb8b6e17231d2c46823d7ad55ec42d9065d41e9"}, "mapk3": {"doc_hash": "7b925d27da975989d1b7e64b4a8b3343d4ec3a6a6114a5e0e2ed03b2e8ab12c0"}, "nfat5": {"doc_hash": "cf19090797ac4a9a986f24d07462956556050060f332b1da48c7076a6d413063"}, "strokes": {"doc_hash": "e443878fcc6558082e782891a5c6dd0ab1c0f05572b0b471afaa1c3ee56e77fe"}, "cerebral hypoperfusion": {"doc_hash": "cd5f0bec202db64b56da52e162ca82d190a9de1c5c3b414a856a445bc7cebf2a"}, "pmid39710754": {"doc_hash": "869ef580093691ef5a264d140e77190989752a5899d517deb5e643e07fd17643"}, "kcnj2": {"doc_hash": "10a52179481c47bc72072b67433981e6e5ad166dddea873d4011a7fbc847a828"}, "neurological deficits": {"doc_hash": "5ced0c413ee57fee325d78964f614b6892a2c1dbb9ac2ebf0b0c764f47641d20"}, "post ischemic": {"doc_hash": "41ffbff889a27a9a0ac07daf78f692c93942e7aa86a64a5dece1f333c5bea197"}, "ischemic brain": {"doc_hash": "48b8115749bc5585dbf57703f19ad171bb75fda94ec0b2477bb0637b29a08254"}, "infarct": {"doc_hash": "242de8c8946206e6fb30b3664ffff93e1e5896e1040039f51500ea277ac8ab22"}, "cerebral ischemia": {"doc_hash": "70d8e1d6f4208e876d7d6fb23075212e7f2e5726d24fcb082944da62af434c53"}, "middle cerebral artery occlusion": {"doc_hash": "dec572b476d5d31986ac4fb3ca79e945577a64080fb03d58924219ea87819d3e"}, "brain atrophy": {"doc_hash": "0b6a8b26c459ec99967367256f047b0ae608037a53af6e27f7d4f79f1bb49dd2"}, "kidney hypofunction": {"doc_hash": "2abc243544f995292d444fab697130bcd97289dbfef7fe5d9fc2870fd5f6decf"}, "hypofunction": {"doc_hash": "12eaa335d693269230bd98a4325eb47f7de052d885073cea87db871ce0406169"}, "coldness": {"doc_hash": "de08cbb40a44b45b418c7602ac6ae378010fd7afa5a013e7872bf3ed8a204c8b"}, "frailty": {"doc_hash": "1f6a22748a9df760303eced671849ffa5b0bb4758501ea6ffba35bec44ff7ff6"}, "ketsu": {"doc_hash": "638ddcbe6df9192b2352be91e3522fe98a5942d472d1a4cbbdaa48cd32fd2c9b"}, "locomotor disease": {"doc_hash": "ac27578ff949fa5b73fb522072ce71f6f06b1076d80d897cce8f3a454283e912"}, "hoki": {"doc_hash": "2deaf63d2bcb2398fbdd9f6622a2e6a75826bb0d3586d0d79cd7b412f3a17e71"}, "anti oketsu": {"doc_hash": "a5299d74808e90b47e555ef2af0dddd193c2750ab94f686bb5c690173d89a586"}, "cutaneous dryness": {"doc_hash": "56b270d70946ec66b4efa9fac86812dd269ba726aa879e0de26bcabf0020c935"}, "microcirculation disorder": {"doc_hash": "799baa444401b528a1864c80f402127fc6bd7503bb03f7c1a9457a9776a31e78"}, "pmid29755984": {"doc_hash": "ba6a45f48db6c02f057954d200526b040c750e4898fca7a21c3d520c760d44a2"}, "degenerative disorder": {"doc_hash": "272ee835df7e560e40135b5c140670a3e3a5d5771d0db034bd85a42c1e83f4c6"}, "cognitive & intellectual impairments": {"doc_hash": "352d4c890795143096f47c08355ebe819a4ff74d260eb12ec9c3e6a5149aca1b"}, "pmid35751201": {"doc_hash": "5ddbba4a7b95b11cdb3c9d8aaaa07c235fcd08b39ae6f068ebb915c6ebc04588"}, "frontotemporal dementia": {"doc_hash": "050847a0991afe71754eda3742b7848fccb913808c16edf769d22d88b2a66b6b"}, "affective disorder": {"doc_hash": "599574b74a11cbb7494b6a99ea50d8e9ac2d54e7940fdf77116d83cab5070604"}, "major depression": {"doc_hash": "87e8f5cd8e627bdf63030812c882f4a344baccff76502eb60bf512bdc252ded5"}, "pmid18368677": {"doc_hash": "eef425979bc56d218d7f9c36cf12cb142f6cd8f6578af5beb85cb02e57240bfc"}, "curcumin": {"doc_hash": "11db9cbeb5a3350c445dab2287b27ad706240823bd4bcdf876b5e469a86ffa93"}, "tetrahydrocurcumin": {"doc_hash": "5fc3c65d2f3993fcb36b5e7426017650476ae4417032977f80b24704bd59ddaa"}, "pmid30766658": {"doc_hash": "30be721bb7159f93fe99afbede029dd4b96a16385437bbc632688aa9166c3f06"}, "pmid37452841": {"doc_hash": "8cfde97adc3debee0793c46e914fba0a0059f30cc3753b55e45a585bb4444a9b"}, "glycan": {"doc_hash": "70fc14a1a7b19e891a2fdda1911936987f97f0b9bad860734c11760b4be9e863"}, "epilepsy": {"doc_hash": "5ce7f0427bf5c9edccb7e2b204be59940049e2d2de4d9a363d74161aac13b3ac"}, "n glycan": {"doc_hash": "2971dd6a7eb33223cf3b8f7c71383ed91084acdd283369361fab9ba98900e2d2"}, "fmoc osu": {"doc_hash": "4ad57c8881b8c6b731f4de7e56fb129d49745cc563281f3beeded501ce078f85"}, "mannose": {"doc_hash": "613ad32e4bff41448f0b821049f14303c3d6620d6a4a3efad34ce40b48539a26"}, "periodontal diseases": {"doc_hash": "8e236a9c740146599fd5df1b8029aa1661746a1fe0eff28a4dd96f0733c054db"}, "maresins": {"doc_hash": "660d01e67745d7af32b357018962f7bb01cd15a2a3dc26ee528460d5a21781a8"}, "lipid mediators": {"doc_hash": "8eb842677e18f94269b0aef42a1794fe6498145386fccbcf3ddccd77d7b08055"}, "rheumatoid arthritis": {"doc_hash": "6c3232a102be580e1694541c907e9fe1d64cd27b559d8619ddf35848df46d85e"}, "chronic inflammatory diseases": {"doc_hash": "3b9a98b3243a8257c50c9e949bb2e22344a8dbfe57eb5d3424c63cd1e1daec83"}, "omega 3 fatty acids": {"doc_hash": "29f232510290823fc40b3e27ba2c85dc2e16ed726884e1b2b936341e68bf4eee"}, "pmid37446190": {"doc_hash": "525f2fac12adeda3fb279c0aafacbea04cf875ce878fa048d0811ce9114fc0d5"}, "gi": {"doc_hash": "233bd40c9104947527f23235880af437c430daeca278b73539560485756b4954"}, "hydroxycarboxylic acid receptor 2": {"doc_hash": "0931372b44f751c8ed51a6441f1007a7fddbcb6c393bdc4703283754cc5e224e"}, "mk 6892": {"doc_hash": "f168107d75a05a644ae1cb310d7a1bb285a58ab13d613ef2bce097bbd2dc45a8"}, "niacin": {"doc_hash": "19fc501d22e22c436a405de28454881cab2537bb4ed8714b880c94673cd4b32b"}, "dyslipidemia": {"doc_hash": "1c2f902acb88a6bf7c160b67a88ad4ea8c47c6a7a70610c08e4364503297102a"}, "skin flushing": {"doc_hash": "9ff6db946f43324fe525bb788a5c806860dad946acd8b2a8b283da0c37ca1288"}, "pmid36973264": {"doc_hash": "4b898daa28e1919630e8dcfee4eda089d45174da6a4fe44e1f401493278545a8"}, "neuronal damage": {"doc_hash": "daff57a4935dd29e6c1f3c74af0d33db9244387b7c7038b60e81ae27090db2c0"}, "impaired cognitive function": {"doc_hash": "26f283d61602db280040228d5b0227835059805ba2a8b07b93c074e0552b2c6e"}, "pmid23339742": {"doc_hash": "b2988b30dc674d9ea4b575b7904d759818492ca9c3db2b63189df086a4da5c91"}, "endothelial dysfunction": {"doc_hash": "1e5f6d7b2c27cc7e00f80e33d2582494f4f29c6d50f5c6f906275c7e0075b14e"}, "amyloid beta1 40": {"doc_hash": "a75f8f3902b4b8cfd04622d3eb5f5dfaecacbf3682bf16d6cac5151e3274240a"}, "superoxide": {"doc_hash": "24abc97921884b64a0efc14570797eea986234abcca551ef2d5338afe1cf4dd4"}, "vasoactivity": {"doc_hash": "abe69c651cf127f074757251f0bf574cbd3ccb71389926f4aa508f538f0d53f1"}, "cu/zn superoxide dismutase": {"doc_hash": "dd7f6acfd5cb0182837af9cb977a24fb84e778beb23035d354d17ba8f55b5e91"}, "superoxide radicals": {"doc_hash": "0da317d898cff5af32d8c7f86e9fbece10f0f41b0c0d6113e53b5df66cf68d15"}, "beta amyloid1 40 peptide": {"doc_hash": "a74acabe82ad4cf9657548caf44712e2662c518373181e605f43eaa301135bb8"}, "mn(iii)tetrakis(4 benzoic acid) porphyrin": {"doc_hash": "99ee1a44e82a353524de2f20f25915bd34d6a82da94ed505cc2c8472e04fe261"}, "peroxynitrite": {"doc_hash": "480429088c4a44b9b65a30f213a06b16263995c13c9c95efdac81d3c3ed31f63"}, "nitrotyrosine": {"doc_hash": "b8aeb12f835d3cdf7e7a8055691a7901d2d82908cc66b84a1bc7df35ea24dfdb"}, "pmid9682018": {"doc_hash": "6f9e718d84b1b56669a19c26a7d473467efac8f90bfcfd20a29aa685d134e09a"}, "epileptic seizures": {"doc_hash": "97c6f4e002b3085ca0967c5457d530ecad7ed43ec388e0fbda4a8b90bb1c65e8"}, "disorder of the brain": {"doc_hash": "e8698f4b9aa4f019e388083466d92bb4cf69f2765955bdcd510f3db045aaa602"}, "pmid28149289": {"doc_hash": "c45526a85881173ebd25f860ceec42384250f57902ee6a0e978f0f399fb04aa3"}, "neuropsychiatric symptoms": {"doc_hash": "3cfda018b2b0c24ccf7eaac24a53be8d66e48eb0cd40042681af104d3626013d"}, "pmid35863150": {"doc_hash": "b75497782ab15c4ef86481d8dc006641434884f2f8472a8dbd7e6757140cd1af"}, "alpha lipoic acid": {"doc_hash": "dfb06181d2e2fa39434be42f6d3102d8be53c20d58448bc56c4fae46037e410c"}, "calpain1": {"doc_hash": "be3925fff3dcb88f0470aee0d9ebae2be1c95dc892d6c7512373a847c553806c"}, "tauopathies": {"doc_hash": "66b4bc4253c40dd1ad28756082b0d2c47b11a959ad19cfaffe79e99ca03c475a"}, "iron overload": {"doc_hash": "8853a0b43000cf0d5845d4407e7e0e7ff8268ff3c706e23c6d7597807725e636"}, "pmid29126071": {"doc_hash": "4b91b7c19b0953ed9a896e7bb382e30fcf707db35261cdf0e14727a71af4ceb3"}, "schizophrenia": {"doc_hash": "9eed00eaf99a9000ef89fd9083cc7645bbaad744f1bfa0a999f4b0e831c09505"}, "cns diseases": {"doc_hash": "6b28e06095044ae13cf8862440ba418eeb7ae12ca820590282a95c01361cbc2e"}, "pmid30195932": {"doc_hash": "aaecd1ac8c9118669a95c0674324834b207a3f5735f508297c860fc3bfb26ae9"}, "hematopoietic diseases": {"doc_hash": "0dc4a364e3ecfc3e392a2d89199dc576d523df14461873d1e4d4665dc678e2b2"}, "acute myeloid leukemia": {"doc_hash": "3eaecced0e14d4624de06e680b2854fc10afdda35d5d3915a072b78a3180f21a"}, "transforming growth factor beta1": {"doc_hash": "7f4c7d8110fcf7cf0cd632f020daafa4a484e11796b86dce7cfe84fb092d1d54"}, "pmid37332612": {"doc_hash": "506ceca5b48fb0a9563422303ee013347cf05d49f9101eeccc76b344e7b1461a"}, "neurologic complications": {"doc_hash": "dab685f1e89a43848dadda55a6adf14d16666899b15e9e509f252e752cb05526"}, "pmid35192952": {"doc_hash": "6db82ab79819a8998503b0ec54af387c51efa2c1d310d56a46a6eba02a70f875"}, "infectious disease": {"doc_hash": "7c4e0b9bc07686a550c085cf743cd4b0089f39a6950251e2e66830406629576c"}, "respiratory infections": {"doc_hash": "d43ca9ba831f38e43e9f18461ac3cfdb1611eb983ea7ab6a6107b2946716f830"}, "3 methylhistidine": {"doc_hash": "1248f58d4752daef1353f8ec3145a4be8577f2e3e59169909354c84feaea7f02"}, "phenyl isothiocyanate": {"doc_hash": "48fb0cf5e960f6c3986dd620204d755feae08145d83173cc5f8bcf2b74c44140"}, "balenine": {"doc_hash": "167977fee20bb9577a8edf8fb9a2010d0e9900579f7c6843aec4395a49c81d15"}, "imidazole peptides": {"doc_hash": "ca14a9c3dc733663821f894a7bab03ca412a573f19683fa2fdb6509324e69727"}, "pmid35206066": {"doc_hash": "0a0bb90c06ca0a5ff8be1e8dbca3657dbc51fa27a6e6bd34ac52c328736be3e6"}, "19f": {"doc_hash": "74170a4d72e005d8255721a34af95d16f85cfb09313ef0a5db8bcfba2d85cdfd"}, "1h": {"doc_hash": "51db1565de7b17c915056c8ddf7decb38653f8644efd718aba3be5c1b1481928"}, "pmid37953866": {"doc_hash": "225f7a548216dcbecfbcf67c9b29b6aafffa4c27ae2ee516423f9b579a7f8081"}, "delusions": {"doc_hash": "bfd2812660f7773baa9f106e6b1faa19721a85770122ed10e84d6b557962d6e7"}, "pmid37637517": {"doc_hash": "92ae08903768d0f446426fe380ec8b9d79a81940fe8120c9fc5ad034bd201bbc"}, "bipolar disorder": {"doc_hash": "299693253f90352e4ba5def61b1c9a7a865bd4ddd68fb6f5235b1c30500ce993"}, "neuropsychiatric dysfunction": {"doc_hash": "c0c59806a8b20e687541695930046936a332d24e124b75d553bce342e9aa35ad"}, "disorientation": {"doc_hash": "8c27d7228a9c4fa8e195b7999abafdaaf0b06af70f21a2e9ddc71528fea03558"}, "hypercalcemia": {"doc_hash": "1950849e062ab18f1f4252fa30b0d191473651c4969488a90767e2dcf6fe994a"}, "schizophreniform disorder": {"doc_hash": "d8fcc9bc18db7225298c9335542c1bace7b36ee4855aa89be9dcaaf4e874ed74"}, "zoledronic acid": {"doc_hash": "5420fe89272bd5055e16be4725d000a9fa9a9ef37b4b28b34f87569408b91813"}, "hallucinations": {"doc_hash": "a36ca06d97fbb392d05dd64487b8f7c8874f771418a56ad8058a7502566bd581"}, "cinacalcet": {"doc_hash": "c8f711cf54e6ec0907521a50962c902141a886896fb977e8196e491ea4038d86"}, "primary hyperparathyroidism": {"doc_hash": "5075ddd99577ef186ebb1f57c157d938c6c2a72bb1509b9ab24dcb418dfccc2b"}, "parathyroid hormone": {"doc_hash": "2c8cef72a4501a1f553d1726a59712af60bc5de44635e1a6a469de66623de5b8"}, "pmid31496063": {"doc_hash": "9aa8800174eeea920cff68e303314cf4fba96fdee9e431900d3fcfd093be98bf"}, "coagulation disorders": {"doc_hash": "338b678a8ddede15b3e280eed79747821d7c2148573259ddeb7933856d97cded"}, "organ damage": {"doc_hash": "1b76f5808fbd6ae871cd145a1862a4350c65d4942ccd10d95d1e30bbd5515e06"}, "pmid36002211": {"doc_hash": "b8c39b7088a5ce2364bcfd4cf8a7509ca605009c0fc47aa44a814ed0528879ef"}, "pmid29299599": {"doc_hash": "405ad2993e3bd78a54f382d3348c3c9441d6debb694e5e01ab607e7e3f117859"}, "abeta(1 42)": {"doc_hash": "5136442e06a606b319d802bf33873be57e6736a4e66ed6e0564b9dc12f0c1334"}, "neuritic degeneration": {"doc_hash": "ff1895505c9f399a6207efc82ccab9db88c11f0052597e995617bee9310cc7bd"}, "abeta(1 40)": {"doc_hash": "922e21d4b0ae9650e83f0b1ead0727d9c1c2f6d19cf659b077add0023af7393e"}, "pmid19175671": {"doc_hash": "9dd3766f539c431838464ffa5639567aea8180b6a5e234edd74ec5a739c93665"}, "retrograde and anterograde amnesia": {"doc_hash": "a69292a417675ea6f0849a48c6e28e13b2304899efaaaddd92948be0a0b1e1ea"}, "atrial fibrillation": {"doc_hash": "4e151350e75d835934c98dbfca119784d3bfa549a6e66b7f920ab52a507624b3"}, "postoperative amnesia": {"doc_hash": "6926341485acacff9912d43922d561d9315748e1d364678a741334d7fb203d75"}, "pmid25429367": {"doc_hash": "f05c6b0d637b453a7304c890b80f81ea35962549e91077900362e3401842a163"}, "appetite dysfunction": {"doc_hash": "0133474eda743392cafbcc6cced362adbd63180602b7a5cf83ed540dbc6939fb"}, "cholesterol": {"doc_hash": "4f0d96f2cd1016505d7f94b1cfed22aeb09319d73acedbcad032305f56402867"}, "lipids": {"doc_hash": "7622b8af6a59fe67710c3a5fe222b1b88267fde7338eecdfe94f1390a8762e4f"}, "c reactive protein": {"doc_hash": "5957af113ff6226c9414a75795fca420bfe6d70add09628fb12fcb8b74b5c798"}, "psychiatric and cognitive abnormalities": {"doc_hash": "7f1f4567f494367e2a0693e3b89d01fd8edd94be24f828a3eaf34f5bf23e1196"}, "glucagon": {"doc_hash": "8c4da6d6b90cd322f77af3ebb8ed8f65c18da5c2e7f72c7974c5f0814e66ef62"}, "prolactin": {"doc_hash": "3f90500cc1aa36664b5094328318e7c4412cc7c1d89c9064214168626f4ee33e"}, "involuntary body movements": {"doc_hash": "cc35dc8946aaf8e773190d2e5aa5e097074c6c63e5bccd2fe010e746a6b377c6"}, "growth hormone": {"doc_hash": "b0799a7c1b6ce428b9acbb8e69552369529bba14eee48bf42b183915b333a032"}, "inherited neurodegenerative disorder": {"doc_hash": "1bd2aabe83225b8f6c5f0abc4a0089c1e9e701327db309344cc4645bb4046c56"}, "ldl c": {"doc_hash": "8ad4274f344da07e1df7109e1a4936da6198c606480f77630cb4db0f5fc59a43"}, "pmid25002850": {"doc_hash": "c70b65b4ae000af56bd023f34f793e372efb4593c8fb08b63e93f24ea1b30faa"}, "toxicities": {"doc_hash": "34ae9c641b81d259aafcf67a235855491ec5ab8291282545ee6b10bb96c8f2e5"}, "car t": {"doc_hash": "8ad1f787d5df554fdd377ea7a60ba0bd3bb1e4b357cb966523e2a91b93fb08a1"}, "chimeric antigen receptor": {"doc_hash": "713cf07055ab8d878a85c158118a5d147f79f3a5c3cbe35134306b8d4c53a576"}, "hemophagocytic lymphohistiocytosis": {"doc_hash": "ecba33cb54b1b13a7448e21554fcd1b55a1e8522184fe56fd7d04eee469d41f1"}, "pmid32801727": {"doc_hash": "632982c3fe94d5b9d7362f520484108f641029e6cdeb414898913a4ad86f4a7e"}, "immune dysregulation": {"doc_hash": "2e9b655cdc00a9e11c0c980e1e2dd95774e19f649faac5e3b942434312ab6999"}, "tocilizumab": {"doc_hash": "66d07e4fa9f2bb6b4c74fdb9bc1ae2cb42114e06a6a11589ef358065e1d5343a"}, "cytokine release syndrome": {"doc_hash": "1b7e38df05ff6743b21bbdb064608bae55abde8252712a63b2929253e8835833"}, "macrophage activation syndrome": {"doc_hash": "a69c779c418e39a6a5fdbab5cc01aeb29284ef39d085cca9b2c006c1e2d31314"}, "pmid23716899": {"doc_hash": "3b0b1724b6d7e30bb1ad1928bfff685cb7a9686b1e3afbca0069c049d36b0a98"}, "fluoroquinolones": {"doc_hash": "457fb81db059d4aeb1af803d13e0d6f7563b42643e44bdee3a97a227970ba682"}, "ofloxacin": {"doc_hash": "b6508c4d9dbcb135764bca4480e20ee4673e553d38ac3a3c86c74144019acad7"}, "psychiatric illness": {"doc_hash": "a8733891cbece1b0abf4d99cc8ede1396e75366c54c8094df0cfc374a2220489"}, "pmid25291460": {"doc_hash": "5f31edf4c158bb687feb0406dac2ffecea6f5a5a2d2cbae3c6c2ebdb6dfe7195"}, "tryptophan": {"doc_hash": "0279f3eb46e1c10df5c724a85279f8192286e959d2f0063676be2e2ea7354a6f"}, "pmid38916729": {"doc_hash": "b7933e29e2b2136e2fad4cfcddb5d19ded1cb85c9679affdf89ae93fd9d2b6f2"}, "minutuminolate": {"doc_hash": "9820c0ad3e3af3551aa5d9ad875aadae2488d393a5a8cfe657192188a6f12eb4"}, "umbelliferone": {"doc_hash": "0ec5025388a42ed607bb6e50751a1e6f3dcc2dc90e3eab0f6622cffce99c5469"}, "tumor necrosis factor alpha": {"doc_hash": "58a2565a119a0d815ebf44b5c203be1bf92f74516c7f7062269daecb41c25743"}, "alpha acyloxyenone": {"doc_hash": "82039c4a0bb64b25de6b1ff51eb66e755ae41154bb885ab4af4e7ebcc75cb18b"}, "coumarin": {"doc_hash": "550b147bf6c7f2b0bb19f1708f0de78c8c5330c6a6e753c4cce47f6970c12f66"}, "palladium": {"doc_hash": "8e1fe68d679e0e9c8f0869e0502e520164dd58c5174c32d38a9bdf53ff357eb1"}, "coumarin 3": {"doc_hash": "4b1f5b9fa4d044c1bd72012432ae8081b56255ee2ef816aff1186f01f06a73b4"}, "muralatin i": {"doc_hash": "02da8e60f429a9dd255d1e7377f404048590a922278c4dc457b27f27988440ca"}, "7 methoxy 8 (2 acetoxy 3 methyl 1 oxobut 2 enyl) coumarin": {"doc_hash": "e7819a26c62885bb1d38a383bf84f4f199508179e26ac902d7374c4666e4da37"}, "pmid37970054": {"doc_hash": "e2edcb5cb01942409b2f8242daa58bb4e7144eb4d752cb324b5c19c28ae8d7d6"}, "pmid33799196": {"doc_hash": "9ebb36f09a9e867b745c7d8acdda05f7ddb020aaa826d520295cf218cde76d76"}, "muscle aging": {"doc_hash": "c74f6db83717716084e0b30a7ac21f7ac95d6a23909dc93d44e01013b3d68e55"}, "pmid35328652": {"doc_hash": "8c523cfd575cc0771bde5c390a6139a64a6402ed86b2e00c798ddf09764d3b64"}, "short peptides": {"doc_hash": "772874c722677ccab28f584a811df4f33cebb4f9208cb879c05d065fe1eb7207"}, "balance disorders": {"doc_hash": "865351ed09f1a8f2e6246db87591ae5b685ce94dfa09a02f5be8a2d749d1ff4d"}, "pmid33467522": {"doc_hash": "31c0180e2dcc1e4843e864b5bdafc1ea8fafba8bb2e8bbf0e16bc7e9175db8ec"}, "pmid37173788": {"doc_hash": "3988086bc4dd2b58e1649dae303114cd0aef9b6abf6ec70276a69721338c7c26"}, "postoperative nausea and vomiting": {"doc_hash": "9a73deec0e01d258ddb4a8ce5bf21a87943890bc8f9dd3867a27e3d9e637b694"}, "cardiopulmonary complications": {"doc_hash": "7c5d02e43fbbc753db58847ca6746d74fab5a3e20171377b2c8ec842727e3741"}, "ros pathway": {"doc_hash": "b3e8ad077afd6641a366ce4d233f241993ed89548d0956c1138fb39d73fb7389"}, "ros": {"doc_hash": "7a0545e195b4f5fddba84da596a251809f1cf76e50e4c89277c1a4fa23b7f0b2"}, "neuronal toxicity": {"doc_hash": "feec4f84aa7feab1aa912f9fa42a32e179455cd67df174adc56b70c9932b3b31"}, "neurotoxin damage": {"doc_hash": "69ae8c06708c068f85514babef0de4dfd93830598dbf5ac14f3329af2790d64f"}, "pgk1": {"doc_hash": "be57295768912c3d216c1f65ea4f73dbfadedefa09584bb8a1fc1ce6e1f28ab5"}, "neurite outgrowth": {"doc_hash": "ba35106037dd265d1e8e8a22f275097d17e86b0778a82d83f7f81055e0266b49"}, "pgk1 t378p": {"doc_hash": "2c917823d65230afab4f4abac561524f7dcc4b68441115086ec4631a13df1548"}, "epgk1": {"doc_hash": "cc852034ba9a585a5ae953416a8fd63af7b15d94570d72768d230dd795c3b697"}, "mptp": {"doc_hash": "842519c123a82bd978bf7682709a4e3ec4059dffa9e6affdcb3c22d19330086c"}, "methyl 4 phenyl 1,2,3,6 tetrahydropyridine": {"doc_hash": "266b32d5069aee2dcddbf6656234aa92e0786cc108238c1db10cef4102851365"}, "ventral diencephalon": {"doc_hash": "4075234a9cc40794c721929d145dd0ce6da3993d14eea778961c311145cea1c7"}, "apoptosis": {"doc_hash": "51b7c108125a5cbc95979b5f37f243aaee36afe4d912f182bbad1d14b2410843"}, "pmid35456967": {"doc_hash": "a216b96e7045fcc6c586a9ca64f85e135be3f56f8b691bdf312dff5ef4cf0bbe"}, "cecal": {"doc_hash": "fa8276d8e114744077ecdbccc2f444cf869fa4c9a889c205e6f29473280c7a99"}, "uncoupling protein 2": {"doc_hash": "36d9a0d85bc21f4caa66a29f6b9f3ed05565fbcbf0a80bbf8acfea82d643e606"}, "cpt1a": {"doc_hash": "e9003786ab3a596afff96211180022677b8155ad2934a1bcabc440e31ae5a74f"}, "lung injury": {"doc_hash": "8492cdb88c99710c31df4b8a012bddb0a74c6749c9e79eb7d56b723f75ee1594"}, "liver and kidney injury": {"doc_hash": "94f6c3cc5542b65ed0af0996ffee9168457b2eedcd4915a203d2815fa4b918b6"}, "5' amp activated protein kinase (ampk)": {"doc_hash": "ec5ad05c0c78a8b9831e2fbbd44bd03709e0dbe45ef2f88cbf6fa7f8a4f22a35"}, "cytokine production": {"doc_hash": "5ee3cafe443aa81f8f5c6601166ef26cb4a4219d6ac4cf53f7ea3c1e772da00a"}, "toll like receptors": {"doc_hash": "6c9cebfd5c3297451197d88dc39ee34aad31916f89935ca1e419a62077e77941"}, "systemic inflammatory response syndrome": {"doc_hash": "e0bac508cc2c57f404a13091c2539b4d1e97c6600851860280cdf6d88d99153b"}, "non esterified fatty acids (nefa)": {"doc_hash": "6b507ef8444713ee08ece0cae622133f5e4c91504cf752cf1d2bc9e2120b7c1a"}, "oa": {"doc_hash": "cc1869233c9ab1a9f2c47fe9d93bbbe15860cf288fd390f4ae79bf5617e68d2e"}, "non esterified fatty acids": {"doc_hash": "245410dbaf195da35911c6a10b3d3eaff2c57f10b26d0da60802385efdc5960a"}, "na+/k+ atpase": {"doc_hash": "680c3e2bf6d3e75e48414923af52d7d09cea8f113b3a065636c376664ec6267c"}, "olive oil": {"doc_hash": "da84c766d0ee2d9e6c0de963a204145424634c6500431a0450c286d9fb661a89"}, "monounsaturated fatty acid": {"doc_hash": "1eb9064143ef4ac5c1cec703117a927a550fdea84ced0ecf4e4c0078c5d8df53"}, "omega 9 oleic acid induces fatty acid": {"doc_hash": "498ce931d968ff1b16023e9310abfe5657baf10c8fc18adcdd9c768e7fb89af1"}, "weight gain": {"doc_hash": "858e3fa060734bd3860ecc643cf3ee4c1ca7f39b201002d85806864d8bae5287"}, "oxidative stress": {"doc_hash": "fa82db9a10005b16a97a5a9a127ef9d6b07bd829d03ae61bf141ee4eee25855b"}, "carnitine palmitoyltransferase ia (cpt1a)": {"doc_hash": "45e9d438c4d6185a0af76862a695babad80caa0c8ddb57b27d79426857eaa225"}, "organ dysfunction": {"doc_hash": "54b71d9d65b7921d8d54692534a72bf26905090b4c9440f7ed43582df2d7ede9"}, "metabolic dysfunction": {"doc_hash": "7d05b6dc6f3a1b29681e25c01dfa8c18b456aa717813f28a9c370f912dca6a03"}, "omega 9 oleic acid": {"doc_hash": "a40680fdc9ac1c6ba89f3a8e850dbbbd0426bc9582f7d272b8836693403b9f46"}, "pmid27078880": {"doc_hash": "5c904ed849f71be34999957c6c613f790160fed62a91f018f7c70999f5130b18"}, "cerebral small vessel disease": {"doc_hash": "d118cf2c6a0a09577889fe3035948d32222108a88c779669636b3434e8914816"}, "cerebellar abnormalities": {"doc_hash": "f0b11496a8d921d40c1883ad6b4e8164ddbaac9af09c741803e1ba5d784a0606"}, "cognitive dysfunction": {"doc_hash": "cd0c343e143268507c60c1f3901d420c42c16a1a85be35b054087abda0aaaaf7"}, "pmid34248601": {"doc_hash": "a130c4b16136ebc33e2325b0e992c443ab8ded1358ed69c6d55bbb316184f316"}, "pp2a": {"doc_hash": "4486760900925bf5006377ca84b154610f97345b1641955bbf3b0dfd07688688"}, "glycogen synthase kinase 3beta": {"doc_hash": "644b8fcd6cc0744fde667c752897851fd4cbc9e4979002e903fd4b01fe747452"}, "protein kinase b": {"doc_hash": "da865a2008c7b6d4844d08f021dbcb5e92281eb4c24607e550306a0b36c0faa1"}, "pp2ac": {"doc_hash": "faf2d8a8883af3e5f59f944332a22faf44b82381fd3ae2f99364ad3d941f0587"}, "pmid19542610": {"doc_hash": "15c643d92dcf67a6796d4d4703ae9b14d52f748e3de43e8db54331c035ffb1ef"}, "microvascular network": {"doc_hash": "48955ec858c0fd51e6716a8b6f9fa045bf13cc6563d102c749497ec1ed8e20cd"}, "mir126 3p": {"doc_hash": "dffa3ad3d8420f43abbcf0cc41e44a4c4abc13ef4c6345c6d8b0bd686e6bd290"}, "mir126": {"doc_hash": "97c0c31633baddbaad1d0fb73823087a43073d975bf86b49fde349218858f73c"}, "melty cpg binding protein 2": {"doc_hash": "d04bcd696c88390e3526bc0d242dc744741a4fdb4416251bc4bf56c4f491325a"}, "etv2": {"doc_hash": "61f8bdf78d61d4b75196ea0d725d68b5c4da6fe617cad60ee6d3965c9f368049"}, "vascular integrity": {"doc_hash": "5ac725a007eee5ccfc080c9c44fa928e4e2f51628def1daf4dd0a71e84afcde1"}, "doxycycline": {"doc_hash": "fbcf27ae5a89b9208d7374ed956d10f773fd0ee896ca10a1de5c6903ed0ff4e2"}, "neurodevelopmental disorder": {"doc_hash": "8a67cd7d11ee06c8264ca097cd5b38763c57996ceb47ed0b1c4580a28d4da821"}, "rett syndrome": {"doc_hash": "d7fef576bf7462a902f79be27eb7e21bdc78b116e82b85c6e047215518de78b4"}, "pmid39415995": {"doc_hash": "44599bac585ca5113625fc90c6bf0cf695a83cd1a686a69ac97326086f0fdcf3"}, "macrophage inflammation": {"doc_hash": "52e31a3050c0883ff80024d5a86ce8f2159394e4b6fca26f63158d0d57929842"}, "nox2": {"doc_hash": "7576417dc1adb9f8d79ce3258b21a3915ba4a3d66f376cf907f0b8148f2bf1de"}, "oxidative signaling": {"doc_hash": "36724c1a5ddaf67d2f9c13ae8830ead88883d14e3331e3117c003bceb72c4744"}, "nadph oxidase": {"doc_hash": "650bac913e93425db60ce01cd1c8cc90a061867251229242afb4872b24abd9df"}, "adiposity": {"doc_hash": "4628425e651c990e89e28edd4ed0197c658b07cf865d982423ad1e7888651fe4"}, "metabolic and neurologic decline": {"doc_hash": "12ffdb9a933ce0b71b37bfc2818d3bc201ca8e890b79ca2d0f7d80abfc95d789"}, "visceral inflammation": {"doc_hash": "d7c2761a8bb69f476d913189c1b67b364732920e545a614db7db2ea2ccb7b4ff"}, "metabolic and physiologic impairment": {"doc_hash": "f4c457aab1da7e0d379f0d67ee09478eef057b9b8c163ef4909736693aad045f"}, "brain injury": {"doc_hash": "ccac67ba7c4e8a64dcc67bab999e7799ec57bb815499733b1b87e99e7e0ceb83"}, "pmid28771483": {"doc_hash": "ff6ae09ff028fcd619e5412e14f90bb21aefe47c930d07aafb4b72477a7d9c1d"}, "swcnt": {"doc_hash": "1666c233a5a2651349096a822a8dfe54e5067250d711ee7378451a6458af8ff4"}, "pegylated": {"doc_hash": "60eecdb0f8ae0b33d56bcb3f8b0555a5da385073f72f01314184badd1a529911"}, "swcnts": {"doc_hash": "a28e1568a630d70e73d27fd8f3c9a48db63a287bc32527ed491efb22a0863a65"}, "carbon nanotubes": {"doc_hash": "aaaa037bff5eb6d62a0d601e19d6f376ca266ada8b4b48522c1d0995932f1c31"}, "polyethylene glycol": {"doc_hash": "7186cc91cf66e3309562942baf85da916d1114fd8ea458befbbac6bc94d3e61a"}, "carbon nanomaterials": {"doc_hash": "853b06d9e85731fbab4726f5795740e566ead6c787377de446b480b648c85604"}, "sulforhodamine b": {"doc_hash": "f315974505c2cee4a51ae0486571e10f6e43c463d7618f89714260b7fad73728"}, "pmid30347680": {"doc_hash": "e5cfb2e803441ea76cd28ff812c4f740ff0027d7672ed69fc30df3504ea6a686"}, "pmid15816783": {"doc_hash": "132587a286432c944f5958a46a340a5c0dc06bff5df574d6801676bbac40eb8a"}, "mood disorders": {"doc_hash": "7483e56388f217b178446d6d5ce81e06d0b86754785a103a9731f9daafd8210b"}, "lithium carbonate": {"doc_hash": "9117e44e26ba54d7a86539223c327a4787fc5369b2abd498285746faf35e17ec"}, "valproate": {"doc_hash": "c75dd257473a4b0d95c10468a73eb5350cde0a62211b5c4ebad406c2d3ed75bf"}, "benztropine": {"doc_hash": "121e0a827c63b9bb076038d9da11fe97c240d219557c28f526143bf4cc42fd87"}, "angina pectoris": {"doc_hash": "e4d40547f92887fd4c8576a872be64adce7125ea03cb551291ddad05910c4c15"}, "cardiac diseases": {"doc_hash": "ad54d25df9ab34f36f082afb6f37ed3052a77754e002b89c581691726abb1094"}, "glaucoma": {"doc_hash": "6074902384e34b3d0d510d33de593f093c5507289d84d67540f8a69f3f4c36a6"}, "cerebrovascular accident": {"doc_hash": "4e3a990329ea58565dff6a62f67e47b89fc563110a9665c676baf4e4ae888129"}, "osteoarthrosis": {"doc_hash": "d3f63522a5afe25159cd1b593e0e26f3eb44439a8b1d3b03bf2bf5bef78f2802"}, "chronic diseases": {"doc_hash": "4ae5165e1062ca77df6b97b2144720c2653e5e81a7038e225a67912ddd3e5358"}, "pmid7477540": {"doc_hash": "eba0d99fab3577e2b7b1a12fd601cecee690d028e3e015b24bd47d3baa8dc090"}, "2beta carbomethoxy 3beta (4 iodophenyl) n (3 fluoropropyl) nortropane": {"doc_hash": "cddcbf40826562b7ce5fb6984dc680dc052e2c69dc7b0c256e94b1b033f0b6c3"}, "dopaminergic degeneration": {"doc_hash": "62dee6994cb33e33ed59531665277f3d4b81e3df1abc4da580d2cfcc331edcae"}, "idiopathic tremor": {"doc_hash": "184c5e0de087f9ce25256594d848e4007ff2b464ef75ff55b4471eb67e868634"}, "iodine 123": {"doc_hash": "fc8714b401ff0b13f971a8190aa39474d0433bee1c5351a661b436a11c73c297"}, "non": {"doc_hash": "f0f6aeea5dfb11e531542cb87ec3d0fb76ed1202915196cbcb92fb679d296c4e"}, "degenerative parkinsonism": {"doc_hash": "4a612e2f94fc74c6c67b271d1e9d70a84133328af73ede8bb10ec0115c2bfc53"}, "123i fp cit": {"doc_hash": "0dd532839ba76dd2ea85499569be23c08b7e796fb3ce2c82341233de5ff1777c"}, "pmid34191214": {"doc_hash": "e9f4a096f54f4c3724b11bf04235264774abcca720223af18104bc3d9a88f73f"}, "pmid30002953": {"doc_hash": "d304dbfb5c29bec330cf09276a99d3ce1e9972c0547dc3f7f30893a0b72c3e85"}, "depressive": {"doc_hash": "edd12a56a083c5143e3b56e15bc67d177f3a40cb462489b22621c7e54e8d7801"}, "bio922": {"doc_hash": "37c736e6d4cef45bde14458f4f4888ff762391d4e2a968819908571a45a69ba5"}, "glua2": {"doc_hash": "a3448c9d054b7ae4995d841e17990db5a7e3d66a759e1ce1df20a136baed307d"}, "pmid24713001": {"doc_hash": "be4370b28b891f42afd1ac5c957b19fdd532ee4c62a74fd87981af51d658eefc"}, "protein interacting with c kinase 1": {"doc_hash": "6e002efd1cdb4886c3e251b3e24cd4adec2520b6722923fc48c0d5646d84dc14"}, "metabolic dysfunctions": {"doc_hash": "e8bf5e0cec153d11144adf239e8972fa0fef128b91dca435f99e568729bc846e"}, "pmid33003412": {"doc_hash": "236bb97a9ffa05770b04d414ea8677d36d572d6b6cc038427c15226967f970bc"}, "glucose intolerance": {"doc_hash": "3b19f0975a6326bf18211649d9dec525ca0c61df8997db98cbd8b4b153d611aa"}, "5xfad": {"doc_hash": "8be6f22add5420d4814a180dc6568ecca0f430295147b48a1c19a91811bc15d1"}, "short chain fatty acid": {"doc_hash": "8982e0f95de06429beb1302f3ce53720d8553fee1f30c22a017c21bd86a9d7b0"}, "butyric acid": {"doc_hash": "eb499a6c4e300347dd59f7734ce1a846d554b628c482689dd2d94f931045c4d4"}, "acetic acid": {"doc_hash": "fd4787e04593d3e78d4ffd92b5375d0e164ded90dec7c3bf508bbb2e1f72ea17"}, "5 ht": {"doc_hash": "0b2589737b61c19bbf0958c19dca21e0204f498d05a0e9ac32a73c3be7c02616"}, "labh": {"doc_hash": "c26458789453842a8f2e1aa10407249d90b330c764189aea357087076fd33ddf"}, "iso butyric acid": {"doc_hash": "75f0decb6c603a33cf63fe99bdc7fb1f7d44b570938fb899debb6f18c556762b"}, "claudin 5": {"doc_hash": "683651ca113d570c2109916ec7683120ddb78df3de311b10f391467b16d75062"}, "propanoic acid": {"doc_hash": "a12ae402e813459df462b7440ea90693db7ac2dc6a0c39a76c87f7dfefa190ec"}, "ampicillin": {"doc_hash": "d2b0041ddff1fcf4fb880625b208490aab8c97a0ee748f2989130a4eb53ea8fc"}, "pmid37189686": {"doc_hash": "14e865a3b4cd694233acf5c6acab5aa8c00ec7f889bd9b8fa6c4fc1fa2a139af"}, "4 mptc": {"doc_hash": "f4b5162d9f14d79a8768daf5e404223f073d3d1c3927732d54e10628f41aeb01"}, "store operated ca2+ entry": {"doc_hash": "d1e13df5ca6fe9d5ff01549b5a4c20d8ee6f96c1ef80c3ba4dcabef2d3793b78"}, "stim1": {"doc_hash": "32d7e1270bd1095650032f1c34119a7deb3c97d417d92caebbee47c829ee7739"}, "stim2": {"doc_hash": "231c4d76c65bdf01df36b7e9409cfbc32d58b6aa91e7c5e34ad5506c6324a695"}, "pmid33959394": {"doc_hash": "c55438670bdf75a5806d2d07b0f9e0dd4d9b1d11ecd78a5e0ed00660b7cfcbc4"}, "mes": {"doc_hash": "bcbf790e8d484216b57ee43bf5b85ba504644bda1b6d6e427fac50260ba53073"}, "pyrido pentapeptide": {"doc_hash": "f1e833049ede6c961ec5b27a880249692bb4d3081f93fdb6d88ef8ab614c8505"}, "agcl": {"doc_hash": "393e052912e655ca1d04ab08bbe2e0270fdf20068767c82e64c4c8da181e91c3"}, "cu2+": {"doc_hash": "be0c5f6895172b07b9f3a713d551b8210f31bdc3261290e4441167dadf481b84"}, "copper(ii)": {"doc_hash": "3613c7a7dabf049618b226db2b383a895042ace0d25d5d0eac55ee821cf8cb71"}, "pmid35480650": {"doc_hash": "93116b43ea70d54be454993d1c46ed6ea282dc706de4faa0c32b9baa2e6a8477"}, "pmid31822300": {"doc_hash": "411418fb89d8c99330b4735c2ace4a6afdd1487909a9ab7f23b71ec601765bd7"}, "transthyretin": {"doc_hash": "96ad67a85401ff9b97198eb98f3c4e26640ba85eda100241e01b8000db95f696"}, "pmid34445655": {"doc_hash": "49f4f589fe20751325845d54bb281c172b9488612385ffa48a901742dc59414a"}, "end stage cancer": {"doc_hash": "b8424920736bf12ef1f652b2403dfea54bc1fa27770638cde42987f2968ebcf7"}, "pmid30380977": {"doc_hash": "8a6ec9b2da3a262ca628bffd6691f7a39c8de97dfc6a33568d1da8f618fa3d6d"}, "chlorpromazine": {"doc_hash": "163defc0cb72e6ea0b32a9fbb8d1f9823968e7a9bf03353eeb3796e9b5b05181"}, "insomnia": {"doc_hash": "32c3c3491cc5323fc9a1c3656051303c22eb4087a30f429b9a1733c3c4cd709a"}, "gabexate": {"doc_hash": "5d2eab8fc90dd56a6d5f939d60c44d8cf11b0f47fe65c90232a262b1c4d88b4d"}, "amidine": {"doc_hash": "93fc7b4a2d1a1f99b89fe136c92952a874e486383f5a2293dc0783a18da38603"}, "camostat": {"doc_hash": "40dec52161e1724446062ad60c5059c7b15145192c38f49b9c4e878ad98ea080"}, "nafamostat": {"doc_hash": "a59cfbfee5b50063a61c6a354792f0ac10a2a3905877b0edc4495a792b4d5ddd"}, "diminazene": {"doc_hash": "0e64b2131459176daf538312a30c8efc40ae92d3535f3636b710a9de5ad3471e"}, "cp": {"doc_hash": "cf7e28ff14264753cd797356949b92f4b3f77718506325d30093b90d50f9bc09"}, "sepimostat": {"doc_hash": "3281648a1c52ec52b0c0e191abd873f888bd1360c66f7c253b45ca1e358034a2"}, "serine protease": {"doc_hash": "237d9bbf0009d1af39d3b29d1931e001aaea4db9044adea906e3a3b207cca892"}, "pmid39444609": {"doc_hash": "83ee6b86def9e962c3fd21e2592473b2aa6e69f425405c5c0b6d3e64e1979a17"}, "yoda1": {"doc_hash": "35f88e457780d383f1bd107368a64d8b53670a3b61e9102f5d67ff8c9c63712f"}, "piezo1": {"doc_hash": "11773ad18428a0213b0f11e8e83f9b06fb76d7fa9a4244872890c631727f15c4"}, "gsmtx4": {"doc_hash": "7a4d2308012bac2aa7ca0905c9c8c337e093ecb4bfa4de6bc6c2ca21a11ef00d"}, "mouse cerebellum": {"doc_hash": "659d049f463d3b3db2b8abd42055668bcef1927a01b26f8368d9c4eef8c552a2"}, "neuronal illnesses": {"doc_hash": "45bd31272c0a7623f1d866b0510a0c8fdcccc17aac378b167ae65d6b4431b8b6"}, "pmid37305437": {"doc_hash": "142bd0cd385b06b72059a3e8ea2c401a97019f13f9ba5afd4ae1c8ea87141a09"}, "chitinase 3 like protein 1": {"doc_hash": "58868d376a886fe8902bbce3d32e4bb5d1a96e0d6e4a3328fdc4324f24afbee5"}, "pmid30617377": {"doc_hash": "53e537a696207d488f108a2e58e5e71d54d2d699b2eb90b5a56dc94f84bde9b5"}, "huntington's": {"doc_hash": "c9f4ddfd5f08dc7aa8561f3c6d750575ba241f17d01357d42f5107514670121d"}, "pmid21683788": {"doc_hash": "805ad3a12602208edf712a7520f95eb0872de46aa018528de13a8fbf5c354cd2"}, "tissue plasminogen activator": {"doc_hash": "950f0f93e5404a538dfd3d6bb4d7b2370545136a729e75f1f1b04f90320ff673"}, "tissue plasminogen activator (tpa)": {"doc_hash": "877bd8f0671ecfe7a82b4a6e67a97d0d2e337e7b55fbf23b4a53587af83e0cea"}, "amyloid accumulation": {"doc_hash": "5dae4f00c724cd8509bd4d291c53fefd480748654e68f3e6eea82710089ccb02"}, "nmda receptors (nmdars)": {"doc_hash": "c3d77ca7b566568569639a379d219aa084721ebba7fbb4b62ee340f2b4b38ed6"}, "nmdar": {"doc_hash": "9ee9f4ced4a6fa330947767e289693c3143192940ed733e1a1bcd41366e14a8a"}, "acetylcholine": {"doc_hash": "8ac18b1dc139c85154afae0c089f300c8ef05097e6b907115e4dbd7fd4f02c0e"}, "plasminogen inhibitor 1": {"doc_hash": "28b51c2a26b7a8c3859a2b3c50226873e17f62835d496e10af98564aecf40ff7"}, "vascular amyloid deposition": {"doc_hash": "3eb87bd5bf6778c4ed7002d8a2d966c90728478a8cfb8a5a898732f1e4fd4940"}, "amyloid beta (abeta)": {"doc_hash": "f5b63e46c908999d33d7917f78b6fad7c1884ac62a2f5fd1a1cec7b40a416668"}, "functional hyperemia": {"doc_hash": "024f86306d94c2118fd27f7fccf6a664185623c0769c4dbbea34b86506348ba8"}, "plasminogen inhibitor 1 (pai 1)": {"doc_hash": "2826f5dec305414a0841c532de8bca4a61bc2f9cb43a99bf2148c78abf592a6d"}, "neurovascular coupling dysfunction": {"doc_hash": "00face2cdd522cdfd2e9d4bcf73272f8abf0936f0a15ff90c653a3640f950540"}, "cerebral": {"doc_hash": "83f6d27b07f6de72a282f20e29e2cc2221b45467538193aa17c5b52c7096a321"}, "pmid32928888": {"doc_hash": "61b57dbb253345034718af2f303820ded9f2b43d624ee624b92d0e56fb425c4d"}, "pmid25515653": {"doc_hash": "43761fee4329800afc98ab974f90006f40dc3d2a6d81fc558b06244ba405f4e7"}, "amnestic mild cognitive impairment": {"doc_hash": "2114759f21736e898c0b7d57e5a5dfabdfeabfa17e632fa5d07b3d6aa5965fb5"}, "pmid28465867": {"doc_hash": "09dc7b504a8d54030aa1b45b942d5a64883c01e0b1f770a82f911a568a237e09"}, "neurologic symptoms": {"doc_hash": "dae34745276c33b2fdb8515690d633bfb2b4cbe5a1ab967379e9533a52d78bc3"}, "behavioral problems": {"doc_hash": "e4b285a84331b98460f06d05a3b09545514dd7e7932d0ab5c77a763616e3de7f"}, "donepezil": {"doc_hash": "80aa0afb0a81c4335436c48d9c4e92b2eb9398165fd327a37fa8fbeb5719ec6e"}, "pmid24436135": {"doc_hash": "f7d86a2a6bf6c9abd1b733c2372d0eef71dc263050991377982f6c041764c6e9"}, "tnf alpha": {"doc_hash": "2bf9e8ebb823ebf5e70b143a7f19bc6f3bb305561e319c3c01868a25b093d3ec"}, "il 10": {"doc_hash": "ceb24f64e14cdcc8ed8034b2bcd2ac672aa11975fab810f76eefc599c7eec2b0"}, "brain dysfunction": {"doc_hash": "038635e21d8f35817f51b9d56e6afd3ca340bc07aff1c78c4d066590b1234487"}, "il 8": {"doc_hash": "72e81a2701902e7cb318936a4d5c7ac0e8702ef21413575dda714e542a4957b3"}, "pmid30027347": {"doc_hash": "e4d3c3f6e59384ab66ef48ce0279cb15086e9a457bbc4f9ed3b63440727162b8"}, "visceral pain": {"doc_hash": "3ece6e8132f7513d453278c1027a04fb088255becf14dcc88ef74fd9a2700632"}, "atrophy": {"doc_hash": "ce4e7038f2f387b314cdca2baa5def4ae12a9733b01642c10d64c7fe909359ad"}, "ifn gamma": {"doc_hash": "ab5c990c10e58b68fd0fb90c5540ee1a229448968f13047346c13ccb3cb479fb"}, "neurodegenerative and neuropsychiatric disorders": {"doc_hash": "7689e6b336626c13d15df0a14a57f47f513e313bdfb814f037e741ccfbe6b88a"}, "memory impairments": {"doc_hash": "719bd40b7a20a2430fded90eaf2409000e937c8d9fca09f30a7a4a307773d416"}, "pmid35705176": {"doc_hash": "15fc2964e6cce4768672e773c6d16e8411fc2eca80cd0b9876ce51ed0ce4521b"}, "infections": {"doc_hash": "b43f6ae1689b81685de31cc097f32c16f71095f20c37d284328b61c413fb9aad"}, "acute b cell lymphoblastic leukemia": {"doc_hash": "d2826b27a512b504a2ccab40a0eda6f36a4d53d1f373cf56a0cc9666fb048983"}, "cd19": {"doc_hash": "df40ad42c5fbdc7104a60458774d6754d1dc795c33b37059e44b529c392ad7c8"}, "hematological toxicity": {"doc_hash": "c6d6f7b7032f01dd8aa96bc08a38c9c1b43d0c6d5d111e1ff5c36815ce3f31b2"}, "hyperinflammatory syndrome": {"doc_hash": "59291065f14d5cedd2ea2c8ffe6011bead68a77590d43f9d4899a0024acbdbcd"}, "b cell malignancies": {"doc_hash": "3bd36bc05b63a2d00cd51991f9f3d1d0ce8fb7e3b41c0dfee1d6f497375da881"}, "immune effector cell associated neurotoxicity syndrome": {"doc_hash": "8da74c28724c55299f4d1a1889298f7337ab9bcbab91cd39b2e76bf4bfb54b85"}, "pmid36891576": {"doc_hash": "178e3baf8ab01b27a7558f36f587d669a11956dd75beca5b460e46e58a53a37f"}, "kynurenic acid": {"doc_hash": "05a9c2b38d8f767d57c7f1f059d7019a5efa0d8417f08f602d4ff470c62783e8"}, "kynurenine pathway": {"doc_hash": "d11e902a9364e26a7bb24a9478c6d575704fa4d67c378c49532658457a9094ed"}, "quinolinic acid": {"doc_hash": "4e6a57e199d990cc3bacf0d3ba37c135bc0d09dbc7e6fc02f98960b271db5678"}, "kynurenine": {"doc_hash": "084449a2638303f65ed78af4486e1029a9c3af80e0d42450206b17ef5b44b61c"}, "indoleamine 2,3 dioxygenase": {"doc_hash": "f4a39641655df5564c5bc59d3bd3897613e04da0aa4ad0a741ee2113b77cda3c"}, "hypoactive delirium": {"doc_hash": "a77739a07c985a591065bae6989749dc890562fc2c4f10f7aff852b34cce9d1b"}, "pmid36982655": {"doc_hash": "3668315e63d3c6ebe2b19122570c573666ba68bddaa3d627f3da20764b5088d0"}, "neurofilament light chain": {"doc_hash": "c374a73af75e84714e49953d43470699dde76745d754878dfeb3a63499a75cdc"}, "pmid36409557": {"doc_hash": "db13412ae0ce7420720ac9bfec0c529f80c1d29ab1b44c777cee3bd477b95689"}, "hip fracture": {"doc_hash": "4cb287d2ed854b5401ed9a66f6d946119f75460404c1428da12ad0a87a5f8d3c"}, "pmid36647830": {"doc_hash": "c8612bd731ecc7ea2f933465944427c6d87d4f9630e7a5a92c64689c185228c1"}, "tryptophan 2,3 dioxygenase": {"doc_hash": "abf3b497d159d8bbaf92580280919f15e61a781eb1b19300e988d2cefd7cc2cd"}, "neurodegenerative cognitive impairment": {"doc_hash": "347e3535ce2bb4977905125bbef279e1400d9df842bdccb3b78fa18059653df3"}, "gliomas": {"doc_hash": "27e8c048795fd863130b4d0c536fa46f7a3cbe71d9f9e770f58ef383a7493873"}, "neurodegenerative conditions": {"doc_hash": "777ca0469992560e03a28bb857be0b4a4d921c034d2d632e6155e4491d1a559d"}, "trp 2,3 dioxygenase": {"doc_hash": "4781b1a17c563a961fc89bd27daee2425c74914f187d7c81e62745c2088cdebc"}, "pmid28469468": {"doc_hash": "ce81ef68765eb0e9f54a8a5a6794530073dbd2cee88da1fec3273ea680dd8544"}, "pmid7145182": {"doc_hash": "24bea56ccd18abf907c0c135bcb4c338cafcc7541e9005781a7534989b9f4a1e"}, "hypopotassemia": {"doc_hash": "a9ff13ad52003b870858c9b5b65311d134b7a236ffcc4dd74f33b432e9ffd20c"}, "alcohol withdrawal syndrome": {"doc_hash": "c7492d26cc0a376d71c8361a42366d8d5e22a04be13e3f29c333739b8aacd81f"}, "delirium tremens": {"doc_hash": "a1c70df68f8454edae3239f34cae052d56c27b44208d7f1f3604a98be44102ab"}}}